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Abstract 
Streptococcus pneumoniae is a normal inhabitant of the human 
nasopharynx, but it is better known for its role in a plethora of human diseases. 
Growing emergence of antibiotic-resistant streptococci and non-type vaccine 
strains increases the urgency of finding new targets for the development of novel 
therapeutic and preventive drugs. As a major concern for global public health,  
S. pneumoniae has always attracted great attention from the scientific community, 
which has translated into knowledge on pathogenesis and virulence and the 
development of a considerable “toolbox” for genetic manipulation and genomic 
analysis, as well as a large number of deciphered genome sequences. 
Interestingly, genome-wide studies have consistently pinpointed genes involved in 
carbohydrate uptake and metabolism as essential for the virulence of  
S. pneumoniae. These global studies offered the opportunity to investigate in 
greater depth the potential connections between basic physiology, and in 
particular central metabolism, and pneumococcal virulence and pathogenesis. 
The general goal of this thesis is to achieve a deeper understanding of the 
molecular mechanisms underlying sugar metabolism and their relation to 
virulence factors in S. pneumoniae, with a special focus on capsule production. In 
the present work, glucose (Glc) and galactose (Gal) were used as carbon sources 
for the study of pneumococcal sugar metabolism. This choice was made for two 
reasons: Firstly, Glc is a common preferred sugar and is also found as a major 
carbon source in niches potentially occupied by S. pneumoniae during host 
inflammation or hyperglycaemia. Secondly, Gal, generally a slowly metabolized 
non-preferred sugar, is a major carbohydrate in the human nasopharynx, the  
non-pathological colonization niche of S. pneumoniae.  
 x 
The study of complex regulatory mechanisms such as those involved in 
sugar metabolism is largely facilitated by the use of well-defined conditions.  We 
developed a chemically defined medium and growth conditions for high yield 
streptococcal growth, applicable to in vivo NMR studies. Time series data on 
metabolite pools have been obtained in vivo by 13C- and 31P- NMR, during Glc 
metabolism of S. pneumoniae. The major end-product formed from the 
metabolism of [1-13C]Glc by resting cells of S. pneumoniae acapsular strain R6 
was lactate (about 35 mM). Fructose 1,6-bisphosphate (FBP) was the only 
glycolytic intermediate detected. The pool of FBP increased at the expense of 
Glc, reached a steady concentration and decreased to undetectable levels before 
Glc exhaustion. In 31P-NMR experiments, upon Glc addition, the levels of 
inorganic phosphate (Pi) decreased, accompanying the consumption of Glc, and 
the levels of NTP reached very small values (circa 2 mM). Moreover, during the 
optimization of growth conditions for S. pneumoniae, an extensive comparative 
metabolic characterization between strains D39 and its non-encapsulated 
derivative R6 was obtained under different environmental and nutritional 
conditions. The effect of oxygen, Glc and nucleobases on the physiology of 
growth of these strains was studied under controlled conditions of pH, 
temperature and gas atmosphere (anaerobic, semi-aerobic or aerobic) in 2-l 
bioreactors. Independently of the growth conditions tested, both strains displayed 
a typical homolactic behavior. However, the growth rates of D39 and R6 were 
stimulated under semi-aerobic and strictly anaerobic conditions, respectively. This 
difference was mainly attributed to lower activity of pyruvate oxidase in strain D39, 
in the presence of oxygen. It was notable that the maximal biomass reached by 
strain D39 was substantially enhanced by supplementation of the culture medium 
with extra uracil, whereas in strain R6 no effect was observed, suggesting a link 
between uracil and capsule production.  
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The synthesis of the NDP-sugars, precursors of D39 capsule, requires 
UTP and dTTP. UTP is formed from UMP in the salvage pathway of pyrimidine 
biosynthesis. UMP may also be synthesized de novo from amino acids and CO2 
or via the salvage pathway using external pyrimidine nucleobases (e.g. uracil) or 
nucleosides. A remarkable adaptation of S. pneumoniae to fluctuating 
environmental conditions in the human host consists in the switch between 
opaque and transparent phenotypes, distinguished by different capsule amounts. 
In this work, the role of uracil on capsule expression and production was 
assessed by studying D39 and a spontaneous non-reversible D39 mutant 
displaying an underproducing capsule phenotype. A comparative transcriptome 
analysis between these strains in medium with and without uracil suggested a 
connection between pyrimidine metabolism and capsule production. In medium 
lacking uracil, strain D39 exhibited a long lag phase, decreased growth rate and 
higher biomass than in the presence of the nucleobase. In accordance, capsule 
promoter activity and capsule amounts were decreased under uracil-deprived 
conditions in strain D39. In contrast, uracil showed no effect on the mutant strain. 
Growth and CFU analysis of co-cultures of both strains in medium without uracil 
clearly showed a prevalence of the mutant strain at mid-exponential phase of 
growth, independently of the initial cell concentrations used for inoculation. Thus, 
we propose that sensing uracil is a potential mechanism by which S. pneumoniae 
alters capsule production.  
Other than uracil, oxygen variability in host niches may also trigger the 
capsular phenotype switch in S. pneumoniae. Pyruvate oxidase (SpxB) is an 
oxygen-consuming enzyme involved in the aerobic metabolism of S. pneumoniae. 
SpxB converts pyruvate, the end-product of glycolysis, O2 and Pi into CO2, H2O2 
and acetyl-phosphate. We show that inactivation of spxB in D39 leads to 
increased production of capsule amounts in medium with Glc. This increase was 
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partially mediated by induction of cps2A, the first gene of the capsule locus. In 
addition, the spxB mutation increased the expression of two putative operons 
involved in carbohydrate uptake and processing, leading to altered sugar 
utilization capabilities of D39, as shown by a combination of metabolite profiling 
analysis and growth experiments. In environments with oxygen and Glc as major 
carbon source, SpxB activity presumably minimizes the use of alternative sugar 
utilization pathways and the amount of capsule, hence improving the fitness of  
S. pneumoniae.   
Besides SpxB, pyruvate formate-lyase (PFL) is also a competing activity 
for the glycolytic end-product, pyruvate. This oxygen-sensitive enzyme is involved 
in mixed-acid fermentation and requires post-translational activation by the 
pyruvate formate-lyase activating enzyme (PFL-AE). PFL activity is associated 
with formation of formate and acetyl-CoA. The sequenced genome of D39 
possesses two copies of pfl and pfl-ae. Mutant strains disrupted in these genes 
were created, and their Glc and Gal metabolism was analyzed. In the presence of 
Glc, all strains, including D39, exhibited homolactic fermentation. However, in Gal, 
strain D39 produced formate, acetate and ethanol in a 2:1:1 ratio, denoting 
activity of PFL, but no formate production was observed by mutants defective in 
spd_0420 and spd_1774, indicating that spd_0420 codes for PFL and spd_1774 
for PFL-AE. The spd_0420 and spd_1774 mutants showed impaired colonization 
and infection in mouse studies, indicating a direct link between pneumococcal 
fermentative metabolism and virulence. 
 S. pneumoniae has to adapt to changing carbon sources in the fluctuating 
environments of the human host. Pathways metabolizing sugars other than the 
preferred one are silenced through mechanisms of catabolite repression. A global 
regulator involved in this process in several Gram-positive bacteria is CcpA. In  
S. pneumoniae, a systemic appraisal of the role of CcpA in the physiology of this 
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bacterium was missing. We clearly demonstrate that CcpA is a global regulator, 
affecting the expression of up to 19% of the genome, covering multiple cellular 
functions. Remarkably, CcpA was not only a major repressor in response to Glc, 
but also to Gal. Additionally, we show that Leloir and tagatose 6-phosphate 
pathways for Gal metabolism are functionally active, despite repression of the 
Leloir genes by CcpA. Of surprise was the shift from mixed-acid towards a more 
homolactic fermentation in the ccpA mutant during growth on Gal, as genes 
involved in mixed-acid fermentation were mostly under CcpA repression. This 
result indicates regulation at other cellular layers, which is further supported by 
dissimilar accumulation in the ccpA and parent strain of intracellular metabolites 
potentially involved in metabolic regulation. Interestingly, capsule amounts were 
higher in response to Gal than to Glc, regardless of CcpA. Overall, the whole-
genome transcriptome analyses provided solid evidence that S. pneumoniae 
optimizes basic metabolic processes in a CcpA-mediated manner. This view is 
further corroborated by the metabolic profiles obtained under the conditions 
studied. Moreover, integration of transcriptional and metabolic data revealed a link 
between CcpA and the association of surface molecules (capsule and 
phosphorylcholine) recognized as virulence factors, to the cell wall. This finding 
indicates an important role of CcpA in modulating the interaction of  
S. pneumoniae with its host.   
Overall, the work presented in this thesis represents an important step 
towards the understanding of basic metabolic processes and, in particular, sugar 
metabolism, in S. pneumoniae. We believe that the insights gained from this study 
will help to better comprehend the role of metabolism in the interaction between 
S. pneumoniae and its host. In this light, the work here described makes a unique 
bridge between the often disconnected fields of fundamental physiology, and 
virulence and infection. 
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Resumo 
A bactéria Streptococcus pneumoniae é uma habitante normal da 
nasofaringe humana, conhecida principalmente por ser a causa de várias 
doenças humanas. Em ambientes hospitalares bem como na comunidade, o 
aparecimento galopante de estreptococos resistentes a antibióticos bem como de 
estirpes não integradas no programa de vacinação incentiva novos estudos com 
o objectivo de identificar alvos para o desenvolvimento de novas drogas 
terapêuticas ou preventivas. Dado o seu impacto ao nível de saúde pública 
mundial, S. pneumoniae tem atraído desde sempre a atenção da comunidade 
científica. Este grande interesse permitiu grandes avanços no conhecimento da 
patogenicidade e virulência deste organismo, e levou ao desenvolvimento de 
muitas ferramentas de manipulação genética e análise genómica e à 
descodificação de um número elevado de sequências genómicas. Em estudos de 
análise pangenómica, genes envolvidos no transporte e metabolismo de hidratos 
de carbono foram consistentemente identificados como sendo essenciais para a 
virulência de S. pneumoniae. Estes estudos globais ofereceram a oportunidade 
de investigar em profundidade uma ligação potencial de processos metabólicos 
básicos, em particular envolvidos no metabolismo central, com a virulência e 
patogenicidade de pneumococos. Assim sendo, este trabalho de tese tem por 
objectivo geral elucidar fundamentos necessários para a compreensão de 
mecanismos moleculares relacionados com o metabolismo de açúcares e sua 
ligação a factores de virulência de S. pneumoniae, em especial a cápsula. As 
hexoses glucose (Glc) e galactose (Gal) foram seleccionadas como fontes de 
carbono para o estudo do metabolismo de açúcares. Esta escolha baseou-se no 
seguinte: i), a Glc é o açúcar preferido por excelência e é a principal fonte de 
carbono encontrada em nichos potencialmente ocupados por S. pneumoniae 
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durante estados inflamatórios ou de hiperglicémia; ii), a Gal, geralmente um 
açúcar não preferido e de metabolismo lento, é um dos hidratos de carbono em 
maior quantidade na nasofaringe humana, o nicho de colonização de S. 
pneumoniae. 
O estudo de mecanismos de regulação complexos, como os envolvidos 
em metabolismo de açúcares, é grandemente facilitado pelo uso de condições 
bem definidas. Neste trabalho, foram desenvolvidos um meio quimicamente 
definido e condições de crescimento para produção de biomassa elevada de 
estreptococos, aplicável também a estudos de NMR in vivo. Pela primeira vez, as 
concentrações de metabolitos formados e consumidos ao longo do tempo, 
durante o metabolismo de Glc em S. pneumoniae, foram obtidas in vivo 
recorrendo a NMR de 13C e 31P. O produto final maioritário do metabolismo de  
[1-13C]Glc pelas células R6 em repouso foi o lactato (cerca de 35 mM). A frutose 
1,6-bisfosfato (FBP) foi o único intermediário glicolítico detectado. Os níveis de 
FBP aumentaram à custa do consumo de Glc, atingiram uma concentração 
estacionária e decresceram para níveis não detectáveis antes da exaustão de 
Glc. Nas experiências de 31P-NMR, após a adição de Glc, os níveis de fosfato 
inorgânico (Pi) decresceram, acompanhando o consumo de Glc, e os níveis de 
NTP atingiram valores muito baixos (cerca de 2 mM). Além disso, durante a 
optimização das condições para crescimento de S. pneumoniae, uma 
caracterização metabólica comparativa entre as estirpes D39 e a sua derivada 
não encapsulada R6 foi obtida em diferentes ambientes manipulados. O efeito do 
oxigénio, Glc e nucleobases na fisiologia do crescimento destas estirpes foi 
estudado em condições controladas de pH, temperatura e atmosfera gasosa 
(anaeróbica, semi-aeróbica e aeróbica), em reactores de 2-l. Independentemente 
das condições de crescimento testadas, ambas as estirpes exibiram um 
comportamento tipicamente homoláctico. Contudo, as taxas de crescimento das 
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estirpes D39 e R6 foram estimuladas em condições semi-aeróbicas e 
estritamente anaeróbicas, respectivamente. Esta diferença foi atribuída 
essencialmente à baixa actividade de piruvato oxidase na primeira estirpe, na 
presença de oxigénio. Curiosamente, a biomassa máxima atingida pela estirpe 
D39 foi substancialmente melhorada suplementando o meio de cultura com 
uracilo adicional, enquanto na estirpe R6 nenhum efeito foi observado, indicando 
uma ligação entre a quantidade de uracilo e produção de cápsula.  
 A síntese dos açúcares ligados quimicamente a NDP, precursores da 
cápsula da estirpe D39, requer UTP e dTTP. O UTP é sintetizado a partir de UMP 
na via de salvamento de síntese de pirimidinas. O UMP pode ser sintetizado de 
novo a partir de aminoácidos e CO2 ou na via de salvamento das nucleobases  
(e.g. uracilo) ou nucleósidos de pirimidinas exógenas. Um mecanismo notável de 
adaptação do S. pneumoniae a condições ambientais inconstantes no hospedeiro 
humano consiste na permuta entre fenótipos opaco e transparente, que se 
distinguem pela quantidade diferente de cápsula exibida. Neste trabalho, o papel 
do uracilo na expressão e produção de cápsula foi demonstrado usando D39 e 
um mutante não reversível da D39 exibindo características associadas à baixa 
produção de cápsula. Uma análise de transcriptómica comparativa entre estas 
estirpes em meio com e sem uracilo sugeriu uma ligação entre o metabolismo de 
pirimidinas e produção de cápsula. Em meio sem uracilo, a estirpe D39 exibiu 
uma fase de adaptação (lag) longa, taxa de crescimento reduzida e biomassa 
mais elevada do que em meio contendo a nucleobase. Em conformidade, a 
actividade do promotor do operão que codifica para a cápsula bem como a 
quantidade de cápsula decresceram em meio sem uracilo na estirpe D39. Em 
contraste, o uracilo não teve qualquer efeito na estirpe mutante. O crescimento e 
análise de CFUs de co-culturas de ambas as estirpes mostrou claramente a 
predominância da estirpe mutante em fase exponencial de crescimento, em meio 
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sem uracilo, independentemente das concentrações iniciais de células usadas 
para inoculação das co-culturas. Posto isto, propomos que a detecção de 
quantidades variáveis de uracilo no ambiente constitui um mecanismo pelo qual o 
S. pneumoniae poderá alterar a produção de cápsula.          
Para além do uracilo, o oxigénio poderá também desencadear a permuta 
dos fenótipos relacionados com diferentes quantidades de cápsula em  
S. pneumoniae. A piruvato oxidase (SpxB) é uma enzima consumidora de 
oxigénio envolvida no metabolismo aeróbio de S. pneumoniae. A SpxB converte 
piruvato, o produto final da glicólise, O2 e Pi em CO2, H2O2 e acetil-fosfato. Neste 
trabalho, mostramos que a inactivação de spxB em D39 leva a um aumento na 
quantidade de cápsula produzida em meio com Glc. Este aumento foi 
parcialmente mediado pela indução de cps2A, o primeiro gene do locus capsular. 
Adicionalmente, a mutação da spxB aumentou a expressão de dois operões 
putativamente envolvidos no transporte e processamento de hidratos de carbono, 
levando a uma alteração da capacidade de utilização de açúcares na estirpe 
D39, como indicado pela combinação de análise de perfis de metabolitos e 
experiências de crescimento. Em ambientes com oxigénio e Glc como principal 
fonte de carbono, a actividade de SpxB minimiza presumivelmente o uso de vias 
alternativas de utilização de açúcares e a quantidade de cápsula, melhorando 
assim a aptidão fisiológica de S. pneumoniae.   
 Para além da SpxB, a piruvato formato-liase (PFL) também compete por 
piruvato. Esta enzima sensível ao oxigénio, está envolvida na fermentação a 
ácidos mistos e sofre activação pós-traducional pela enzima activadora da 
piruvato formato-liase (PFL-AE). A actividade de PFL está associada à formação 
de formato e acetil-coenzima A. O genoma de D39 apresenta duas cópias de pfl 
e pfl-ae. Neste trabalho, estirpes mutantes inactivadas nestes genes foram 
construídas e o metabolismo de Glc e Gal foi analisado. Em Glc, todas as 
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estirpes, incluindo a D39, exibiram fermentação homoláctica. Em Gal, a estirpe 
D39 produziu formato, acetato e etanol na razão 2:1:1, indicando actividade de 
PFL, mas não se observou formação de formato nos mutantes com inactivação 
dos genes spd_0420 e spd_1774, indicando que spd_0420 codifica para a PFL e 
spd_1774 para a PFL-AE. Os mutantes spd_0420 e spd_1774 mostraram 
deficiências na colonização e infecção de ratos, indicando uma ligação directa 
entre o metabolismo fermentativo de pneumococos e patogenicidade. 
Nos ambientes inconstantes do hospedeiro humano S. pneumoniae é 
forçado a adaptar-se a variações na acessibilidade de fontes de carbono. As vias 
envolvidas no metabolismo de açúcares, que não o preferido, são silenciadas 
através de mecanismos de repressão catabólica. Um regulador global envolvido 
neste processo em várias bactérias é a CcpA. Em S. pneumoniae, uma avaliação 
sistémica do papel da CcpA na fisiologia desta bactéria não existia. Neste 
trabalho, mostrou-se claramente que a CcpA é um regulador global que afecta a 
expressão de cerca de 19% do genoma, abrangendo inúmeros processos 
celulares. Curiosamente, o papel repressor da CcpA não foi observado apenas 
em Glc, mas também em Gal. Adicionalmente, mostrou-se que as vias Leloir e 
tagatose 6-fosfato envolvidas no metabolismo de Gal estão funcionalmente 
activas, apesar da CcpA reprimir os genes da via de Leloir. Considerando que os 
genes envolvidos na fermentação a ácidos mistos estão sob repressão pela 
CcpA, o desvio do metabolismo de Gal de ácidos mistos para fermentação 
homoláctica no mutante da ccpA foi claramente surpreendente. Esta observação 
indica regulação ao nível de outras camadas celulares, e é fortemente 
corroborada pelos diferentes conteúdos intracelulares no mutante e na estirpe 
parental potencialmente envolvidos em regulação metabólica. Notavelmente, os 
níveis de cápsula foram maiores em Gal do que em Glc, independentemente da 
presença da CcpA. Em geral, as análises globais de transcriptómica 
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providenciaram evidência sólida de que S. pneumoniae optimiza processos 
metabólicos básicos através da CcpA. Esta observação é corroborada pelos 
perfis metabólicos obtidos nas condições estudadas. Mais ainda, a integração 
dos dados de transcriptómica e de metabolismo revelaram uma ligação entre a 
CcpA e a associação de moléculas da superfície celular (cápsula e fosforilcolina), 
reconhecidas como factores de virulência, com a parede celular. Desta forma, a 
CcpA pode ter um papel preponderante nas interações hospedeiro-micróbio.  
 Em suma, o trabalho apresentado nesta tese representa um passo 
importante para a compreensão de processos metabólicos básicos e, em 
particular, metabolismo de açúcares, em S. pneumoniae. Estamos convictos que 
os conhecimentos adquiridos neste estudo contribuirão para um conhecimento 
mais profundo do papel do metabolismo na interacção entre S. pneumoniae e o 
hospedeiro. O trabalho aqui descrito estabelece uma ponte única entre duas 
áreas, muitas vezes desconectadas, ou sejam, a fisiologia fundamental e 
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 Diseases caused by Streptococcus pneumoniae constitute a major global 
health problem. The ever-increasing emergence of antibiotic resistant strains 
exacerbates the need to find new targets for the development of effective 
therapeutic and prophylactic drugs. The work in this thesis aimed at gaining 
further knowledge on central metabolism and its connections to virulence in  
S. pneumoniae. 
 Chapter 1 starts with an introduction to the pneumococcus and its 
virulence factors. Next, an overview of carbohydrate metabolism, including 
capsule synthesis in the pneumococcus, is presented. Finally, a detailed 
description of the current knowledge concerning regulation of sugar metabolism in 
Streptococcaceae and links between basic physiology in S. pneumoniae and 
virulence is provided.   
Chapter 2 describes the development of a culture medium and growth 
conditions for high yield pneumococcal growth, that enable the application of  in 
vivo NMR techniques to study metabolism in S. pneumoniae. During this 
optimization a comparative metabolic characterization between the model strain 
D39 and its unencapsulated derivative R6 was performed.  
In Chapter 3, the effect of uracil in the physiology of growth and capsule 
expression/production of D39 and D39SM, a spontaneous mutant displaying 
characteristics of underproducing capsule phenotype, was analyzed. Additionally, 
a genome wide transcriptional response of both strains to uracil and uracil 
limitation was studied by using DNA microarrays. 
In Chapter 4, the transcriptional response of S. pneumoniae to spxB, 
encoding pyruvate oxidase, deletion was examined. The effect of this mutation in 
the profile of intracellular metabolites, end-products accumulation and capsule 
 xxiv 
amount was determined by resorting to 31P-NMR, HPLC and capsule 
quantification, respectively. The effect of the spxB knock-out on the utilization of a 
number of sugars was also studied.  
The identification of S. pneumoniae pyruvate formate-lyase (PFL) and the 
PFL activating enzyme (PFL-AE) is described in Chapter 5. Deletion of putative 
genes coding for these proteins was performed and functional assignment was 
determined by measuring the fermentation products of the mutant strains during 
metabolism of Glc and Gal. 
Chapter 6 describes the carbon catabolite protein A (CcpA) regulon on Glc 
and Gal and the impact of this transcriptional regulator on the expression of 
virulence factors. In this work CcpA is demonstrated to act as a global regulator in 
S. pneumoniae. Overall, our results support the hypothesis that S. pneumoniae 
optimizes basic metabolic processes, likely enhancing in vivo fitness, in a CcpA-
mediated manner.  
A general discussion of the findings resulting from this work is presented 









ABC ATP-binding cassette 
ACKA Acetate kinase A 
Ac-P Acetyl-phosphate  
ADH Alcohol dehydrogenase  
BgaA β-galactosidase A 
CBP Choline-binding protein 
CcpA Carbon catabolite protein A 
CCR Carbon catabolite repression 
CDM Chemically defined medium  
CDP-Cho CDP-Choline 
CFU Colony forming unit 
COG Clusters of Orthologous Groups 
Cre Catabolite responsive element 
DHAP Dihydroxyacetone phosphate 




FAD Flavine adenine dinucleotide 
FBP Fructose 1,6-bisphosphate 
Gal Galactose 
Gal1P Galactose 1-phosphate 
GAP Glyceraldehyde 3-phosphate 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase  
Glc Glucose 
 xxvi 
GlcA Gluconic acid 
GlcNAc N-acetylglucosamine 
GlcUA Glucuronic acid 
G1P Glucose 1-phosphate 
G6P Glucose 6-phosphate 
H2O2 Hydrogen peroxide 
HPLC High Performance Liquid Chromatography 
HPr Histidine-containing phosphocarrier protein 
HPr(His15)~P HPr phosphorylated at histidine 15   
HPrK/P HPr kinase/phosphorylase  
HPr(Ser46)~P HPr phosphorylated at serine 46  
LAB Lactic acid bacteria 
LDH Lactate dehydrogenase  
LOX Lactate oxidase 
MIC Minimal inhibitory concentration  
NAD+ Nicotinamide adenine dinucleotide 
NADH Dihydronicotinamide adenine dinucleotide 
NMR Nuclear magnetic resonance 
PCho Phosphorylcholine 
PDHc Pyruvate dehydrogenase complex 
PEP Phosphoenolpyruvate 
PFK 6-Phosphofructokinase  
PFL Pyruvate formate-lyase  
PFL-AE Pyruvate formate-lyase activating enzyme 
3-PGA 3-Phosphoglycerate 
6-PGD 6-Phosphogluconate dehydrogenase 
PGM Phosphoglucomutase 
 xxvii 
Pi Inorganic phosphate  
PK Pyruvate kinase  
PRDs PTS-regulatory domains 
PTA Phosphotransacetylase 
PTS Phosphoenolpryruvate:carbohydrate phosphotransferase system 
PTSMan Mannose-PTS (domains IIAMan, IIBMan, IICMan and IIDMan) 
RT-PCR Real time PCR 
SpxB Pyruvate oxidase 
TBP Tagatose 1,6-bisphosphate  
TEM Transmission electron microscopy 
UDP-Gal UDP-galactose 
UDP-Glc UDP-glucose 
















































Chapter 1 – Contents  
 
Streptococcus pneumoniae .................................................................................. 3 
General characteristics of S. pneumoniae ......................................................... 3 
Virulence factors ............................................................................................... 6 
Carbohydrate metabolism in S. pneumoniae ...................................................... 13 
Transport of glucose and galactose ................................................................ 15 
Metabolism of glucose and galactose.............................................................. 18 
Pyruvate metabolism in S. pneumoniae .......................................................... 22 
Synthesis of capsule ....................................................................................... 25 
Regulation of carbohydrate metabolism .............................................................. 31 
Control of glucose and galactose metabolism in Streptococcaceae ................ 35 
Carbon catabolite repression (CCR) and CcpA ............................................... 38 














Streptococcus pneumoniae   
Streptococcus pneumoniae, also called the pneumococcus, was first 
isolated and identified independently by George M. Sternberg and Louis Pasteur, 
in 1880 (Gray and Musher, 2008). During the following decade the pneumococcus 
would be recognized as the major cause of human lobar pneumonia (Gray and 
Musher, 2008). In the beginning of the 20th century the pneumococcus was 
among the leading causes of human death and a major concern in medicine 
(Gray and Musher, 2008). For this reason, S. pneumoniae was the subject of 
intensive research in a number of groundbreaking scientific discoveries, including 
the discovery of DNA as the carrier of genetic inheritance, and the therapeutic 
efficacy of the antibiotic penicillin (Avery et al., 1944; Watson et al., 1993). In the 
present time, an increase in antibiotic-resistant pneumococcal strains due to the 
widespread and uncontrolled antibiotic usage encourages the scientific 
community to find and develop novel preventive and prophylactic drugs (López, 
2006).    
 
General characteristics of S. pneumoniae 
S. pneumoniae is a Gram-positive, low-GC microorganism. The 
pneumococcus may appear singly, as two joined cells (diplococcus) or in short or 
long chains (Fig. 1.1). The individual cells are ovoid, spherical or lancet-shaped 
with a size of 0.5 – 1.25 µm, and display a capsule surrounding the cell wall (Fig. 
1.1). S. pneumoniae is non-motile and non-spore forming. This organism is a non-
respiring, catalase-negative, aerotolerant fermentative anaerobe that requires 
several nutrients for growth, normally supplied by its natural habitats (mucosal 
secretions or blood); it produces mainly lactic acid from fermentation of 
carbohydrates (Tuomanen, 2006). The ideal temperature and pH for growth of the 
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pneumococcus is 37ºC and 6.5 – 7.5, respectively. In batch cultures, this 
microorganism undergoes autolysis at stationary phase (Severin et al., 1997). 
 
                                   
 
Fig. 1.1. Transmission electron micrograph of S. pneumoniae cells grown in liquid 
medium. The red arrow points to the polysaccharide capsule. This image was obtained at 
the University of Groningen during the course of this work (Chapter 4).  
 
 
Due to its appearance as pairs of cocci under the microscope the 
pneumococcus was generally known as Diplococcus pneumoniae. This 
denomination remained official until 1974, when the bacterium was reclassified as 
Streptococcus pneumoniae based on its growth as chains in liquid media and the 
proximity with other streptococcal species (López, 2006; Gray and Musher, 2008). 
The genus Streptococcus includes other highly relevant pathogenic bacteria (e.g. 
S. agalactiae, S. pyogenes, S. mutans, S. mitis, S. gordonii, S. sanguis, S. bovis, 
and S. suis), infecting humans and/or animals, and a dairy bacterium, S. 
thermophilus (reviewed in Facklam, 2002). Some of these microorganisms 
colonize niches (oral cavity) in close proximity to that of S. pneumoniae 
(nasopharynx). Differentiation of nasopharyngeal swab isolated pneumococci 
from other streptococci, is provided by dissimilarities in bile solubility, fermentation 
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of inulin, sensitivity to optochin, agglutination with anti-polysaccharide capsule 
antibodies (Quellung reaction) and alpha-haemolytic activity in blood agar plates, 
namely the formation of a green halo surrounding pneumococcal colonies 
(Dowson, 2004). The genus Streptococcus belongs to the family 
Streptococcaceae, which also includes the genus Lactococcus (Schleifer et al., 
1985).   
S. pneumoniae is a frequent colonizer of the human nasopharynx of 
healthy individuals, especially children (Obaro and Adegbola, 2002; Bogaert et al., 
2004; Cardozo et al., 2006). Prevalence of carriage as high as 90% has been 
reported for children in some African regions, whereas in western societies the 
values can be as high as 70% (Bogaert et al., 2004; Cardozo et al., 2006). Hence, 
children are believed to be an important vehicle for the horizontal spread of S. 
pneumoniae within the communities (Obaro and Adegbola, 2002; Bogaert et al., 
2004; Cardozo et al., 2006). The transmission of the pneumococcus occurs 
through direct droplet contact with colonized individuals. S. pneumoniae is also an 
opportunistic bacterium, therefore, when the host immune system is immature 
(e.g. in children) or debilitated (e.g. in elderly and immuno-compromised people), 
it can migrate from the nasopharynx to normal sterile parts of the human body, 
such as middle ear, paranasal sinuses, lungs, blood or meninges, causing otitis 
media and sinusitis, or other  less prevalent, but more severe conditions such as 
pneumonia, septicaemia and meningitis (Obaro and Adegbola, 2002; Mitchell, 
2003; Cardozo et al., 2006). The mortality caused by pneumococcal infections is 
very high and is often age-associated. For instance, in the developed world 
serious pneumococcal infections occur in children below two years of age and in 
the elderly (> 65 years); in developing countries (e.g. African and South Asian) S. 
pneumoniae kills more than 1 million children under the age of 5 years anually, 
including newborn infants (Obaro and Adegbola, 2002; Bogaert et al., 2004; 
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Cardozo et al., 2006). In these countries, pneumonia is the leading cause of 
children death, earning the name of “The Forgotten Killer of Children” 
(UNICEF/WHO, Pneumonia: The Forgotten Killer of Children, 2006 
(http://www.unicef.org/publications/files/Pneumonia_The_Forgotten_Killer_of_Chil
dren.pdf). The progression from carriage to invasive disease is often associated 
with changes in the expression of pneumococcal virulence factors (reviewed in 
Mitchell, 2003). Virulence factors enable the microorganism to overcome host 
defence mechanisms and survive in different host niches. The properties 




In classical terms, a virulence factor is any molecule of a pathogen that 
damages the host (Casadevall and Pirofski, 1999). In S. pneumoniae most of 
these factors are surface exposed proteins that interact directly with the host, 
soluble toxins and structures protecting the pneumococcus from the host immune 
system (reviewed in Jedrzejas, 2001). The role of many virulence factors in the 
pathogenicity of S. pneumoniae has been reported (reviewed in Jedrzejas, 2001; 
Kadioglu et al., 2008; Mitchell and Mitchell, 2010). Major pneumococcal virulence 











Table 1.1. Pneumococcal virulence factors and their main role in virulence (adapted from 
Kadioglu et al., 2008) 
Main role in virulence Virulence factors 
Upper airway colonization Capsule, PCho, PspC (or CbpA), NanA, BgaA, 
StrH, Hyl, PavA, Eno, GAPDH 
Competition in upper airway Bacteriocins, H2O2 
Respiratory tract infection  
and pneumonia 
Ply, PspA, LytA, PsaA, PiaA, PiuA, NanA, NanB, 
IgA1 protease 
PCho, phosphorylcholine; PspC, pneumococcal surface protein C (or CbpA, choline-binding protein 
A); NanA, neuraminidase A; BgaA, β-galactosidase A; StrH, β-N-acetylglucosaminidase; Hyl, 
hyaluronidase; PavA, pneumococcal adhesion and virulence A; Eno, enolase; GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase; H2O2, hydrogen peroxide; Ply, pneumolysin; PspA, 
pneumococcal surface protein A; LytA, autolysin A; PsaA, pneumococcal surface antigen A; PiaA, 
pneumococcal iron acquisition A; PiuA, pneumococcal iron uptake A; NanB, neuraminidase B; IgA1, 
immunoglobulin A1.   
 
 
Of all classical virulence factors, capsule is the only one meeting the 
criteria of condition sine qua non of virulence (Iannelli et al., 1999; Ogunniyi et al., 
2002). Capsule is a hydrophilic polysaccharide structure surrounding the cell wall 
(see the red arrow in Fig. 1.1, Fig. 1.2). The pneumococcal serotypes are defined 
by the composition of the capsular polysaccharide. When this work started 90 
serotypes were documented, but currently at least 3 more have been described 
(Song et al., 2012), denoting the high genetic plasticity of this microorganism. The 
intrinsic properties of each capsule type, i.e., carbohydrate chemical nature, 
degree of electronegative charge and thickness, confer specific host anti-
phagocytic and neutrophil responses and therefore, different ability to cause 
invasive disease (Lee et al., 1991; AlonsoDeVelasco et al., 1995; Wartha et al., 
2007; Kadioglu et al., 2008; Mitchell and Mitchell, 2010). Capsule interferes with 
the binding of antibodies (e.g. Fc of IgG) and complement system (e.g. iC3b 
protein) proteins, attached to the surface of the pneumococcal cells, to the 
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specific receptors in phagocytic cells (AlonsoDeVelasco et al., 1995; Abeyta et al., 
2003; Kadioglu et al., 2008; Mitchell and Mitchell, 2010). Capsule has also been 
shown to reduce transformation (Weiser and Kapoor, 1999) and spontaneous or 
antibiotic-induced lysis, contributing to tolerance to antibiotics (Fernebro et al., 
2004; Kadioglu et al., 2008). Moreover, capsule is essential for colonization since 
it prevents mechanical exclusion of the pneumococcal cells by the mucus in 
mucosal surfaces (Nelson et al., 2007; Kadioglu et al., 2008; Mitchell and Mitchell, 
2010). Intra-strain and serotype-dependent variation of the amount of capsule is 
also an important feature in colonization and disease: a very thick capsule is 
detrimental for adhesion of S. pneumoniae surface proteins to host cell receptors. 
On the other hand, in blood a thick capsule contributes to persistence of the 
pneumococcus in this planktonic environment (Weiser et al., 1994; Cundell et al., 


























Fig. 1.2. Schematic representation depicting pneumococcal virulence factors and 
their localization in the cell. Abbreviations: LytA, autolysin A; Ply, pneumolysin; PspA 
and PspC, pneumococcal surface proteins A and C; NanA, neuraminidase A; Hyl, 
hyaluronidase; PsaA, pneumococcal surface antigen A; PavA, pneumococcal adhesion 
and virulence A; Eno, enolase; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; 
H2O2, hydrogen peroxide.  
 
 
The nasopharynx is a densely populated niche. In assymptomatic 
individuals, and particularly in children,  various S. pneumoniae serotypes may 
cohabit with other species, including Haemophilus influenzae, Moraxella 
catarrhalis, Neisseria meningitidis and even Staphylococcus aureus (Pericone et 
al., 2000; García-Rodríguez and Martínez, 2002; Pettigrew et al., 2008; Brugger 
et al., 2009; Margolis et al., 2010). In such communities, intra- and inter-strain 
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competition phenomena may occur. Among the streptococcal virulence factors, 
the bactericidal bacteriocins (e.g. the bacterial pneumocins BlpM and BlpN) and 
hydrogen peroxide (H2O2) are known for their roles targeting others bacteria in the 
upper airway (Fig. 1.2) (Pericone et al., 2000; Dawid et al., 2007; Pettigrew et al., 
2008). The H2O2 produced by S. pneumoniae may reach extracellular 
concentrations in the mM range, higher than those generated by many other 
species, and sufficient to kill the competitors (Pericone et al., 2000). Interestingly, 
H2O2 was also shown to have cytotoxic effects on epithelial cells (Duane et al., 
1993; Hirst et al., 2000; Braun et al., 2002). Another important virulence factor is 
pneumolysin (Ply). Ply is a pore-forming cytotoxin belonging to the family of 
cholesterol-dependent cytolysins (CDCs). Pneumococcal autolysis triggers the 
release of this cytoplasmic soluble protein (Fig. 1.2), which displays multiple 
functions important for infection. In short, Ply oligomers polymerize in cholesterol-
containing host cell membranes forming a transmembrane pore inducing cell 
lysis; Ply activates and binds the complement of the host immune system, e.g. 
C3b protein, diverting it from the surface of pneumococcal cells; it affects host cell 
activities at sub-lytic concentrations (reviewed in  Kadioglu et al., 2008; Mitchell 
and Mitchell, 2010). The major autolysin inducing pneumococcal lysis, and thus, 
release of intracellular content (e.g. pneumolysin and DNA), is autolysin A (LytA) 
(Fig. 1.2) (reviewed in Kadioglu et al., 2008; Mitchell and Mitchell, 2010). LytA is 
also a virulence factor and belongs to the group of choline-binding proteins 
(CBPs). CBPs are surface exposed proteins that anchor non-covalently to the cell 
wall teichoic acid and membrane-bound lipoteichoic acids through residues of 
phosphorylcholine (PCho). PCho is an atypical bacterial cell wall component, 
present in S. pneumoniae, that stimulates adherence of bacterial cells to the 
platelet-activating factor receptor (rPAF) in epithelial surfaces of the nasopharynx 
(reviewed in Bergmann and Hammerschmidt, 2006; Kadioglu et al., 2008). LytA is 
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an N-acetylmuramoyl-L-alanine-amidase that digests peptidoglycan; its major role 
in virulence is presumably mediated by the release of pneumolysin and cell wall 
(Fig. 1.2) (reviewed in Kadioglu et al., 2008; Mitchell and Mitchell, 2010). Cell wall 
has a pivotal function in triggering inflammatory processes (reviewed in Kadioglu 
et al., 2008; Mitchell and Mitchell, 2010). Other two known virulent CBPs are the 
pneumococcal surface proteins C (PspC, also known as choline-binding protein 
A, CbpA) and A (PspA) (Fig. 1.2), with function in colonization and infection, 
respectively. During transcytosis across the surface epithelium, PspC binds the 
immunoglobulin A (IgA) receptor and the complement factor H-binding protein, 
inhibiting complement activation (reviewed in Kadioglu et al., 2008; Mitchell and 
Mitchell, 2010). PspA binds the bactericidal protein lactoferrin and the C3 protein 
of the complement system preventing its deposition on the surface of 
pneumococcal cells (reviewed in Kadioglu et al., 2008; Mitchell and Mitchell, 
2010). Among the surface proteins, several LPxTG-proteins, which are anchored 
by an amino acid LPxTG motif to peptidoglycan, are well described virulence 
factors (Fig. 1.2) (reviewed in Bergmann and Hammerschmidt, 2006; Kadioglu et 
al., 2008). Of these, neuraminidase A (NanA), also called sialidase A, is a good 
example. NanA cleaves N-acetylneuraminic acid or sialic acid from glycosylated 
proteins or lipids and oligosaccharides in the mucosal cell surfaces. By cleaving 
these residues, NanA unmasks potential receptors in the host surface epithelium, 
promoting colonization, and modifies the function of sialidated proteins of the host 
involved in clearance of bacteria, stimulating invasion (reviewed in Kadioglu et al., 
2008; Mitchell and Mitchell, 2010). The pneumococcal surface antigen A (PsaA), 
a lipoprotein that is part of the Psa(ABC) transporter (Fig. 1.2), is involved in the 
translocation of manganese ions into the cell. The contribution of this protein in 
the resistance to oxidative stress and in increased adhesion has been shown 
(reviewed in Kadioglu et al., 2008; Mitchell and Mitchell, 2010). Other key surface 
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proteins involved in adherence to host cells and/or invasion are the pneumococcal 
adherence and virulence A (PavA), enolase (Eno), glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), 6-phosphogluconate dehydrogenase (6-PGD), β-
galactosidase A (BgaA), β-N-acetylglucosaminidase (StrH) and hyaluronate lyase 
A (HylA) (Fig. 1.2) (Berry and Paton, 2000; Bergmann et al., 2001; Holmes et al., 
2001; Bergmann et al., 2003; Pracht et al., 2005; King et al., 2006; Daniely et al., 
2006; Terra et al., 2010; Dalia et al., 2010; Limoli et al., 2011). BgaA, StrH and 
HylA are involved in the hydrolysis of surface glycoproteins and unmasking of 
host receptors, which ultimately facilitates pneumococcal adherence to epithelial 
cells. Remarkably, BgaA and Hyl were also found to be important for growth in 
certain media (van Opijnen et al., 2009; Marion et al., 2012). The glycolytic 
enzymes Eno and GAPDH bind the host plasminogen, which prevents activation 
of plasmin and cleavage of fibrin clots (Henderson and Martin, 2011). The 
moonlighting facet of these proteins suggests a more relevant role of sugar 
metabolic enzymes than previously imagined (Henderson and Martin, 2011). In 
accordance, a number of studies showed that deletion of genes involved in sugar 
metabolism and regulation (e.g. pyruvate oxidase (SpxB)) and the global regulator 
CcpA leads to virulence attenuation (Giammarinaro and Paton, 2002; Iyer et al., 
2005; Ramos-Montañez et al., 2008). Although not classical virulence factors, 
these proteins, also common to non-pathogenic bacteria, are very important for 
the fitness of S. pneumoniae in host niches. The study of sugar metabolism may 
therefore disclose unforeseen metabolic factors as potential targets for the 




Carbohydrate metabolism in S. pneumoniae  
Over the past few decades, most investigators centered their attention in 
trying to understand the mechanisms by which S. pneumoniae classical virulence 
factors interact with the host (reviewed in Kadioglu et al., 2008). However, factors 
involved in basic metabolic physiology, allowing for fitness and adaptation of this 
strictly fermentative bacterium in the microenvironments of the host, have been 
largely ignored. In the nasopharynx, free sugars, and in particular the often 
preferred hexose glucose ([Glc]nasopharynx < 1 mM), are scarce (Shelburne et al., 
2008a). In this environment, S. pneumoniae most likely relies on wide range of 
glycosylated proteins (mucins) present in the mucus lining the epithelial cell 
surfaces of airway structures (e.g. nasopharynx, tracheae, bronqui) (Rose and 
Voynow, 2006; Yesilkaya et al., 2008). The most abundant mucin present in 
mucus contains a chain of different sugars (N-acetylgalactosamine, N-
acetylglucosamine, fucose, sialic acid, galactose and sulfated sugars) in varied 
proportions that is O-glycosydically linked to the polypeptide (apomucin) 
(Yesilkaya et al., 2008; Terra et al., 2010). The determination of the relative 
proportion of each sugar in these chains showed that Gal is one of the sugars 
present at higher concentrations (Holmén et al., 2004; Yesilkaya et al., 2008; 
Terra et al., 2010). Release of Gal from deglycosylation of human mucins by 
exoglycosidases expressed by S. pneumoniae has been reported (King et al., 
2006). Contrastingly, in other host niches, such as blood, S. pneumoniae 
encounters Glc as major carbon source, [Glc]blood ~ 4-6 mM (Shelburne et al., 
2008a). Glc and Gal are thus relevant sugars for the study of sugar metabolism in 
S. pneumoniae.  
Complete genome sequences of S. pneumoniae are available since 2001 
(Tettelin et al., 2001; Hoskins et al., 2001; Lanie et al., 2007). Deciphering of the 
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genomes brought to light the importance of sugars to the lifestyle of  
S. pneumoniae and provided the framework for the development of a number of 
genome-wide analysis (e.g. microarray analysis and signature-tagged 
mutagenesis) (Hava and Camilli, 2002; Orihuela et al., 2004a; Shelburne et al., 
2008a). Interestingly, studies designed to identify genes essential for virulence at 
the genome level consistently revealed genes involved in sugar catabolism.  
Capitalizing on these genome-wide studies, several research efforts have shown 
that non-classical virulence factors such as carbohydrate uptake systems, 
metabolic enzymes and a global regulator of carbon metabolism (CcpA) directly 
contribute to S. pneumoniae colonization and disease (Giammarinaro and Paton, 
2002; King et al., 2004; Iyer et al., 2005; King et al., 2006; Iyer and Camilli, 2007; 
Burnaugh et al., 2008; Ramos-Montañez et al., 2008; Yesilkaya et al., 2009; 
Trappetti et al., 2009; Marion et al., 2011; Marion et al., 2012). 
Although the value of sugar metabolic proteins for the infectivity of  
S. pneumoniae is starting to be recognized, the need for in depth studies enabling 
integration of basic metabolic processes, regulation and connections to virulence 
in S. pneumoniae is evident. In the following subsections a genome and literature 
based overview of the putative sugar transport and metabolic capabilities, 
particularly for the sugars Glc and Gal, of S. pneumoniae will be presented. 
Subsequently, the cross talk between the synthesis of the polysaccharide capsule 








Transport of glucose and galactose 
The transport of any exogenous carbohydrate across the sugar-
impermeable lipidic membrane is the first step committed to its metabolism. In the 
Streptococacceae family this translocation may occur through three different 
types of carbohydrate uptake systems: secondary carriers (uniporters, symporters 
and antiporters), ABC-transporters and phosphoenolpyruvate: carbohydrate 
phosphotransferase systems (PTS-systems) (Fig. 1.3) (Lorca et al., 2007). The 
driving force impelling the transport of carbohydrates through secondary carriers 
is an electrochemical gradient of other solutes across the cell membrane 
(Poolman and Konings, 1993). In ABC transporters, also called ATP-binding 
cassettes, this driving force is the intracellular hydrolysis of ATP (reviewed in 
Rees et al., 2009). The PTS systems are multiprotein complexes comprising both 
cytoplasmatic and transmembranar proteins (reviewed in Postma et al., 1993). 
Although more complex, this system is more efficient in energetic terms, since 
rather than ATP it utilizes phosphoenolpyruvate (PEP) to phosphorylate the 
incoming sugar (Fig. 1.3) (reviewed in Postma et al., 1993). In S. pneumoniae, a 
genome survey revealed the occurrence of twenty-one PTS systems, seven ABC-
transporters, one symporter and a permease (uniporter) for carbohydrate uptake 
(Bidossi et al., 2012). The number of sugar transporters in the pneumococcus is 
higher than for any other prokaryote relative to genome size (Tettelin et al., 2001; 
Bidossi et al., 2012) and is variable between serotypes (Bidossi et al., 2012). The 
ensemble of transporters have specificity for several sugars, such as Glc, Gal,  
N-acetylglucosamine, mannose, fructose, sialic acid, cellobiose, fructose and  
β-glucosides (Bidossi et al., 2012). However, firm functional assignments are only 
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Fig. 1.3. Schematic figure showing the three classes of carbohydrate uptake 
systems in Streptococcaceae. SC (in green), secondary carriers; ABC (in pink), ABC-
transporters; PTS (in purple), phosphoenolpyruvate: carbohydrate phosphotransferase 
system. Abbreviations: NBP, nucleotide-binding protein; TMD, transmembrane domain; 
SPB, sugar/solute-binding protein; PEP, phosphoenolpyruvate; EI, HPr are the 
cytoplasmatic proteins of the PTS-system; IIAB and IICD are the cytoplasmatic and 
transmembranar proteins of the carbohydrate-specific PTS, respectively. The PTS-system 






As for the hexose Glc, its transport is not fully elucidated in  
S. pneumoniae, but a PTS system (spd_0264-2 or manLMN) of the PTS 
mannose-fructose-sorbose (Man) family, referred as PTSMan, is presumably the 
major transporter of Glc in S. pneumoniae (Bidossi et al., 2012). Growth on Glc 
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was, however, not abolished by a manLMN mutation, a result consistent with the 
presence of other uptake systems (Bidossi et al., 2012). Furthermore, the ability 
of a ptsI mutant, disrupted for the general PTS protein EI, to grow on Glc supports 
the occurrence of non-PTS systems for Glc transport (Bidossi et al., 2012). 
Current work in our laboratory is aimed at identifying additional Glc uptake routes 
in S. pneumoniae.  
Transport of Gal in S. pneumoniae is even more obscure; however, the 
PTS system of the family PTS-galactitol (Gat) encoded by spd_0559-61 aka 
gatABC was pointed out in two independent studies as playing a role on Gal 
uptake (Kaufman and Yother, 2007; Bidossi et al., 2012). Confirmation has been 
hampered by the weak phenotype of the null mutant. Which other transporters are 
involved in Gal uptake remain to be elucidated, but Bidossi et al. reported a 
decreased ability of a manLMN mutant to grow on Gal (Bidossi et al., 2012). 
Hitherto, firm identification of Glc and Gal transporters and their ensuing 
biochemical characterization in S. pneumoniae is still missing. Interestingly, PTS 
sugar transporters are only present in prokaryotes. Considering their location in 
bacterial cells (superficial), these transporters could be good targets for the 









Metabolism of glucose and galactose 
 S. pneumoniae is a strictly fermentative bacterium, relying on sugar 
substrates for growth. Since it lacks a respiratory chain, this organism depends on 
substrate-level phosphorylation to form ATP (Tettelin et al., 2001; Hoskins et al., 
2001; Lanie et al., 2007). In this process, ATP is originated from the direct transfer 
of a phosphoryl group from phosphorylated reactive intermediates to ADP (Nelson 
and Cox, 2000).  
S. pneumoniae is a homofermentative bacterium that converts hexoses to 
pyruvate via the Embden-Meyerhof-Parnas (EMP) pathway; recycling of reducing 
equivalents is achieved mainly through reduction of pyruvate to lactate (Fig. 1.4).  
Glc can be transported and concomitantly phosphorylated by PTS 
systems or enter the cell via non-PTS transporters and be subsequently 
phosphorylated to G6P by intracellular glucokinases (Fig. 1.4). The ensuing 




















































Fig. 1.4. Glucose catabolism in S. pneumoniae via the Embden-Meyherhof-Parnas 
(EMP) pathway. Glc can be imported by the PTS
Man
 or other PTS systems and non-
PTS transporters (Bidossi et al., 2012). The intracellular reactions depicted are 
catalyzed by the following enzymes (the genes that code for the enzymes are in 
parenthesis): glucokinase (gki), phosphoglucose isomerase (pgi), 6-
phosphofructokinase (pfkA), fructose 1,6-bisphosphate aldolase (fba), triosephosphate 
isomerase (tpiA), glyceraldehyde 3-phosphate dehydrogenase (gap), phosphoglycerate 
kinase (pgk), phosphoglyceromutase (gpmA), enolase (eno), pyruvate kinase (pyk), 
lactate dehydrogenase (ldh). Abbreviations: G6P, glucose 6-phosphate; F6P, fructose 
6-phosphate; FBP, fructose 1,6-bisphosphate; GAP, glyceraldehyde 3-phosphate; 
DHAP, dihydroxyacetone phosphate; BPG, 1,3-bisphosphoglycerate; 3-PGA, 3-
phosphoglycerate; 2-PGA, 2-phosphoglycerate; PEP, phosphoenolpyruvate.  
Chapter 1 
 20 
Gal is generally recognized as a slowly metabolized carbohydrate 
(reviewed in Deutscher et al., 2006). The metabolism of Gal is well documented 
for a number of Streptococcaceae, including S. mutans, S. pyogenes, L. lactis, 
and S. salivarius) (Steele et al., 1954; Pierce, 1957; Thomas et al., 1980; 
Abranches et al., 2004; Neves et al., 2010). In these organisms, Gal can be 
metabolized by the Leloir and/or tagatose 6-phosphate pathways (Fig. 1.5). In  
S. mutans, Gal can only be efficiently metabolized when both pathways are 
operating simultaneously (Abranches et al., 2004). In L. lactis, the use of the 
Leloir and/or the tagatose 6-phosphate pathway for Gal utilization is currently 
viewed as strain-dependent, but the relative efficacy in the degradation of the 
sugar has not been established (Thomas et al., 1980; Neves et al., 2010). In  
S. salivarius, due to absence of Gal-PTS transporters only the Leloir pathway is 
functional (Chen et al., 2002). In S. pneumoniae, the functionality of the two 
pathways is yet to be proven, but the enzymatic steps of both pathways can be 
inferred from the genome (Fig. 1.5) (Tettelin et al., 2001; Hoskins et al., 2001; 




      





































Fig. 1.5. Putative routes for galactose transport and catabolism in S. pneumoniae. 
Gal can be imported by PTS and non-PTS systems (Kaufman and Yother, 2007; Bidossi 
et al., 2012). The intracellular reactions depicted are catalyzed by the following enzymes 
(the genes that code for the enzymes are in parenthesis): galactose 6-phosphate 
isomerase (lacAB), tagatose 6-phosphate kinase (lacC), tagatose 1,6-diphosphate 
aldolase (lacD), galactose mutarotase (galM), galactokinase (galK), galactose 1-
phosphate uridylyltransferase (galT), UDP-galactose 4-epimerase (galE), α-
phosphoglucomutase (pgm). Abbreviations: Gal, galactose; Gal6P, galactose 6-
phosphate; Gal1P, galactose 1-phosphate; Tag6P, tagatose 6-phosphate; TBP, tagatose 
1,6-bisphosphate; G6P, glucose 6-phosphate; α-G1P, α-glucose 1-phosphate; GAP, 
glyceraldehyde 3-phosphate; DHAP, dihydroxyacetone phosphate; UDP-Glc, UDP-
glucose; UDP-Gal, UDP-galactose. 
 
 
 The type of Gal uptake system dictates to a large extent the intracellular 
pathway used to process the incoming Gal. Often, but not always, Gal imported 
and concomitantly phosphorylated to galactose 6-phosphate (Gal6P) via a PTS-
system follows the tagatose 6-phosphate pathway. In short, Gal6P is converted to 
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glycolytic triose-phosphates via the sequential action of three enzymes, galactose 
6-phosphate isomerase (LacAB), Tag6P kinase (LacC) and tagatose 1,6-
diphosphate aldolase (LacD) (Fig. 1.5). Gal taken up by non-PTS transporters 
(second carriers or ABC-transporters) converges into the Leloir pathway. In this 
route, Gal is converted to α-glucose 1-phosphate (α-G1P), which in turn forms the 
glycolytic intermediate G6P by the action of α-phosphoglucomutase (pgm) (Fig. 
1.5). However, Gal6P, the product of Gal-PTSs, can also be processed via the 
Leloir pathway, upon dephosphorylation by yet unknown Gal6P phosphatases 
(Neves et al., 2010; Solopova et al., 2012).  
 
Pyruvate metabolism in S. pneumoniae 
Independently of which sugar is metabolized, the end-product of the EMP 
pathway is pyruvate. Genes encoding the pyruvate consuming enzymes lactate 
dehydrogenase (LDH), pyruvate oxidase (SpxB), and pyruvate formate-lyase 
(PFL) are present in genome sequences of S. pneumoniae (Tettelin et al., 2001; 
Hoskins et al., 2001; Lanie et al., 2007). Biochemical characterization of the 
enzymes is missing, but the functions of LDH and SpxB have been experimentally 
validated by product and activity measurements, and loss-of-function mutants for 
SpxB (Spellerberg et al., 1996; Chapuy-Regaud et al., 2001; Ramos-Montañez et 
al., 2008; Taniai et al., 2008; Ramos-Montañez et al., 2010). Furthermore, the 
identification of a functional PFL encoding gene was achieved during the course 
of this work (Chapter 5). 
Many Streptococcaceae also possess a pyruvate dehydrogenase complex 
(PDHc), which catalyzes the conversion of pyruvate to acetyl-CoA and CO2 at the 
expense of NAD+ (Snoep et al., 1993; Seki et al., 2004). Homologues of the PDHc 
proteins were not found in the genomes of S. pneumoniae (Tettelin et al., 2001; 
Hoskins et al., 2001; Lanie et al., 2007), but recent reports suggest the presence 
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Fig. 1.6. Schematic representation of pyruvate metabolism in S. pneumoniae. The 
reactions depicted are catalyzed by the following enzymes (the genes that code for the 
enzymes are in parenthesis): pyruvate oxidase (spxB), pyruvate formate-lyase (pfl), 
bifunctional acetaldehyde-CoA/alcohol dehydrogenase (adh), phosphotransacetylase 
(pta), acetate kinase (ackA), pyruvate dehydrogenase complex (PDHc), L-lactate 
dehydrogenase (ldh), lactate oxidase (lcto). The reaction catalyzed by PDHc is in grey 
because its occurrence remains to be proved.  
 
 
LDH, which activity originates lactate and NAD+ at the expense of 
pyruvate and NADH (homolactic fermentation) (Fig. 1.6), is one of the most 
ubiquitous activities, and ldh genes are present in all genomes of lactic acid 
bacteria (LAB), frequently in several copies (reviewed in Garvie, 1980). Curiously, 
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S. pneumoniae possesses a single copy of ldh (Tettelin et al., 2001; Hoskins et 
al., 2001; Lanie et al., 2007) and so far null mutants have not been reported. PFL 
catalyses the conversion of pyruvate to formate and acetyl-CoA (mixed-acid 
fermentation); the latter is the precursor for ethanol and acetate production via 
ADH and PTA/ACKA activities, respectively (Fig. 1.6). Formation of ethanol leads 
to NAD+ regeneration, whereas acetate production results in extra ATP (Fig. 1.6). 
PFL is synthesized as an inactive enzyme. The enzyme is activated post-
translationally via a PFL-activating enzyme (PFL-AE) that introduces a glycyl 
radical in PFL (Melchiorsen et al., 2000; Buis and Broderick, 2005). Due to the 
presence of this radical, the active form of PFL is highly sensitive to molecular 
oxygen, explaining its better performance in hypoxia (Yamada et al., 1985; 
Melchiorsen et al., 2000; Takahashi-Abbe et al., 2003; Buis and Broderick, 2005). 
The degree of sensitivity to O2 is strain-dependent and is related to different self-
protecting mechanisms of bacteria (Yamada et al., 1985; Takahashi et al., 1987; 
Melchiorsen et al., 2000; Takahashi-Abbe et al., 2003). The genome of  
S. pneumoniae revealed the presence of two copies each of pfl and pfl-ae 
(Tettelin et al., 2001; Hoskins et al., 2001; Lanie et al., 2007), but in Chapter 5 we 
show that only one copy of each enzyme is functional. SpxB is a FAD and 
thiamine requiring flavoprotein that converts pyruvate, oxygen and phosphate (Pi) 
into CO2, H2O2 and acetyl-phosphate (Fig. 1.6) (Spellerberg et al., 1996). Acetyl-
phosphate is a highly energetic compound and is the substrate for acetate kinase, 
which produces acetate and ATP (Fig. 1.6). SpxB is expressed during all phases 
of growth and has presumably a prominent role in the aerobic metabolism of  
S. pneumoniae (Taniai et al., 2008). In agreement, the expression of SpxB in  
S. pneumoniae is higher in the nasopharynx, an oxygen-rich environment, than in 
blood, where O2 is mostly associated with haemoglobin (LeMessurier et al., 
2006). In S. pneumoniae, a number of studies describe the involvement of SpxB 
General introduction 
 25 
in virulence and colony phenotypic variation (Spellerberg et al., 1996; Pericone et 
al., 2000; Overweg et al., 2000; Belanger et al., 2004; Ramos-Montañez et al., 
2008; Allegrucci and Sauer, 2008). The role of SpxB in virulence is in part 
mediated by the potential deleterious effects of its product, H2O2 (Duane et al., 
1993; Spellerberg et al., 1996; Hirst et al., 2000; Pericone et al., 2000). However, 
SpxB was also shown to be differentially expressed in phenotypic variants of  
S. pneumoniae displaying different capsule amounts (Overweg et al., 2000; 
Belanger et al., 2004; Ramos-Montañez et al., 2008; Allegrucci and Sauer, 2008). 
In this light, a potential function of SpxB in virulence may be on the regulation of 
capsule production. In this work, we directed efforts to assess the role of this 
enzyme in capsule production and sugar utilization in S. pneumoniae (Chapter 4).  
 
Synthesis of capsule  
Capsules are composed of carbohydrate repeating units and are widely 
distributed and diversified among bacteria (e.g. S. aureus, S. haemolyticus,  
S. agalactiae, S. pneumoniae, E. coli, Bacteroides fragilis) (Tsui et al., 1988; 
Bhasin et al., 1998; Cieslewicz et al., 2005; Bentley et al., 2006; Flahaut et al., 
2008; Patrick et al., 2010; Yother, 2011). Capsule synthesis in bacteria occurs 
through one of three existing mechanisms, the Wzy-, the synthase- or the ABC- 
transporter-dependent mechanisms. The three are observed in Gram-negative 
bacteria, but only the first two are described in Gram-positive bacteria (reviewed 
in Yother, 2011). In S. pneumoniae, 93 different capsular types are recognized. 
Remarkably, all pneumococcal capsular serotypes are synthesized by a Wzy-
dependent mechanism, except serotypes 3 and 37, which are synthesized by a 
synthase-dependent mechanism (reviewed in Yother, 2011). The diversity of 
Wzy-dependent capsule is conferred by the existence of multiple distinct sugars 
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forming the repeating units, glycosydic bonds and branching points. The repeating 
units are polymerized in a non-processive way, i.e. the polymerizing enzyme 
breaks free after adding each repeating unit to the polymer (reviewed in Yother, 
2011). In S. pneumoniae, the capsular Wzy-dependent genes are localized within 
a fixed region in the chromosome, i.e. between the dexB and aliA genes  
(Fig. 1.7-B) (Iannelli et al., 1999; Bentley et al., 2006; Yother, 2011). The capsular 
(cps) operon is transcribed as a single transcript; the promoter region is localized 
upstream of the wzg gene (Guidolin et al., 1994; Moscoso and Garcia, 2009; 
Yother, 2011). CpsA coded by this gene (wzg) is believed to affect transcription of 
the cps operon, since its deletion reduces capsule production (Guidolin et al., 
1994; Morona et al., 2000; Bender et al., 2003; Yother, 2011). 
S. pneumoniae serotype 2 strain D39 is a good example of a strain that 
uses the Wzy-dependent mechanism for capsule synthesis (Figs. 1.7 and 1.8). 
Furthermore, D39 is a historical and model strain used frequently in the study of 
pneumococcal physiology and pathogenesis, and is also the model strain used in 
this work. Its capsule is composed of repeating units of glucuronic acid, glucose 
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Fig. 1.7. Carbohydrate repeating unit (A) and genetic locus (B) of the Wzy-
dependent S. pneumoniae serotype 2 (strain D39) polysaccharide capsule. A) The 
type of glycosydic bond between sugars is shown in parenthesis. Symbols: , D-
glucuronic acid; , L-rhamnose; , D-glucose. B) The capsule locus is transcribed as a 
single operon; the arrow indicates the transcript (Guidolin et al., 1994). The first four 
genes are common to all serotypes and the next thirteen are serotype-specific. Purple, 
regulatory genes; Pink, glycosyltransferases; Blue, polymerase; Orange, flippase; Grey 
and Green, NDP-sugar biosynthesis genes; Brown, pseudogene; NDP-sugar, nucleotide 
diphospho-sugar; GlcUA, glucuronic acid; Rha, rhamnose. Adapted from Yother, 2011 
and Bentley et al., 2006.  
 
 
In strain D39, likewise in many other serotypes, α-G1P is the primary 
precursor in the biosynthesis of capsule. α-G1P can arise by the action of the 
housekeeping enzyme α-phosphoglucomutase (pgm) on the glycolytic 
intermediate G6P or can derive directly from the metabolism of other sugars, such 
as Gal (Fig. 1.8). Deletions in pgm and galU genes, located outside the cps locus, 
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lead to a drastic decrease in capsule amounts, growth defects and attenuation of 
virulence of S. pneumoniae (Mollerach et al., 1998; Hardy et al., 2000; Hardy et 
al., 2001). The enzymes that convert UDP-glucose to UDP-glucuronic acid and α-
G1P to dTDP-rhamnose (serotype 2 activated NDP-sugars), required to form the 
capsular repeating units, are encoded by the downstream regions of the cps locus 
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Fig. 1.8. Capsule synthesis in S. pneumoniae D39. The metabolism of Glc and Gal 
originate α-G1P, the primary precursor of capsule production. The reactions depicted are 
catalyzed by the following enzymes (the genes that code for the enzymes are in 
parenthesis): α-phosphoglucomutase (pgm), glucose 1-P uridylyltransferase (galU), UDP-
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glucose 6-dehydrogenase CpsK (ugd), glucose 1-P thymidylyltransferase CpsL (rmlA), 
dTDP-glc 4,6-dehydratase CpsN (rmlB), dTDP-4-keto-6-deoxy-D-glc 3,5-epimerase CpsM 
(rmlC), dTDP-4-keto-L-rhamnose reductase CpsO (rmlD), undecaprenylphosphate 
glucosephosphotransferase CpsE (wchA), tyrosine-protein phosphatase CpsB (wzh), 
integral membrane regulatory protein CpsA (wzg), chain length determinant 
protein/polysaccharide export protein, MPA1 family protein, CpsC (wzd), tyrosine-protein 
kinase CpsD, cytosolic ATPase (wze), glycoside hydrolase family protein CpsT (wchF), 
glycoside transferase family protein CpsF (wchG), glycoside hydrolase family protein 
CpsG (wchH), polysaccharide polymerase CpsH (wzy), glycoside hydrolase family protein 
CpsI (wchI), UDP-galactopyranose mutase CpsP (glf). GlcUA, glucuronic acid; Rha, 
rhamnose. Symbols: , D-glucuronic acid; , L-rhamnose; , D-glucose. Part of this 
figure was adapted from Yother, 2011. 
 
 
The synthesis of D39 capsule, and of most Wzy-dependent polymers, initiates 
with the transfer of glucose 1-phosphate from UDP-Glc to a membrane 
undecaprenyl-phosphate (Und-P) acceptor, catalyzed by CpsE (wchA) (Cartee et 
al., 2005a; Cartee et al., 2005b; Bentley et al., 2006; Yother, 2011). The 
subsequent sugars are added by the remaining glycosyltransferases (CpsTFG 
and CpsI in serotype 2), forming a repeating unit (Fig. 1.8) (Bentley et al., 2006; 
Yother, 2011). The transfer of the repeating unit from the inner membrane to the 
outer membrane and its polymerization in the outer membrane is catalyzed by a 
flippase (CpsJ coded by wzx) and a polymerase (CpsH coded by wzy), 
respectively (Fig. 1.8) (Bentley et al., 2006; Kadioglu et al., 2008; Yother, 2011). 
Mutations in these proteins are lethal unless accompanied by the occurrence of 
suppressor mutations in wchA (CpsE) (Xayarath and Yother, 2007; Yother, 2011). 
Most of the capsule polymer binds covalently to peptidoglycan or membrane, but 
some can also be released from the cell (Fig. 1.8) (Bender et al., 2003; Morona et 
al., 2006; Yother, 2011). The enzyme(s) linking the polymer to the cell wall remain 
unknown (reviewed in Kadioglu et al., 2008; Yother, 2011). However, it is 
assumed that the polymer attaches to N-acetylglucosamine residues in the cell 
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wall or the membrane (reviewed in Yother, 2011). Polysaccharides not attached 
to the cell wall or membrane are called exopolysaccharides and their existence is 
very well documented in other Streptococcaceae, such as L. lactis and  
S. thermophilus (De Vuyst et al., 1998; Boels et al., 2001). In S. pneumoniae, the 
length of the capsular polymers is modulated by a tyrosine kinase 
phosphoregulatory system (CpsBCD) encoded by the genes wzh, wzd and wze, 
common to all Wzy-dependent capsular serotypes (Fig. 1.8) (Bender and Yother, 
2001; Morona et al., 2002; Morona et al., 2003; Bender et al., 2003; Kadioglu et 
al., 2008; Yother, 2011). The autophosphorylation of CpsD induces a 
conformational change in CpsC, which in turn slows down the capsule 
polymerization. The polymer is attached to the cell wall or membrane by a 
putative ligase. Dephosphorylation of CpsD by the CpsB phosphatase accelerates 
the polymerization process (Fig. 1.8). The phosphorylation and dephosphorylation 
cycles allow the complete synthesis of capsule (Bender and Yother, 2001; Bender 
et al., 2003; Yother, 2011). Deletion of wzd (cpsC) or wze (cpsD) reduces capsule 
amounts and the length of the chains (Bender et al., 2003; Xayarath and Yother, 
2007; Kadioglu et al., 2008; Yother, 2011). Inactivation of wzh (cpsB) leads to 
increased CpsD phosphorylation and increased amounts of capsule; size is 
apparently not affected (Bender and Yother, 2001; Yother, 2011). High levels of 
oxygen decrease phosphorylation of CpsD and therefore, decrease capsule 
amounts in S. pneumoniae (Weiser et al., 2001; Yother, 2011). In a recent review 
manuscript, J. Yother proposed that an elevated oxygen tension leads to 
decreased CpsC activity and increased CpsB phosphatase activity (reviewed in 
Yother, 2011). Despite the advances, the molecular mechanism by which this 
system controls capsule synthesis is not completely unraveled. Mutations in the 
genes coding the regulatory enzymes lead to attenuation of pneumococcal 
virulence (Morona et al., 2003; Morona et al., 2004).  
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Curiously, D39 pneumococcal ugd mutants, which lost the ability to form 
UDP-glucuronic acid, are only viable in the presence of a suppressor mutation in 
the wchA gene (Xayarath and Yother, 2007). These mutants show a reduction in 
capsule synthesis. The inability to synthesize or process a complete repeating 
unit is detrimental to the cell due to failure to transfer the carbohydrate polymers 
to the cell wall, indicating that UDP-glucuronic acid is essential in this process 
(Xayarath and Yother, 2007). Polymer chain length is affected by the availability 
of NDP-sugars (Ventura et al., 2006). Pyrimidine nucleotides, and in particular 
UTP and dTTP in serotype 2, are required for the activation of NDP-sugars  
(Fig. 1.8). In this thesis we directed efforts to prove the importance of the 
pyrimidine nucleobase uracil in capsule expression and production in  
S. pneumoniae (Chapters 2 and 3). 
 
Regulation of carbohydrate metabolism 
During its lifecycle in the host S. pneumoniae is exposed to a multitude of 
environmental conditions and specific microenvironments, such as the 
nasopharynx, lungs, blood, etc. To survive fluctuating environments bacteria 
evolved regulatory systems that sense extra- and intracellular conditions to mount 
appropriate cellular responses (reviewed in Brooks et al., 2011; Hindré et al., 
2012). At the molecular level, these responses are characterized by a 
readjustment of components at every layer of biological complexity, ultimately 
resulting in shaping of the cellular physiology to the new condition.  
Metabolic adaption to changing nutritional conditions is of central 
importance to bacterial survival, and thus is among the best studied functional 
responses in microorganisms (reviewed in Kilstrup et al., 2005; Deutscher et al., 
2006; Görke and Stülke, 2008; Amon et al., 2010). The in vivo capacity of 
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metabolic enzymes to realize catalytic fluxes is a function of their abundance and 
kinetic properties (Gerosa and Sauer, 2011). The layers of cellular regulatory 
mechanisms, transcription, post-transcription, translation and post-translation 
(degradation mechanisms) modulate enzyme abundance (Fig. 1.9) (Gerosa and 
Sauer, 2011). Post-translational modification, e.g. protein phosphorylation, may 
also affect enzymatic kinetic parameters (Fig. 1.9). On the other hand, allosteric 
regulation by effector molecules mediates exclusively enzyme kinetic parameters 
(Fig. 1.9). The in vivo reaction rates (i.e. metabolic flux) are the result of all the 
above mechanisms, plus the in vivo substrate (reactant) concentrations and 
competitive substrate inhibitors (Fig. 1.9). Feedback regulation of metabolite pools 
on the cellular regulatory layers increase tremendously the complexity of 
metabolism and its regulation (Fig. 1.9) (Gerosa and Sauer, 2011). Of all 
regulatory mechanisms, large-scale efforts were mostly directed towards 
transcriptional regulation, since mRNA abundance and DNA-binding are easier to 
measure than protein abundance and activity (Herrgård et al., 2004; Gerosa and 
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Fig. 1.9. Metabolism and points of regulation. Interplay between cellular regulation 
(transcriptional, post- transcriptional, translational, post-translational, allosteric) of enzyme 
capacities (enzyme abundance and kinetic properties), the environment and the 
metabolite pools, which feedbacks to all modes of enzyme regulation. Part of this figure 
was adapted from Gerosa and Sauer, 2011.  
 
 
Therefore, it is without surprise that in S. pneumoniae regulation of sugar 
metabolic enzymes has mainly been shown at the level of transcription. A number 
of transcriptional regulators, namely CcpA, CelR, SusR and ScrR, RafR and 
RafS, MalR, and two-component systems, such as TCS08 and CiaRH, affect the 
expression of sugar metabolic enzymes in S. pneumoniae (Nieto et al., 1997; 
Rosenow et al., 1999; Iyer et al., 2005; McKessar and Hakenbeck, 2007; Iyer and 
Camilli, 2007; Halfman et al., 2007; Shafeeq et al., 2011). MalR belongs to the 
LacI-GalR family of transcriptional repressors. In the presence of maltose, 
maltotriose or maltotetraose, the binding of MalR to operator sequences of 
operons involved in maltosaccharide uptake (malXCD) and utilization (malMP) is 
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inhibited (Nieto et al., 1997). RafR and RafS, identified in a gene cluster for 
raffinose metabolism, activate and repress, respectively, the aga (α-
galactosidase) gene in the presence of raffinose (trisaccharide of galactose, 
fructose and glucose) (Rosenow et al., 1999). SusR (coded by susR) and ScrR 
(coded by scrR) repress the expression of the downstream genes in the sus and 
scr operons, respectively, involved in sucrose transport and catabolism, in the 
absence of sucrose (Iyer and Camilli, 2007). CelR activates the expression of the 
gene cluster for utilization of cellobiose (Shafeeq et al., 2011). On the other hand, 
TCS08, in its active form (i.e. phosphorylated), downregulates cellobiose 
metabolism (McKessar and Hakenbeck, 2007). The results concerning the effect 
of the carbon catabolite protein A (CcpA) on sugar metabolism of S. pneumoniae 
are apparently strain-dependent: in strain D39 CcpA was shown to affect the 
growth rate on Glc and repress β-galactosidase activity in lactose-containing 
medium, independently of Glc, while in TIGR4 CcpA showed no effect on growth 
in Glc-medium, and repression of β-galactosidase in lactose-medium was only 
observed when Glc or sucrose (repressing sugars) were added (Giammarinaro 
and Paton, 2002; Iyer et al., 2005). The CiaR response regulator of the CiaRH 
two-component system controls various genes unrelated to sugar metabolism 
(e.g. sRNAs). Furthermore, it represses the manLMN operon (PTSMan) and 
weakly activates the malMP operon for maltosaccharide utilization (Halfmann et 
al., 2007). From these studies a model of the transcriptional regulatory networks 
controlling sugar metabolism is emerging. On the contrary, little is known about 
metabolic regulation of sugar metabolism in S. pneumoniae. To our knowledge, 
kinetic and other properties of central pathway (glycolysis and fermentation) 
enzymes remain largely unknown. Furthermore, predicting direct regulation in this 
organism is to a great extent hampered by the limited knowledge on intracellular 
metabolite pool sizes and dynamics. In other Streptococcaceae, such as L. lactis, 
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S. bovis and the oral streptococci (S. mutans, S. pyogenes, S. sanguis) regulation 
of glycolysis and pyruvate fermentation has been intensively investigated (Steele 
et al., 1954; White et al., 1955; Pierce, 1957; Yamada and Carlsson, 1975a; 
Yamada and Carlsson, 1975b; Keevil et al., 1984; Neves et al., 2002a; Neves et 
al., 2002b; Neves et al., 2005). Despite numerous research efforts, questions as 
to what controls the glycolytic flux or the shift from homolactic to mixed-acid 
fermentation remain unanswered. The wealth of data accumulated throughout the 
years permitted however to determine that the fate of pyruvate is dependent at 
least on sugar composition/concentration, levels of intracellular metabolites, 
oxygen content and transcriptional regulation (Yamada and Carlsson, 1975a; 
Yamada and Carlsson, 1975b; Keevil et al., 1984; Garrigues et al., 1997; 
Melchiorsen et al., 2000; Neves et al., 2002a; Cocaign-Bousquet et al., 2002; 
Neves et al., 2002b; van Niel et al., 2004; Neves et al., 2005; Abranches et al., 
2008). In the following subsections we will provide information about allosteric and 
transcriptional regulation of Glc and Gal metabolism in other Streptococcaceae, 
based on genome and literature surveys. Then we will focus on global 
transcriptional regulation and end with links between basic physiology and 
virulence.   
 
Control of glucose and galactose metabolism in Streptococcaceae 
 In Streptococcaceae the metabolism of Glc is typically homolactic, 
whereas the metabolism of Gal tends to mixed-acid fermentation (Fig. 1.10) 
(Cocaign-Bousquet et al., 2002; Neves et al., 2005). Under anaerobic conditions, 
this metabolic shift results from diminished flux through LDH combined with 
decreased flux through PFL, as evaluated by the end-products profile (Fig. 1.10). 
However, the mechanisms controlling these fluxes remain to be elucidated. 
Initially, in a number of Streptococcaceae (S. mutans, S. bovis, L. lactis, S. 
Chapter 1 
 36 
sanguis), the metabolic shift to mixed-acid was viewed as a consequence of 
allosteric metabolic regulation over the enzymes involved in the metabolism of 
pyruvate. In these studies, the production of lactate as major end-product from the 
anaerobic metabolism of Glc was explained as due to accumulation of the upper 
glycolytic metabolites G6P and FBP, which activate LDH and PK, and GAP and 
DHAP, potent PFL inhibitors (Fig. 1.10) (Wolin, 1964; Yamada and Carlsson, 
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Fig. 1.10. Fate of pyruvate during anaerobic Glc and Gal metabolism in 
Streptococcaceae. Allosteric activation and inhibition of enzymes by glycolytic 
intermediates are shown in dashed green and red arrows, respectively. Abbreviations: 
G6P, glucose 6-phosphate; PFK, phosphofructokinase A; FBP, fructose 1,6-bisphosphate; 
DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde 3-phosphate; 3-PGA, 3-
phosphoglycerate; PEP, phosphoenolpyruvate; PK, pyruvate kinase; LDH, lactate 
dehydrogenase; PFL, pyruvate formate-lyase; Acetyl-CoA, acetyl-coenzyme A. The 
information displayed in this figure derives from data obtained for Glc and Gal metabolism 
and allosteric regulation in different Streptococcaceae species.  
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 A later study suggested that the NADH/NAD+ ratio determines the pattern 
of end-products by affecting LDH and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) activities (Garrigues et al., 1997). It was also suggested 
that homolactic fermentation is a consequence of high glycolytic flux (Garrigues et 
al., 1997), which in turn was proposed to be controlled at the level of sugar 
transport (Even et al., 2001). More recently, LDH activity in L. lactis was shown to 
be modulated both by the FBP/Pi and the NADH/NAD
+ ratios. These findings 
allowed putting forward the idea that the fate of pyruvate is determined by the 
simultaneous operation of both (van Niel et al., 2004). 
Besides the allosteric control of metabolic enzymes, the transcriptional 
regulation of glycolytic enzymes and enzymes downstream of pyruvate also 
influences the distribution of end-products. For instance, in S. mutans and L. 
lactis, pfl expression is strongly activated on Gal when compared to Glc 
(Melchiorsen et al., 2000; Abranches et al., 2008). In L. lactis, the las operon, 
comprising pfk, pyk and ldh genes, was shown to be activated on Glc by the 
global transcriptional regulator CcpA, while pfl, ackA and adh genes involved in 
mixed-acid fermentation where strongly repressed by this regulator (Luesink et 
al., 1998; Zomer et al., 2007). The shift from homolactic towards mixed-acid 
fermentation under aeration observed in L. lactis in a null ccpA mutant led to the 
hypothesis that CcpA is a mixed-acid repressor (Gaudu et al., 2003; Lopez de 
Felipe and Gaudu, 2009). In S. mutans, pfl was also strongly repressed by CcpA 
on Glc (Abranches et al., 2008). In S. bovis, inactivation of ccpA also renders a 
more mixed-acid profile in Glc containing medium (Asanuma et al., 2004). Thus, 
CcpA presumably plays a chief role in the control of the fermentation type in 
Streptococcaceae. The mechanisms by which CcpA regulates gene expression 
will be described in the next subsection.  
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In summary, the factors governing the shift in fermentation are complex 
and involve at least allosteric and transcriptional regulation. 
Despite the relatedness between Streptococcaceae species, regulatory 
mechanisms specific to each species seem to be in effect (reviewed in Görke and 
Stülke, 2008). This view is even more relevant when considering the pathogenic 
members. Thus, in this thesis we investigated the metabolism of Glc and Gal in  
S. pneumoniae (Chapters 5 and 6).  
 
Carbon catabolite repression (CCR) and CcpA 
 One of the topics of this thesis is the transcriptional regulation of the 
adaptive response to Glc and Gal by the global transcriptional regulator CcpA 
(Chapter 6). Most fermentative bacteria, including S. pneumoniae, can use 
several sugars as sources of carbon. Each sugar has a specific set of enzymes 
dedicated to its transport and initial catabolism. Generally, when encountering a 
variety of carbon sources bacteria use them in a hierarchical manner, i.e. 
selectively and sequentially. Using all sugars simultaneously would be 
metabolically inefficient and a waste of energy (reviewed in Brückner and 
Titgemeyer, 2002; Deutscher, 2008; Görke and Stülke, 2008; Fujita, 2009). In 
Gram-positive bacteria, Glc is generally the selected or preferred sugar 
(repressing sugar), since it confers fastest growth. The process of repressing the 
expression of enzymes involved in the metabolism of alternative or less preferred 
carbon sources is termed carbon catabolite repression (CCR) (reviewed in 
Brückner and Titgemeyer, 2002; Deutscher, 2008; Görke and Stülke, 2008). CCR 
has been extensively studied in E. coli and Gram-positive bacteria (e.g. Bacillus 
subtilis, L. lactis, S. mutans, S. pyogenes). CCR may be achieved by global or 
operon/carbohydrate-specific regulatory mechanisms (e.g. inducer exclusion and 
inducer expulsion) (reviewed in Brückner and Titgemeyer, 2002; Deutscher, 2008; 
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Görke and Stülke, 2008). In the model Gram-positive bacterium B. subtilis as well 
as in pathogenic streptococci and the dairy L. lactis the main global regulator of 
gene expression involved in Glc-mediated CCR is CcpA. This protein is a LacI-
GalR family regulator and was initially discovered in B. subtilis (reviewed in 
Warner and Lolkema, 2003; Fujita, 2009). Other key players involved in CCR are 
the PTS component HPr protein, HPr kinase/phosphorylase (HPrK/P) and the 
glycolytic metabolites FBP and G6P (reviewed in Görke and Stülke, 2008).  
When a preferred sugar like Glc is in excess, the Glc-PTS components 
predominate in the unphosphorylated form and G6P, FBP and ATP accumulate to 
a high extent due to high glycolytic flux (Fig. 1.11). The high levels of FBP and 
ATP stimulate the activity of kinase of the bifunctional HPrK/P, which 
phosphorylates HPr in a Ser46 residue (Fig. 1.11) (Nessler et al., 2003). In turn, 
G6P and FBP stimulate allosterically the interaction of HPr(Ser46)~P with CcpA  
(Fig. 1.11) (Seidel et al., 2005; Schumacher et al., 2007; Görke and Stülke, 2008). 
The binding of HPr(Ser46)~P induces a conformational change in the dimeric protein 
CcpA that brings the N-terminal DNA-binding domain of CcpA into a position 
capable of binding DNA (Schumacher et al., 2004; Görke and Stülke, 2008). 
CcpA binds to operator sites called carbon catabolite responsive elements (cre) 
and interacts positively or negatively with RNA polymerase (RNAP) depending on 
the location of the cre site (Miwa et al., 2000; Kim et al., 2005; Zomer et al., 
2007). Binding of CcpA to a cre in the promoter region blocks the binding of RNA 
polymerase, thus repressing the expression of the catabolic genes (Fig. 1.11) 
(Zomer et al., 2007). For instance, in S. mutans Glc-mediated CCR of the 
virulence factor fructanase (fruA) is to a great extent regulated directly by the 
binding of CcpA to the fruA cre site localized in the transcription initiation site of 
the gene (Abranches et al., 2008). In several Gram-positive bacteria, CcpA was 
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found to repress its own expression in Glc (Egeter and Brückner, 1996; Mahr et 













































Fig. 1.11. Carbon catabolite control mediated by CcpA in Gram-positive bacteria. 
Under Glc-excess, the complex HPr(Ser46)~P/CcpA is formed and regulates the expression 
of catabolic genes. Grey lines: HPr(His15)~P, EIIAB~P and HPr(Ser46)~P modulate the 
expression of operon-specific catabolic genes, in a CcpA-independent manner. Allosteric 
activation by glycolytic intermediates is shown in dashed green arrows. Gene repression 
and activation are represented by red and green arrows, respectively. Abbreviations: G6P, 
glucose 6-phosphate; FBP, fructose 1,6-bisphosphate; PEP, phosphoenolpyruvate; EI 
and HPr are the cytoplasmatic proteins of the PTS-system; IIAB and IICD are the 
cytoplasmatic and transmembranar proteins of carbohydrate-specific PTS, respectively. 
RNAP, RNA polymerase; cre, catabolite responsive element; CCR, carbon catabolite 




When the cre site is within the gene, CcpA forms a roadblock for RNAP, 
thus repressing transcription (Fig. 1.11). Good examples are provided by the 
negative control exerted over the araB gene for the utilization of L-arabinose and 
the sigL structural gene controlling the levanase operon in B. subtilis (Inácio et al., 
2003; Choi and Saier, 2005; Görke and Stülke, 2008; Fujita, 2009).  
On the other hand, binding of CcpA to a cre site upstream of the promoter 
region may enhance the RNAP binding-activity leading to activation of gene 
expression (Fig. 1.11). This event is well described for the ackA and pta genes of 
B. subtilis and the las operon of L. lactis (Grundy et al., 1993; Luesink et al., 1998; 
Presecan-Siedel et al., 1999; Zomer et al., 2007). Generally, transcriptome 
studies comparing wild-type and ccpA strains grown on Glc show that CcpA acts 
primarily as a repressor (Tobisch et al., 1999; Zomer et al., 2007; Lulko et al., 
2007; Abranches et al., 2008; Shelburne et al., 2008b).  
Most studies concerning CCR/CcpA focused on the repression exerted by 
the preferred sugar Glc. However, CcpA-dependent CCR triggered by less 
preferred carbon sources has also been reported (Singh et al., 2008). In this 
study, it was demonstrated that the extent to which a variety of carbon sources 
exert CCR correlates with the amount of HPr(Ser46)~P in the cell. In view of these 
results, the authors hypothesized that the extent of the CcpA-dependent 
responses depends on the size of the glycolytic metabolite pools, and 
consequently the degree of HPrK activity, induced by each carbon source.  
Carbon catabolite regulation is not necessarily mediated by CcpA. Indeed, 
CCR mechanisms independent of CcpA have been described (reviewed in 
Brückner and Titgemeyer, 2002; Deutscher, 2008; Görke and Stülke, 2008). 
These mechanisms prevent operon/carbohydrate-specific induction of catabolic 
genes and include inducer exclusion and inducer expulsion processes and 
transcription regulators containing PTS-regulatory domains (PRDs) (reviewed in 
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Brückner and Titgemeyer, 2002; Deutscher, 2008; Görke and Stülke, 2008). In 
Gram-positive bacteria, the key players involved in these regulatory events are 
the PTS elements HPr(His15)~P, EII~P and HPr(Ser46)~P (Fig. 1.11) (reviewed in 
Brückner and Titgemeyer, 2002; Deutscher, 2008; Görke and Stülke, 2008). An 
example of an inducer exclusion process has been reported for S. thermophilus: 
in the presence of lactose and absence of Glc, the phosphorylation of the lactose 
permease (LacS) by HPr(His15)~P activates the transport of lactose; if Glc becomes 
available HPr is phosphorylated on Ser46, preventing the activation of LacS. 
Thus, in the presence of Glc the uptake of the inducer (lactose) is excluded 
(Gunnewijk and Poolman, 2000; Görke and Stülke, 2008). HPr(Ser46)~P was also 
shown to be involved in inducer exclusion phenomena by repressing non-PTS 
permeases in L. casei and L. lactis (Dossonet et al., 2000; Monedero et al., 2001; 
Brückner and Titgemeyer, 2002).  
 Inducer expulsion events are less common and not so well characterized. 
Classical examples of these phenomena are the expulsion of the non-
metabolizable thiomethyl-β-galactoside (TMG) and 2-deoxy-D-glucose 
carbohydrates, which accumulate intracellularly, in the presence of a fast 
metabolizable substrate (Reizer and Panos, 1980; Thompson and Saier, 1981).   
 The third mechanism controlling operon-specific induction of catabolic 
genes involves PRDs. PRDs are present in several proteins, including 
transcriptional regulators and transport systems. Direct phosphorylation of PRDs 
by HPr(His15)~P and EII~P changes the activity of the PRD-containing protein, 
which can act as transcriptional activator or RNA-binding anti-terminator protein 
(Stülke et al., 1998; Brückner and Titgemeyer, 2002; Görke and Stülke, 2008). A 
good example is provided by the LicT system in B. subtilis: in the absence of Glc 
and beta-glucosides, the PRD-containing anti-terminator LicT is phosphorylated 
by EII~P (from beta-glucoside PTS) and HPr(His15)~P in its two domains (PRD1~P 
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and PRD2~P), becoming inactive (Krüger et al., 1996; Stülke et al., 1998; Lindner 
et al., 1999; Tortosa et al., 2001; Lindner et al., 2002; Görke and Stülke, 2008). In 
the presence of beta-glucosides (inducer), EII~P phosphorylates the incoming 
sugar, leading to PRD dephosphorylation in one domain (PRD1). HPr(His15)~P 
maintains the remaining domain phosphorylated (PRD2~P). In this form, LicT 
activates a catabolic operon for the utilization of beta-glucosides (bglPH). If Glc 
becomes available, HPr(His15)~P phosphorylates the incoming Glc, thus leading to 
complete dephosphorylation of PRD, which renders LicT inactive (Krüger et al., 
1996; Stülke et al., 1998; Lindner et al., 1999; Tortosa et al., 2001; Lindner et al., 
2002; Görke and Stülke, 2008). 
In summary, the hierarchical utilization of sugars is conferred by a plethora 
of CcpA-dependent and independent CCR mechanisms. 
In the recent past a few studies appeared in the literature covering some 
aspects of carbon catabolite regulation in S. pneumoniae, and in particular of the 
role of CcpA in CCR. In this bacterium, CcpA was found to repress the activities 
of α-glucosidase and β-galactosidase in a Glc-independent manner 
(Giammarinaro and Paton, 2002). Later on, Iyer and co-workers showed that in 
the pneumococcus CcpA is involved in Glc-mediated CCR of lactose-inducible β-
galactosidase activity, but fails to regulate the expression of maltose-inducible α-
glucosidase, raffinose-inducible α-galactosidase and cellobiose-inducible β-
glucosidase (Iyer et al., 2005). More recently, Kaufman and Yother showed that 
the pts-bgaA operon, coding for a galactitol family PTS and β-galactosidase A, is 
directly controlled by CcpA, as denoted by the position of a cre site between -35 
and -10 promoter regions (Kaufman and Yother, 2007). The involvement of a 
second regulator in the control of the pts-bgaA operon was also postulated 
(Kaufman and Yother, 2007). In the above mentioned studies, CcpA-independent 
CCR mechanisms were a recurrent observation, which initially led to the idea that 
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in pneumococcus CcpA was not a global regulator of gene expression. In Chapter 
6 of this thesis we show that CcpA is indeed a global transcriptional regulator in  
S. pneumoniae.   
 
Links to virulence 
The primary goal of pathogenic bacteria, including S. pneumoniae, in 
transition between different niches is to gain access to nutrients for growth and 
cell division (reviewed in Görke and Stülke, 2008). A consequence of the 
adaptation to different environmental cues is the expression of virulence genes 
(reviewed in Görke and Stülke, 2008). The identification of regulators and their 
regulons helps understanding how S. pneumoniae responds to signals 
encountered during colonization and disease (reviewed in Hava et al., 2003). 
Several regulators and their role in virulence of S. pneumoniae have been 
described. Some of these regulators influence directly classical virulence genes, 
but others affect virulence indirectly by controlling the expression of metabolic 
pathways and other regulators. Regulators affecting sugar metabolic enzymes 














Table 1.2. Important regulators of S. pneumoniae affecting sugar metabolism and 
virulence.  
Regulators Main known regulatory role  References 
CelR Activates the expression of the cellobiose-utilization gene 
cluster  
Lau et al., 2001; 
Hava and Camilli, 
2002; Shafeeq et 
al., 2011  
RegR Represses hyaluronidase expression, which besides being 
involved in the metabolism of hyaluronic acid is a cell wall 
anchored protein and virulence factor  
Berry and Paton, 
2000; Chapuy-
Regaud et al., 
2003; Marion et 
al., 2012 
RegM/CcpA Impacts on sugar metabolic capabilities; the effect on capsule 
is serotype-dependent; the authors undermine the pleiotropic 
effect of this regulator 
Giammarinaro 
and Paton, 2002; 
Iyer et al., 2005 
SpxR Regulates positively spxB transcription; SpxB is an enzyme 
involved in the aerobic metabolism of S. pneumoniae and 
H2O2 virulence factor is the product of its activity 
Ramos-Montañez 
et al., 2008 
CiaRH  Activates htrA coding for a surface exposed serine protease, 
important for colonization and virulence; influences 
competence; slightly activates genes involved in sugar and 
choline metabolism; activates strongly 5 genes coding sRNAs  
Sebert et al., 
2002; Ibrahim et 
al., 2004; 
Halfmann et al., 
2007 




TCS09 This system is involved in regulation of several genes in a 
strain-dependent manner; activates genes involved in sugar 
metabolism in serotype 2 and 4.  
Throup et al., 
2000; Lau et al., 
2001; Hava and 
Camilli, 2002; 




The significance of in-depth studies on basic metabolic processes, and in 
particular those involved in sugar catabolism, is strengthened by the growing 
evidence connecting basic metabolism to virulence in S. pneumoniae. As 
depicted in Table 1.2, several transcriptional regulators control the expression of 
genes involved in sugar catabolic pathways as well as virulence factors. On the 
other hand, key metabolic enzymes, such as glyceraldehyde 3-phosphate 
dehydrogenase and enolase are also implicated in virulence. The work described 
in this thesis was devised to gain insight into basic physiology and sugar 
metabolism in S. pneumoniae, a still relatively unexplored and exciting field of 
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Summary 
Links between carbohydrate metabolism and virulence in Streptococcus 
pneumoniae have been recurrently established. Nevertheless, a deep 
understanding of basic physiology and metabolism of this human pathogen is 
missing. We developed a chemically defined medium (CDM) and growth 
conditions that allow high yield of strains D39 and R6 and application of NMR to 
study metabolism. The utilization of the defined medium enabled the evaluation of 
different environmental and nutritional factors on growth and fermentation pattern 
of strains D39 and R6 under controlled conditions of pH, temperature and gas 
atmosphere. Surprisingly, the same growth conditions impacted differently on D39 
capsulated, and its isogenic nonencapsulated derivative R6. A semi-aerobic 
atmosphere and a raised concentration of uracil, a fundamental component of 
D39 capsule, improved considerably D39 growth rate and biomass, respectively. 
In contrast, in strain R6, the growth rate was enhanced by strictly anaerobic 
conditions and uracil had no effect on biomass. In the presence of oxygen, the 
difference in the growth rates was mainly attributed to lower activity of pyruvate 
oxidase in strain D39. Moreover, our data indicate an intricate connection 
between capsule production in strain D39 and uracil availability. In this study, we 
have successfully applied the in vivo NMR technique to study sugar metabolism in 
S. pneumoniae R6. Glucose consumption, end-products formation and evolution 
of intracellular metabolite pools were monitored online by 13C-NMR. Additionally, 
the pools of NTP and inorganic phosphate were followed by 31P-NMR after a 
pulse of Glc. These results represent the first metabolic profiling data obtained 





Streptococcus pneumoniae is a commensal organism of the human 
nasopharynx, and an opportunistic bacterium that can cause a number of serious 
diseases such as pneumonia, meningitis and septicaemia (reviewed in Mitchell, 
2003). According to the World Health Organization (WHO), diseases caused by  
S. pneumoniae constitute a major global public health problem, leading to an 
estimated 1 million deaths per year in children under the age of five 
(http://www.who.int/nuvi/pneumococcus/en/). This high mortality is exacerbated 
by the rate at which the organism acquires resistance to traditional antibiotics. 
Therefore, it is without surprise that the study of S. pneumoniae pathogenesis has 
focused on attributes influencing host-pathogen interactions, such as toxins, cell 
wall components and capsule (reviewed in Kadioglu et al., 2008). However, 
factors that enable persistence and proliferation of the pneumococcus in different 
host niches, as well as the mechanisms coordinating expression of genes 
required to adapt have been largely neglected. As a strictly fermentative 
bacterium, carbohydrates are most likely the only nutrients from which the 
pneumococcus can obtain sufficient energy to support growth. This view is 
strengthened by the large portion of the pneumococcal genome that is devoted to 
carbohydrate uptake and metabolism (Tettelin et al., 2001; Hoskins et al., 2001; 
Lanie et al., 2007). It is, therefore, not surprising that genes involved in central 
metabolic processes, namely carbohydrate transport and utilization, recurrently 
appear in genome-wide studies aimed at identifying genes essential for virulence 
(Shelburne et al., 2008a). Growing evidence adds to these findings by showing 
that carbohydrate transport systems, metabolic enzymes and a global regulator of 
carbon metabolism (CcpA) directly contribute to S. pneumoniae colonization and 
disease (Giammarinaro and Paton, 2002; Iyer et al., 2005; Kaufman and Yother, 
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2007; Iyer and Camilli, 2007; Trappetti et al., 2009; Yesilkaya et al., 2009; Marion 
et al., 2011; Marion et al., 2012). These studies establish a link between 
regulation of virulence and carbohydrate metabolism, denoting a far greater 
importance of basic metabolic physiology than previously imagined. Recently, it 
was recognized that a true understanding of metabolism is perhaps more difficult 
to attain than that of any other cellular system (Heinemann and Sauer, 2010), 
because metabolism is influenced by a vast number of regulatory activities at 
different cellular levels, and metabolism itself feeds back to all the other cellular 
processes, including metabolic networks. In accordance, lack of correlation 
between metabolic behaviors and changes in transcript levels (Griffin et al., 2002; 
Daran-Lapujade et al., 2007; Hathaway et al., 2012), emphasize the importance 
of examining in detail metabolic operation. Capturing the essence of complex 
regulatory mechanisms as those involved in carbohydrate metabolism demands 
the use of well-defined physiological conditions.  
A powerful technique for studying metabolism in a non-invasive way is in 
vivo NMR spectroscopy. This methodology provides real time information on the 
pools of intracellular metabolites and metabolic fluxes and can also be used to 
identify metabolic bottlenecks and regulatory sites (reviewed in Neves et al., 
2005). The application of NMR to study metabolism is largely facilitated by the 
use of a proper chemically defined medium (CDM) for growth (Neves et al., 1999). 
In CDM all the components and respective concentrations are defined facilitating 
data interpretation and improving reproducibility between experiments (Cocaign-
Bousquet et al., 1995; Zhang et al., 2009). CDM formulations for S. pneumoniae 
are available, but the maximal pneumococcal biomass formed in these media is 
generally below an optical density value of 1 (Tomasz, 1964; Sicard, 1964; 
Kloosterman et al., 2006a). Low biomass yields are inadequate when in vivo NMR 
is to be used for metabolic studies, as this technique requires the utilization of 
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dense cell suspensions. Furthermore, paramagnetic ions (e.g. Mn2+, Fe2+), which 
are well known for lowering the sensitivity of NMR spectroscopy (reviewed in 
Neves et al., 2005), are generally present in relatively high concentrations in the 
defined media for the pneumococcus.   
Most cultivation optimizations for streptococcal growth were performed in 
complex media with the goal of producing capsular polysaccharide on a large-
scale for industrial application (e.g. manufactured vaccines) (Gonçalves et al., 
2003; Massaldi et al., 2010). To our knowledge, there is no specific data on 
growth and cultivation conditions in CDM supporting high biomass production of 
the laboratory model S. pneumoniae serotype 2 strain D39 and its acapsular 
derivative R6 (Avery et al., 1944; Tomasz, 1964; Hoskins et al., 2001; Lanie et al., 
2007). Curiously, and despite the historical significance of these two strains, a 
thorough comparative metabolic characterization is missing. In this work, we 
optimized a CDM and growth conditions that support high yields of strains D39 
and R6. Growth and fermentation profiles in the improved CDM were obtained for 
both strains under controlled conditions of pH, gas atmosphere and temperature. 
The effect of oxygen, Glc and nucleobases on the growth physiology of the two 
strains was assessed. Dissimilarities in growth profiles were tentatively interpreted 
on the basis of the reported differences in the genetic content of strains D39 and 
R6 (Lanie et al., 2007). Finally, the optimized cultivation conditions achieved for 
strain R6 were proven suitable for in vivo NMR experiments. The metabolism of 
Glc was studied non-invasively in real time. Time series for the consumption of 
Glc, end-products formation and accumulation of the glycolytic intermediate 
fructose 1,6-bisphosphate (FBP) were obtained by 13C-NMR with a time resolution 
of 30 s, while the pools of NTP and inorganic phosphate were followed by 31P-
NMR. The application of this technique to S. pneumoniae is expected to extend 
our knowledge on the intricate metabolic operation of this human pathogen.  
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Materials and Methods  
Bacterial strains, stocks preparation and storage 
The S. pneumoniae strains used in this study were a serotype 2 D39 and 
its unencapsulated derivative R6 obtained from the Department of Molecular 
Biology of the University of Groningen. This strain D39 displays characteristics of 
the D39 Lilly isolate (Avery et al., 1944; Lanie et al., 2007). Long-term storage of 
strains D39 and R6. Permanent stock cultures (1 ml) were prepared in cryogenic 
vials from cells grown in M17 broth (Difco) supplemented with 0.5% (wt/vol) Glc 
(Glc-M17), harvested in exponential phase, and were maintained at -80ºC in 25% 
(vol/vol) glycerol. Stocks preparation. D39 and R6 cells scraped from the 
permanent frozen stocks were grown overnight (~14 h) in 5 ml Glc-M17, at 37ºC 
and stored as 1 ml aliquots in 10% (vol/vol) glycerol at -80ºC. Preparation of 
working stocks. Strains D39 and R6 were cultured by transferring 1 ml aliquot of 
the frozen stock cultures into 50 ml of Glc-M17, followed by incubation at 37ºC 
until late-exponential phase (OD600 0.8 - 1.0). Cultures were then centrifuged  
(5750 × g, 7 min, 4ºC), the supernatants discarded and the pellets were 
concentrated 2-fold in fresh M17. Aliquots of 1 ml were stored in 10% (vol/vol) 
glycerol at -80ºC. 
 
S. pneumoniae growth studies 
S. pneumoniae was grown in the CDM described in Table 2.1 prepared in 
bi-distilled water (Millipore E-POD), except when stated otherwise. Growth was 
monitored hourly by measuring the optical density at 600 nm (OD600). Batch 
cultivations were initiated at an OD600 of 0.05-0.06 by the addition of a preculture 
(3-4% vol/vol). The precultures were prepared as follows: 1 ml working stock (D39 
or R6) was used to inoculate 80 ml of CDM buffered with disodium β-
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glycerophosphate and containing 60 mM Glc, in 100-ml static rubber-stoppered 
bottles; cultures were incubated 6-7 h (OD600 0.8 - 1.0) at 37ºC, without pH control 
(initial pH 6.5). Incubation was kept below 7 h to avoid using stationary phase 
cells for inoculation. Preculturing allows for adjustment of the bacteria to the 
culture medium and decreases culture variability. Specific growth rates (µ) were 
calculated through linear regressions of the plots of ln(OD600) versus time during 
the exponential growth phase. Figures throughout this chapter show individual 
growth curves from representative experiments. 
Batch cultivations without pH control. For S. pneumoniae cultures 
grown without pH control (initial pH 6.5) the CDM was buffered with disodium β-
glycerophosphate (higher buffering capacity than phosphate buffer) and 
supplemented with 60 mM Glc. Routinely, cells were cultivated in static rubber-
stoppered bottles (semi-aerobic conditions, 80 ml in 100-ml bottles); for aerobic 
conditions cells were grown in shake flasks (CDM volume 1/5 of the flasks total 
capacity) in an orbital shaker (AGITORB 200, Aralab) at 150 rpm. For each 
growth condition at least two independent experiments were performed. The error 
in each point of the growth curves was always below 15%.  
The uracil-dependency on growth of strain D39 was assessed by 
cultivating cells in semi-aerobic conditions as above, except that uracil was 
omitted or added to the medium in the following concentrations: 0.67, 1, 3.3, 5, 
10, 30 and 40 mg l-1. Two independent experiments were performed at least for 
each growth condition. The error in each point of the growth curves was always 
below 10%.  
The effect of nucleobases (xanthine, adenine, guanine and uracil) on the 
growth of strain D39 was tested as follows: cultures of 250 µl were prepared in 
CDM containing 0.25% (wt/vol) Glc and each nitrogenous base was added 
individually to a final concentration of 30 mg l-1. Cultures were started at an initial 
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OD595 of 0.25-0.3, by addition of an exponential growing preculture suspended in 
fresh CDM without nucleobases, and grown for 24 h at 37°C in 96-well microtiter 
plates. Growth was monitored every 30 min at 595 nm with a ELx808 microplate 
spectrophotometer (BioTek Instruments, Inc.), and growth curves generated by 
using Gen5TM (BioTek Instruments, Inc.). Each growth condition was done in 
triplicate using two independent precultures. The error in each point of the growth 
curves was always below 5%. 
Batch cultivations in bioreactors with pH control. D39 and R6 strains 
were grown in CDM in a 2-l bioreactor (Sartorius Biostat® B plus) with the pH-
controlled at 6.5, and under anaerobic (argon atmosphere), semi-aerobic (initial 
specific air tension of 50-60%) or aerobic (continuous specific air tension of 40%) 
conditions. For anaerobic growth, the medium was degassed by flushing argon 
overnight preceding inoculation, and the headspace was continuously sparged 
with argon at a rate of 50 ml min-1 during growth. For the semi-aerobic conditions 
and aerobic growth, dissolved oxygen was monitored with a polarographic oxygen 
electrode (Mettler-Toledo International). The electrode was calibrated to zero or 
100% by bubbling sterile argon or air through the medium, respectively. The 
continuous specific air tension of 40% in the culture medium was maintained by 
automatic control of the airflow and agitation. Specific air tension consumption 
over time in growth under semi-aerobic conditions was registered in the 
MFCS/DA software (B. Braun Biotech International) coupled to the fermentation 
unit. Independently of the growth condition, Glc was used as carbon source at a 
final concentration of about 60 mM, except when the effect of Glc concentration 
on growth was tested. For these experiments, Glc was added to the medium at 
concentrations of 0.5%, 1% and 3% (wt/vol). To investigate the effect of 
nucleobases (Table 2.1) on growth, their concentrations were raised from 10 to 30 
mg l-1 in the culture medium. To test the effect of uracil per se on growth of strains 
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D39 and R6 the concentration of this nucleobase was increased from 10 to 30 mg 
l-1. The pH was kept at 6.5 by the automatic addition of 10 M NaOH, and the 
temperature was set to 37ºC. Under anaerobic and semi-aerobic conditions 
culture homogenization was achieved by maintaining an agitation speed of 70 
rpm. For each growth condition at least two independent experiments were 
performed. The error in each point of the plotted growth curves was always below 
20%. 
 
Kinetics of oxygen consumption  
Oxygen concentration in the culture medium was calculated using the 
equation of Henry’s Law: XO2 (mol O2 mol
-1 H2O) = PO2/H. The partial pressure of 
oxygen (PO2, atm) in the culture medium was calculated by multiplying the 
percentage of air in the culture medium by the percentage of O2 in an atmosphere 
saturated with air (20.95% (vol/vol) of O2). The Henry’s Law constant (H) for O2 at 
37ºC is 5.18 x 10-4 atm mol-1 O2 mol
-1 H2O. Water concentration (mol H2O l
-1 H2O) 
is 55.5 M. The oxygen consumption rate (qs
max in Fig. 2.5) was estimated from a 
first-order derivative of a polynomial fit of the observed O2 consumption time 
series. Dry weight (DW) was used as a measure of cell mass. 
 
Quantification of glucose and fermentation products  
Strains were grown in CDM supplemented with Glc and with pH control. 
Culture samples (2 ml) were taken at different time-points of growth, centrifuged 
(16,000 × g, 2 min, 4ºC), filtered (Millex-GN 0.22 µm filters) and the supernatant 
solutions were stored at -20ºC until analysis by high performance liquid 
chromatography (HPLC). Substrates and end-products were quantified in an 
HPLC apparatus equipped with a refractive index detector (Shodex RI-101, 
Showa Denko K. K.) using an HPX-87H anion exchange column (Bio-Rad 
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Laboratories Inc.) at 60ºC, with 5 mM H2SO4 as the elution fluid and a flow rate of 
0.5 ml min-1. Alternatively, quantification of metabolites in the supernatant 
solutions was performed by 1H-NMR in a Bruker AMX300 spectrometer (Bruker 
BioSpin GmbH). Formic acid (sodium salt) was added to the samples and used as 
an internal concentration standard. The ATP yield was calculated as the ratio of 
ATP produced to Glc consumed. The global yields of ATP were calculated from 
the fermentation products determined at the time-point of growth arrest assuming 
that all ATP was synthesized by substrate-level phosphorylation. A factor of 0.39, 
determined from a DW (mg ml-1) versus OD600 curve, was used to convert OD600 
into dry weight (mg biomass ml-1). For the aerobic samples, hydrogen peroxide 
was quantified in fresh supernatant solutions as described below. 
 
Determination of hydrogen peroxide (H2O2) 
Hydrogen peroxide was determined in supernatants of cultures grown 
under semi-aerobic and aerobic conditions and with pH set to 6.5. Culture 
samples of 1-ml were harvested at different time-points of the growth curves, 
centrifuged (16,000 × g, 2 min, 4ºC) and filtered (Millex-GN 0.22 µm filters). The 
Amplex® Red Hydrogen Peroxide/Peroxidase assay kit (Invitrogen) was used to 
quantify H2O2 contents below 10 µM. Determinations of H2O2 up to 300 µM were 
performed as described elsewhere (Meiattini, 1988). Briefly, 1.25 ml of peroxide 
reagent (192 mM phosphate, 14.8 mM azide, 0.96 ml l-1 Triton X-100, 2 KU l-1 
horseradish peroxidase (Roche), 0.48 mM 4-aminophenazone and 9.6 mM 
chromotropic acid) was added to 50 µl of supernatant, mixed and allowed to stand 
for 5 minutes at room temperature. In the presence of H2O2, the chromotropic acid 
was converted by the peroxidase into a blue coloured compound with maximal 
absorbance at 600 nm. Absorbance was read at 600 nm. Water was used as the 
blank and standard curves were performed with fresh dilutions of a stabilized 
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solution of 30% (wt/vol) H2O2. The absorbance of the samples was compared to 
that of the standard solutions. 
 
Enzymatic activities  
(i) Pyruvate oxidase activity. Cell lysates and pyruvate oxidase activity 
were performed as described in (Belanger et al., 2004) with minor modifications. 
Cells grown aerobically with pH control were harvested in late-exponential phase 
of growth (R6, OD600 0.16 ± 0.00; D39, OD600 0.29 ± 0.06), centrifuged (5750 × g, 
5 min, 4ºC), and the pellets washed twice in one volume of 50 mM KPi, pH 7.4. 
Cells were re-suspended in 0.1 volume of the same buffer containing 0.1% Triton 
X-100, and incubated for 10 min at 37ºC. Reactions for determination of pyruvate 
oxidase activity contained 50 mM potassium phosphate (pH 6.0), 5 mM MgSO4, 
0.5 mM thiamine pyrophosphate, 0.1 mM FAD, 15 mM sodium pyruvate,  
0.2 U ml-1 horseradish peroxidase, 100 µM Amplex® Red Reagent (Invitrogen) 
and 10 µl of cell lysate. Standard curves were performed with fresh dilutions of a 
stabilized solution of 30% (wt/vol) of H2O2. The assays were incubated at 37ºC 
and the absorbance of the reaction was read in a SmartSpecTMPlus 
spectrophotometer (BioRad) at 563 nm every 5 min for 1h. 
(ii) NADH oxidase activity. NADH oxidase activity was determined in 
cells grown without pH control under semi-aerobic and aerobic conditions. Cells 
were harvested in late-exponential phase of growth (Fig. 2.1), and cell lysates 
prepared as above. NADH oxidase activity was assayed spectrophotometrically 
(Beckman DU70) at 37ºC in a total volume of 1 ml containing 100 mM Tris-HCl 
buffer, pH 7.2, 5 mM MgCl2, and 0.29  mM NADH. The reaction was initiated by 
the addition of an adequate amount of cell lysate and monitored by the decrease 
in absorbance at 340 nm. One unit of enzyme activity was defined as the amount 
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of enzyme catalyzing the conversion of 1 µmol of substrate per minute under the 
experimental conditions used.  
(iii) Lactate dehydrogenase activity. Lactate dehydrogenase (LDH) 
activity was determined in cells grown without pH control under semi-aerobic 
conditions. Cells were grown until late-exponential phase, centrifuged (5750 × g, 
5 min, 4ºC), washed with KPi 10 mM (pH 7.0) and suspended in the same buffer. 
The cell suspensions were disrupted in a French Press (SLM Aminco 
Instruments, Golden Valley, MN, USA) at 36 MPa. LDH activity was assayed 
spectrophotometrically by NADH measurement, as described elsewhere (Gaspar 
et al., 2007), except that the temperature was kept at 37ºC. 
 
In vivo 13C-NMR experiments 
S. pneumoniae R6 cells (2l) were grown under anaerobic conditions with 
pH control as described above, harvested in the late-exponential phase of growth 
(OD600 1.9), centrifuged (5750 × g, 7 min, 4ºC), washed twice with 5 mM KPi 
buffer with 2% (wt/vol) choline, pH 6.5 (5750 × g, 5 min, 4ºC) and suspended to a 
protein concentration of 13-14 mg ml-1 in 50 mM KPi with 2% (wt/vol) choline, pH 
6.5. Deuterium oxide (2H2O) was added to a final concentration of 6% (vol/vol) to 
provide a lock signal. NMR experiments were performed using the on-line system 
described elsewhere, which consists of a mini-bioreactor (50 ml working volume) 
coupled to NMR detection with a circulating system that allows for non-invasive 
studies of metabolism under controlled conditions of pH, gas atmosphere and 
temperature (Neves et al., 1999). Glc specifically labeled with 13C on carbon one 
(20 mM) was added to the cell suspension at time-point zero and spectra (30 s) 
acquired sequentially after its addition. The time course of Glc consumption, 
product formation, and changes in the pools of intracellular metabolites were 
monitored in vivo. At the end of the in vivo NMR experiment the cell suspension 
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was passed through a French press: the resulting cell extract was incubated at 
80-90 C (10 min) in a stoppered tube, cooled down on ice and cell debris and 
denatured macromolecules were removed by centrifugation. The supernatant 
(NMR-extract) was used for quantification of end-products and minor metabolites 
as below. Due to the fast pulsing conditions used for acquiring in vivo 13C-spectra, 
correction factors for resonances due to C1 and C6 of FBP (0.73 ± 0.02) were 
determined to convert peak intensities into concentrations as described by Neves 
et al. (2002a), except that the temperature was kept at 37ºC. The quantitative 
kinetic data for intracellular metabolites were calculated as described elsewhere 
(Neves et al., 1999). The lower limit for in vivo NMR detection of intracellular 
metabolites under these conditions was 3-4 mM. Intracellular metabolite 
concentrations were calculated using a value of 3.0 µl (mg of protein)-1 
determined for the intracellular volume of S. pneumoniae as in Ramos-Montañez 
et al. (2010). Although individual experiments are illustrated in each figure, each 
type of in vivo NMR experiment was repeated at least twice and the results were 
highly reproducible. The values reported are averages of two experiments and the 
accuracy varied from 5% to 15% in the case of metabolites with concentrations 
below 5 mM.  
 
In vivo 31P-NMR experiments  
Cell suspensions were prepared as above, except that 50 mM MES buffer, 
pH 6.5, was used. Glc (20 mM) was added to the cell suspension at time-point 
zero and spectra (2 min 6 s) acquired sequentially after its addition. Pools of NTP 
and inorganic phosphate (Pi) were obtained in real time non-invasively. 
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Quantification of products by NMR  
Lactate and acetate were quantified in NMR-extracts by 1H-NMR (Neves 
et al., 1999). Formic acid (sodium salt) was added to the samples and used as an 
internal concentration standard. The concentration of minor products (glycerol, 
glycerate, alanine, aspartate, ethanol) and metabolic intermediates that remained 
inside the cells (3-phosphoglycerate, 3-PGA) was determined from the analysis of 
13C spectra of NMR-extracts as described by Neves et al. (1999). The 
concentration of labeled lactate determined by 1H-NMR was used as a standard 
to calculate the concentration of the other metabolites in the sample. 
 
NMR Spectroscopy 
Carbon-13 and phosphorus-31 spectra were acquired at 125.77 MHz and 
202.48 MHz, respectively on a Bruker AVANCE II 500 MHz spectrometer (Bruker 
BioSpin GmbH). All in vivo experiments were run using a quadruple nuclei probe 
head at 37ºC as described elsewhere (Neves et al., 1999). Acquisition of 
31P-NMR and 13C-NMR spectra was performed as described by Neves et al. 
(1999). For calculation of the correction factors 13C-NMR spectra were acquired 
with a 60º flip angle and a recycle delay of 1.5 s (saturating conditions) or 60.5 s 
(relaxed conditions). Carbon and phosphorus chemical shifts are referenced to 
the resonance of external methanol and H3PO4 (85% vol/vol) designated at 49.3 








Results and Discussion  
Chemically defined medium for high yield streptococcal growth  
The study of metabolic complexity is largely facilitated by the application of 
well defined environmental and nutritional conditions. In this respect, bacterial 
growth in media for which the exact component concentrations are known 
(chemically defined media) is preferred. A number of CDM formulations have 
been described before for S. pneumoniae (Tomasz, 1964; Sicard, 1964; 
Kloosterman et al., 2006a). However, these CDM were not suitable to obtain 
enough biomass for in vivo NMR experiments due to the presence of high 
concentrations of paramagnetic ions and to the low biomass yields obtained 
during growth. Paramagnetic ions broaden the line width of NMR spectra, 
decreasing significantly the spectral quality and hampering detection of 
intracellular metabolites. Thus, we sought for a CDM formulation devoid of 
paramagnetic ions that could be used routinely in the laboratory to grow S. 
pneumoniae with high biomass production. A CDM enabling the acquisition of 
high quality NMR data has been described for the closely related bacterium 
Lactococcus lactis (Neves et al., 1999). We used the lactococcal medium as 
starting point to develop a CDM intended for all physiological studies performed in 
our laboratory. However, a simplification and optimization of the medium was not 
carried out, since our aim was not to design a minimal medium containing only 
essential nutrients. Conversely, our goal was to obtain a CDM for high yield 
streptococcal growth. Thus, initial growth tests, in which the lactococcal CDM was 
supplemented with additional nutrients, were performed with S. pneumoniae 
strain R6 in standing rubber-stoppered bottles using 60 mM of Glc as carbon 
source. Choline-HCl and pyruvate (Table 2.1) are chemicals generally used in 
CDM for S. pneumoniae growth (Tomasz, 1964; Sicard, 1964; Kloosterman et al., 
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2006a). The growth dependency of S. pneumoniae on exogenous choline, which 
is used to decorate its unusual teichoic acids, is well known (Tomasz, 1967), and 
was confirmed in our conditions (data not shown). Furthermore, we verified that 
increasing the choline-HCl concentration from 5 to 10 mg l-1 increased the final 
biomass by 30%.  
 
Table 2.1. Composition of CDM used for growth of S. pneumoniae in pH-controlled batch cultures 
Components Concentration (g l-1) Components Concentration (g l-1) 
Buffers/Salts Aminoacids (10-3) 
KH2PO4 3.0 Alanine 0.24 
K2HPO4
a 2.5 Arginine 0.13 
Na - acetate 1.0 Asparagine 0.35 
(NH4)3 - citrate 0.6 Aspartate 0.40 
Na- pyruvate 0.1 Cysteine-HCl 0.40 
Vitamins (10-3) Glutamate 0.50 
Choline-HCl 0.01 Glutamine 0.39 
Na-p-Aminobenzoate 5.0 Glycine 0.18 
D-biotin 2.5 Histidine 0.15 
Folic acid 1.0 Isoleucine 0.21 
Nicotinic acid 1.0 Leucine 0.46 
Ca (D+) Pantothenate 1.0 Lysine 0.44 
Pyridoxamine-HCL 2.5 Methionine 0.13 
Pyridoxine-HCl 2.0 Phenylalanine 0.28 
Riboflavin 1.0 Proline 0.68 
Thiamine-HCl 1.0 Serine 0.34 
DL-6,8-Thioctic acid 1.5 Threonine 0.22 
Vitamin B12 1.0 Tryptophane 0.05 
Nucleobases (10-2) Valine  0.33 
Adenine 1.0 Micronutrients (10-1) 
Uracil 1.0 MgCl2 2.0 
Guanine 1.0 CaCl2 0.4 
Xanthine 1.0 ZnSO4 0.05 
aK2HPO4 is replaced by disodium β-glycerophosphate (21 g l
-1) for growth without pH control 
Chapter 2 
 64 
Sodium pyruvate (0.1 g l-1, Table 2.1) is an ingredient of our CDM, but a 10-fold 
concentration reduction or even its omission had no effect on biomass or growth 
rate of strains (data not shown). Possibly, the acetate present in our CDM (Table 
2.1) masks the effect arising from pyruvate depletion (Ramos-Montañez et al., 
2010). Moreover, individual addition of CuSO4, FeCl3, CoCl2, or MnSO4 to a final 
concentration of 0.05 mg l-1 in the medium had no effect on the growth profile of 
S. pneumoniae R6 (data not shown). Also, supplementation with tyrosine  
(0.025 g l-1) or inositol (0.5 mg l-1) showed no effect, while ascorbate (0.5 g l-1) 
affected the growth negatively and complex nitrogenous sources (soytone and 
casein EH) improved the final biomass by about 50%. The latter result might 
indicate a preference of S. pneumoniae for oligopeptides over single amino acids. 
Oligopeptide transporters have been identified in S. pneumoniae (Alloing et al., 
1994; Hoskins et al., 2001). The undefined composition of the complex 
nitrogenous sources hinders, however, their inclusion in our CDM. Thus, the final 
composition of the medium was set as in Table 2.1, and typical growth curves for 
precultures and cultures obtained under semi-aerobic conditions (standing rubber-
stoppered bottles, cultivation conditions as in Materials and Methods) for strains 





























































R6 () 0.64 0.02
D39 () 0.80 0.01
µ (h-1)
R6 () 0.42 0.03























Fig. 2.1. Growth profiles of strains D39 and R6 without pH control. Growth of strains 
D39 () and R6 () in CDM containing 60 mM Glc, without pH control (initial pH of 6.5), 
at 37ºC, under different oxygen atmospheres. (A) precultures (graph above) and cultures 
(graph below) were grown under semi-aerobic conditions in static rubber-stoppered 
bottles (B) cultures were grown aerobically in shake flasks at 150 rpm. OD600 was 
measured at 1-h intervals. Cultures were inoculated with a preculture in late-exponential 
phase (6-7 hours incubation at 37ºC, OD600 0.8-1.0). The arrows indicate the time-points 
at which cells were harvested for measurement of NADH oxidase and LDH activities. The 
growth rates for each culture grown semi-aerobically and aerobically are also indicated 




Batch cultivations under controlled environmental conditions 
S. pneumoniae is a strictly fermentative organism that relies on the energy 
obtained during the conversion of sugars into pyruvate for growth. To fulfill the 
redox balance, the NAD+ consumed in glycolysis is primarily recycled through 
reduction of pyruvate to lactate, causing acidification of the medium and ultimately 
growth arrest. It is well established that increasing acidities progressively inhibit 
growth of Streptococcaceae (Béal et al., 1989; Mercade et al., 2000). Thus, we 
hypothesized that biomass production could be improved by maintaining the 
medium pH at 6.5, a value determined in independent experiments to be 
beneficial for growth of S. pneumoniae (data not shown). To circumvent medium 
acidification we resorted to high performance bioreactors to perform batch 
cultivations of S. pneumoniae. Bioreactors allow for the tight control of pH, as well 
as other growth parameters, such as gas atmosphere and temperature, and 
provide increased working volumes. Hence, strain R6 was grown in a 2-l 
fermentor vessel under controlled conditions of pH (6.5), temperature (37ºC) and 
gas atmosphere (anaerobiosis), and the effects of pH control and preculture age 
examined in CDM supplemented with 60 mM Glc.  
(i) Effect of pH control and preculture age on growth of  
S. pneumoniae R6. Preliminary results pinpointed the age of the starting 
preculture as a determinant factor in the physiology of growth. This observation 
was confirmed in batch cultivations in which all other parameters were kept 
constant, except for the age of the preculture used to initiate growth (Fig. 2.2 and 
Table 2.2).  
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Fig. 2.2. Effect of preculture age. Growth of strain R6 in CDM containing 60 mM Glc, 
under controlled conditions of pH (6.5), temperature (37ºC) and atmosphere (anaerobiosis 
with argon atmosphere), in a 2-l bioreactor. OD600 was measured at 1-h intervals. 
Symbols: (), inoculation with a preculture in late-exponential phase (LExp, 6-7 hours of 
incubation at 37ºC); (), inoculation with a preculture in early-stationary phase (EStat, 8-9 
hours of incubation at 37ºC); (), inoculation with a preculture in late-stationary phase 
(LStat, 18 hours of incubation at 37ºC).  
 
 
Table 2.2. Growth parameters (length of lag, maximal growth rate and biomass) obtained 
for strain R6 cultures started with precultures harvested in different phases of growth, as 
in Fig. 2.2. The values for maximal growth rate and maximal biomass are averages of at 
least two independent experiments and the errors are reported as ± SD. 
Preculture Culture (as in Fig. 2.2) 
Growth phase Time (h) OD600 Lag μmax (h
-1
) ODMax 
LExp 6-7 0.8-1.0 No 0.78 ± 0.03 3.7 ± 0.0 
EStat 8-9 1.4-1.6 No 0.37 ± 0.00 2.0 ± 0.3 
LStat 18 ~1.0 No growth
a
 - - 
LExp, late-exponential, EStat, early-stationary, LStat, late-stationary phases of growth; 
a
No growth 




Indeed, both the growth rate (μ, h-1) and the maximal cell mass (ODMax) were 
considerably higher when late-exponentially phase precultures (6-7 hours at 
37ºC) rather than early-stationary precultures (8-9 hours at 37ºC) were used for 
inoculation. Moreover, no growth was detected during the 14 h of monitoring 
when precultures in late-stationary phase (18 h) were used for inoculation. 
Although a full explanation cannot be put forward, it is likely that with ageing 
larger fractions of the cell population switch to the lytic phase and are thereby 
unable to divide (Tomasz et al., 1970; López and García, 2004; Regev-Yochay et 
al., 2007). Cell viability was not determined under these conditions, but a 
repeatedly observed decrease in the maximal OD600 after 10-11 hours of 
incubation at 37ºC is indicative of cell death/lysis. The initial growth retardation 
can be understood in this basis, but the reason as to why the maximal biomass is 
much lower remains unclear. It is well documented that both the metabolic status 
and gene expression are dramatically affected in cells entering stationary phase 
(Kolter et al., 1993; Regev-Yochay et al., 2007; Navarro Llorens et al., 2010), and 
consequently the observed dissimilar behaviors can lie in complex mechanisms, 
which study is out of the scope of this work. Considering the results, the utilization 
of exponentially harvested S. pneumoniae cells to initiate cultures was applied 
and is routinely used in our laboratory. Implementation of this procedure 
circumvented an array of growth defects, such as long lag phases, inability to 
enter exponential phase or low biomass production.  
As for pH control, in accordance to our hypothesis R6 cultures grown at 
constant pH of 6.5, under semi-aerobic conditions (Fig. 2.3-A), showed a 2-fold 
increase in maximal biomass (ODMax 3.6 as compared to 1.7-1.9 in cultures 
without pH control) and identical growth rate (Table 2.3 and Fig. 2.1-A). Thus, pH 
is a key parameter to control when high biomass yields are to be obtained. 
 









































































Fig. 2.3. Effect of oxygen on growth profiles. Growth of strains D39 () and R6 () in 
CDM containing 61 ± 1 mM Glc, under controlled conditions of pH (6.5), temperature 
(37ºC) and atmosphere (A) semi-aerobiosis (initial specific air tension of 50-60%) (B) 
anaerobiosis with argon atmosphere (C) aerobiosis (continuous specific air tension of 
40%), in a 2-l bioreactor. OD600 was measured at 1-h intervals or less for aerobic growths. 
All cultures were inoculated with a preculture in late-exponential phase (6-7 hours 









Table 2.3. Growth parameters (length of lag, maximal growth rate and biomass) obtained 
for strains R6 and D39 cultured in CDM containing 61 ± 1 mM Glc, with pH-controlled at 
6.5, at 37ºC and semi-aerobic (initial air tension 50-60%), anaerobic (argon atmosphere) 
or aerobic (constant air tension 40%) conditions, as in Fig. 2.3. The values for maximal 
growth rate and maximal biomass are averages of at least two independent experiments 
and the errors are reported as ± SD. 
 Semi-aerobic Anaerobic Aerobic 
 D39 R6 D39 R6 D39 R6 
Lag No No No No No No 
μmax (h
-1
) 0.80 ± 0.00 0.69 ± 0.03 0.55 ± 0.04 0.78 ± 0.03 1.00 ± 0.05 1.07 ± 0.04 
ODMax 1.3 ± 0.1 3.6 ± 0.2 1.4 ± 0.2 3.7 ± 0.0 0.49 ± 0.03 0.23 ± 0.02 
 
 
(ii) Growth and fermentation profiles of S. pneumoniae D39 at 
constant pH of 6.5. pH control was shown to positively affect the performance in 
terms of ODMax of  the unencapsulated D39 derivative strain R6 (Fig. 2.3-A, Fig. 
2.1-A and Table 2.3). Considering the genomic relatedness of strain R6 and its 
progenitor strain D39 (Lanie et al., 2007), we expected the latter to perform 
similarly when grown under the same conditions (CDM with 60 mM Glc, semi-
aerobiosis, pH 6.5, and 37ºC). To our surprise, strain D39 reached an ODMax 
value of 1.3 ± 0.1, slightly lower than that under non-controlled pH conditions  
(1.6 ± 0.2), and reduced by 64% when compared to ODMax value of strain R6  
(3.6 ± 0.2). The growth rate was independent of pH control, and higher than that 
of strain R6 by 15%. Intrigued by these results we questioned to whether the 
dissimilar growth profiles could be due to altered central metabolism. Accordingly, 
we examined substrate consumption and the pattern of end-products resulting 
from the fermentation of Glc (for a metabolic scheme see Fig. 2.4).  
 

















































Fig. 2.4. Schematic overview of the pathways for Glc metabolism and capsule 
production in S. pneumoniae. Glc is oxidized to pyruvate via the Embden-Meyerhof-
Parnas pathway (glycolysis); a common metabolic intermediate in glycolysis is glucose 6-
phosphate (G6P), which is also a precursor for the biosynthesis of capsule NDP-sugars; 
NDP-sugars are synthesized at the expense of UTP. Pyruvate is the substrate of three 
competing enzymes: lactate dehydrogenase, pyruvate formate-lyase and pyruvate 
oxidase. Homolactic fermentation reduces pyruvate into lactate, through lactate 
dehydrogenase (LDH), whereas mixed-acid fermentation leads to formate, acetate and 
ethanol. Oxygen might be consumed at the level of lactate oxidase (LOX coded by lcto), 
pyruvate oxidase (SpxB) or H2O-NADH oxidase (NOX). The occurrence of the pyruvate 
dehydrogenase complex (PDHc) depicted in grey remains to be proved. Proposed 
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pathways were reconstructed based on genome information 
(http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi), literature and database surveys 
(KEGG, MetaCyc). Gene annotation downloaded from NCBI: nox, NADH oxidase; pyk, 
pyruvate kinase; ldh, L-lactate dehydrogenase; lcto, lactate oxidase; spxB, pyruvate 
oxidase; ackA, acetate kinase; pfl, pyruvate formate-lyase; pta,  phosphotransacetylase; 




Under controlled pH conditions, strain R6 stopped growing due to Glc limitation 
(Glc was totally consumed in the early-stationary phase after 9 h of growth, Fig. 
2.3-A and Table 2.4). A similar behavior had previously been reported for L. lactis 
grown under constant pH in the CDM improved for NMR (Neves et al., 1999), and 
is common among the Streptococcaceae. In contrast, growth arrest in D39 
cultures occurred at time-point 5 h while Glc was still abundant in the medium 
(Fig. 2.3-A and Table 2.4), suggesting that a factor (nutritional or environmental) 
other than the carbon substrate is limiting growth. Both strains showed, however, 
typical homolactic fermentation, lactate being by far the major end-product. Minor 
amounts of mixed-acid fermentation products were also detected in supernatants 
of both strains, but pyruvate accumulation was only observed for strain D39 
(Table 2.4). To our knowledge, in S. pneumoniae three competing enzymes, 
lactate dehydrogenase, pyruvate formate-lyase and pyruvate oxidase, might 
catalyze the conversion of pyruvate to end-products (Fig. 2.4). The pyruvate 
dehydrogenase complex has been postulated (grey lines in scheme portrayed in 
Fig. 2.4), but its occurrence remains to be proved (Taniai et al., 2008; Ramos-
Montañez et al., 2010). The distribution of end-products is thereby dependent on 
the specific activities and the affinities of each enzyme for pyruvate as well as the 
presence or not of oxygen (Fig. 2.4). Production of formate (3.4 ± 0.4 mM), 
ethanol (1.3 ± 0.3 mM) and acetate (2.2 ± 0.5 mM) in strain R6 is consistent with 
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pyruvate formate-lyase activity, since formate is produced in an equimolar amount 
to the sum of acetate and ethanol (Chapter 5). Formate (1.1 ± 0.1 mM) was also 
detected in the culture medium of strain D39, but ethanol and acetate were most 
likely below the detection limit (0.4 - 0.5 mM) of the HPLC technique. Considering 
this end-product distribution, the mixed-acid products accounted only for 3% of 
the Glc used in each strain. Accumulation of pyruvate in the medium suggests 
impairment of the activities at the pyruvate node in strain D39. In view of the 
fermentation type exhibited by S. pneumoniae, the most obvious candidate to be 

























Table 2.4. Product yields, substrate consumption rate, total substrate consumed, carbon 
and redox balances and growth and energetic parameters as determined from substrate 
and fermentation product analysis at the time-point of maximal biomass achieved by D39 
and R6 strains cultured in CDM containing 61 ± 1 mM Glc, with pH-controlled at 6.5, at 
37ºC, under semi-aerobic (initial air tension 50-60%) and anaerobic (argon atmosphere) 
conditions. Values of at least two independent experiments were averaged and errors are 
reported as ± SD. 
 Semi-aerobic Anaerobic 
 D39 R6 D39 R6 
Product yields
a
     
Lactate 1.63 ± 0.01 1.81 ± 0.10 1.77 ± 0.01 1.86 ± 0.04 
Pyruvate
b
 0.04 ± 0.01  0.01 ± 0.00  
Formate 0.06 ± 0.01 0.06 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 
Acetate BDL 0.04 ± 0.02 BDL 0.05 ± 0.00 
Ethanol BDL 0.02 ± 0.01 BDL 0.02 ± 0.00 









 0.92 ± 0.04 0.76 ± 0.16 0.60 ± 0.16 0.94 ± 0.05 
Consumed substrate (%) 28 ± 0 100 ± 0 34 ± 5 98 ± 1 
Carbon balance
d
 87 ± 1 93 ± 5 93 ± 1 96 ± 2 
Redox balance 85 ± 1 93 ± 6 89 ± 1 94 ± 2 
Biomass yield (g mol
-1
 Glc) 26.2 ± 1.0 23.1 ± 1.2 24.5 ± 0.1 24.6 ± 1.9 
ATP yield (mol mol
-1
 Glc) 1.7 ± 0.0 1.9 ± 0.1 1.8 ± 0.0 2.0 ± 0.0 
YATP (g biomass mol
-1
 ATP) 15.0 ± 0.7 19.3 ± 0.6 13.8 ± 0.0 12.6 ± 0.8 
a
Product yields, [End-product] / [Glc consumed]; 
b
Blank cells, negative yields were found for these 




 was estimated from a first-order derivative 
of a polynomial fit of the measured substrate consumption time series. 
d
Carbon balance is the 
percentage of carbon in metabolized Glc that is recovered in the fermentation products (lactate, 
formate, acetate and ethanol) and pyruvate. Dry weight (DW) was used as a measure of cell mass. 
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However, the activity values determined for LDH in cell extracts of strains D39 
and R6 (Table 2.5) were in the same range, indicating similar expression of LDH 
in both strains. The in vivo activity could, however, be directly influenced by 
metabolic regulation. In view of the higher Glc consumption rate of strain D39 
relative to strain R6, it is reasonable to hypothesize dissimilar accumulation of 
intracellular metabolites, potentially involved in metabolic regulation (Table 2.4). 
Considering that LDH activity does not seem to be in great excess, since a lactate 
flux of 1.5 µmol min-1 mg-1 prot. can be estimated from a maximal Glc 
consumption rate of 0.92 µmol min-1 mg-1 prot. and a lactate yield of 1.63,  direct 
modulation could easily explain the pyruvate accumulation. To the best of our 
knowledge a thorough biochemical characterization of the pneumococcal LDH is 
not available and, hence, potential activity inhibitors and/or activators unknown.  
 
 
Table 2.5. Enzyme specific activities determined in late-exponential fresh cell lysates or 
cell-free extracts of the D39 and R6 strains grown in CDM containing 60 mM Glc under 
semi-aerobic (rubber-stoppered bottles) or aerobic conditions (constant air tension 40%).  
 Semi-aerobic  Aerobic 
Enzyme
a
 D39 R6 D39 R6 
NADH oxidase 1.34 ± 0.00 1.02 ± 0.05 0.99 ± 0.13 0.42 ± 0.01 
Pyruvate oxidase ND ND 0.04 ± 0.00 0.15 ± 0.00 
Lactate dehydrogenase 4.75 ± 0.24 3.98 ± 0.40 ND ND 
a
Enzyme activities are expressed in micromoles per minute per milligram of protein and are means 







The gene encoding pyruvate oxidase, spxB, is among the 81 allelic variants in 
strain R6 and D39 (Lanie et al., 2007). A major consequence of this genetic 
variation is the different pyruvate oxidase activity values reported in the literature 
for D39 and R6 strains (Belanger et al., 2004; Ramos-Montañez et al., 2008), and 
fully corroborated by our own activity measurements in fresh lysates of cells 
grown aerobically (Table 2.5). Furthermore, the detection of H2O2 in the cultivation 
medium of strain D39 grown semi-aerobically is indicative of in vivo activity under 
the conditions studied. Thus, the lower pyruvate oxidase activity of strain D39 
could in part explain the higher accumulation of pyruvate in the growth medium. In 
addition, this metabolic trait is likely reinforced in strain D39 by the higher NADH 
oxidase activity (Table 2.5), which overcomes the need to regenerate NAD+ 
through pyruvate reduction (Fig. 2.4). However, these mechanisms cannot 
account for the total pyruvate accumulation (0.78 ± 0.08 mM), mainly because 
under semi-aerobic conditions the oxidase activities are limited by the oxygen in 
the medium (initial concentration of circa 0.13-0.14 mM), which decreased to 
undetectable levels in about 60 min for strain D39 (Fig. 2.5). The rate of oxygen 
consumption was lower in strain D39 than in R6 (Fig. 2.5), which is consistent 
with the lower pyruvate oxidase activity, but not the higher NADH oxidase activity. 
Considering that the specific pyruvate oxidase activity is lower than that of NADH 
oxidase, the latter results can only be explained assuming a higher affinity of the 
pyruvate oxidase for oxygen.  
The carbon and redox recoveries were consistently lower for strain D39 
(Table 2.4). Based on this observation it is tempting to speculate that in the 
capsulated strain carbon is being re-directed from merely catabolic processes to 
biosynthesis.   
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max (mmol g-1 h-1) (T10min)
D39 0.18 0.01
R6 0.23  0.01
 
 
Fig. 2.5. Kinetics of oxygen consumption. Strains D39 () and R6 () were grown 
under semi-aerobic conditions (initial specific air tension of 50-60%) as in Fig. 2.3-A. The 
oxygen consumption rates (qs
max
) are also shown. The plotted curves are averages of two 
independent experiments ± SD.  
 
 
Effect of oxygen on growth and metabolism of S. pneumoniae D39 and R6  
Our data under semi-aerobic conditions establishes substantial differences 
in the growth profiles of strains D39 and R6. The level of oxygenation influences a 
number of cellular processes in S. pneumoniae, including central metabolism and 
competence (Echenique et al., 2000; Taniai et al., 2008). Thus, we deemed 
important to examine the effect of oxygen availability on the growth of strains D39 
and R6.  
(i) Growth and fermentation profiles of S. pneumoniae D39 and R6 
under anaerobic conditions (argon atmosphere). The growth profile of strains 
D39 and R6 under strictly anaerobic conditions is depicted in Fig. 2.3-B. The 
values of ODMax obtained, 1.4 ± 0.2 and 3.7 ± 0.0 for strains D39 and R6, 
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respectively, were similar to those observed in semi-aerobic conditions (Table 
2.3). Under anoxic conditions, while the growth rate of strain D39 was decreased 
by 30%, that of strain R6 was slightly higher as compared to semi-aerobic 
conditions (Table 2.3). Likewise under semi-aerobiosis, Glc was still abundant 
when growth of strain D39 ceased (66% of the initial Glc remained in the culture 
medium at the time-point of maximal biomass, 8h, Table 2.4), whereas strain R6 
consumed all the Glc present in the medium (time-point 7h, Table 2.4). The 
distribution of end-products was comparable to that observed under semi-aerobic 
conditions, except for the accumulation of pyruvate, lactate and formate in strain 
D39. In D39, at the time-point of growth arrest (maximal biomass, 8h), pyruvate, 
lactate and formate reached concentrations of 0.12 ± 0.01 mM, 38 ± 6 mM and 
1.5 ± 0.1 mM, respectively. The concentrations of these end-products under semi-
aerobic conditions at the time-point of growth arrest were 0.78 ± 0.08 mM, 28 ± 0 
mM and 1.1 ± 0.2 mM, respectively. Considering that pyruvate reduction under O2 
nil conditions is only dependent on the activities of LDH and PFL (Fig. 2.4), most 
likely the lower accumulation of pyruvate results from the higher pressure to 
regenerate NAD+ via the dehydrogenases downstream of pyruvate. In strain R6, 
lactate reached a concentration of 107 ± 6 mM, accounting for 89% of the Glc 
consumed and formate (3.7 ± 0.7 mM), acetate (2.8 ± 0.5 mM) and ethanol (0.86 
± 0.16 mM) were produced in a 2:1:1 ratio, denoting activity of PFL. Assuming 
that all ATP is formed by substrate level phosphorylation the higher ATP yield 
(mol ATP mol-1 Glc) in strain R6 (Table 2.4) is consistent with higher acetate 
production.  
Considering the fermentation profiles exhibited by strains D39 and R6, the 
differences in the growth rates between semi-aerobic and anaerobic conditions 
can tentatively be explained on the basis of pneumococcal metabolic activities. 
The 30% decline in D39´s growth rate when switching the atmosphere from semi-
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aerobiosis to anaerobiosis can partly be due to the decreased Glc consumption 
rate (0.92 ± 0.04 in semi-aerobiosis as compared to 0.60 ± 0.16 µmol min-1 mg-1 
prot. in anaerobiosis) (Table 2.4), which in turn can be attributed to a lower NAD+ 
recycling capacity under anoxic conditions, as NADH oxidases are inoperative. 
Under semi-aerobic conditions, while oxygen is available (60 min), activity of 
NADH oxidase presumably enables a faster NAD+ regeneration, and 
consequently a higher Glc consumption rate (Table 2.4). It is worth noting that the   
activity of NADH oxidase measured in cell extracts of strains R6 and D39 (Table 
2.5) was considerably higher than that found for other related bacteria (Higuchi et 
al., 1993, Neves et al., 2002a). The lower growth rate of R6 under semi-aerobic 
conditions can be a direct consequence of the activity of pyruvate oxidase (Table 
2.5). The involvement of its product, H2O2, in oxidative stress and genetic 
instability in S. pneumoniae is documented (Pericone et al., 2000; Pericone et al., 
2003). 
(ii) Growth and fermentation profiles of S. pneumoniae D39 in aerobic 
conditions (continuous supply of 40% air). We then examined the effect of 
supplying a constant oxygen tension on the growth of strains D39 and R6. Under 
aerobic conditions the maximal biomass (ODMax) reached for strains D39 (0.49 ± 
0.03) and R6 (0.23 ± 0.02) were, respectively, 3-fold and 16-fold lower than those 
observed under semi-aerobic conditions (Fig. 2.3-C and Table 2.3). This drastic 
decrease in the ODMax contrasts with the higher growth rates obtained for both 
strains (around 1 h-1) (Table 2.3). Noteworthy, at the time-point of transition to 
stationary phase of growth (time-point 2h), strains D39 and R6 consumed only  






Table 2.6. Product yields, total substrate consumed, carbon and redox balances and 
growth and energetic parameters as determined from substrate and fermentation product 
analysis, at the time-points 2h (transition phase) and 3h (stationary), in D39 and R6 
strains cultured in CDM containing 61 ± 1 mM Glc, with pH-controlled at 6.5, at 37ºC, 
under aerobic conditions (constant air tension of 40%). Values of at least two independent 
experiments were averaged and errors are reported as ± SD. 
 Aerobic 
 Transition phase Stationary 
 D39 R6 D39 R6 
Product yields
a
     
Lactate 1.06 ± 0.07 0.67 ± 0.09 0.47 ± 0.09 0.34 ± 0.02 
Pyruvate
b
     
Formate BDL BDL BDL BDL 
Acetate 0.92 ± 0.11 1.32 ± 0.08 1.53 ± 0.09 1.64 ± 0.01 
Ethanol BDL BDL BDL BDL 
H2O2  0.37 ± 0.01 0.60 ± 0.01 0.82 ± 0.01 0.91 ± 0.01 
Consumed substrate (%) 3.7 ± 0.5 2.8 ± 0.2 4.4 ± 0.1 2.8 ± 0.4 
Carbon balance
c
 100 ± 0 100 ± 0 100 ± 0 99 ± 1 
Redox balance ND ND ND ND 
Biomass yield (g mol
-1
 Glc) 64.6 ± 0.4 52.6 ± 4.0 68.1 ± 2.4 50.9 ± 6.6 
ATP yield (mol mol
-1
 Glc) 2.9 ± 0.2 3.3 ± 0.1 3.5 ± 0.1 3.6 ± 0.0 
YATP (g biomass mol
-1
 ATP) 22.2 ± 1.2 15.8 ± 1.6 19.3 ± 1.1 14.1 ± 1.8 
a
Product yields, [End-product] / [Glc consumed]; 
b
Blank cells, negative yields were found for these 
conditions (cells used pyruvate from the medium); 
c
Carbon balance is the percentage of carbon in 
metabolized Glc that is recovered in the fermentation products (lactate and acetate). Dry weight 
(DW) was used as a measure of cell mass. BDL, below detection limit; ND, not determined.  
 


































































































Fig. 2.6. Fermentation profiles of strains D39 and R6 under aerobic conditions. 
Growth curves, substrate consumption and end-products formed by the D39 (A) and R6 
(B) strains growing aerobically (continuous specific air tension of 40%) as in Fig. 2.3-C. 
Culture supernatant samples for end-product analysis by HPLC and/or 
1
H-NMR were 
harvested during growth. Symbols: (), Glc consumption; (), growth curve of D39; (), 
growth curve of R6; (), lactate; (), acetate; (), H2O2. The error was below 7% for 
major products (>2 mM) and 25% for minor products (<2 mM).  
 
 
In both strains, the presence of oxygen (at a concentration of 0.09 mM) shifted the 
metabolism from lactate to acetate and H2O2 production, denoting high activity of 
pyruvate oxidase (SpxB) (Fig. 2.4 and Fig. 2.6). In strain R6 this shift was more 
pronounced, as indicated by the higher yields of acetate and H2O2 (Table 2.6). 
This observation is in good agreement with the higher activity of pyruvate oxidase 
measured for this strain and, possibly, with lower activity of the competing 
enzyme, NADH oxidase (Table 2.5 and Fig. 2.4). In contrast to work by others, in 
our study, a considerable reduction of NADH oxidase activity was observed in 
cells grown aerobically relative to semi-aerobically grown cells (Table 2.5) (Auzat 
et al., 1999; Yu et al., 2001). Under these aeration conditions, formate was not 
detected in the culture medium, indicating total inhibition of PFL (Fig. 2.6 and 
Table 2.6). Interestingly, growth arrest was observed when the levels of acetate 
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and H2O2 in the medium reached the values of about 2 and 1 mM, respectively, 
independently of the strain (Fig. 2.6). After the transition to stationary phase of 
growth (time-point 2h) no Glc was significantly consumed (Fig. 2.6 and Table 2.6) 
and the levels of acetate and H2O2 increased at the expense of lactate, showing 
lactate oxidase (LOX coded by lcto) activity (Fig. 2.4 and Fig. 2.6). In accordance, 
in the early-stationary phase of growth (time-point 3h) the yields of lactate 
decreased and the yields of acetate and H2O2 increased (Table 2.6).  
S. pneumoniae strain GTC13809, when grown aerobically, displayed similar 
metabolic features (Taniai et al., 2008). This, however, is not a general 
mechanism among lactic acid bacteria (Neves et al., 2002a; Seki et al., 2004; 
Quatravaux et al., 2006). Most commonly, activity of lactate and/or pyruvate 
oxidase is only apparent after Glc depletion, a phenomenon that allows additional 
metabolism after Glc starvation (Seki et al., 2004; Quatravaux et al., 2006). The 
advantage of pyruvate recycling via lactate oxidase is extra generation of ATP in 
the ensuing conversion to acetate (Fig. 2.4). Therefore, in accordance with higher 
acetate production, the higher ATP yields (mol ATP mol-1 Glc) determined for 
strains D39 and R6 under aerobic conditions were expected (Table 2.6).  
In aerobic conditions, the surplus of ATP produced by S. pneumoniae D39 
and R6 strains most likely enhanced their growth rates, leading to increased 
biomass yields (g mol-1 Glc), but did not impact on the maximal biomass (ODMax) 
achieved (Table 2.3 and Table 2.6). This observation suggests a re-direction of 
ATP away from biosynthetic purposes into the maintenance of cellular processes, 
an event that can be triggered by a stressful condition, like high accumulation of 
H2O2. Considering the excess of nutrients and substrate present in the medium at 
the time-point of growth arrest and the control of pH to 6.5, the most plausible 
candidate affecting biomass production is H2O2. In accordance, studies have 
shown induction of pneumococcal death by H2O2 (Regev-Yochay et al., 2007; 
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Ramos-Montañez et al., 2008). Moreover, the concentration of H2O2 accumulated 
at the time-point of growth arrest (Fig. 2.6), about 1 mM, is in good agreements 
with the reported minimal inhibitory concentration (MIC) necessary to prevent 
growth of strain D39 (Pericone et al., 2003). Therefore, the higher maximal 
biomass achieved by strain D39 can be explained by the 3-fold lower H2O2 to 
biomass ratio in this strain as compared to R6 (compare 5.7 ± 0.1 in D39 to 15.5 ± 
0.1 nmol H2O2 mg DW
-1 in R6 at time-point 2h). A major drawback in the aerobic 
metabolism of sugars by S. pneumoniae is its poor capacity to break down H2O2. 
Indeed, the pneumococcus does not possess the typical defense mechanisms 
against oxidative stress, such as catalase activity or expression of homologues of 
the OxyR/PerR transcriptional regulators (Tettelin et al., 2001; Hoskins et al., 
2001; Lanie et al., 2007). However, production of H2O2 in the mM range is also a 
competitive advantage used by S. pneumoniae to kill or inhibit other potential 
nasopharyngeal flora members, including H. influenzae and N. meningitidis 
(Pericone et al., 2000; Pericone et al., 2003). In this context, metabolic activities 
downstream of pyruvate in S. pneumoniae could have arisen from an evolutionary 
adaptation to the oxygen-rich environment of the nasopharynx, which is 
abundantly populated by other competitor microorganisms.  
 
Manipulation of the concentration of nutrients in culture medium 
Our data showed that both growth and metabolic profiles of strains D39 
and R6 are differently affected by oxygen. Semi-aerobiosis (50-60% initial air 
tension) supported the highest growth parameters (growth rate and biomass) in 
strain D39. Therefore, this condition was chosen for further studies. 
Recently Hathaway and co-workers showed that capsule is a cost in 
energetic terms and probably competes for energy with the other metabolic 
processes (Hathaway et al., 2012). We showed that growth arrest of strain D39 
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occurred well before Glc depletion, independently of the parameters tested. 
Conversely, total consumption of Glc was detected for strain R6 under anaerobic 
and semi-aerobic conditions. Considering that capsule is a major difference 
between the two strains, it is plausible to assume that its production is an 
additional cost in nutritional terms at the expense of biomass (Fig. 2.4). This 
hypothesis was investigated by varying the amounts of medium components 
presumably required for capsule synthesis. In S. pneumoniae strain D39, 
serotype 2 capsule is a major virulence factor formed by repeating units of 
glucose, glucuronic acid and rhamnose in the proportion of 1:2:3 (Iannelli et al., 
1999). The precursors of these sugar monomers (UDP-glucose, UDP-glucuronic 
acid and dTDP-rhamnose) require UTP and dTTP for their synthesis (Iannelli et 
al., 1999). The sugar moiety in the NDP-sugars derives from the glycolytic 
intermediate glucose 6-phosphate (Fig. 2.4). Hence, in addition to ATP 
generation, Glc is also used for capsule biosynthesis. In our conditions, Glc (~1% 
wt/vol) is apparently in excess in D39 cultivations, and thereby the nucleobases 
are the most promising candidates as growth-limiting nutrients. Thus, the effect of 
varying the nucleobases in the culture medium was assessed. To completely rule 
out Glc as the limiting nutrient, fermentations at a lower and a higher initial Glc 
concentration were also performed.  
(i) Effect of glucose concentration on growth of S. pneumoniae D39 
and R6. Fig. 2.7 shows the growth profiles of strains D39 and R6 in the presence 
of different Glc concentrations. The growth profile of strain D39 was not 
significantly changed when 0.5% rather than 1% (wt/vol) Glc was used as carbon 
source (Fig. 2.7-A). The growth parameters, growth rate (0.80 ± 0.06) and ODmax 
(1.5 ± 0.0), were identical to those observed on 1% Glc (Table 2.7). This behavior 
was not unexpected considering that, D39 had consumed only 28% of the Glc in 
medium containing 1% (wt/vol) of the sugar. On the other hand, strain R6 showed 
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a decrease in maximal biomass of about 40% when grown on 0.5% as compared 
to 1% Glc (Fig. 2.7-B and Table 2.7). Interestingly, triplicating the Glc in the 
culture medium led to an initial 2-fold decrease in the growth rate of strain D39 
(from time-point 0 to time-point 2h, Fig. 2.7-A), when comparing with the growth 
on 1% Glc, and a lag of 1h in strain R6 (Fig. 2.7-B). However, after the time-point 
2h, strain D39 recovered to 88% of the growth rate on 1% Glc. The growth rate of 
strain R6 on 3% Glc was 1.5-fold lower than that on 1% Glc. Unexpectedly, the 
maximal biomass achieved by strain R6 on 3% Glc was slightly lower than that on  




















































Fig. 2.7. Growth profiles at different glucose concentrations. Growth of strains D39 
(A) and R6 (B) in CDM containing (,) 0.5%, (,) 1% or (,) 3% (wt/vol) Glc, under 
controlled conditions of pH (6.5), temperature (37ºC) and atmosphere (initial specific air 
tension of 50-60%), in a 2-l bioreactor. OD600 was measured at 1-h intervals. All cultures 
were inoculated with a preculture in late-exponential phase (6-7 hours incubation at 37ºC, 







Table 2.7. Growth parameters (length of lag, maximal growth rate and biomass) obtained 
for strains R6 and D39 cultured in CDM containing 0.5, 1 or 3% (wt/vol) Glc, with pH- 
controlled at 6.5, at 37ºC, and under semi-aerobic conditions (initial air tension 50-60%). 
The values for maximal growth rate and maximal biomass are averages of at least two 
independent experiments and the errors are reported as ± SD. 
 0.5% Glc 1% Glc 3% Glc 
 D39 R6 D39 R6 D39 R6 
Lag No No No No No Yes (1h) 
μmax (h
-1
) 0.80 ± 0.06 0.68 ± 0.01 0.80 ± 0.00 0.69 ± 0.03 0.70 ± 0.01 0.47 ± 0.01 
ODMax 1.5 ± 0.0 2.2 ± 0.2 1.3 ± 0.1 3.6 ± 0.2 1.4 ± 0.0 3.1 ± 0.1 
 
 
In the dairy L. lactis, a positive correlation between biomass and sugar 
concentration has been reported up to concentrations of 2.5% (wt/vol); at an 
external concentration of 5%, a slight decrease (about 10%) in maximal biomass 
was observed (Papagianni et al., 2007). Thus, S. pneumoniae seems to be more 
sensitive to high Glc concentrations than the dairy L. lactis. A complete 
explanation for the different behaviors is difficult to put forward, but it might be 
related to the environments sensed by these microorganisms in their natural 
habitats: while the dairy L. lactis is continuously exposed to a high sugar 
concentration in milk (~150 mM lactose), S. pneumoniae thrives in the 
nasopharynx where free sugars, and in particular Glc (< 1 mM), are low 
(Shelburne et al., 2008a). Lipid bilayers are impermeable to Glc, thus the 
inhibitory effect of Glc (3% wt/vol) most likely occurs in the cellular membrane. 
Since the growth of strains D39 and R6 was not limited or inhibited by 1% (wt/vol) 
of Glc, this concentration was used in subsequent studies. Furthermore, our data 
clearly shows that Glc is not the limiting-nutrient in pH-controlled batch cultures of 
strain D39. 
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(ii) Effect of nucleobases concentration on growth of S. pneumoniae 
D39 and R6. The nucleobases present in our CDM (Table 2.1) are the purines 
adenine, guanine and xanthine and the pyrimidine uracil. To investigate the effect 
of this group of nucleobases on the growth of strains D39 and R6, their 
concentrations were raised simultaneously from 10 to 30 mg l-1 in the culture 
medium. This increase had a marked positive effect on the maximal biomass 















































Fig. 2.8. Effect of nucleobases concentration on growth profiles. Growth of strains 
D39 (A) and R6 (B) in CDM containing 1% (wt/vol) Glc, under controlled conditions of pH 
(6.5), temperature (37ºC), and atmosphere (initial specific air tension of 50-60%), in a 2-l 
bioreactor. The nucleobases were added to the medium as follows: (,), G, A, X, U 10 
mg l
-1
 each; (,), G, A, X, U 30 mg l
-1
 each; (,), G, A, X 10 mg l
-1
 each plus 30 mg l
-1
 
U. G= guanine; A= Adenine; X= Xanthine; U= Uracil. OD600 was measured at 1-h 
intervals. All cultures were inoculated with a preculture in late-exponential phase (6-7 
hours incubation at 37ºC, OD600 0.8-1.0).  
 
 
The ODMax reached by strain D39 in CDM containing 30 mg l
-1 of nucleobases 
was 3.2 ± 0.0, a value 2.5-fold higher than that obtained in CDM with 10 mg l-1 of 
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nucleobases (1.3 ± 0.1) (Fig. 2.8-A). The growth rate and the growth profile of 
strains D39 and R6, respectively, were not affected by increasing the 
concentration of nucleobases (Fig. 2.8). The data indicate that capsule 
biosynthesis demands a group of nucleobases or a particular nucleobase. In line, 
dissimilar behaviors were also expected between strains D39 and R6 grown in 
CDM without nucleobases. Growth of strain D39 in the absence of nucleobases 
was characterized by a long lag-phase and an ODMax of about 3 at time-point 27h 
(data not shown). On the other hand, strain R6 exhibited no lag-phase, a growth 
rate of about 0.54 h-1, and an ODMax of approximately 2.3, in CDM without 
nucleobases (data not shown). Our data indicate that strains D39 and R6 are able 
to synthesize nucleobases. The presence of genes encoding their biosynthetic 
pathways in the genome sequences of strains R6 and D39 fully corroborates our 
results (Hoskins et al., 2001; Lanie et al., 2007). Furthermore, the maximal 
biomass obtained for strain D39 grown without nucleobases (ODMax 3), was 2.3-
fold higher than that achieved by the same strain on 10 mg l-1 of nucleobases 
(ODMax 1.3), implying that the pathways for their synthesis were repressed when 
the nucleobases were present in the medium. Thus, growth was limited by 
concentration. 
(iii) Effect of uracil on growth and glucose fermentation in  
S. pneumoniae D39 and R6. Given the results above, we deemed important to 
determine if the positive effect of the nucleobases on growth of strain D39 was 
due to a particular base or the ensemble. Of the four nucleobases present in our 
CDM (Table 2.1), uracil is a constituent of UDP-Glc and UDP-glucuronic acid, 
precursors of D39 serotype 2 capsule repeating units (Fig. 2.4) (Iannelli et al., 
1999). Transporters for uracil are predicted in the genome sequence of strain D39 
(Lanie et al., 2007). Thus, we hypothesize uracil to be the limiting nutrient. 
Thymine nucleosides are formed from uracil nucleosides in the salvage pathway 
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of pyrimidine biosynthesis, (reviewed in Kilstrup et al., 2005), and to our 
knowledge transporters for thymine in Streptococcaceae have not been described 
(reviewed in Kilstrup et al., 2005). To test our hypothesis, strain D39 was grown in 
microtiter plates in CDM containing 0.25% (wt/vol) Glc (initial pH 6.5), and each 
nucleobase was added individually to a final concentration of 30 mg l-1. Among 
the nucleobases tested, only an increase in uracil concentration led to improved 
growth of strain D39 (Fig. 2.9). Therefore, the effect of uracil per se was 
investigated. 
 

































Fig. 2.9. Effect on growth of increasing a single nucleobase. Growth profile of strain 
D39 in CDM containing 0.25% (wt/vol) Glc with 30 mg l
-1
 of the specified nucleobase. 
Cultures were prepared in 250 µl in 96-well microtiter plates and growth monitored at 595 
nm and 37ºC. Symbols: (),G, A, X, U 10 mg l
-1
 each; (), G, A, X 10 mg l
-1 
each plus 30 
mg l
-1 
U; (), G, A, U 10 mg l
-1 
each plus 30 mg l
-1 
X; (), G, X, U 10 mg l
-1
 each plus 30 
mg l
-1 
A; (), A, X, U 10 mg l
-1 
each plus 30 mg l
-1
 G. G= guanine; A= Adenine; X= 





D39 was grown in static rubber-stoppered bottles in CDM containing 1% 
(wt/vol) Glc, without pH control (initial pH 6.5), and uracil was added to final 
concentrations of 40, 30, 10, 5, 3.3, 1, 0.67 and 0 mg l-1. Interestingly, 
incrementing the final concentration of uracil in the culture medium from  
0.67 mg l-1 to 30 mg l-1, led to an increase in maximal biomass from about 0.2 to 
2.2 of ODMax (Fig. 2.10-A). Notably, this increase was linear from 0.67 mg l
-1 to 10 
mg l-1 uracil (Fig. 2.10-B). The maximum growth rate (approximately 0.8 h-1) was 
not significantly affected, except for the lower concentrations of 3.3, 1 and 0.67 








































Fig. 2.10. Effect of varying uracil concentration on growth of strain D39. (A) Growth 
of strain D39 in CDM containing 1% (wt/vol) Glc with different concentrations of uracil (U), 
as specified below. Growth was performed at 37ºC, without pH control (initial pH 6.5), in 
static rubber-stoppered bottles, after inoculation with a preculture in late-exponential 
phase (6-7 hours incubation at 37ºC, OD600 0.8-1.0). OD600 was measured at 1-h intervals. 
Uracil concentrations in mg l
-1
: (), 0; (), 0.67; (), 1; (), 3.3; (), 5; (), 10; (), 30; 
(), 40. The other three nucleobases (G, X, A) were always present in the medium at a 
concentration of 10 mg l
-1
.  G=guanine; X, xanthine; A, adenine. (B) Linear correlation 
between the maximal D39 biomass (ODMax) and the medium uracil concentration (from 
0.67 to 10 mg l
-1
).   
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A saturation at around 30 mg l-1 of uracil was found, as increasing the 
concentration even further, i.e. to 40 mg l-1, did not improve growth (Fig. 2.10).  
Strain D39 was able to grow in uracil-free medium, as expected from genome 
analysis (Lanie et al., 2007), and the growth profile displayed a lag of 6h, a growth 
rate of 0.42 h-1 and 1.8 of ODMax. In lactic acid bacteria, pyrimidine nucleobases 
are synthesized de novo using bicarbonate (HCO3
-) or CO2 and amino acids as 
substrates (reviewed in Kilstrup et al., 2005).   
In pH-controlled batch cultivations, a 3-fold increase in the concentration 
of uracil had a similar effect on growth (µ, 0.80 ± 0.02 h-1 and ODMax of 3.2 ± 0.1) 
as that produced when all the four nucleobases were 3 times increased (Fig. 2.8-
A). This result unequivocally shows that uracil is the sole base stimulating 
biomass production in the capsulated strain D39. Indeed, the increment of uracil 
concentration did not affect the growth rate of strain R6. Curiously, strain D39 
showed a more pronounced shift to mixed-acid fermentation in Glc-CDM 
containing 30 mg l-1 uracil (Fig. 2.11). Lactate was the major end-product, 
accounting for 76% of the Glc consumed (Table 2.8), and formate (6.3 ± 1.3 mM) 
was produced in a ratio of 2:1:1 relative to ethanol (2.8 ± 1.1 mM) and acetate 
(3.1 ± 0.4 mM), which is ascribed to PFL activity. The pyruvate accumulated in 
this condition (circa 0.44 mM) was 2-fold lower than in medium containing  
10 mg l-1 uracil (Table 2.4 and Table 2.8). This represents a shift to mixed-acid 
products 3-fold higher than that when uracil was limiting (Fig. 2.11-A and C). The 
levels of acetate accumulated by strain D39 in uracil-enriched medium were at 
least 2-fold higher than those accumulated in normal CDM. However, the ATP 
yields (mol ATP mol-1 Glc) were similar between both conditions (circa 1.8 and 1.7 
in 30 and 10 mg l-1 uracil, respectively) and relative to strain R6 (Table 2.4 and 
Table 2.8).  



























































































































Fig. 2.11. Growth and fermentation products as a function of uracil concentration in 
pH-controlled batch cultures. Growth curves, substrate consumption and end-products 
formed by the D39 (A and C) and R6 (B and D) strains in CDM containing 10 mg l
-1
 uracil 
(A and C) or 30 mg l
-1
 uracil (B and D) under controlled conditions of pH (6.5), 
temperature (37ºC) and gas atmosphere (initial specific air tension of 50-60%) in a 2-l 
bioreactor after inoculation with a preculture in late-exponential phase (6-7 hours 
incubation at 37ºC, OD600 0.8-1.0). Initial concentrations of Glc were for both strains 60 ± 
1 mM. At 1-h time intervals OD600 was measured. Culture supernatant samples for end-
product analysis by HPLC and/or 
1
H-NMR were harvested for each of the conditions at  
time-points zero, exponential and growth arrest (maximal biomass) (bars in the plots). 
Symbols: (,), growth curves in 10 mg l
-1
 uracil; (,), growth curves in 30 mg l
-1
 
uracil; (white bars), Glc; (grey bars), lactate; (hatched bars), formate; (black bars), 
acetate; (stripped bars), ethanol. D39 and R6 growth curves in 10 and 30 mg l
-1
 uracil as 
in Fig. 2.8, except that OD600 scale (y-axis) is logarithmic.      
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Table 2.8. Product yields, total substrate consumed, carbon and redox balances and 
growth and energetic parameters as determined from substrate and fermentation product 
analysis, at the time-point of maximal biomass achieved by D39 and R6 strains cultured in 
CDM containing 61 ± 1 mM Glc and supplemented with 30 mg l
-1
 uracil, with pH-controlled 
at 6.5, at 37ºC, under semi-aerobic conditions (initial air tension 50-60%). Values of at 
least two independent experiments were averaged and errors are reported as ± SD. 
 Semi-aerobic 
 30 mg l
-1
 uracil 
 D39 R6 
Product yields
a
   
Lactate 1.62 ± 0.04 1.82 ± 0.01 
Pyruvate
b
 0.01 ± 0.00  
Formate 0.20 ± 0.02 0.05 ± 0.00 
Acetate 0.10 ± 0.02 0.04 ± 0.00 
Ethanol 0.09 ± 0.03 0.01 ± 0.00 
Consumed substrate (%) 55 ± 0.4 100 ± 0 
Carbon balance
c
 91 ± 1 93 ± 1 
Redox balance 90 ± 1 92 ± 1 
Biomass yield (g mol
-1
 Glc) 34.7 ± 0.1 22.9 ± 0.2 
ATP yield (mol mol
-1
 Glc) 1.8 ± 0.1 1.9 ± 0.1 
YATP (g biomass mol
-1
 ATP) 19.3 ± 0.6 12.1 ± 0.2 
a
Product yields, [End-product] / [Glc consumed]; 
b
Blank cells, negative yields were found for these 
conditions (cells used pyruvate from the medium); 
c
Carbon balance is the percentage of carbon in 
metabolized Glc that is recovered in the fermentation products (lactate, formate, acetate and 
ethanol) and pyruvate; Dry weight (DW) was used as a measure of cell mass.  
 
 
Our data establish a positive correlation between uracil supply and production of 
capsule in S. pneumoniae serotype 2. Under the conditions studied, we showed 
that uracil is the factor limiting growth of strain D39, while the acapsular strain R6 
is irresponsive to the uracil concentration in the medium. The bioenergetic 
parameters fully support this view. In summary, we developed a CDM and growth 
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conditions that support high yield of strains D39 and R6. For strain D39, a better 
growth performance was observed in CDM (Table 2.1) containing 1% (wt/vol) Glc 
and supplemented with uracil to a final concentration of 30 mg l-1, under controlled 
conditions of temperature (37ºC), pH (6.5) and gas atmosphere (semi-aerobic, 
initial air tension of 50-60%). For strain R6, the best growth was observed in CDM 
containing 1% (wt/vol) Glc, under controlled conditions of temperature (37ºC), pH 
(6.5) and gas atmosphere (strictly anaerobic). The optimized conditions were 
used to perform in vivo NMR studies. 
 
Glucose metabolism monitored by in vivo NMR  
The use of the in vivo NMR technique to study bacterial metabolism has 
been reported before (Neves et al., 1999). However, due to the low sensitivity of 
this technique, dense cell suspensions are usually required. Thus, we sought to 
prepare dense cell suspensions of strains D39 and R6. However, and despite 
several attempts and condition variations we were unable to pellet strain D39 by 
centrifugation. This is most likely a consequence of electrostatic repulsion due to 
its heavily negative charged capsule. In contrast, compact pellets were obtained 
upon centrifugation of R6 cultures, which enabled the preparation of dense cell 
suspensions and the application of in vivo NMR techniques to study sugar 
metabolism. For in vivo NMR studies, strain R6 was grown in CDM containing 1% 
(wt/vol) Glc, at 37ºC, pH 6.5 and under strictly anaerobic conditions (argon 
atmosphere). Cells were harvested in the late-exponential phase of growth  
(OD600 = 1.9, as in Fig. 2.3-B), washed twice in 5 mM KPi or MES buffer with 2% 
(wt/vol) choline and then suspended in 50 mM KPi or MES buffer with 2% (wt/vol) 
choline to a protein concentration of 13-14 mg ml-1. Choline was added to prevent 
cell lysis (Giudicelli and Tomasz, 1984; Balachandran et al., 2001; Steinmoen et 
al., 2002). In buffer containing choline, lysis was marginal during the time span of 
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13C-NMR experiments (30 min). The OD600 value of the suspension decreased by 
less than 3% in 30 min and 6.5% in 1h, while in the absence of choline the optical 
density values had decreased by 40% and 85% after 30 and 60 min, respectively 
(Fig. 2.12). Glc metabolism of R6 resting cells was monitored under controlled 
conditions of pH (6.5), temperature (37ºC) and gas atmosphere (anaerobic) using 
the on-line NMR system developed by Neves et al. (1999).  
 
































Fig. 2.12. Pneumococcal lysis in resting cell suspensions. Optical density variation 
during Glc (20 mM) metabolism of resting cells of strain R6, grown as for in vivo NMR, 
suspended in 50 mM KPi with () 2% or () 0% (wt/vol) choline. OD600 was measured 
with intervals of 15 minutes.  
 
 
(i) Pools of metabolites by in vivo 13C-NMR. The time course for Glc 
consumption and product formation under anaerobic conditions is shown in Fig. 
2.13. The end-products of [1-13C]Glc (20 mM) metabolism were lactate (35.8 ± 
0.4) mM), acetate (2.6 ± 0.4 mM) and glycerol (0.36 ± 0.04 mM). As expected 
lactate was the major end-product accounting for 89% of the Glc consumed. 
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Interestingly, a 2 min delay for Glc consumption was observed after the pulse of 
Glc, which was then consumed at a maximal rate of 0.32 µmol min-1 mg-1 of 
protein (Fig. 2.13). The pool of fructose 1,6-bisphosphate (FBP) increased to a 
steady concentration of about 30 mM, and declined to undetectable levels at the 
onset of Glc exhaustion (Fig. 2.13). FBP was the only glycolytic metabolite 
detected. The glycolytic dynamics in S. pneumoniae are considerably different 
from those reported for the closely related organism L. lactis (reviewed in Neves 
et al., 2005). In L. lactis, at the onset of Glc depletion the pool of FBP declines to 
an intermediate level, and thereafter decreases slowly to undetectable 
concentrations (reviewed in Neves et al., 2005). Moreover, in L. lactis, 3-
phosphoglycerate (3-PGA) and phosphoenolpyruvate (PEP) accumulate after Glc 
depletion (reviewed in Neves et al., 2005). In the dairy bacterium, slow depletion 
of FBP and accumulation of 3-PGA and PEP were rationalized as resulting from 
progressive obstruction at the level of pyruvate kinase (PK), a glycolytic enzyme 
regulated at the metabolic level by FBP (activator) and inorganic phosphate 
(inhibitor) (reviewed in Neves et al., 2005). Based on the established differences 
between the metabolic profiles in L. lactis and S. pneumoniae, a different 
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Fig. 2.13. Glucose metabolism in resting cell suspensions of S. pneumoniae R6 
monitored by in vivo 
13
C-NMR. Kinetics of 20 mM [1-
13
C]glucose consumption, end-
products formation and build-up of glycolytic intermediate pools by a cell suspension (50 
ml) of resting cells of S. pneumoniae R6 under anaerobic conditions as monitored in vivo 
by 
13
C-NMR. R6 cells, grown anaerobically as in Fig. 2.3-B until late-exponential phase 
(OD600 1.9), were suspended in 50 mM KPi with 2% (wt/vol) choline (pH 6.5) at a 




C]glucose was added at time zero and 30 s 
spectra were acquired sequentially after its addition. The extracellular pH was maintained 
at 6.5 during the experiment by automatic addition of NaOH. Symbols: (), glucose; (), 
lactic acid; (), acetate; (), glycerol; (), fructose 1,6-bisphosphate.  
 
  
(ii) Pools of NTP and Pi by in vivo 
31P-NMR. To obtain information on 
the energetic status of the cells, in vivo 31P-NMR spectra were obtained during the 
metabolism of Glc by resting cells of strain R6. Glc (20 mM) was supplied at a 
time designated zero (0 min) and the time course for formation of NTP and total Pi 
is shown in Fig. 2.14. Upon Glc addition, the pool of inorganic phosphate (Pi) 
decreased from about 60 to 2 mM, in 7 min, consistent with glycolytic usage. In 
accordance, this was also the time required for total consumption of Glc in the in 
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vivo 13C-NMR experiment of strain R6. During Glc consumption the NTP pools 
reached values of about 2.2 mM, which were maintained until the time-point 10 
min, and disappeared afterwards. The pool of Pi became visible well after NTP 
depletion (after Glc disappearance) reaching values of approximately 60 mM. The 
build-up of the Pi pool in S. pneumoniae differs from that in L. lactis, for which Pi 
accumulates much earlier.  Moreover, the NTP pools in L. lactis are 3-fold higher 
than in S. pneumoniae R6, and remain high beyond Glc depletion (Neves et al., 
1999; Neves et al., 2005). The levels of NTP detected in vivo in S. pneumoniae 
are similar to the concentrations measured in vitro (Chapter 6). In S. pneumoniae, 
the dynamics of glycolytic intermediates at the onset of Glc exhaustion (Fig. 2.13) 
could in part be explained by the delay in Pi accumulation, and thus lack of 
inhibition of PK. However, our own preliminary results indicate that the 
pneumococcal PK is less sensitive to Pi than its lactococcal homologue (data not 
shown). The effects of FBP and Pi on PK activity are currently under investigation 
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Fig. 2.14. Determination of the pools of NTP and Pi by in vivo 
31
P-NMR.  Time course 
for the concentration of NTP () and total inorganic phosphate, Pi () in resting cells of  
S. pneumoniae R6 under anaerobic conditions as monitored in vivo by 
31
P-NMR. R6 cells, 
grown anaerobically as in Fig. 2.3-B until late-exponential phase (OD600 1.9), were 
suspended in 50 mM MES buffer with 2% (wt/vol) choline (pH 6.5) at a concentration of 
13-14 mg protein ml
-1
. Glc was added at time zero and spectra (126 s) were acquired 
sequentially after its addition. The extracellular pH was maintained at 6.5 during the 





A chemically defined medium and growth conditions supporting high 
biomass yield of S. pneumoniae strains D39 and R6 have been developed. 
Importantly, during this process an extensive comparative metabolic 
characterization between these strains under controlled conditions of pH, 
temperature and gas atmosphere has been accomplished. The results of these 
studies showed that strains D39 and R6 display a better growth performance 
under different environmental and nutritional conditions. In strain D39 the growth 
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rate was stimulated under semi-aerobic conditions, while in strain R6 strictly 
anaerobic conditions rendered optimal growth. The better performance of D39 in 
semi-aerobic conditions was attributed to the lower activity of pyruvate oxidase 
and higher activity of NADH oxidase as compared to R6. Furthermore, the 
maximal biomass achieved by strain D39 was substantially enhanced when a 
supplement of uracil was added to the culture medium, whereas R6 was 
irresponsive to the nucleobase. Our metabolic data showed that more than an 
energetic burden capsule is a cost in nutritional terms and uracil is the limiting 
nutrient. This view indicates a direct link between capsule production and the 
requirement for uracil. The surprising marked physiological differences between 
strains D39 and R6, showed in our studies substantiate the view that findings in 
strain R6 cannot be generalized to D39, at least in what growth physiology is 
concerned (Lanie et al., 2007). Finally, the chemically defined medium optimized 
in this study was suitable for the application of in vivo NMR to study sugar 
metabolism. We were the first to obtain time series data on concentrations of 
metabolite pools online and non-invasively for S. pneumoniae. Our data suggest 
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Summary 
Pyrimidine nucleotides play an important role in the biosynthesis of NDP- 
sugars, the precursors of structural polysaccharides in bacteria. The precursors 
for the biosynthesis of capsule, a major virulence factor of the human pathogen  
S. pneumoniae, are activated by pyrimidine nucleotides. S. pneumoniae is known 
to switch between opaque and transparent phenotypes, which are among other 
factors characterized by different capsule amounts. We identified a spontaneous 
non-reversible mutant of strain D39 that displayed characteristics of 
underproducing capsule similar to a transparent variant. Sequencing analysis of 
the dexB-cps2A intergenic region containing the capsule operon promoter 
revealed a point mutation in the -10 box of Pcps. By directed mutagenesis we 
showed that this mutation was solely responsible for the drastic decrease in 
capsule expression and production. Transcriptome analysis comparing the 
spontaneous mutant with its progenitor resulted in altered expression of several 
genes, including the capsule operon, a gene involved in uracil transport 
(spd_0267) and pyrC (spd_1030), coding for a protein of de novo pathway for 
pyrimidine biosynthesis. These data suggested a link between pyrimidine 
metabolism and capsule production. In medium lacking uracil, D39 showed 
increased lag phase, decreased growth rate and higher biomass, as compared to 
growth in uracil-containing medium. Moreover, the activity of the capsule promoter 
and the amounts of capsule were lower in uracil-deprived conditions. In contrast, 
uracil had no effect on the spontaneous mutant strain. Co-cultivation of both 
strains indicated a competitive advantage of the spontaneous mutant (transparent 
phenotype) in medium devoid of uracil. Taken together, our data suggest that 
uracil may act as a signal in the molecular switch between the distinct capsular 




Streptococcus pneumoniae is a deadly human pathogen. This bacterium 
that resides in the human nasopharynx can, when the host immune system is 
debilitated, migrate to and infect normally sterile niches, such as the lower 
respiratory tract (bronchi and lungs), middle ear, meninges and blood (reviewed in 
Mitchell, 2003). The fluctuating environments in the host elicit different gene 
expression patterns in S. pneumoniae, leading to different phenotypes (Orihuela 
et al., 2004b; LeMessurier et al., 2006; Oggioni et al., 2006). One of the most 
remarkable examples of pneumococcal adaptation to the microenvironments of 
the human host is the so-called ON and OFF switch of phase variation (Kim and 
Weiser, 1998; Hammerschmidt et al., 2005). In this process, the switch occurs 
between two phenotypic variants of S. pneumoniae, the opaque and the 
transparent (Kim and Weiser, 1998; Kim et al., 1999). Opaque pneumococci are 
less efficient colonizers of the nasopharynx, produce more capsule and are more 
virulent than transparent variants (Kim and Weiser, 1998; Kim et al., 1999; Magee 
and Yother, 2001; Ogunniyi et al., 2002; Morona et al., 2004; Hammerschmidt et 
al., 2005; Nelson et al., 2007). This specific phase variation (opaque versus 
transparent phenotype), which differs in capsule amounts, is generally reversible 
(Saluja and Weiser, 1995; Weiser et al., 2001; Waite et al., 2001; Waite et al., 
2003). However, irreversible phase transitions have also been reported 
(Hammerschmidt et al., 2005; McEllistrem et al., 2007; Allegrucci and Sauer, 
2008). Adaptation mechanisms leading to pneumococcal irreversible mutations 
and thereof to readjustment of regulatory networks have been described 
(Claverys et al., 2000; Hakenbeck et al., 2001; Pericone et al., 2002; Stevens and 
Sebert, 2011). These mechanisms include horizontal gene transfer and 
homologous recombination, transposition of insertion sequences (ISs), gene 
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duplication, rearrangement of short-sequence DNA repeats (namely RUP and 
BOX elements), and oxidative damage-mediated responses (Claverys et al., 
2000; Hakenbeck et al., 2001; Hoskins et al., 2001; Tettelin et al., 2001; Pericone 
et al., 2002; Lanie et al., 2007; Stevens and Sebert, 2011; Hakenbeck et al., 
2012). The aptitude to acquire new mutations is further corroborated by the recent 
findings showing that S. pneumoniae accumulates beneficial mutations at a rate 
of 4.8 x 10-4 per genome per generation time, during single-colony serial transfer 
(Stevens and Sebert, 2011), a value similar to that obtained for E. coli by Perfeito 
and co-workers (Perfeito et al., 2007).  
The present study started with the identification of a non-reversible D39 
spontaneous mutant displaying characteristics of underproducing capsule, similar 
to a transparent phenotypic variant. This isolate arose together in solid cultures 
with D39 opaque colonies. Capsule has been recognized as a condition sine qua 
non of virulence in S. pneumoniae. Hence, regulation of its synthesis and of 
phase variation is central to the ability of the pneumococcus to cause invasive 
disease (Kim and Weiser, 1998; Llull et al., 2001). The involvement of the global 
regulator CcpA, pyruvate oxidase (SpxB), and the tyrosine phosphoregulatory 
system (CpsBCD) in the control of pneumococcal capsule production has been 
postulated (Chapters 4 and 6) (Weiser et al., 2001; Giammarinaro and Paton, 
2002; Bender et al., 2003; Morona et al., 2006; Ramos-Montañez et al., 2008; 
Yother, 2011). Despite recent advances, a true understanding of the mechanisms 
connecting capsule production and central metabolism in S. pneumoniae remains 
unclear (reviewed in Yother, 2011).  
In Chapter 2, a link between the pyrimidine uracil metabolism and capsule 
production in strain D39 is surmised. The capsule of strain D39 is formed by 
repeating units of glucose, glucuronic acid and rhamnose in the proportion of 
1:2:3 (Iannelli et al., 1999). The sugar constituents are activated by UTP, yielding 
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UDP-glucose and UDP-glucuronic acid, and dTTP, yielding dTDP-rhamnose 
(Iannelli et al., 1999). In several Gram positive microorganisms, UTP is produced 
from UMP in the salvage pathway of pyrimidine biosynthesis (reviewed in Kilstrup 
et al., 2005). However, the precursors for UMP production may be synthesized 
endogenously in the pathway of de novo synthesis of pyrimidines or from uracil or 
uridine supplied exogenously (reviewed in Kilstrup et al., 2005).  
In this work, we show that the underproducing capsule phenotype of the 
D39 spontaneous mutant (D39SM) can be ascribed to a point mutation in the -10 
box element of the capsule (cps) promoter. Reconstitution of the single mutation 
in D39 rendered a strain defective in capsule production, but in other aspects 
phenotipically distinct from D39SM. This finding indicates the occurrence of 
additional mutations in D39SM, which are currently being investigated by whole 
genome sequencing. Resorting to growth characterization and transcriptome 
analysis of D39 and its derivative strains in the presence or absence of uracil, a 
link between pyrimidine metabolism and capsule was unveiled. In light of these 
results, we speculate that the stressful condition triggering the mutations in D39 
changed UMP/UTP availability, leading to the underproducing capsule phenotype. 
Considering this assumption, we analyzed the growth profiles of D39 and D39SM 
in co-cultivation in medium with or without uracil and observed that in uracil-
deprived conditions the transparent phenotype is a competitive advantage. In 
addition, we investigated how capsule production and growth of S. pneumoniae 
responded to the presence and absence of uracil. Based on our findings we 
propose that sensing of uracil is one mean by which S. pneumoniae alters 
capsule production, and thus, virulence.  
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Materials and Methods  
Bacterial strains and growth conditions for strain isolation  
Strains and plasmids used in this study are shown in Table 3.1.  
S. pneumoniae strains were routinely grown in M17 agar containing 0.5 % (wt/vol) 
Glc and 1% (vol/vol) defibrinated sheep blood (Probiológica, Portugal) or as 
standing cultures without aeration in M17 broth (DifcoTM) supplemented with 
0.5% (wt/vol) Glc, at 37ºC. Stocks and working stocks of isolated strains were 
prepared as described in Chapter 2. When appropriate, 0.25 µg ml-1 erythromycin 
or 2.5 µg ml-1 tetracycline were added to the medium. E. coli EC1000 was grown 
in TY broth in a shaking incubator at 37ºC; erythromycin was used in a 
concentration of 120 µg ml-1.  
 
Growth conditions for physiological studies 
S. pneumoniae was grown in the CDM described in Chapter 2, except 
when stated otherwise. S. pneumoniae cultures were started at an initial optical 
density at 600 nm (OD600) of 0.05-0.06 by addition of preculture cells harvested in 
exponential phase (OD600 0.8 - 1.0), centrifuged and suspended in fresh CDM 
without uracil. Cultivations were performed in static rubber-stoppered bottles at 
37ºC without pH control (initial pH 6.5). Glc (1% wt/vol) was used as the carbon 
source. Growth was monitored by measuring OD600 every hour. Maximum specific 
growth rates ( max) were calculated through linear regressions of the plots of  
ln (OD600) versus time during the exponential growth phase.  
The effect of uracil deprivation on growth of the pneumococcus strains 
was assessed by cultivating cells as above, except that uracil was omitted from 




Table 3.1. Bacterial strains and plasmids used in this work 
Strains Description Source/Reference 
S. pneumoniae   
D39  Serotype 2 strain 
Avery et al., 1944; 
Lanie et al., 2007 
D39SM 
Spontaneous mutant derived from serotype 2 strain 
D39 with characteristics of underproducing capsule. 
Colony phenotype on plate: small and transparent.  
This work 
D39PcpsT→C 
D39 containing a point mutation (T→C, 30 
nucleotides upstream of the starting codon (ATG) of 
the cps2A gene) in the -10 region of the cps 
promoter (Pcps) 
This work 
D39pPP2[PcpsT→C] D39 ∆bgaA::PcpsT→C-lacZ; Tet
R This work 
D39pPP2[Pcps] D39 ∆bgaA::Pcps-lacZ; TetR This work 
D39SMpPP2[PcpsT→C] D39SM ∆bgaA::PcpsT→C-lacZ; Tet
R This work 
D39SMpPP2[Pcps] D39SM ∆bgaA::Pcps-lacZ; TetR This work 
E. coli   
EC1000 
MC1000 derivative carrying a single copy of the 
pWV01 repA gene in glgB; kmR 
Leenhouts et al., 
1996 
Plasmids   
pPP2 
Promoter-less lacZ. For replacement of bgaA with 
promoter-lacZ fusions. Derivative of pPP1; AmpR, 
TetR. 
Halfmann et al., 
2007 
pORI280 
ori+ repA-, deletion derivative of pWV01; constitutive 
lacZ expression from P32 promoter; EmR 
Leenhouts et al., 
1996 
pORI[PcpsT→C] 
pORI280 carrying a 1268-bp fragment, which 
contains a point mutation (T→C, 30 nucleotides 
upstream of the starting codon (ATG) of the cps2A 




pPP2 carrying a 1268-bp fragment, which contains 
the native cps promoter (Pcps), in front of lacZ; TetR. 
This work 
pPP2[PcpsT→C] 
pPP2 carrying a 1268-bp fragment, which contains a 
point mutation (T→C, 30 nucleotides upstream of the 
starting codon (ATG) of the cps2A gene) in the -10 
region of the cps promoter (Pcps), in front of lacZ; 
TetR 
This work 
Abbreviations: TetR, tetracycline resistance; AmpR, ampicillin resistance; EmR, erythromycin resistance; 
KmR, kanamycin resistance. 
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Intraspecies competition growth experiments  
D39 and D39SM were grown in CDM supplemented or not with uracil  
(10 mg l-1) in monoculture or co-culture. Both monocultures and co-cultures were 
started at an initial OD600 of 0.06 ± 0.03 by addition of exponentially growing 
precultures suspended in fresh CDM without uracil, as described above. In the co-
culture experiments, in which uracil is present, D39 and D39SM were inoculated 
at a cell ratio of 4:1, 1:1 and 1:4. For experiments in the absence of uracil D39 
and D39SM were inoculated at a cell ratio of 3:1, 1:1 and 1:4. Colony forming 
units per ml (CFUs ml-1) of D39 and D39SM were determined at time-point zero of 
inoculation (OD600 of 0.06 ± 0.03) as follows: suspensions were diluted 1000 times 
in CDM without uracil and plated (2 µl) in M17 blood agar containing 0.5% (wt/vol) 
Glc. For the determination of strain relative abundance, samples in mid-
exponential phase (OD600 of 0.48 ± 0.05) were collected, diluted 100 times and 
plated (100 µl) in M17 blood agar containing 0.5% (wt/vol) Glc. Plated cells were 
always grown at 37ºC in a 5% (vol/vol) CO2 incubator. The estimation of the 
relative abundances of the D39 and D39SM populations was determined by cell 
counting (CFUs ml-1). All the plates were scanned with white light epi-illumination 
and stored as digitized image files with a Molecular Imager® ChemiDocTM XRS+ 
Imaging System (Bio-Rad). The Quantity one software package was used to 
adjust the contrast, thus enhancing the visualization of the colonies on the plates.  
 
Molecular techniques 
Chromosomal DNA isolation was performed according to the procedure of 
Johansen and Kibenich (1992). Plasmid isolation was carried out using the 
plasmid isolation kit from Roche. Pwo DNA polymerase (Roche), T4 DNA ligase 
(Biolabs, New England) and restriction enzymes (Biolabs, New England) were 
used according to the supplier’s recommendations. Purification of the PCR 
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products was performed using the High pure PCR product purification kit from 
Roche. Purified PCR products or recombinant plasmids were introduced into  
S. pneumoniae by transformation as described in Kloosterman et al. (2006a). 
Positive transformants were selected in M17 blood agar containing 0.5% (wt/vol) 
Glc with the appropriate antibiotic and confirmed by PCR and sequencing.  
 
Sequencing of the dexB-cps2A genomic region  
The genomic region comprising 1453-bp before and 396-bp after the 
starting codon (ATG) of the cps2A gene was PCR amplified with primers 
P1_capsule to P5_capsule and sent for sequencing (Service XS, Leiden, The 
Netherlands).   
 
Construction of a point mutation in the -10 box of the capsule locus (Pcps)  
The oligonucleotide primers used in this study are listed in Table 3.2. 
Thymine, located 30 nucleotides upstream of the initiation codon (ATG) of the 
cps2A gene, was replaced in the TATAAT binding box of the cps locus with a 
cytosine, thereby leading to TATAAC (Fig. 3.3-A), as follows. Up- and 
downstream DNA fragments of 659- and 625-bp, respectively, comprising the 
desired mutation were obtained by PCR amplification with the primer pairs 
Pcapsule-1/ Pcapsule-mut2 and Pcapsule-2/ Pcapsule-mut1, using D39 wild-type 
DNA as a template. The internal primers, Pcapsule-mut2 and Pcapsule-mut1, 
comprise the point mutation leading to the TATAA(T→C) change. The resulting 
PCR products were fused by means of overlap extension PCR (Song et al., 2005) 
using the primers Pcapsule-1 and Pcapsule-2, leading to the formation of a DNA 
fragment (1263-bp) containing the altered -10 binding box (TATAAC). This 
fragment was cloned into the EcoRI/BamHI sites of pORI280, forming the 
pORI[PcpsT→C] construct. E. coli EC1000 was used as cloning host. This 
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construct was used to introduce the point mutation in the -10 promoter region of 
the cps locus of the chromosome of strain D39 following the procedure described 




Table 3.2. Oligonucleotide primers used in this study 
Primers Sequence (from 5’ to 3’ end) REnz 
Spec_Fp CTAATCAAAATAGTGAGGAGG - 
Spec_Rp ACTAAACGAAATAAACGC - 
Pcapsule-1
a
 CGGAATTCAGTATCGAATCCTGTTTCGTC EcoRI 
Pcapsule-2
a
 CGGGATCCGTCTGGATACTCTAACTCGATG BamHI 
Pcapsule-mut1
b
 AACCGTAAGATGTTCAATGTATAG - 
Pcapsule-mut2
b
 TACATTGAACATCTTACGGTTATA - 
P1_capsule CCATGGGATGCTTTCTGTG - 
P2_capsule GAGGTGCTTTTTGATATGAG - 
P3_capsule AGCCCATAGCTTTGAGCGC - 
P4_capsule AGGTGTAGACATTACCG - 
P5_capsule GTTACGCAACTGACGAGTG - 
REnz, restriction enzyme; 
a
Restriction enzyme sites are underlined. 
b
Point mutations are underlined. 
Overlap of primers Pcapsule-mut1 and Pcapsule-mut2 is indicated in bold.  
 
 
Construction of ectopic Pcps-lacZ and PcpsT→C-lacZ fusions 
An ectopic transcriptional fusion of the capsule locus promoter (Pcps) with 
the lacZ reporter gene was constructed using the pPP2 plasmid (Halfmann et al., 
2007). A DNA fragment comprising Pcps was PCR-amplified from D39 
chromosomal DNA using the primer pair Pcapsule-1/Pcapsule-2. This fragment 
(1284-bp) was cloned into the EcoRI/BamHI sites of pPP2 and the resulting 
plasmid (pPP2[Pcps]) was integrated via double cross-over into the bgaA locus of 
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strains D39 and D39SM, yielding strains D39pPP2[Pcps] and D39SMpPP2[Pcps], 
respectively. To construct a lacZ fusion with the mutated cps locus promoter 
(PcpsT→C), the PCR fragment containing PcpsT→C, generated as described above, 
was cloned into the EcoRI/BamHI sites of pPP2. The resulting plasmid 
(pPP2[PcpsT→C]) was integrated via a double cross-over event into the bgaA locus 
of strains D39 and D39SM, leading to the formation of strains D39pPP2[PcpsT→C] 
and D39SMpPP2[PcpsT→C], respectively. 
 
β-galactosidase activity measurements  
Cells containing the promoter-lacZ fusions were grown in CDM containing 
1% (wt/vol) Glc, with or without uracil, as described above. Culture samples of 2 
ml were harvested during mid-exponential phases of growth and the activity of the 
promoters was assayed by measuring -galactosidase activities as described 
before by Kloosterman et al. (2006a).  
  
Transcriptome analysis 
Strains D39SM and D39PcpsT→C were compared to S. pneumoniae D39 
by transcriptome analysis using whole-genome S. pneumoniae DNA microarrays, 
representing all TIGR4 ORFs, as well as R6 and D39 ORFs that are not in TIGR4 
(Kloosterman et al., 2006b). A complete description of amplicons and 
oligonucleotides is provided at http://www.ncbi.nlm.nih.gov/geo/query/ 
acc.cgi?acc=GPL11484. Each strain was grown in triplicate in CDM containing 
1% (wt/vol) Glc and with or without uracil as described above. Cells for RNA 
isolation were harvested in mid-exponential phase of growth (see time-points 
indicated by arrows in Fig. 3.2-A and Fig. 3.4-A). mRNA isolation, synthesis of 
cDNA and labelling of cDNA was performed as described in Chapter 6. All 
samples were hybridized in duplicate in the spotted DNA microarrays. Scanning 
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of the slides and the processing and analysis of the data was carried out as 
described in Chapter 6. Genes were considered to have significantly altered 
expression when the bayesian p-value was <0.0001 and the ratio (signal  
D39SM /signal D39 or signal D39PcpsT→C /signal D39) was >3 and <-3. An  
in silico comparison was done between conditions with and without uracil in both 
D39 wild-type as well as D39SM. To this end, raw signals (i.e. slide images) of the 
experiments with uracil were compared with the corresponding signals of the 
experiments without uracil and analyzed as described above. The microarray data 
will be deposited at GEO. 
 
Quantification of the glucuronic acid content of capsular polysaccharide 
Samples for the determination of the capsular glucuronic acid amounts 
were grown in CDM supplemented with 1% (wt/vol) Glc, with or without uracil, as 
described above, harvested during mid-exponential phases of growth (see time-
points indicated by arrows in Fig. 3.2-A and 3.4-A) and treated as in Chapter 6. 
Capsule measurements were performed in duplicate using samples from two 
independent cultures. 
 
          
Results  
Isolation of a D39 mutant with underproducing capsule phenotype 
Unexpectedly, streaking a single working stock of strain D39 on GM17-
agar plates resulted in the appearance of two colony phenotypes. One colony 
type displayed the typical characteristics of the D39 Lilly isolate (Lanie et al., 
2007), i.e. large and opaque colonies. The other colony type, hereafter 
denominated D39SM (D39 spontaneous mutant), exhibited a substantially smaller 
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colony size and higher transparency than D39 (Fig. 3.1-A). The phenotype of 
D39SM colonies, resembling that of strain R6 (data not shown), could be due to a 
considerably lower growth rate or to a decreased capsule production (Kim and 
Weiser, 1998).  
 








Fig. 3.1. Colony phenotype of D39 and derivative strains in Glc-M17 blood agar. 
Phenotypic appearance of D39 and D39SM (A) and D39SM and D39PcpsT→C (B) strains 





 XRS+ Imaging System (Bio-Rad) and the Quantity one software package.  
 
 
A single colony isolate of the phenotypic variant was selected for further 
characterization. Both wild-type and D39SM strains were grown in CDM 
containing 1% (wt/vol) Glc, as described in Material and Methods, and the amount 
of capsule was determined in the mid-exponential phase of growth (D39, OD600 of 
0.40 ± 0.00; D39SM, OD600 of 0.48 ± 0.02) (see time-points indicated by the 
arrows in Fig. 3.2-A). The maximal growth rate of strain D39SM was 1.4-fold 
lower than that of strain D39 (Fig. 3.2-A). Interestingly, this decrease in the growth 
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rate is in contrast with the 1.4-fold increase in the final biomass reached by 
D39SM strain relative to the parent strain (Fig. 3.2-A). Moreover, the amount of 






























































D39 () 0.82 ± 0.03 
D39SM () 0.57 ± 0.04 
D39PcpsT→C () 0.86 ± 0.01 
R6 () 0.68 ± 0.01 
 
Fig. 3.2. Growth profile and capsule production in D39 and its derivative strains. (A) 
Growth of strains D39 (), D39SM (), D39PcpsT→C () and R6 () in CDM with 1% 
(wt/vol) Glc, at 37ºC, without pH control (initial pH 6.5), in static rubber-stoppered bottles, 
after inoculation with precultures in late-exponential phase (OD600 0.8-1.0). The arrows 
indicate time of sampling for measurement of capsule amounts and for transcriptome 
analysis. The growth rates for each strain are indicated in the table and the values shown 
are averages ± SD. For each growth at least three independent experiments were 
performed. The plotted growth curves are from a representative experiment and the error 
in each point was in all cases below 15%. (B) Estimation of capsule was performed based 
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on the determination of its glucuronic acid content in strains D39 (black bars), D39SM 
(dark grey bars), D39PcpsT→C (light grey bars) and R6 (white bars) in mid-exponential 
phases of growth. All the determinations were done twice in two independent cultures and 
the values are means ± SD. +U, with uracil. 
 
 
 Considering these data, the small colony and high transparency 
phenotype most likely reflects the substantial reduction in capsule amount, rather 
than the slight decrease in growth rate. Interestingly, the amounts of glucuronic 
acid (GlcUA) in D39SM were similar to those of R6, the non-encapsulated 
derivative of strain D39, showing that D39SM is almost or entirely devoid of 
capsule as well (Fig. 3.2-B).  
Further analysis of the original culture from which D39SM was isolated 
revealed a frequency of D39SM colonies approximately 100-fold lower than that 
of the wild-type colonies. The scarce number of mutant colonies suggests that 
their appearance was an exceptional event that occurred exclusively during the 
preparation of this working stock. Supporting this notion, the only phenotype 
recovered upon growth of any other of our working stocks in Glc-M17 agar was 
that of the progenitor D39 strain.  
 
A point mutation in D39 Pcps locus leads to decreased capsule production 
To explain the diminished capsule production in strain D39SM we 
hypothesized two possible scenarios: a deletion within the cps locus or point-
mutations in the cps operon, particularly in the initial five genes cps2A-E and/or in 
the promoter region of the capsule cluster (Pcps). A correlation between 
decreased cps expression and polymorphisms in the promoter of the cps gene 
cluster or in the cps2A gene in S. pneumoniae is not unprecedented (Moscoso 
and Garcia, 2009; Hanson et al., 2011; Yother, 2011). Sequencing of the dexB-
Uracil utilization and capsule synthesis in Streptococcus pneumoniae 
 119 
cps2A genomic region was performed and its analysis revealed a single point 
mutation in the -10 promoter region localized 30 nucleotides upstream of the 
starting codon of cps2A, and leading to the transition of the consensus sequence 













































Fig. 3.3. Expression of Pcps and PcpsT→C in S. pneumoniae D39 and D39SM.  
(A) Schematic overview of the dexB-cps2A region and magnification of the cps promoter 
area of D39SM. Hooked arrow, cps promoter; lollipop, putative terminator; zoomed area 
(inset), promoter region of the cps gene cluster; -35 and -10 binding box, and the starting 
codon of the cps2A gene are indicated in bold; the number of bp of the cps2A gene next 
to the starting codon is subscripted after {n}; *, point mutation (T→C) in -10 binding box of 
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D39SM strain. (B) Transcription of cps and cpsT→C promoters was estimated by measuring 
β-galactosidase activity in strains D39 (white and black bars) and D39SM (dark and light 
grey bars) carrying the pPP2 integrative lacZ reporter plasmid (see Table 3.1). Cultures 
were grown in CDM with 1% (wt/vol) Glc, at 37ºC, without pH control (initial pH 6.5), in 
static rubber-stoppered bottles, and samples for activity measurement were harvested in 
mid-exponential phase of growth (for details see Materials and Methods). All the 
determinations were done in duplicate in two independent experiments and the values are 
means ± SD. β-galactosidase activities are expressed as Miller units.   
 
 
Interestingly, the same base substitution is present in the Pcps of the non-
encapsulated D39 derivative strain R6 (Lanie et al., 2007; Moscoso and Garcia, 
2009). In addition, strain R6 harbors a large deletion (7.5 kbp) in the cps locus 
comprising genes cps2A to cps2H. Using PCR we verified that cps2A and the 
downstream cps2B-D genes are present in D39SM (data not shown), suggesting 
that the events leading to arousal of the two strains were distinct. To investigate 
whether the decreased capsule production was mediated at the transcriptional 
level by PcpsT→C mutation, the activity of cps and cpsT→C promoters was 
measured. Fusions of these promoters with the lacZ reporter gene were 
generated in the pPP2 plasmid (Halfmann et al., 2006) and introduced into D39 
and D39SM backgrounds. The D39pPP2[Pcps], D39pPP2[PcpsT→C], 
D39SMpPP2[Pcps] and D39SMpPP2[PcpsT→C] strains generated in this way were 
grown in CDM containing 1% (wt/vol) Glc, harvested in exponential phase and  
β-galactosidase activities were determined. The activity of the cpsT→C promoter 
was decreased by 18-fold relative to the activity of the Pcps in D39 and D39SM 
strains (Fig. 3.3-B). Even though data are only shown for mid-exponential phase 
of growth (Fig. 3.3-B), low promoter activity was observed throughout growth 
(data not shown). This suggests that the reduction in capsule production is 
caused solely by the PcpsT→C mutation. To strengthen our hypothesis, the 
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PcpsT→C point mutation was generated in the chromosome of strain D39 by using 
the pORI280 plasmid as described in Material and Methods. The amount of 
capsule in the D39PcpsT→C mutant, as estimated from the GlcUA method, was 
similar to that in D39SM and 8-fold lower than that of the parent strain D39 (Fig. 
3.2-B). Furthermore, in Glc-M17 blood agar plates the morphology of D39PcpsT→C 
colonies totally resembled that of D39SM (Fig. 3.1-B). These data provides 
conclusive evidence that the PcpsT→C mutation is responsible for reduction of 
capsule synthesis. Differences in maximal growth rate and final biomass between 
strains D39PcpsT→C and D39SM (Fig. 3.2-A) are perhaps indicative of additional 
mutations in the latter strain. Moreover, the growth profile of strain D39SM, closer 
to that of strain R6, and altered relative to the progenitor strain D39 (Fig. 3.2-A), 
further supports the assumption of the occurrence of other mutations in D39SM. 
This possibility is currently being investigated by whole genome sequencing of 
strains D39SM and its progenitor D39.  
 
Genomic changes in strain D39SM influence greatly the transcriptome  
Clearly, strains D39SM and D39PcpsT→C presented disparate growth 
profiles, which were also distinct from that of the parent D39. Based on these 
results and considering the systemic character of growth we hypothesized distinct 
transcriptional responses in the spontaneous and engineered mutant. To 
investigate this assumption we performed whole-genome transcriptome analysis 
comparing mRNA levels in the mutant strains to those in strain D39. This type of 
approach proved useful in providing clues to genomic mutations in strain variants 
(Caymaris et al., 2010; Linares et al., 2010). Thus, we expected to obtain clues 
possibly leading to the identification of other mutations in D39SM. The 
D39PcpsT→C versus D39 transcriptional response was 5.8-fold lower than that of 
D39SM versus D39 (please see Table S.3.1 and Table S.3.2 provided in digital 
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format on the included CD), showing that the engineered strain was more similar 
to the parent than D39SM. This could imply a larger number of genomic 
differences between D39SM and D39 or the alteration of one major or several 
regulatory mechanisms. As expected from our targeted analysis, the cps genes 
(spd_315-18, spd_321-2) were strongly downregulated in the mutant strains. 
In D39PcpsT→C the transcriptional response was modest and besides 
capsule repression, the most significant alterations were the upregulation of the 
spd_0277-83 operon, coding for a 6-phospho-beta-glucosidase, a lactose-type 
PTS- transporter and a multidomain transcriptional regulator, presumably involved 
in the transport of beta-glucosides (Bidossi et al., 2012), and the downregulation 
of three hypothetical proteins (spd_0486, spd_2001, spd_2038) and of the 
spd_0514-6 operon, which includes an ABC transporter and two hypothetical 
proteins (Table S.3.2 on the CD).  
The transcriptional response of strain D39SM affected about 5% of the 
whole genome, i.e. about 100 genes. Most of the genes (35 genes) showing 
altered expression belonged to the carbohydrate transport and metabolism 
category. In addition, many genes with unknown (7 genes) or unpredicted (21 
genes) function, as well as a number of genes (9 genes) with general function 
prediction only, were among the differentially expressed genes (Table S.3.1, on 
the CD). Noteworthy, eight PTS uptake systems (spd_0066-9, spd_0502, 
spd_0559-61, spd_0661, spd_1047-8, spd_1057, spd_1959 and spd_1992-89), 
and the enzymes involved in the metabolism of the PTS-incoming sugars 
(spd_0063, spd_0065, spd_0070-1, spd_0503, spd_0562, spd_1046, spd_1958-7 
and spd_1995-4) were all strongly induced in the mutant strain (Table S.3.1, on 
the CD). The spd_0277-83 operon induced in the D39PcpsT→C mutant was, 
however, not among the upregulated genes in strain D39SM. The PTS 
transporters upregulated in D39SM are hypothetically involved in the uptake of 
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sugars (galactose, beta-glucosides, lactose, galactitol, maltose, tagatose, fucose, 
L-arabinose) other than glucose (Table S.3.1 on the CD) (Bidossi et al., 2012). 
RegR, a global regulator of the family LacI/LacR, involved in carbohydrate 
metabolism, was upregulated in D39SM. In addition to the PTS transporters, the 
catabolic enzymes, and RegR, the altered expression of two other genes called 
our attention in strain D39SM. The first gene (spd_0267) encodes a permease 
that putatively transports xanthine/uracil and the second gene encodes a putative 
dihydroorotase (pyrC, spd_1030), which is known in other species to dehydrate 
carbamoyl aspartate (CAA) forming dihydroorotate (DHO) in the de novo pathway 
for pyrimidine synthesis (reviewed in Kilstrup et al., 2005). pyrC is part of a 
transcriptional unit comprising two other genes, ung and mutT, also induced in the 
mutant strain, and encoding functions unrelated to the de novo synthesis of 
pyrimidines (Table S.3.1 on the CD). Dihydroorotate is an early precursor for the 
synthesis of UMP, which is subsequently converted to UTP via the salvage 
pathway for pyrimidine biosynthesis (reviewed in Kilstrup et al., 2005). In Chapter 
2 we showed that growth of S. pneumoniae D39 is limited by the nucleobase 
uracil. Since the unencapsulated strain R6 was rather insensitive to uracil and 
only marginally affected when the nucleobase was omitted from the cultivation 
medium, we speculated that the effects on D39 were related to capsule synthesis, 
a process that consumes UTP. In this context, the differential regulation of genes 
involved in the pyrimidine biosynthetic pathways, a putative uracil transporter and 
pyrC, in D39SM, a strain impaired in capsule synthesis, when uracil was present 
in the medium was intriguing. Furthermore, repression of the xanthine/uracil 
permease gene or induction of the pyrC gene was not observed in D39PcpsT→C 
strain, also deficient in capsule production.  
Our genome-wide transcriptome analysis confirmed our hypothesis of 
larger transcriptional response in the spontaneous mutant as compared to that of 
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the strain with a single point-mutation. The altered expression of genes involved 
in pyrimidine biosynthetic pathways further reinforces the assumption of a tight 
connection between uracil metabolism and capsule production.  
   
D39 mutants impaired in capsule production are largely unresponsive to the 
presence of uracil  
Strains D39SM and D39PcpsT→C are “quasi” non-encapsulated (Fig. 3.2-
B), and consequently should have a lower requirement for uracil/UTP as shown 
for strain R6 in Chapter 2. The influence of uracil on capsule production was 
evaluated by cultivating strains D39, D39SM and D39PcpsT→C in the absence of 
the nucleobase (Fig. 3.4) and comparing with the results obtained in complete 
medium (Fig. 3.2). In the absence of uracil, strains D39SM and D39PcpsT→C 
presented growth profiles and capsule amounts similar to those in medium with 
uracil (compare Fig. 3.4 with Fig. 3.2). In contrast, strain D39 was profoundly 
affected by the omission of uracil: growth was characterized by a lag of about 6 
hours, a growth rate of 0.42 ± 0.01 h-1, 2-fold lower than in medium containing 
uracil, and a maximal biomass 1.8 ± 0.0, which represented a 20% increase as 
compared to the standard conditions (uracil 10 mg l-1) (Fig. 3.4-A). Furthermore, 
strain D39 exhibited a significant 22% decrease (unpaired t-test, P=0.0002) in 
capsule amount relative to that produced in medium containing uracil (Fig. 3.4-B). 
Our data show a subtle coupling between uracil metabolism, capsule production 
and growth of strain D39. In agreement, the growth dependency on uracil is lost in 
unencapsulated strains.  
 




























































D39 () 0.42 ± 0.01 
D39SM () 0.59 ± 0.09 
D39PcpsT→C () 0.85 ± 0.01 
 
 
Fig. 3.4. Growth profile and amount of capsule in the absence of uracil. (A) Growth of 
strains D39 (), D39SM () and D39PcpsT→C () in CDM without uracil containing 1% 
(wt/vol) Glc, at 37ºC, without pH control (initial pH 6.5), in static rubber-stoppered bottles. 
Cultures were inoculated with late-exponential phase (OD600 0.8-1.0) precultures 
suspended in fresh CDM without uracil. The arrows indicate time of sampling for 
measurement of capsule amounts and for transcriptome analysis. The growth rates for 
each strain are indicated in the table and the values shown are averages ± SD. For each 
growth at least three independent experiments were performed. The plotted growth curves 
are from a representative experiment and the error in each point was in all cases below 
15%. (B) Estimation of capsule was performed based on the determination of its 
glucuronic acid content in strains D39 (black bars), D39SM (dark grey bars) and 
D39PcpsT→C (light grey bars) in mid-exponential phases of growth. All the determinations 




Uracil affects the transcriptome of strain D39 
In other microorganisms the genes of the de novo synthesis of pyrimidines 
are exclusively induced in the absence of pyrimidines (O’Donovan and Neuhard, 
1970; Potvin et al., 1975; Nicoloff et al., 2005; Kilstrup et al., 2005; Turnbough 
and Switzer, 2008). Therefore, the 5-fold induction of pyrC in D39SM in medium 
containing uracil was a complete surprise (Table S.3.1 on the CD). Intrigued by 
this effect we questioned to whether induction of the pyrC gene in strain D39SM 
would also occur in the absence of uracil. Therefore, we grew strains D39SM and 
D39 as in Fig. 3.4-A, and harvested samples at the time-points indicated by the 
arrows for transcriptome analysis (Fig. 3.4-A). In the absence of uracil, the 
D39SM versus D39 transcriptional response affected 4.2% of the whole genome 
(2069 genes). Of the genes showing altered transcript levels, 87% were common 
in medium with and without uracil, including pyrC (Table S.3.3 on the CD). This 
gene showed increased expression in D39SM, in a uracil-independent manner 
(Table S.3.1 and S.3.3 on the CD). Considering the low requirement of D39SM for 
uracil, the data suggest different or no regulation of pyrC by pyrimidines in 
D39SM. An in silico DNA microarray analysis comparing D39 grown in CDM with 
and without uracil revealed a strong derepression of genes involved in de novo 
synthesis of pyrimidines (spd_0608-9 (pyrFE) and spd_0851-2 (pyrKDb)) in the 
absence of uracil (Table S.3.4 on the CD); pyrC was not significantly changed. 
Consistent with activation of the genes of the de novo synthesis of pyrimidines, 
the gene encoding a putative PyrR regulatory protein (spd_1134), an homologue 
of the lactococcal PyrR protein known to activate the expression of pyrimidine 
biosynthetic genes (reviewed in Kilstrup et al., 2005), was also upregulated in  
S. pneumoniae strain D39 when uracil was omitted (Table S.3.4 on the CD). Our 
in silico data are in good agreement with the accepted view for other 
Streptococcaeae (reviewed in Kilstrup et al., 2005). 
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The in silico DNA microarray analysis comparing D39SM grown in CDM 
with and without uracil showed no significant altered expression of genes (a cut-
off of >3 or <-3 was used for the fold change and a Bayesian  p-value ≤0.0001 to 
consider fold change statistically significant). Similarly, the absence of uracil did 
not induce major changes in the transcriptome profile of strain D39PcpsT→C when 
compared with its parent strain D39, exceptions being the operon spd_1514-6 
and gene spd_0109 (Table S.3.5 compared to Table S.3.2 on the CD). Overall, 
these results show that uracil (or pyrimidines) has no major effect on the 
transcriptome of strains D39SM and D39PcpsT→C, while inducing a considerable 
transcriptional response in the capsulated strain D39.  
 
The activity of the cps promoter is lower in the absence of uracil  
In strain D39 the amounts of capsule decreased in medium lacking uracil. 
To investigate whether this effect was mediated at the transcriptional level we 
measured the activity of the native and mutated cps promoters in cells grown 
without uracil (Fig. 3.5). Interestingly, in the absence of uracil the activity of the 
native cps promoter was 25% lower, a decrease similar to that observed for the 
reduction of capsule in strain D39 in uracil depleted conditions (Fig. 3.5). As 
expected, uracil had no effect on the activity of the cpsT→C promoter, 
independently of the strain genetic background (Fig. 3.5, compare with Fig. 3.3). 
In this light, the observed reduction in capsule production is controlled at the 
transcriptional level through modulation of the cps promoter activity by uracil or a 
product of its intracellular metabolism, such as UMP or UTP. In the capsulated 
strain D39, the UTP pool was higher in medium containing uracil (data not 
shown). The same pattern was observed for strain D39SM (data not shown), but 
since this variant produced little or no capsule, its requirements for UTP are lower, 
and thus growth is not affected.  
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Fig. 3.5. Effect of uracil depletion on the expression of Pcps and PcpsT→C. 
Transcription of cps and cpsT→C promoters was estimated by measuring β-galactosidase 
activities of strains D39 (white and black bars) and D39SM (dark and light grey bars) 
carrying the pPP2 integrative lacZ reporter plasmid (see Table 3.1) in the exponential 
phase of growth. Cultures were grown in CDM without uracil with 1% (wt/vol) Glc, at 37ºC, 
without pH control (initial pH 6.5), in static rubber-stoppered bottles (for details see 
Materials and Methods). All the determinations were done in duplicate in two independent 
experiments and the values are means ± SD. β-galactosidase activities are expressed as 
Miller units. 
 
   
 
In uracil-free medium D39SM performs better than the parent D39  
Bacterial spontaneous mutations generally occur during adaptation to a 
stressful environment. In this context, it is likely that loss of the ability to produce 
capsule conferred the resulting phenotype with a competitive advantage. 
Considering the established interplay between uracil metabolism and capsule 
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production we surmised that the mutant strain would perform better in uracil-
devoid environments. To verify our hypothesis D39SM and its parent D39 were 
















































 Uracil (+U) No uracil (-U) 





1:0 () 0.82±0.03 0.42±0.01 
0:1 () 0.57±0.04 0.59±0.09 
1:1 () 0.79±0.00 0.53±0.01 
1:4 () 0.68±0.01 0.58±0.03 
3.5:1 () 0.80±0.00 0.50±0.01 
 
Fig. 3.6. Growth profiles of strains D39 wild-type and D39SM in co-cultivation. D39 
and D39SM strains were inoculated at a cell ratio of 1:1 (), 1:4 (), and 3.5:1 () in (A) 
CDM or (B) CDM without uracil, containing 1% (wt/vol) Glc, with precultures in late-
exponential phase (OD600 0.8-1.0) suspended in fresh CDM without uracil and grown at 
37ºC, without pH control (initial pH 6.5), in static rubber-stoppered bottles. The growth 
rates of the co-cultures are presented in the table. The values are averages ± SD. For 
comparison the growth curves and growth rates of monocultures of D39 () and D39SM 
() are also shown. For each condition at least three independent growth experiments 
were performed. The plotted growth curves are from a representative experiment and the 
error in each point was in all cases below 15%. +U, with uracil; -U, without uracil. 
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Strain abundance in the co-cultures was assessed by the CFU counts of samples 
harvested in mid-exponential phase of growth (Table 3.3 and Fig. 3.7). In medium 
containing uracil, in mid-exponential growth the most abundant species was the 
one predominating at the time of inoculation (Table 3.3 and Fig. 3.7-A and 3.7-B). 
 
 
Table 3.3. D39 to D39SM ratios of viable cell counts (CFU ml
-1
) in co-culture at the time of 
inoculation (T_0) and in mid-exponential phase of growth (T_MExp). Co-cultures of D39 
wild-type and D39SM were grown as in Fig. 3.6 and plated as in Fig. 3.7.  





























Moreover, the dominant strain in the co-culture dictated to a great extent the 
growth profile of the mixture (Fig. 3.6-A). Curiously, a D39:D39SM ratio of 1 at the 
beginning of growth resulted in a very slight prevalence of strain D39 at mid-
exponential phase (ratio D39:D39SM of 1.34, Table 3.3); the growth rate of the 
co-culture was more similar to that of D39, but the maximal biomass reached 
values similar to those achieved by D39SM (Fig. 3.6-A and Fig. 3.7-A and 3.7-B). 
A possible explanation resides on the ability of D39SM to grow well in the 
absence uracil, which at 10 mg l-1 is limiting for strain D39. Notably, in uracil-free 
medium at mid-exponential growth strain D39SM prevailed over D39, 
independently of the inoculation ratio (Table 3.3 and Fig. 3.7-C and 3.7-D). The 
predominance of strain D39SM in uracil-deprived medium resulted in maximal 
biomass of about 2.1 (ODMax) in the different co-cultures, values similar to those 
reached by strain D39SM alone (Fig. 3.6-B). In uracil-free medium, the average 
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growth rate of the co-cultures also reflected the predominance of strain D39SM 
(Fig. 3.6).  
Our data show that D39SM presents competitive fitness over strain D39 in 
uracil-free conditions. This advantage most likely derives from the low 
requirement of the mutant strain for uracil due to impairment in capsule 
production. In conclusion, our data indicate that in uracil poor media capsule 








1:1 D39:D39SM 1:1 D39:D39SM
1:4 D39:D39SM 1:2 D39:D39SM
4:1 D39:D39SM 5:1 D39:D39SM
A) Inoculation time (T0) B) Mid-Exponential (MExp)
+Uracil
1:1 D39:D39SM 1:11 D39:D39SM
1:4 D39:D39SM 1:25 D39:D39SM
C) Inoculation time (T0) D) Mid-Exponential (MExp) 
-Uracil
3:1 D39:D39SM 1:3 D39:D39SM
 
 
Fig. 3.7. Colony morphology in co-cultures of strains D39 and D39SM. D39 and 
D39SM colony-forming units formed from D39 and D39SM co-cultures, grown with uracil 
as in Fig. 3.6-A (A and B) or without uracil as in Fig. 3.6-B (C and D). Samples harvested 
at the time of inoculation (T0, A and C) or at the mid-exponential phase of growth (MExp, 
B and D) were streaked on Glc-M17 blood agar plates and incubated at 37ºC for 24 h in a 
CO2 chamber. For the sake of clarity, D39:D39SM CFU ratios are also shown. Plating was 
performed in triplicate for each independent growth. The error in each count was always 
below 30%.  
 
 
Uracil utilization and capsule synthesis in Streptococcus pneumoniae 
 133 
Discussion 
Capsule is the major virulence factor of S. pneumoniae, and conditions 
affecting its synthesis are of great interest for the scientific community. 
Pneumococcal phase variants commonly isolated from the human host are, 
among other traits, differentiated by high and low capsule expression (reviewed in 
Weiser, 2010). Transparent variants show less capsule and are found 
predominantly in the nasopharynx, due to their ability to adhere. In contrast, the 
opaque phenotype prevails in the blood, an environment in which a thicker 
capsule is an absolute requirement to escape the immune system of the host. The 
involvement of oxygen in the regulation of the phase switch event has been 
postulated, however, the factors controlling capsule production remain at large 
unknown (Weiser et al., 2001; Hammerschmidt et al., 2005).  
In Chapter 2, we proposed a link between pyrimidine metabolism and 
capsule biosynthesis in S. pneumoniae D39. In this Chapter, we show that uracil 
affects capsule promoter expression and capsule production in S. pneumoniae 
strain D39. Uracil is a pyrimidine nucleobase involved in the production of sugar-
precursors for the synthesis of exopolysaccharides and peptidoglycan in lactic 
acid bacteria (De Vuyst and Degeest, 1999; Delcour et al., 1999). In  
S. pneumoniae strain D39, formation of the activated sugar precursors, UDP-Glc, 
UDP-GlcUA, and dTDP-Rha, for capsule production, requires the pyrimidine 
nucleotides, UTP and dTTP. Generally, UTP is synthesized via the salvage 
pathway for pyrimidine biosynthesis, but it can as well be synthesized de novo 
from glutamine, aspartate and CO2 (Fig. 3.8). The routes for pyrimidine 
biosynthesis in this bacterium are not biochemically characterized, but the 
complete salvage and de novo pathways can be deduced from genome 
information (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi) and database 
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surveys (KEGG, MetaCyc) (Fig. 3.8). Moreover, transporters for uracil are 
predicted in the genome sequence of strain D39 (Lanie et al., 2007). In light of our 
results we propose that in S. pneumoniae strain D39 the operative pathway for 
pyrimidine biosynthesis in uracil-containing media is the salvage, whereas in the 
absence of uracil the de novo route is activated. In agreement is the long lag 
phase displayed by D39 in medium devoid of uracil that most likely reflects the 
time required for significant expression of the genes of de novo synthesis of 
pyrimidines (Fig. 3.8). This idea is further corroborated by the strong induction of 
the de novo pathway genes in medium without uracil. Induction of the pathways of 
de novo synthesis of pyrimidines in the absence of pyrimidines is not 
unprecedented (O’Donovan and Neuhard et al., 1970; Potvin et al., 1975; Nicoloff 
et al., 2005; Kilstrup et al., 2005; Turnbough and Switzer, 2008). The lower growth 
rate observed for strain D39 in uracil-free medium could derive from a less 
efficient de novo pyrimidine production.  
We also hypothesized that capsule expression of strain D39 is influenced 
by the levels of intracellular pyrimidine(s). The lower UTP concentrations and 
capsule amounts determined for strain D39 in medium lacking uracil is in good 
agreement with this assumption. Changes in pyrimidine concentrations have been 
reported to affect polysaccharide expression in E. coli (Garavaglia et al., 2012). 
Limitation of the de novo pyrimidine pathway by its own substrates (aspartate, 
glutamine and bicarbonate/CO2) cannot be ruled out, but is improbable under our 
conditions: the initial concentrations of aspartate and glutamine in the growth 
medium are relatively high (circa 3 mM), thus depletion is not expected. 
Furthermore, the growth profile of strain D39 in CDM without uracil is not affected 
by addition of bicarbonate up to 50 mM (data not shown).   
 

































































Salvage pathways for pyrimidine biosynthesis






Fig. 3.8. Putative routes for the metabolism of pyrimidines in S. pneumoniae. The 
intracellular reactions depicted are catalyzed by the following enzymes (the genes that 
code for the enzymes are in parenthesis): carbamoyl-phosphate synthase, small and large 
subunit (carAB), aspartate carbamoyltransferase (pyrB), dihydroorotase (pyrC), 
dihydroorotate dehydrogenase A (pyrDa), dihydroorotate dehydrogenases (pyrDb-pyrK), 
orotate phosphoribosyltransferase (pyrE), orotidine 5-phosphate decarboxylase (pyrF), 
uridylate kinase (pyrH), pyrimidine-nucleoside phosphorylase (pdp), uridine kinase (udk), 
cytidine deaminase (cdd), uracil phosphoribosyltransferase (upp), cytidylate kinase (cmk), 
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nucleoside-diphosphate kinase (ndk), ribonucleoside-diphosphate reductases, alpha and 
beta subunits (nrdEF), ribonucleoside-triphosphate reductases (nrdDG), CTP synthase 
(pyrG), deoxyuridine 5’-triphosphate nucleotidodehydrolase (dut), thymidine kinase (tdk), 




In the absence of uracil, D39 produces less capsule, but more biomass. 
Even though a full explanation cannot be put forward, we can speculate that the 
coupling between uracil metabolism and capsule production is somewhat lost in 
the absence of external uracil. Very recently capsule was indicated as an 
enormous energetic burden, and its production was suggested to compete directly 
with central metabolism for energy (Hathaway et al., 2012). In this light, in uracil-
free medium the lower production of capsule is accompanied by a lesser energy 
demand, and consequently the energy surplus can be redirected for growth and 
cell division. This energy can be in the form of ATP, but also UTP, as herein we 
demonstrate that capsule is also a nutritional burden that imposes a high demand 
for uracil to support fast growth.  
We have shown that a point mutation in the -10 box of the cps promoter 
region is responsible for the remarkable decrease in promoter activity leading to 
reduced capsule production in strain D39. This point mutation was identified in the 
D39 spontaneous mutant, D39SM, exhibiting phenotypic characteristics of a 
transparent phase variant. Unexpectedly, this mutant arose in a rich/complex 
medium from D39 opaque colonies. Even though a chronology of the events 
leading to the mutant is available, a mechanistic explanation is difficult to put 
forward. This view is exacerbated by the considerable transcriptional changes 
(about 5% of genome) in the mutant when compared to its parent D39. The 
desensitization to uracil of the mutant strain and the differential expression of 
genes involved in its metabolism could indicate a batch-specific deficiency of the 
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nucleobase in the M17 powder used. However, a deficiency of other components, 
such as sugars, cannot be discarded. Importantly, reconstitution of the cps 
promoter single mutation in D39 rendered a strain D39PcpsT→C phenotipically 
different from D39SM, except for the deficiency in capsule synthesis. These 
findings strongly point towards the occurrence of additional mutations in strain 
D39SM. Comparative transcript levels analysis of D39SM versus D39 and 
D39PcpsT→C versus D39 further supports our assumption. To establish additional 
genomic differences, genomes of strain D39SM and its parent D39 are currently 
being sequenced.  
A number of carbohydrate PTS transporters and associated sugar 
catabolic enzymes were induced in the mutant strain as compared to the parent 
D39 in the microarray analysis. In several Gram-positive microorganisms, 
including S. pneumoniae, CcpA is a global regulator of carbon metabolism 
affecting a high number of sugar transporters and catabolic enzymes (Chapter 6) 
(Abranches et al., 2008; Shelburne et al., 2008b; Singh et al., 2008). In our 
conditions, ccpA was not altered. On the other hand, the gene encoding RegR, a 
regulator of the LacI/LacR, was strongly induced in the mutant strain. It is 
tempting to suggest the involvement of RegR in the regulation of the PTS 
transporters and sugar-specific enzymes. It should be noted however, that the 
role of RegR in the metabolism of sugars has been minimized (Chapuy-Regaud et 
al., 2003). 
The differential expression of genes involved in the metabolism of 
pyrimidines in the spontaneous mutant D39SM was a positive surprise. In 
Chapter 2 we inferred a connection between capsule synthesis and demand for 
uracil. In this work, we identified a mutant deficient in capsule production that 
shows downregulation of a putative uracil transporter (spd_0267) and 
upregulation of pyrC (spd_1030) (Fig. 3.8). In S. pneumoniae, pyrC is in an 
Chapter 3 
 138
operon containing two other genes, spd_1032 (ung, uracil DNA-glycosylase) and 
spd_1031 (mutT protein), encoding functions involved in DNA repair and 
trapping/removing of uracil residues from dUTP precursors during replication 
(Chen and Lacks, 1991). The transcriptome analysis might shed some light on the 
event leading to the spontaneous generation of strain D39SM. A plausible 
explanation could entail the induction of the ung-mutT-pyrC operon by a stressful 
condition, followed by changed pyrimidine availability, which would ultimately lead 
to a suppressor cps promoter mutation. In accordance, the spontaneous mutant 
D39SM exhibited lower accumulation of UTP pools (data not shown) and uracil 
showed no effect on growth and capsule expression and production of this strain. 
The cps promoter point mutation and thus, the underproducing capsule 
phenotype, should improve the bacterium fitness under a particular stressful 
condition. We showed that the underproducing capsule phenotype confers a 
competitive advantage to strain D39SM when co-cultivated with its parent D39 in 
uracil-free medium. In this light, in host niches poor in uracil a predominance of 
transparent phenotypes could be expected, suggesting that uracil would provide a 
selective pressure. Pyrimidine bases and nucleosides are often unavailable as 
exogenous nutrients, which most likely explain the conservation of the genes of 
the de novo pathways for pyrimidine biosynthesis in extracellular microorganisms 
(reviewed in Turnbough and Switzer, 2008). Curiously, pyrimidines, in particular 
uridine, were detected in blood, where capsule is an absolute requirement for the 
survival of S. pneumoniae. In healthy men, the homeostatic concentration of 
uridine is about 3-4 µmol l-1 (Simmonds and Harkness, 1981). This concentration 
is substantially lower than the standard initial uracil concentration in our medium 
(89 µmol l-1). However, it might not be limiting for growth since in the blood the 
uridine is quasi constantly available. Replacement of uracil by uridine showed no 
effect on batch cultures of strains D39 and D39SM (data not shown).  
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In this work, we ascertained that expression of the capsule operon and 
production of the polysaccharide in S. pneumoniae is altered in response to uracil. 
A subtle interplay between uracil metabolism, the pathways for pyrimidine 
synthesis and the production of capsule is unveiled. In light of our results, we 
propose that the sensing of pyrimidines by S. pneumoniae triggers changes in 
capsule production. Exploring the mechanisms integrating pyrimidine metabolism 
and capsule synthesis will certainly contribute to an improved understanding of 
the regulatory phenomena underlying the control of capsule synthesis, and 
ultimately virulence in the human pathogen S. pneumoniae.  
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Pyruvate oxidase is a key function in the metabolism and lifestyle of many 
lactic acid bacteria and its activity depends on the presence of environmental 
oxygen. In S. pneumoniae the protein has been suggested to play a major role in 
metabolism and has been implicated in virulence, oxidative stress survival and 
death in stationary phase. Under semi-aerobic conditions, transcriptomic and 
metabolite profiling analysis of a spxB mutant showed minor changes compared 
to the wild-type, indicating that the role of the enzyme in metabolism is most likely 
milieu-dependent. More importantly, we show that mutation of spxB results in the 
production of increased amounts of capsule, the major virulence factor of  
S. pneumoniae. Part of this increase might be due to induction of cps2A 
transcription. Additionally, mutation of spxB results in an increase of the 
expression of two putative operons involved in carbohydrate uptake and 
processing. A combination of metabolic analysis and growth experiments showed 
that this increase leads to a change in the sugar utilization capabilities of the 
bacterium. Therefore, we propose that S. pneumoniae utilizes pyruvate oxidase 
as an indirect sensor of the oxygenation of the environment, resulting in the 
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Introduction 
Streptococcus pneumoniae is an important human pathogen as it is a 
common cause of respiratory pathologies and serious invasive diseases such as 
pneumonia, sepsis and meningitis; especially infants, the elderly and immuno-
compromised individuals are at risk. Annually, over 1 million children die of 
pneumonia and meningitis and in the US alone 40.000 deaths each year are 
caused by pneumococcal pneumonia or meningitis (Obaro and Adegbola, 2002). 
Capsule, an extracellular structure of polysaccharide nature attached to the cell 
wall, is one of the main virulence factors of S. pneumoniae; its main purpose is to 
inhibit complement-mediated opsonophagocytosis and acapsular mutants are 
avirulent (Paton et al., 1993; Hardy et al., 2001; Magee and Yother, 2001). The 
composition of the capsule varies from strain to strain and up to 93 different 
capsular serotypes have been identified (Song et al., 2012). Capsular 
polysaccharide synthesis is intimately connected with central carbon metabolism 
as it requires activated carbohydrates; a number of these NDP-sugars derive from 
the glycolytic intermediates glucose 6-phosphate and fructose 6-phosphate 
(Iannelli et al., 1999; Hardy et al., 2000; Bentley et al., 2006). A direct correlation 
between capsule thickness and virulence has been reported (Magee and Yother, 
2001; Morona et al., 2004). The amount of capsule varies throughout infection 
and decreases dramatically in the proximity of, and while invading, eukaryotic 
cells (Ogunniyi et al., 2002; Hammerschmidt et al., 2005). In addition,  
S. pneumoniae displays at least two phenotypic variants, transparent and opaque, 
that are to a large extent determined by the quantity of capsule and have 
differences in virulence properties (Kim and Weiser, 1998; Kim et al., 1999). 
Transparent pneumococci are more efficient colonizers of the nasopharynx, 
produce less capsule, but more cell-wall associated teichoic acids than opaque 
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variants (Kim and Weiser, 1998; Kim et al., 1999; Nelson et al., 2007). 
Additionally, the two variants show differential production of various proteins, one 
of which is the pneumococcal pyruvate oxidase enzyme SpxB (Overweg et al., 
2000). However, the factors determining the occurrence of phase variation and 
the regulation of the amount of capsule are still not entirely clear, nor the 
connections that exist between central carbon metabolism and capsule 
production. 
SpxB is reported to play a central role in fermentation and in particular in 
the generation of the phosphoryl donor metabolite acetyl-phosphate (Ac-P) 
(Spellerberg et al., 1996). The enzyme decarboxylates pyruvate into Ac-P by 
reducing oxygen (O2) to hydrogen peroxide (H2O2) and consuming inorganic 
phosphate (Pi). SpxB activity in S. pneumoniae might produce H2O2 in the mM 
range (Spellerberg et al., 1996; Pericone et al., 2002), concentrations higher than 
those generated by many other species (Pericone et al., 2002; Pericone et al., 
2003), and sufficient to kill or inhibit other nasopharyngeal flora members, such as 
H. influenzae and N. meningitidis (Pericone et al., 2000). Furthermore, these 
amounts have cytotoxic effects on human cells (Duane et al., 1993; Hirst et al., 
2000; Braun et al., 2002). The spxB gene has also been designated as a suicide 
gene since the H2O2 induces pneumococcal death and reduces survival in 
stationary phase in the presence of oxygen (Regev-Yochay et al., 2007). In 
addition, the H2O2 produced endogenously influences the membrane composition 
through modulation of fatty-acid biosynthesis F (FabF) protein activity (Pesakhov 
et al., 2007; Benisty et al., 2010). Interestingly, and despite the potential 
deleterious effect of its product, SpxB has also been associated with 
streptococcal resistance to H2O2 (Pericone et al., 2003). Besides its function in 
central metabolism, a prominent role of SpxB in the virulence of the bacterium, 
especially in colonization and pneumonia, is corroborated by a number of studies 
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(Spellerberg et al., 1996; Orihuela et al., 2004b; Regev-Yochay et al., 2007; 
Ramos-Montañez et al., 2008). Here, we studied the role of SpxB under semi-
aerobic conditions as this is likely to reflect the atmospheric conditions 
encountered by S. pneumoniae in the deeper layers of the mucus, close to the 
epithelial cells. We describe that the inactivation of spxB results in the 
overproduction of capsule under semi-aerobic conditions, which is partially 
mediated by increased transcription of the capsule locus. Furthermore, we 
characterized the transcriptomic and metabolic consequences of spxB 
inactivation, which consist of a change in sugar utilization capacities and 
hypothesize that these effects also contribute to its role in virulence. 
 
  
Materials and Methods  
Bacterial strains and growth conditions 
Strains used in this study are listed in Table 4.1 and were stored in 
glycerol at -80ºC. S. pneumoniae was routinely grown as standing cultures in M17 
broth (Oxoid) containing 0.5% (wt/vol) Glc (Glc-M17) at 37ºC. L. lactis NZ9000 
was grown in the same medium at 30ºC and E. coli was grown in LB broth in 
shaken cultures at 37ºC. Chloramphenicol and erythromycin were used at 
concentrations of 2.5 and 0.25 µg ml-1 for S. pneumoniae and 5 and 4 µg ml-1 for 
L. lactis. Trimethoprim was used at a concentration of 15 µg ml-1, and ampicillin 
was used at 100 µg ml-1 for E. coli. For S. pneumoniae growth on plates, 3% 
(vol/vol) defibrinated sheep blood (Johnny Rottier, Kloosterzande, the 






Table 4.1. Strains and plasmids used in this study 
Strains/Plasmid Description Reference/Source 
S. pneumoniae   
D39 Serotype 2 strain Avery et al., 1944 
TIGR4 Serotype 4 strain Tettelin et al., 2001 
D39 pGh9 T7 D39 spxB:: pGh9:ISS1T7; EmR This study 
TIGR4 pGh9 T7 TIGR4 spxB:: pGh9:ISS1T7; EmR This study 
D39spxB- D39 spxB::ISS1 This study 
D39nisRK D39 ∆bgaA::nisRK; TmR Kloosterman et al., 
2006a 
D39nisRKpNZ8048 D39 ∆bgaA::nisRK harbouring pNZ8048; 
TmR, CmR 
Neef et al., 2011 
D39nisRKspxB- D39 ∆bgaA::nisRK spxB::ISS1; TmR This study 
D39nisRKspxB-pNZ8048 D39 ∆bgaA::nisRK spxB::ISS1 harbouring 
pNZ8048; TmR, CmR 
This study 
D39nisRKpNZ spd_0637 D39 ∆bgaA::nisRK harbouring pNZ 
spd_0637; TmR, CmR 
This study 
D39nisRKspxB-pNZ spd_0637 D39 ∆bgaA::nisRK spxB::ISS1 harbouring 
pNZ spd_0637; TmR, CmR 
This study 
D39pORI Pcps2A D39 harbouring pORI Pcps2A-lacZ; EmR Kloosterman et al., 
2006a 
D39pORI Pcps2A spxB- D39 spxB::ISS1 harbouring pORI[PcpsA-
lacZ]; EmR 
This study 
L. lactis   
NZ9000 MG1363 ∆pepN::nisRK Kuipers et al., 1998 
Plasmids   
pGh9:ISS1T7 Insertion mutagenesis plasmid with T7 RNA 
polymerase promoter 
Bijlsma et al., 2007 
pNZ8048 Nisin-inducible PnisA; CmR de Ruyter et al., 
1996 
pNZ spd_0637 pNZ8048 carrying spd_0637 under nisin-
inducible PnisA; CmR 
This study 
pORI13 ori+ repA- ; promoterless lacZ; EmR Sanders et al., 1998 
pORI Pcps2A pORI13 carrying cps2A promoter in front of 
the promoterless lacZ ; EmR 
Kloosterman et al., 
2006a 
Abbreviations: EmR, erythromycin resistance; TmR, trimethoprim resistance; TetR, tetracycline resistance; 
CmR, chloramphenicol resistance; AmpR, ampicillin resistance. 
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Generation of mutants in S. pneumoniae  
S. pneumoniae D39 was transformed with pGh9 T7 as described before 
(Bijlsma et al., 2007). To excise the plasmid from the genome of S. pneumoniae, 
which leaves behind one copy of the ISS1 element (Maguin et al., 1996), the 
strain containing the pGh9 T7 plasmid was grown overnight at 28ºC after which 
serial dilutions were plated on Glc-M17 agar without antibiotics. Erythromycin 
sensitive colonies were selected for further study. The site of insertion into the 
genome was determined using a PCR based method as described in Karlyshev et 
al. (2000). 
 
Transmission electron microscopy of S. pneumoniae 
Aliquots of S. pneumoniae were quickly thawed at 37ºC and diluted 1:40 in 
Glc-M17 and grown under semi-aerobic conditions at 37ºC. Bacteria were 
harvested by centrifugation for 10 minutes at 3000 x g  at 4ºC and subsequently 
stained with lysine ruthenium red (LRR) and treated as described before 
(Hammerschmidt et al., 2005). For visualization a Philips EM201 (maximum 
resolution of ~ 0.5 nm) electron microscope was used. 
 
Construction of a pNZ8048 derivative that expresses spd_0637 
A pNZ8048 derivative containing the spd_0637 gene under the control of a 
nisin inducible promoter was constructed. The gene was amplified from the 
chromosome of D39 using the primers pair Spd0637.fw 
(CATGCCATGGATGAATTTAAATCAATTAGATATTATCG) and Spd0637.rev 
(CTAGTCTAGACTATTTCATACGATAAAAATCAAGC) that contained an NcoI 
and XbaI site, respectively. The resulting 350-bp PCR fragment was cloned into 
the pNZ8048 plasmid using NcoI and XbaI, transformed into L. lactis NZ9000, 
sequenced and transferred to the D39nisRK and D39nisRKspxB- strains. 
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Determination of transcription using lacZ  
To measure transcription of the cpsA gene, a pORI13 derivative 
containing the D39 cpsA promoter was used in the D39 and D39spxB- 
backgrounds (Kloosterman et al., 2006a). Strains were grown standing in CDM 
containing 1% Glc and harvested at mid-exponential (~OD600 0.2) or late-
exponential (~OD600 0.4) phase. Activity of the cps2A promoter was assayed by 




For DNA microarray analysis, D39 wild-type and two independently 
obtained D39spxB- mutants were grown as four, two and two biological replicates, 
respectively, in Glc-M17 under semi-aerobic conditions and harvested at an OD595 
of approximately 0.25. The RNA of both D39spxB- strains was compared to D39 
and the combined data was analyzed. All other procedures regarding microarray 
analyses were done as described before (Neef et al., 2011). A gene was 
considered differentially expressed when the fold change was ≥ 2, ≤ 0.5, with a 
Bayes p ≤ 0.00001 and when at least 7 measurements were available. The 
microarray data is now being submitted to the GEO database. 
 
Growth conditions for metabolic analysis 
Cells were grown at 37ºC in static rubber-stoppered bottles (500-ml) in 
complex medium M17 (DifcoTM), supplemented with Glc 1% (wt/vol) and without 
pH control (initial pH 6.5). Prior to inoculation sterile air was bubbled through the 
medium for 20 min. Alternatively cells were grown in 2-l bioreactors in the CDM 
described in Chapter 2 with the pH controlled at 6.5, and under initial specific air 
tension of 50-60% (semi-aerobic, maximum dissolved O2 concentration of 130 
Pyruvate oxidase and capsule of Streptococcus pneumoniae 
 151 
µM) or aerobic (continuous specific air tension of 40%, constant dissolved oxygen 
concentration of 90 µM) conditions. In the bioreactors, dissolved oxygen was 
monitored with a polarographic oxygen electrode (Mettler-Toledo International). 
The electrode was calibrated to zero or 100% by bubbling sterile argon or air 
through the medium, respectively. A specific air tension of 40% was maintained 
by automatic control of the airflow and agitation. Irrespectively of the growth 
conditions, Glc (1% wt/vol) was used as carbon source. Cultures were inoculated 
to an initial optical density at 600 nm (OD600) of 0.05 with cells growing 
exponentially in the same medium. Growth was monitored by measuring the 
OD600. Specific growth rates ( ) were calculated through linear regressions of the 
plots of ln(OD600) versus time during the exponential growth phase. A factor of 
0.39, determined from a DW (mg ml-1) versus OD600 curve, was used to convert 
OD600 into dry weight (mg biomass ml
-1).  
 
Quantification of fermentation products during growth on glucose 
Strains were grown in Glc-M17 or Glc-CDM as described above. Culture 
samples (2 ml) were taken at different time-points of the growth curves, 
centrifuged (16,000 × g, 2 min, 4ºC), filtered (Millex-GN 0.22 µm filters), and the 
supernatant solutions were stored at 20ºC until analysis by high performance 
liquid chromatography (HPLC). Substrates and end-products were quantified in 
an HPLC apparatus equipped with a refractive index detector (Shodex RI-101, 
Showa Denko K. K., Japan) using an HPX-87H anion exchange column (Bio-Rad 
Laboratories Inc., California, USA) at 60ºC, with 5 mM H2SO4 as the elution fluid 
and a flow rate of 0.5 ml min1. Alternatively, quantification of metabolites in 
supernatants was performed by 1H-NMR in a Bruker AMX300 spectrometer 
(Bruker BioSpin GmbH). Formic acid (sodium salt) was added to the samples and 
used as an internal concentration standard. The ATP yield was calculated as the 
Chapter 4 
 152
ratio of ATP produced to glucose consumed. The global yields of ATP were 
calculated from the fermentation products determined at the time-point of growth 
arrest assuming that all ATP was synthesized by substrate-level phosphorylation. 
 
Determination of hydrogen peroxide (H2O2) 
Strains were grown in Glc-CDM as described above. Culture samples of  
1-ml were harvested at different time-points of the growth curves, centrifuged 
(16,000 × g, 2 min, 4ºC) and filtered (Millex-GN 0.22 µm filters). The Amplex® 
Red Hydrogen Peroxide/Peroxidase assay kit (Invitrogen) was used to quantify 
hydrogen peroxide contents below 10 µM. Determinations of H2O2 up to 300 µM 
were performed as described elsewhere (Meiattini, 1988). Briefly, 1.25 ml of 
peroxide reagent (192 mM phosphate, 14.8 mM azide, 0.96 ml l-1 Triton X-100, 2 
KU l-1 horseradish peroxidase (Roche), 0.48 mM 4-aminophenazone and 9.6 mM 
chromotropic acid) was added to 50 µl of supernatant, mixed and allowed to stand 
for 5 minutes at room temperature. In the presence of H2O2, the chromotropic acid 
was converted by the peroxidase into a blue coloured compound with maximal 
absorbance at 600 nm. Absorbance was read at 600 nm. Water was used as the 
blank and standard curves were performed with fresh dilutions of a stabilized 
solution of 30% (wt/vol) H2O2. The absorbance of the samples was compared to 
that of the standard solutions. 
 
Determination of intracellular metabolites during growth on glucose 
Strains were grown in Glc-CDM under semi-aerobic as described above. 
Ethanol extracts for analysis by 31P-NMR and quantification of phosphorylated 
metabolites in D39spxB- and control strain D39 at late-exponential (LExp) and 
early-stationary (EStat) phases of growth (time-points indicated by the arrows in 
Fig. 4.4-B) were prepared as described in Chapter 6. In brief, a volume of culture 
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was withdrawn from the fermentor, adjusted to obtain approximately 16-18 mg of 
cell protein for extract, and centrifuged (21,000 x g, 15 min, 4ºC). The pellet was 
suspended in 28 ml of 5 mM 3-(N-morpholino) propanesulfonic acid (MOPS) 
buffer, pH 7.2 (Sigma-Aldrich), transferred to 70 ml of cold ethanol (final 
concentration 70% vol/vol) in an ice bath, and extraction was performed for 30 
min with vigorous agitation. Cell debris was removed by centrifugation (35,000 x 
g, 30 min, 4°C), the ethanol was evaporated and the residue lyophilized. The 
dried extracts were dissolved in 1 ml 2H2O containing 5 mM EDTA (final pH 
approximately 6.5) and stored at -20ºC. Assignment of resonances was based on 
previous studies (Ramos et al., 2001; Neves et al., 2006), work presented in 
Chapter 6 or by spiking the sample extracts with the suspected, pure compounds. 
The concentrations of intracellular metabolites were calculated from the areas of 
their resonances in 31P-spectra by comparison with the area of the resonance due 
to methylphosphonic acid (Sigma-Aldrich), added as an internal standard, and 
after application of an appropriate factor for correcting saturation of resonances. 
The reported values for intracellular phosphorylated compounds are averages of 
two to four independent growth experiments. The accuracy was around 15-20%. 
Phosphorus-31 spectra were acquired on a Bruker AVANCE II 500 spectrometer 
(Bruker BioSpin GmbH) with a phosphorus selective 5-mm-diameter probe head 
at 30°C with a pulse width of 6.5 µs (flip angle, 70°) and a recycle delay of 1s. 
Saturation of resonances due to fast pulsing conditions was calculated by 
comparison with spectra acquired under fully relaxed conditions (recycle delay, 
20s). Phosphorus chemical shifts were referenced to the resonances of external 




Quantification of the glucuronic acid content of the capsular polysaccharide 
Samples for the determination of the capsular glucuronic acid amounts 
were prepared as follows: cells grown in Glc-CDM under semi-aerobic conditions 
as above and harvested during the late-exponential (LExp) and early-stationary 
(EStat) phases of growth (time-points indicated by the arrows in Fig. 4.4-B) were 
centrifuged (6,000 x g, 3-7 min, 4ºC), resuspended in PBS and pelleted at 3000 x 
g, 4ºC, for 20 min. The pellet was resuspended in 500 µl of 150 mM Tris-HCl (pH 
7.0) and 1 mM MgSO4 and treated as described elsewhere (Morona et al., 2006). 
The supernatants derived from the two centrifugations referred before were 
pooled and treated with 20% (wt/vol) trichloroacetic acid for protein precipitation. 
After 2 h of incubation in an ice bath proteins were pelleted and the 
exopolysaccharides were precipitated with cold ethanol as in Ramos et al. (2001). 
The glucuronic acid of capsule attached or loosely attached (lost in centrifugations 
to the supernatants) to the cell wall was quantified by the method for quantitative 
determination of uronic acids as described in Blumenkrantz and Asboe-Hansen, 
1973. Capsule measurements were performed in duplicate using samples from 
two independent cultures. 
 
Growth of D39spxB- and D39 strains on specified sugars 
To test the ability of specific sugars to support growth of S. pneumoniae 
strains D39 and D39spxB- cultures of 250 µl were prepared in CDM containing 
0.25% (wt/vol) of glucose (Glc), glucuronic acid (GlcUA), rhamnose (Rha), 
gluconic acid  (GlcA), N-acetylglucosamine  (GlcNAc) or a 1:2:3 mixture of GlcUA, 
Glc and Rha, respectively. Cultures were started at an initial OD595 of 0.25-0.3 by 
addition of a preculture, grown on Glc-M17 (0.5% Glc wt/vol), suspended in fresh 
CDM without sugar. Cultures were grown for 24 h at 37°C in 96-well microtiter 
plates. Cell density was monitored at 595 nm with a ELx808 microplate 
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spectrophotometer (BioTek Instruments, Inc.) and the growth curves were 
generated using Gen5TM (BioTek Instruments, Inc.) with readings taken every 30 
min. Each growth condition was done in triplicate using two independent 
precultures. Growth rates and other growth parameters were generated as above 




Inactivation of spxB leads to an increase in capsule production 
While generating a transposon library in strain D39 using the pGh9:ISS1 
T7 plasmid (Bijlsma et al., 2007), a colony displaying characteristics of 
overproducing capsule was isolated; on solid medium this isolate yielded large, 
opaque and slimy colonies (Fig. 4.1-A). To ensure that the observed phenotype 
was genetically linked to the transposon insertion, the chromosomal DNA of this 
mutant was back-crossed into strain D39 which gave rise to the same phenotype. 
Transformation into strain TIGR4 also resulted in the same phenotype, indicating 
that the phenotype was serotype-independent (Fig. 4.1-B). Comparison of the 
TIGR4 strain containing the insertion with an opaque and transparent variant of 
the same strain indicated that the phenotype of the mutant was dissimilar to the 
opaque phase variant as it seemed to produce even more capsule (Fig. 4.1-B). 
Introduction of the chromosomal DNA into strain R6 and an unencapsulated 
mutant of D39 did not result in this phenotype (data not shown), indicating that the 
observed phenotype is exclusively capsule-dependent. Excision of the pGh9:ISS1 
T7 plasmid did not alter the phenotype and sequencing showed that the ISS1 
element was inserted into the 3’ end of the spxB gene. This gene encodes the  
S. pneumoniae pyruvate oxidase, which generates Ac-P and H2O2 and whose 
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activity plays a key role in pneumococcal colonization and pathogenesis 
(Spellerberg et al., 1996; Orihuela et al., 2003; Regev-Yochay et al., 2007; 
Ramos-Montañez et al., 2008). The amount of H2O2 produced by the mutant was 
reduced about 80% compared to the wild-type and PCR analysis showed the 
insertion of approximately 600-bp into the spxB gene (data not shown), confirming 
that the insertion of ISS1 disrupted spxB and its function. The observed 
phenotype of the colonies (large, opaque and slimy) could be due to the reported 
absence of death in stationary phase of spxB mutants and the ensuing increase in 
biomass production over time (Regev-Yochay et al., 2007) or due to increased 
capsule production. Therefore the amount of capsule was determined in both the 
wild-type and the spxB mutant (from here on denominated D39spxB-) in late-
exponential (Fig. 4.2-A) and early-stationary phases of growth (Fig. 4.2-B) in liquid 
medium. The data showed that the amount of capsule in the D39spxB- mutant 
was significantly increased compared to that of the wild-type levels (students t-
test P ≤ 0.01), meaning that the observed larger colonies are to a large extent due 
to increased capsule amounts rather than differences in survival. Furthermore, 
TEM pictures of bacteria grown to exponential phase in liquid medium, also 
indicated an increased amount of capsule in the mutant (Fig. 4.1-C and 4.1-D) as 
well as some subtle changes in the cell membrane (Fig. 4.1-E and 4.1-F). Thus, 
we showed that inactivation of spxB increased the amount of capsule in  
S. pneumoniae. 
 
Pyruvate oxidase and capsule of Streptococcus pneumoniae 
 157 
 
                       
  
Fig. 4.1. Inactivation of spxB led to an increase in capsule production. (A) Phenotype 
on Glc-M17 agar plate of D39 (D39), D39 containing the pGh9 T7 plasmid (D39pGh9 T7) 
and D39 in which the plasmid is excised leaving the ISS1 element in spxB (D39spxB
-
). (B) 
Phenotype on Glc-M17 agar plate of TIGR4 transparent variant (T4 transparent), TIGR4 
opaque variant (T4 opaque) and TIGR4 in which the pGh9 T7 plasmid is inserted into the 
genome (T4 pGh9 T7). (C-F) TEM pictures of S. pneumoniae grown in broth to 
exponential phase and stained with LRR. (C) D39, 9700 times magnified, (D) D39spxB
-
, 
9700 times magnified, (E) D39, 135.000 times magnified, (F) D39spxB
-
, 135.000 times 
magnified. 
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Fig. 4.2. Effect of spxB mutation on capsule production. Estimation of capsule was 
performed based on the determination of its glucuronic acid content in strains D39 (white 
bars) and D39spxB
-
 (grey bars) in late-exponential (LExp) (A) and early-stationary (EStat) 
(B) phases of growth. Cultures were grown in CDM containing 1% (wt/vol) Glc at 37ºC, 
with pH control (6.5), and under semi-aerobic conditions (for details see Materials & 
Methods). All the determinations were done twice in two independent cultures and the 
values are means ± SD. 
 
 
Transcription of cps2A is increased in the spxB mutant  
Next we determined whether the increase in capsule production was 
mediated by changes in transcription of the capsule locus by determining the 
activity of the promoter of the first gene of the capsule locus, cpsA. A fusion with a 
promoterless lacZ was generated in pORI13 (Kloosterman et al., 2006a) and 
introduced into D39 and the D39spxB- mutant. Both in mid-exponential phase as 
well as late-exponential phase, transcription of the cpsA promoter was increased 
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capsule production is at least partially mediated by a change in transcription of the 
capsule locus. 
 
                    
 
Fig. 4.3. Effect of spxB mutation on cpsA transcription. Transcription of the cpsA 
promoter was estimated by measuring the β-galactosidase activities of strains D39 (bars 
with white background) and D39spxB
- 
(bars with grey background) harbouring pORI 
Pcps2A (see table 4.1) in mid-exponential (MExp) (left panel) and late-exponential (LExp) 
(right panel) phases of growth. Cultures were grown in CDM containing 1% (wt/vol) Glc at 
37ºC, and under semi-aerobic conditions. All the determinations were done at least in 
triplicate and the values are means ± SD. a.u. = arbitrary units. 
 
 
Deletion of spxB has only a minor influence on the transcriptome of D39 
To obtain a better insight into why inactivation of spxB resulted in an 
increase in capsule production, the transcriptome of the spxB mutant was 
compared to that of the wild-type strain (Table 4.2). As the insertion of the ISS1 
element was at the 3’ end of the spxB gene, no changes in its transcription level 


































amplicons on the array, which include the genes of the capsule locus except 
cps2A to G, no reliable signals were obtained for the capsule locus. Although 
spxB and its downstream gene spd_0637 do not appear to be located in an 
operon, expression of spd_0637 was significantly reduced in the mutant. 
Theoretically, this could also be the cause of the observed effects of the ISS1 
insertion into spxB. However, overexpression of this gene in the D39spxB- mutant 
did not revert the phenotype of the colonies back to wild-type appearance (data 
not shown), indicating that spd_0637 repression played no role in the increase in 
capsule production. Interestingly, despite the reported major influence of SpxB 
activity on the metabolism of S. pneumoniae (Pericone et al., 2003; Taniai et al., 
2008; Ramos-Montañez et al., 2010), the transcriptional response was modest 
(Table 4.2). Strikingly, two divergent putative operons were (highly) induced in the 
D39spxB- mutant (Table 4.2). The first one (spd_0289 to spd_0292) contains 
genes whose homology indicates involvement in the catabolism of ketogluconate 
(Yum et al., 1999). The second putative operon encodes four genes (spd_0293, 
spd_0295-7) showing homology to a mannose-family PTS system that is 
predicted, based on homology of the IIC and IID components, to use as substrate 
N-acetylglucosamine (TransportDB, www.membranetransport.org), and one gene, 
spd_0294 encoding a glucuronyl hydrolase (Maruyama et al., 2009). A recent 
report provided evidence for the involvement of the Man-family PTS in the 
utilization of hyaluronic acid, a glycosaminoglycan consisting of repeating 
disaccharides, which are composed of D-glucuronic acid and D-N-
acetylglucosamine (Marion et al., 2012). Thus, in line with its role in metabolism 
and the observed increase in capsule production, two putative operons that are 
likely involved in carbohydrate metabolism were highly induced. 
 
 
Pyruvate oxidase and capsule of Streptococcus pneumoniae 
 161 
Table 4.2. Genes differentially regulated in the D39spxB
-





TIGR annotation Fold 
change 
Bayes. p 
SP0095 SPD0091 conserved hypothetical protein 0.4 8.38E-08 
SP0317 SPD0289 4-hydroxy-2-oxoglutarate aldolase/2-deydro-3-
deoxyphosphogluconate aldolase 
7.4 3.00E-15 
SP0318 SPD0290 carbohydrate kinase, PfkB family 9.5 0 
SP0319 SPD0291 conserved domain protein 9.6 0 
SP0320 SPD0292 oxidoreductase, short chain dehydrogenase 
/reductase 
8.6 0 
SP0321 SPD0293 PTS system, IIA component 2.3 7.08E-07 
SP0322 SPD0294 glucuronyl hydrolase 3.5 4.66E-12 
SP0323 SPD0295 PTS system, IIB component 2.6 4.30E-07 
SP0324 SPD0296 PTS system, IIC component 4.6 4.54E-09 
SP0325 SPD0297 PTS system, IID component 10.2 0 
SP0506 SPD0452 integrase/recombinase, phage integrase family 2.4 1.67E-06 
SP0626 SPD0546 branched-chain amino acid transport system II 
carrier 
0.3 3.61E-11 
SP0731 SPD0637 conserved domain protein 0.3 2.22E-16 
Genes were considered differentially expressed when the fold change was ≥ 2, ≤ 0.5 with a 
Bayesian p ≤ 0.00001    
 
Growth and fermentation profiles are not affected by spxB inactivation 
under semi-aerobic conditions 
Given the metabolic function of SpxB and in order to explore a potential 
connection between carbohydrate metabolism and capsule production, growth 
properties of D39spxB- and its parent strain D39 were determined in Glc-M17. 
Under these conditions, the spxB mutation had no significant effect on the growth 
profile or fermentation type of S. pneumoniae D39 (Fig. 4.4-A and Table 4.3). 
Both the D39 and it spxB derivative grew to maximal OD600 of about 1.5 in 6 h at 
similar specific growth rates (Table 4.3), showing a typical homolactic 
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fermentation pattern (Table 4.3), with lactate accounting for about 90% of the Glc 
consumed.  
Considering the minor differences in growth characteristics of strain D39 
and its D39spxB- mutant in the complex medium M17, we asked whether in a 
chemically defined medium the loss of the metabolic enzyme SpxB would have a 
more pronounced effect. Furthermore, the use of CDM not only facilitates the 
interpretation of results, but also allows the use of NMR techniques for metabolic 
characterization. Strains D39 and D39spxB- were grown in Glc-CDM as described 
in Materials & Methods (Fig. 4.4-B, Table 4.3). The specific growth rates and 
maximal OD600 were lower in Glc-CDM than in the complex medium (Glc-M17). In 
the defined medium D39 and D39spxB- displayed identical growth properties, 
namely, the biomass yield, lactate and formate yields, and bioenergetic 
parameters (Table 4.3). Strain D39 presented, however, a maximal growth rate 
significantly higher (P value of 0.002) than D39spxB-. Consistent with inactivation 
of pyruvate oxidase, the pyruvate yield was 2-fold higher in the D39spxB- mutant 
(Table 4.3). Also in agreement, H2O2 (about 10 µM) was detected in the 
extracellular medium during the growth of the parent strain, but not in D39spxB-. 
We were surprised with the low amount produced by D39, since the maximal 
dissolved oxygen concentration was at least 10-fold higher. Nevertheless, we are 
not the first to report lower H2O2 production in S. pneumoniae than the expected 
from stoichiometry (Taniai et al., 2008). Thus, it is plausible to assume that the 
low H2O2 observed under semi-aerobic conditions arose from a combination of 
factors: the low dissolved oxygen and H2O2 decomposition by the action of 
protection mechanisms against its toxicity.  
As in Chapter 2, Glc was still abundant when growth ceased (70% of the 
initial Glc remained in the culture medium, Table 4.3). Strains D39 and D39spxB- 
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were grown under controlled neutral pH, thus growth arrest was likely due to 
uracil limitation (Chapter 2).  
Overall, spxB mutation decreases slightly the growth rate of D39 under 
semi-aerobic conditions and pyruvate accumulation during Glc metabolism. Lower 





Fig. 4.4. Growth profiles of S. pneumoniae D39spxB
-
 and its parent strain D39 under 
semi-aerobic conditions. (A) Cultures were grown in M17 (open symbols) or in (B) CDM 
supplemented with 1% (wt/vol) Glc at 37ºC, with pH control (6.5), and under semi-aerobic 
conditions (closed symbols) (for details see Materials & Methods). The plotted growth 
curves are from a representative experiment. For each condition at least three 
independent experiments were performed and the error was below 15%. Symbols: (,), 
D39spxB
-
; (,), D39. Arrows indicate sampling time for capsule determination and 















































Table 4.3. Product yields, total substrate consumed, carbon and redox balances, growth 
and energetic parameters as determined from substrate and fermentation product 
analysis at the time-point of maximal biomass achieved by D39spxB
-
 and D39 strains 
cultured in complex medium (M17) or CDM supplemented with Glc (1% wt/vol), under 
semi-aerobic conditions as described in Material and Methods. The specific growth rates 
are also shown. Values of at least two independent experiments were averaged and 
errors are reported as ± SD. 
 Semi-aerobic 








      
Lactate 1.75 ± 0.06 1.78 ± 0.02 1.69 ± 0.03 1.63 ± 0.01 
Formate 0.05 ± 0.05 0.10 ± 0.03 0.08 ± 0.01 0.06 ± 0.01 
Pyruvate
b
   0.09 ± 0.02 0.04 ± 0.01 
Acetate BDL BDL BDL BDL 
H2O2 (µM) ND ND BDL 10 ± 0 
Consumed substrate (%) 36 ± 2 35 ± 1 28 ± 1 28 ± 0 
Carbon balance
c
 88 ± 1 89 ± 1 93 ± 1 87 ± 1 
Redox balance 84 ± 3 83 ± 1 88 ± 1 85 ± 1 
Biomass yield (g mol
-1
 of Glc) 24.8 ± 0.4 23.7 ± 0.2 24.9 ± 3.1 26.2 ± 1.0 
ATP yield (mol mol
-1
 of Glc) 1.8 ± 0.0 1.8 ± 0.1 1.8 ± 0.1 1.7± 0.0 
YATP (g of biomass mol
-1
 of ATP) 14.1 ± 0.2 13.3 ± 0.1 14.2 ± 1.3 15.0 ± 0.7 
µmax (h
-1
) 0.85 ± 0.01 0.87 ± 0.06 0.70 ± 0.05 0.83 ± 0.04 
a
Product yields, [End-product] / [Glc consumed]; 
b
Blank cells, negative yields were found for these 
conditions (cells used pyruvate from the medium); 
c
Carbon balance is the percentage of carbon in 
metabolized Glc that is recovered in the fermentation products (lactate and formate) and pyruvate; 
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spxB deletion has an effect on the pools of intracellular metabolites 
Our data showed that the spxB mutation had a modest impact on growth 
and fermentation products in cultures under semi-aerobic conditions, but clearly 
affected the production of the polysaccharide capsule (Fig. 4.2). The disparate 
capsule production could suggest an altered intracellular metabolism. In line, the 
specific growth rate of D39spxB- was slightly, but consistently, lower than that of 
D39. To verify this hypothesis we measured the intracellular metabolites at the 
partitioning node between glycolysis and the polysaccharide 2 biosynthetic 
pathway, as well as several NDP-sugars, including the capsule precursors UDP-
Glc and UDP-GlcUA (Fig. 4.5). Metabolite concentrations were determined in 
ethanol extracts obtained during late-exponential and early-stationary phases of 
growth by 31P-NMR (see the time-points indicated by the arrows in Fig. 4.4-B). 
Interestingly, the loss of spxB led to a considerable reduction in the levels of the 
upper glycolytic metabolites glucose 6-phosphate (G6P) and fructose 1,6-
bisphosphate (FBP) (Fig. 4.5-A). G6P is a key metabolite at the hub of glycolysis 
and several biosynthetic pathways, and its conversion to α-glucose 1-phosphate 
(α-G1P) is the first step that commits it to the synthesis of many structural 
polysaccharides, including type 2 polysaccharide (Fig. 4.8). The intracellular 
concentration of α-G1P was similar in D39 and its D39spxB- mutant. The same 
was true for the UDP-activated capsule precursors, UDP-Glc and UDP-GlcUA 
(Fig. 4.5). These data indicate a redirection of carbon away from glycolysis in the 
D39spxB-, and is consistent with the higher capsule production. In addition, no 
major differences were detected between the levels of other NDP-activated 
metabolites in D39 and the D39spxB- mutant. As expected, the product of SpxB 
activity, the high energy phosphoryl donor acetyl-P (Ac-P), was reduced in the 
mutant by 65% of the parent strain (Fig. 4.5), which is in the same range as the 
values recently reported by Ramos-Montañez et al. (2010). The ATP levels in the 
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late-exponential phase of growth were not affected by the loss of spxB (2.3 ± 0.3 
and 2.1 ± 0.2 nmol mg DW-1 in D39 and spxB mutant, respectively). In general, 
the intracellular concentrations of phosphorylated metabolites in both strains were 
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Fig. 4.5. Effect of spxB mutation on intracellular phosphorylated metabolites during 
growth in Glc-CDM under semi-aerobic conditions. Phosphorylated metabolites were 
measured by 
31
P-NMR in ethanol extracts of D39 and D39spxB
-
 cells grown to late-
exponential (LExp) (A, B) and early-stationary (EStat) (C, D) phases of growth in CDM 
supplemented with 1% (wt/vol) Glc as in Fig. 4.4-B. The results are averages of four 
independent growths and the average accuracy was ± 15%. Symbols: (dark grey bars), 
D39, (light grey bars), D39spxB
-
. FBP, fructose 1,6-bisphosphate; G6P, glucose 6-
phosphate; PEP, phosphoenolpyruvate; α-G1P, α-glucose 1-phosphate;  Ac-P, acetyl-
phosphate; CDP-Cho, CDP-choline; UDP-GlcUA, UDP-glucuronate; UDP-Glc, UDP-
glucose; UDP-GlcNAc, UDP-N-acetylglucosamine; UDP-MurNAcp-Pep, UDP-N-acetyl-
muramoyl-pentapeptide; UDP-GlcN, UDP-glucosamine; LExp, late-exponential phase of 
growth; EStat, early-stationary phase of growth; A and C, phosphomonoesters; B and D, 




SpxB skews the sugar utilization profile of S. pneumoniae 
The fact that the majority of transcriptomic differences between D39 and 
D39spxB- were observed for genes potentially involved in central metabolism, and 
in particular sugar catabolic pathways, prompted us to analyze the growth of the 
two strains on selected sugars. Genome annotation and homology studies 
suggested that the genes differentially expressed might play roles in the 
catabolism of N-acetylglucosamine (GlcNAc), glucuronic acid (GlcUA) and/or 
gluconic acid (GlcU). Since loss of spxB leads to higher amount of capsule 
polysaccharide, and considering the higher expression of a putative glucuronyl 
hydrolase (spd_0294) and the PTS system needed to import its products (Marion 
et al., 2012), we surmised an aptitude of the D39spxB- strain to utilize type 2 
polysaccharide derived sugars (GlcUA, Glc, and rhamnose, Rha) as carbon 
sources. Thus, rhamnose and a sugar mixture mimicking the type 2 capsule  
(1 GlcUA: 2 Glc: 3 Rha) were also tested. Growth was performed in CDM 
supplemented with 0.25% (wt/vol) sugar in 96-well microtiter plates (Fig. 4.6). As 
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expected, on Glc, D39 showed a modest, but significant (P value < 0.05) higher 
specific growth rate than the D39spxB- strain (1.18 ± 0.06 as compared to 0.91 ± 
0.06 h-1). The maximal OD595 was similar for both strains on Glc (about 1.1).  
 
         
 
Fig. 4.6. Effect of spxB mutation on the ability to grow on specified sugars.  Growth 
profiles of S. pneumoniae D39 (A) and its derivative D39spxB
-
 (B) in CDM containing 
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microtiter plates and growth monitored at 595 nm and 37ºC. Symbols: (), Glc; (), 
GlcNAc; () 1 GlcUA : 2 Glc: 3 Rha; (), GlcUA; (), Rha; (), GlcA. Zoomed areas: 
expansions of time-points 5 to 20 h for growths in rhamnose, gluconic acid and glucuronic 
acid. Each point of the growth curves is an average of triplicate experiments from two 
independent cultures, and the error was in all cases below 20%, except for rhamnose 
which was below 30%. 
 
 
Growth on GlcNAc was characterized by identical specific growth rates (around 
0.83 h-1) for both strains, but lack of spxB resulted in 25% increase in the final 
biomass (from OD595 of 0.75 to 1.03). This result supports a role of the PTS 
system (spd_0293-0297), which is differentially expressed in our transcriptomic 
analysis, in the catabolism of GlcNAc. In the sugar mixture, both strains displayed 
identical specific growth rates and maximal biomass; however, while the OD595 
values of D39 decreased upon growth arrest, the D39spxB- mutant showed a 
slow but steady increase of the OD595 values during the time of monitoring (24 h). 
Also, the D39spxB- strain showed residual growth on GlcUA, Rha and GlcU, while 
D39 was totally unable to use these sugars as sole carbon sources for growth. 
These data strongly indicate that spxB considerably influences the nutritional 
utilization capabilities of S. pneumoniae. 
 
Oxygen affects differently end-product distribution in strain D39 and spxB- 
mutant under aerobic conditions 
Molecular oxygen is the substrate for the SpxB reaction. Hence, to firmly 
assign the SpxB deficient phenotype, we grew strain D39 and its derivative spxB 
mutant under a continuous specific air tension of 40% (constant dissolved oxygen 
concentration of 90 µM at 37ºC). We expected visible changes in end-product 
profiles in strain D39 (SpxB+), but minor or no changes in D39spxB-. Indeed, the 
increase in oxygen availability was translated into a substantial raise in H2O2 
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production to about 2 mM in the parent strain D39. The concentration of hydrogen 
peroxide in supernatants of strain D39spxB- was still in the micromolar range (2 
µM), three order of magnitude lower than in D39 (Fig. 4.7 and Table 4.4). These 




Fig. 4.7. Growth and fermentation profiles in S. pneumoniae D39spxB
-
 and its 
parent strain D39 under aerobic conditions. Growth curves, substrate consumption 
and end-products formed by D39 (A) and D39spxB
- 
(B) strains growing on Glc-CDM, at 
37ºC, with pH control (6.5), and under aerobic conditions (for details see supplemental 
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analysis by HPLC and/or 
1
H-NMR were harvested at denominated time-points along 
growth (bars in the plots). The plotted growth curves, substrate consumption curves and 
end-products bars are from a representative experiment. For each condition at least two 
independent experiments were performed. For the growth and substrate consumption 
curves the error in each point was below 10%. For the end-products concentrations, the 
error was below 7% for major products (> 3.5 mM) and 30% for minor products (< 3.5 
mM) Symbols: (○), substrate consumption; (■), growth curve; white bars, lactate; dark 
grey bars, pyruvate; light grey bars, acetate; stripped bars, hydrogen peroxide. 
 
 
Under aerobic conditions, the maximal biomass reached for strains D39 
and D39spxB- was 0.49 ± 0.03 (time-point 3h) and 1.64 ± 0.13 (time-point 8h), 
respectively (Fig. 4.7-A and 4.7-B). At these time-points the D39spxB- mutant 
consumed approximately 50% of the Glc supplied and the control strain only 
about 4% (Table 4.4). Under these conditions, the low biomass generated by D39 
is most likely a consequence of high H2O2 accumulation due to SpxB activity. Loss 
of spxB caused a significant decrease (about 20%) in the maximal growth rate 
(Table 4.4), which suggests that when oxygen is available SpxB stimulates faster 
growth on Glc. In terms of end-products, D39 produced from Glc, acetate, H2O2 
and lactate, which reached at the time-point of growth arrest (maximal biomass) 
concentrations of 4.2 ± 0.1 mM, 2.2 ± 0.1 mM and 1.3 ± 0.3 mM, respectively. 
Before entering the stationary phase of growth a continuous increment in the 
yields of lactate, acetate and H2O2 was observed for strain D39. Interestingly, in 
the stationary phase the levels of acetate and H2O2 increased at the expense of 
lactate, suggesting the occurrence of lactate oxidase activity in this strain (Fig. 
4.7-A and 4.7-B). As expected, loss of spxB led to a typical homolactic behavior, 
with lactate as major end-product (maximal concentration 44 ± 0 mM), accounting 
for 75% of the Glc consumed (Table 4.4); acetate was also formed in minor 
amounts and the yield of pyruvate was 2-fold enhanced as compared to semi-
aerobic conditions. No formate was observed, suggesting suppression of pyruvate 
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formate lyase (PFL) activity when the oxygen concentration is kept steady around 
0.09 mM. In the D39spxB- mutant, the H2O2 detected was below 10 µM, 
confirming inactivation of pyruvate oxidase. Detection of acetate in the spxB- 
mutant while spxB is inactivated and PFL suppressed by O2 indicates an 
alternative pathway for the formation of this organic acid. 
In summary, the high accumulation of H2O2 exclusively in strain D39 fully 
confirms the absence of SpxB activity in the mutant strain. Furthermore, our data 
show that the metabolic response to oxygen is largely mediated by SpxB, since 
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Table 4.4. Product yields, total substrate consumed, carbon and redox balances, growth 
and energetic parameters as determined from substrate and fermentation product 
analysis at the time-point of maximal biomass achieved by D39spxB
-
 and D39 strains 
cultured in CDM supplemented with Glc (1% wt/vol) under aerobic conditions (constant air 
tension of 40%) (see Materials and Methods). The specific growth rates are also shown. 
Values of at least two independent experiments were averaged and errors are reported as 
± SD. 
 Aerobic 






    
Lactate 1.47 ± 0.02 0.47 ± 0.09 
Formate BDL BDL 
Pyruvate
b
 0.16 ± 0.01  
Acetate 0.11 ± 0.00 1.53 ± 0.09 
H2O2  BDL 0.82 ± 0.01 
Consumed substrate (%) 49 ± 0 4.4 ± 0.6 
Carbon balance
c
 87 ± 2 100 ± 0 
Redox balance ND ND 
Biomass yield (g mol
-1
 of Glc) 20.9 ± 2.6 68.1 ± 2.4 
ATP yield (mol mol
-1
 of Glc) 1.9 ± 0.0 3.5 ± 0.1 
YATP (g of biomass mol
-1
 of ATP) 11.3 ± 1.1 19.3 ± 1.1 
µmax (h
-1
) 0.82 ± 0.03 1.00 ± 0.05 
a
Product yields, [End-product] / [Glc consumed]; 
b
Blank cells, negative yields were found for these 
conditions (cells used pyruvate from the medium); 
c
Carbon balance is the percentage of carbon in 
metabolized Glc that is recovered in the fermentation products (lactate and acetate) and pyruvate; 







The role of pyruvate oxidase (SpxB) in the aerobic metabolism of several 
Gram-positive bacteria is well established (Sedewitz et al., 1984; Seki et al., 2004; 
Lorquet et al., 2004; Goffin et al., 2006). In the human pathogen S. pneumoniae, 
a number of studies describe the involvement of SpxB in virulence (Spellerberg et 
al., 1996; Pericone et al., 2000), fermentation (Taniai et al., 2008) and colony 
phenotypic variation (Overweg et al., 2000; Belanger et al., 2004; Ramos-
Montañez et al., 2008; Allegrucci and Sauer, 2008). However, in depth 
investigation of the molecular mechanisms underlying these modes of action is far 
from complete. In this study we show that inactivation of spxB leads to an 
increase in capsule production. High capsule amounts have been consistently 
associated with opaque phase variants, which are interestingly also characterized 
by low SpxB activity (Kim and Weiser, 1998; Kim et al., 1999; Overweg et al., 
2000). However, a comparison of phenotypes on plate showed that, although 
displaying similar properties, the D39spxB- mutant is not an opaque variant. 
Nevertheless, the observation that deletion of spxB or a reduction in SpxB activity 
leads to an opaque-like or mucoid phenotype on plate is recurrent (Overweg et 
al., 2000; Ramos-Montañez et al., 2008; Allegrucci and Sauer, 2008). 
Our data show for the first time, that the mucoid phenotype appearance of 
D39 colonies lacking SpxB activity is due to an increase in capsule biosynthesis, 
as indicated by the higher expression levels of the cps promoter and glucuronic 
acid amounts, and is independent of differences in growth or death rate. Capsule 
hinders the attachment of S. pneumoniae to host cells, a step that has been 
described as important for colonization and for the ability to cause invasive 
disease (Ring et al., 1998; Magee and Yother, 2001; Morona et al., 2004). On the 
other hand, it prevents opsonophagocytosis and is presumably essential for 
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growth in blood. Additionally, it prevents mucus-mediated clearance from the 
nasopharynx (Nelson et al., 2007). Interestingly, most studies report that deletion 
of spxB leads to a defect in nasopharyngeal colonization (Spellerberg et al., 1996; 
Orihuela et al., 2003; Regev-Yochay et al., 2007; Ramos-Montañez et al., 2008). 
The data from our study show that this attenuation can partially be due to the 
increased amounts of capsule present in the D39spxB-. Although capsule is 
needed for colonization (Magee and Yother, 2001), too much capsule is 
detrimental especially during the establishment phase of colonization as 
demonstrated by comparing opaque and transparent variants (Magee and Yother, 
2001; Nelson et al., 2007). In this light, it is expected that the capsule surplus of 
the spxB mutant will impair colonization, and subsequent invasive disease. On the 
other hand, spxB mutants are less attenuated in invasive disease and bacteremia 
models where capsule is an absolute requirement (Orihuela et al., 2003). In 
concordance with this idea, spxB expression is higher in the nasopharynx than in 
the lungs and the blood (LeMessurier et al., 2006) probably ensuring that not too 
much capsule is being produced. Conversely, in transparent variants thought to 
be better equipped for colonization, as they contain more teichoic acids and less 
capsule, spxB is higher expressed than in opaque variants which contain more 
capsule and are poor colonizers (Overweg et al., 2000; Li-Korotky et al., 2009). 
Thus, we would like to propose that SpxB activity in response to the oxygen 
concentration of its environment is an important signal for S. pneumoniae to 
determine the amount of capsule that needs to be produced. This hypothesis is 
strengthened by the observation that changes in oxygen seem to induce changes 
in capsule production. Furthermore, transparent variants were predominantly 
isolated from the nasopharynx and opaque variants from blood (Weiser et al., 
2001). Furthermore, growth of D39 under anaerobic conditions also led to a 
uniform mucoid appearance of the colonies on blood agar plates (data not 
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shown). How this signaling would occur is currently unclear, one possibility is that 
the changes in the membrane induced by SpxB activity (Benisty et al., 2010) 
mediate alterations in the production and expression of the capsule locus. 
Capsule synthesis is tightly interconnected with peptidoglycan synthesis 
and is partly regulated by membrane proteins (Yother, 2011), thus it is not unlikely 
that disturbances in the membrane or cell wall influence capsule synthesis and 
vice versa. The high magnification TEM pictures of the D39spxB- mutant also 
indicated changes in the membrane which could be mediated by spxB inactivation 
and thus result in a change in capsule production. In other streptococci, CcpA, the 
main regulator of carbon metabolism in S. pneumoniae (Chapter 6) and other 
Gram-positive bacteria, represses spxB (Zheng et al., 2011a; Zheng et al., 
2011b). Although there is no cre site in the S. pneumoniae spxB promoter and the 
gene was also not found in extensive transcriptome analysis (Chapter 6), we did 
attempt to generate a ΔccpA mutant in the D39spxB- background. This failed 
unless the ccpA gene was already ectopically present in the D39spxB- mutant, 
indicating that this combination is lethal for S. pneumoniae (data not shown). 
Thus, in S. pneumoniae CcpA does not regulate spxB but repression (or 
activation) of a product of the CcpA regulon does seem necessary to counteract 
deleterious effects of spxB inactivation. Another alternative to mediate this 
regulation is SpxR, however no capsule genes were differentially regulated in the 
transcriptome analysis of this mutant, making it a less likely candidate (Ramos-
Montañez et al., 2008). It is worth mentioning that while Winkler and co-workers 
used D39 strain NCTC7466 as genetic background, in our work we have 
characterized a Lilly derivative strain and in a different medium (Lanie et al., 
2007). D39 NCTC and Lilly are allelic variants of thirteen genes, including a 
putative capsule regulator cpsY and spxB; in terms of the latter mutation the 
major consequence is a considerably lower SpxB activity in the Lilly D39 (Ramos-
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Montañez et al., 2008). Thus, a direct extrapolation from previous work performed 
with D39 NCTC might not be possible.  Interestingly, transcriptome analysis of our 
D39spxB- mutant did not show the same pattern as that of the spxB mutant in the 
NCTC isolate (Ramos-Montañez et al., 2008). This could be due to the allelic 
variance between the two D39 isolates (NCTC and Lilly), differences in sampling 
time (phase of growth) and or in the composition of the medium used for growth. 
To our surprise, the transcriptome analysis of D39spxB- showed only minor 
changes (13 altered transcripts) compared to the wild-type, despite the fact that 
the experiments were carried out under semi-aerobic conditions and harvest took 
place during early-exponential growth phase when we expect that oxygen is still 
present and SpxB activity can be detected. Loss of spxB did not affect the 
transcript levels of regulatory proteins. These findings reinforce the idea that 
neither SpxR nor CcpA play prominent roles in the signaling pathways mediating 
the SpxB phenotypes. 
Of the genes that were differentially expressed, 77% encode functions 
involved in central metabolism (Table 4.2). Of these, 9 genes organized in two 
transcriptional units (spd_0289-92, spd_0293-97) were highly induced in the spxB 
mutant. Spd_0293-97 encodes a Man-family PTS system and a glucuronyl 
hydrolase, which have recently been implicated in the metabolism of hyaluronic 
acid, and in particular in the uptake and degradation of GlcNAc-GlcUA 
disaccharides (Marion et al., 2012; Bidossi et al., 2012). The four genes in 
spd_0289-92 are most likely involved in the degradation of ketogluconic acid, as 
judged by homology comparisons (Yum et al., 1999). Thus, a role for SpxB was 
surmised on the utilization of carbon sources for growth, which was corroborated 
by the better growth on GlcNAc compared to the wild-type and the observed 
residual growth of the D39spxB- strain on sugars potentially present in capsules 
or host glycans (Fig. 4.8). Growing evidence supports the utilization of host 
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glycans as nutritional sources for pneumococcal growth (Burnaugh et al., 2008; 
Yesilkaya et al., 2008; Marion et al., 2012). To our knowledge, we are the first to 
show a link between SpxB and carbohydrate utilization. Based on our results, it is 
tempting to hypothesize that in specific host microenvironments  with oxygen 
where Glc becomes the major carbon source available, for instance during 
inflammation or hyperglycemia (e.g. lungs during infection) (Philips et al., 2003), 
SpxB activity minimizes the use of alternative sugar utilization pathways 
(repression of specific catabolic steps involved in the metabolism of sugars other 
than Glc) in a cost effective manner, which will allow for rapid proliferation and 
fast energy production, i.e. improved fitness. 
We found that SpxB stimulated the pneumococcal rate of growth on Glc 
and inhibited capsule production (Fig. 4.2 and Fig. 4.3; Table 4.3 and Fig. 4.8). 
Importantly, the soluble activated precursors for serotype 2 capsule synthesis are 
all derivatives of α-glucose 1-phosphate, which originates from the action of α-
phosphoglucomutase on the glycolytic intermediate glucose 6-phosphate. The 
lower accumulation of glucose 6-phosphate and fructose 1,6-bisphosphate in the 
D39spxB- mutant indicate a redirection of carbon towards biosynthetic pathways, 
in particular capsule (Fig. 4.8). The data on intracellular metabolites is therefore in 
full agreement with our findings in respect to capsule production and growth rate, 












Fig. 4.8. Model of the spxB deletion effect on glucose metabolism and capsule 
production in S. pneumoniae. Glucose is converted by the conventional glycolytic 
pathway to pyruvate. Fermentation products result from the action of different competing 
enzymes (lactate dehydrogenase, pyruvate formate-lyase, pyruvate oxidase and 
hypothetically the pyruvate dehydrogenase complex). Overall, our data show that SpxB 
represses carbohydrate specific pathways (ketogluconate and hyaluronic acid utilization), 
capsule production, and stimulates formation of acetyl-P and acetate at the expense of 
pyruvate and lactate. Pyruvate and end-products are represented by three-dimensional 
bars and the height of the bar represents the relative amount; grey slashed arrows, 
function not experimentally verified; boxed metabolites indicate higher metabolite 
accumulation. Thick pointed-line, repression; Thick black arrow, activation. KDG, 
ketogluconate; HA, hyaluronic acid; GlcNAc, N-acetylglucosamine, GlcUA, glucuronic 
acid; Ac-P, acetyl-phosphate; α-G1P, α-glucose 1-phosphate; G6P, glucose 6-phosphate; 



















































































Curiously, under the imposed semi-aerobic conditions the fermentation pattern of 
the pneumococcus was only marginally affected by loss of spxB, the major 
difference being a higher accumulation of pyruvate in the mutant (Fig. 4.8). This 
effect was consistent with a decreased level of Ac-P in D39spxB-. In bacteria, a 
role of the central metabolite Ac-P in linking the nutritional status to global 
signaling, namely by acting as a phosphoryl donor to two-component response 
regulators has been proposed (Wolfe, 2010). One could argue that similar 
molecular mechanisms are in effect in S. pneumoniae, i.e. Ac-P phosphorylation 
of response regulators. In fact, the cross talk between capsule synthesis and 
SpxB function could also be mediated by this high energy molecule acting directly 
on the phosphorylation of the auto-phosphorylating kinase CpsD. Although some 
controversy remains, a positive correlation between CpsD phosphorylation and 
capsule production is accepted (Yother 2011). The capsule production is, 
however, enhanced in the spxB mutant (Fig. 4.2), a phenomenon that is not in 
agreement with Ac-P acting as phosphoryl donor for CpsD, since the intracellular 
accumulation of this metabolite is smaller in D39spxB-. It cannot be excluded that 
the lower Ac-P concentration results both from lack of SpxB activity and higher 
demand for biosynthetic purposes. In a recent work, Winkler and co-workers 
provided some evidence suggesting cross talk phosphorylation of a response 
regulator (VicR aka WalR) by Ac-P, but most their work did not support 
phosphorylation of regulators by Ac-P as a general signaling mechanism in  
S. pneumoniae (Ramos-Montañez et al., 2010). This is in line with the minimal 
effect of spxB deletion on the transcriptome, inferred in our and other studies. 
Rather than relaying the metabolic state to regulatory pathways, Ac-P is a major 
energy reservoir for ATP synthesis. Likewise, in our study loss of spxB did not 
affect the steady-state ATP concentration (exponential cells). It has been 
suggested that maintenance of wild-type ATP levels is essential to cope with H2O2 
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imposed stress (Pericone et al., 2003; Ramos-Montañez et al., 2010). Our 
observation that the level of H2O2 produced under semi-aerobic conditions is 10-
fold lower than that expected from a stoichiometry of one molecule of O2 
consumed per molecule of hydrogen peroxide formed attests to the presence of 
H2O2 scavenging mechanisms in strain D39. However, the presence of other O2 
consuming activities, such as NADH oxidase, cannot be ruled out, but the 
similarity of the carbon and redox balance values observed for strain D39 (Table 
4.3) is in stark disagreement with the presence of high NADH-oxidase activity. 
When environmental oxygen is provided continuously (constant partial air tension 
of 40%), the yield of strain D39 was dramatically reduced to about 30% of the 
semi-aerobic level, while no significant difference in biomass was detected for 
strain D39spxB- (Fig. 4.4 and Fig. 4.7). In terms of fermentative products, 
oxygenation induced a mild shift to acetate production in the spxB mutant, 
denoting an alternative aerobic acetate producing pathway. The presence of a 
functional pyruvate dehydrogenase complex in the pneumococcus has been 
suggested, but is still to be proven (Taniai et al., 2008; Ramos-Montañez et al., 
2010). On the other hand, lactate production was severely decreased and a 
switch to acetate and H2O2, which accumulated up to 2-3 mM, was observed in 
strain D39. This metabolic shift is in accordance with a higher cell demand for 
ATP, and is well known to occur in other Streptococcaceae as a response to 
stress conditions (aerobiosis, substrate limitation, poor substrates, etc.) (Neves et 
al., 2005; Price et al., 2011). Despite the substantially higher yields of acetate in 
strain D39, the biomass produced was much lower and the ATP concentration in 
exponential cells was comparable to that under semi-aerobic conditions (data not 
shown). An important implication from the combined results is that ATP is being 
redirected to other purposes, seemingly H2O2 detoxification. This view is further 
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corroborated by the growth properties of strain D39spxB- under the same 
conditions.   
  Despite the modest response of spxB deletion in the transcriptome of 
strain D39, we show in this study that SpxB affects the pattern of carbohydrate 
utilization in S. pneumoniae, and thereby is likely to contribute to the fitness of this 
microorganism in specific microenvironments. In line, it is reasonable to assume 
that the influence of environmental oxygen on capsule production and to a lesser 
extent on growth of S. pneumoniae is partially concurred by modulation of 
pyruvate oxidase activity. Interestingly, oxygen is one of the main environmental 
factors varying in host niches. In this light, the observed connection between 
capsule amount and oxygen-dependent SpxB activity is plausible.  Based on our 
data we propose that in the nasopharynx, where the oxygen is high, improved 
SpxB activity restrains capsule production facilitating effective colonization. In 
contrast, in more internal host niches with no or very limited oxygen, SpxB activity 
is reduced which relieves the repressing effect on capsule production. This leads 
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Summary 
Knowledge of the in vivo physiology and metabolism of S. pneumoniae is 
limited, even though pneumococci rely on efficient acquisition and metabolism of 
the host nutrients for growth and survival. Under glucose excess conditions  
S. pneumoniae displays typical homolactic fermentation, but the nutrient-limited 
milieu of host tissues most likely favor mixed-acid fermentation. In fermentative 
Gram-positive bacteria, pyruvate formate-lyase (PFL), an enzyme that requires 
post-translational activation by pyruvate formate-lyase activating enzyme (PFL-
AE), plays a key role in end-product distribution. Pneumococcal genomes 
possess two copies each of genes whose products show homology to PFL and 
PFL-AE. In this work, the functional PFL and PFL-AE enzymes were assigned. To 
this end, we generated by gene replacement loss-of-function mutants of the 
putative pfl genes, spd_0235 and spd_0420, as well as the potential pfl-ae genes, 
spd_0229 and spd_1774. End-product analysis showed that formate, the 
signature product of the reaction catalyzed by PFL, was still produced by 
spd_0235 and spd_0229 mutants, but not by spd_0420 and spd_1774. These 
findings identify spd_0420 and spd_1774 as the genes encoding the 




Energy metabolism is one of the most understudied fields of 
pneumococcal biology. The pneumococcus is strictly fermentative and sugars are 
the major sources of energy for biosynthesis and growth (Tettelin et al., 2001; 
Hoskins et al., 2001). Therefore in vivo fitness is to a large extent determined by 
the efficiency of sugar metabolism. Accumulating evidence suggests a direct link 
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between pneumococcal virulence and sugar metabolism (Spellerberg et al., 1996; 
Auzat et al., 1999; Giammarinaro and Paton, 2002; Iyer et al., 2005; Iyer and 
Camilli, 2007). This connection is not limited to proteins involved in 
polysaccharide production/degradation, transport and regulation (Giammarinaro 
and Paton, 2002; Manco et al., 2006), but also includes metabolic enzymes 
involved in redox metabolism, such as NADH oxidase (NOX) (Auzat et al., 1999), 
and in pyruvate metabolism (Spellerberg et al., 1996; Pericone et al., 2003). For 
example, mutation of nox caused diminished virulence in a systemic infection 
model, and this was attributed to a probable change in the NADH/NAD+ ratio or 
the increased sensitivity of S. pneumoniae to oxidative stress (Auzat et al., 1999). 
Mutation of spxB (pyruvate oxidase) led to a reduction in virulence, in both 
pneumonia and sepsis models in mice, which was attributed to a decrease in the 
products of SpxB activity and downregulation of adhesive proteins (Spellerberg et 
al., 1996; Regev-Yochay et al., 2007; Ramos-Montañez et al., 2008). 
The pneumococcus is known to maintain a fermentative metabolism 
regardless of oxygen, since it lacks a complete set of genes required for 
respiration (Tettelin et al., 2001; Hoskins et al., 2001). Breakdown of 
carbohydrates by classical Embden-Meyerhof pathway results in generation of 
pyruvate, NADH and a net gain of two ATP per mole of substrate (Neves et al., 
2002a). In homolactic bacteria, NAD+ regeneration is mainly accomplished via the 
lactate dehydrogenase (LDH) catalyzed conversion of pyruvate to lactate (Fig. 
5.1) (Neijssel et al., 1997). However, under certain conditions, such as aerobiosis, 
sugar limitation or the presence of sugars less preferred than Glc, such as Gal, 
there is a metabolic shift from homolactic (lactate production) to mixed-acid 
fermentation with the formation of products other than lactate (e.g. ethanol, 
acetate, and formate) (Fig. 5.1) (Neijssel et al., 1997; Melchiorsen et al., 2000; 
Neves et al., 2002a). Mixed-acid fermentation is mediated in part by the activities 
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of the pyruvate dehydrogenase complex (PDHc), or pyruvate formate-lyase (PFL) 
(Neijssel et al., 1997; Melchiorsen et al., 2000; Neves et al., 2002a). While PDHc 
catalyses the oxidative decarboxylation of pyruvate to form acetyl-CoA and CO2 in 
aerobiosis, under microaerobic and anaerobic conditions, most of the pyruvate is 
converted to acetyl-CoA and formate by the oxygen-sensitive PFL (Neves et al., 
2002a; Zhu and Shimizu, 2004). Further metabolism of acetyl-CoA by 
phosphotransacetylase/acetate kinase, or by aldehyde and alcohol 
dehydrogenases leads to the generation of acetate or ethanol, respectively. While 
acetate formation generates an additional molecule of ATP, ethanol production 
from acetyl-CoA regenerates two molecules of NAD+ (Melchiorsen et al., 2000; 
Neves et al., 2002a). Unlike other lactic acid bacteria (Yamada et al., 1985; Arnau 
et al., 1997), in S. pneumoniae no genes for PDHc activity have been predicted 
(Tettelin et al., 2001; Hoskins et al., 2001). The presence of a functional pyruvate 
dehydrogenase complex in the pneumococcus has been suggested, but is still to 
be proven (Taniai et al., 2008; Ramos-Montañez et al., 2010). Therefore, mixed-
acid fermentation is expected to occur mainly by the action of PFL. The regulation 
of PFL activity in other bacteria has been reported to arise at three levels (Sauter 
and Sawers, 1990; Knappe and Sawers, 1990). PFL is synthesized as an inactive 
enzyme and then post-translationally converted to an active form by accepting an 
electron from the PFL-activating enzyme (PFL-AE) (Buis and Broderick, 2005). 
PFL may also be regulated transcriptionally, and allosterically (Asanuma et al., 
2004). In L. lactis, transcription of pfl was found to be significantly higher when the 
organism was grown in Gal as compared to Glc-containing media (Arnau et al., 
1997; Melchiorsen et al., 2000). In addition, in other lactic acid bacteria, low pH 
and excess supplies of energy reduced pfl–mRNA levels, while the level of ldh-
mRNA increased (Asanuma et al., 1999). The regulation of PFL is allosterically 
controlled in L. lactis by the glycolytic intermediates fructose 1,6-bisphosphate 
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(FBP), glyceraldehydes 3-phosphate (GAP) and dihydroxyacetone phosphate 
(DHAP), which are strong inhibitors of PFL (Melchiorsen et al., 2001).  
The sequenced genome of S. pneumoniae D39 strain has two copies of 
both the pfl, annotated as spd_0235 and spd_0420, and pfl-ae homologs, 
annotated as spd_0229 and spd_1774 (Tettelin et al., 2001; Hoskins et al., 2001; 
Lanie et al., 2007). However, the role of the PFL/PFL-AE system in pneumococci 
is not known, despite the fact that spd_0420 and spd_1774 were predicted to be 
among the highest expressed genes based on codon usage (Karlin et al., 2004). 
In addition, it is not clear why the pneumococcus has multiple copies of these 
genes. Given that host tissues are limited environments for free readily fermented 
sugars (Philips et al., 2003), such as Glc, but are rich in glycoproteins with O- and 
N-linked glycans that contain monosaccharides including Gal (Sheehan et al., 
1995), and because deep tissue sites are hypoxic, both conditions that favor 
mixed-acid fermentation (reviewed in Neves et al., 2005), we hypothesized that 
the PFL/PFL-AE system must be important for the in vivo fitness of the 
pneumococcus. In this Chapter, we identified the genes responsible for 
pneumococcal PFL activity by relying on a bioinformatic analysis and on the 
fermentation types of wild-type and putative mutant pfl and pfl-ae strains. A 
detailed description of the impact of the assigned pfl and pfl-ae genes on the 
expression of selected genes involved in glycolysis, on lipid composition of cell 
membrane and on virulence can be found on the published version of this 
Chapter (Yesilkaya et al., 2009), which is provided in digital form on the included 
CD.  
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Fig. 5.1. Schematic representation of reactions downstream of pyruvate in lactic 
acid bacteria. Glc or Gal are converted to pyruvate which is then further catabolized by 
homolactic or mixed-acid fermentation pathways. LDH, lactate dehydrogenase; PFL, 
pyruvate formate-lyase; iPFL, inactive pyruvate formate-lyase; PFL-AE, pyruvate formate-
lyase activating enzyme; PDHc, pyruvate dehydrogenase complex; SpxB, pyruvate 
oxidase; ADH, bifunctional acetaldehyde-CoA/alcohol dehydrogenase; ACK, acetate 
kinase; PTA, phosphotransacetylase. The occurrence of the pyruvate dehydrogenase 




Materials and Methods  
Bacterial growth conditions 
S. pneumoniae type 2 strain D39 and its isogenic mutants were used in 
this work. Routinely, pneumococci were grown at 37ºC in microaerophilic 
conditions either in brain heart infusion broth (BHI) (Oxoid, Basingstoke, UK) or 
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on Blood Agar Base (Oxoid) supplemented with 5% (vol/vol) horse blood. When 
appropriate the growth medium was supplemented with 100 µg ml-1 
spectinomycin or 500 µg ml-1 kanamycin.  
Bacteria were also grown in CDM (Chapter 2) at 37ºC without pH control 
(initial pH 6.5). Glc (1% wt/vol) or Gal (1% wt/vol) was used as the carbon source. 
S. pneumoniae was grown under anaerobic conditions in rubber-stoppered bottles 
(200 ml). Aerobic growth was established under low oxygen tension in 
Erlenmeyer flasks with an agitation of 50 rpm. Growth was monitored by 
measuring the optical density at 600 nm. Growth rates (µ) were calculated 
through linear regressions of the plots of ln(OD600) versus time during the 
exponential growth phase. 
 
Mariner mutagenesis 
In vitro mariner mutagenesis was used to construct the mutants (Martin et 
al., 2000). Approximately 2 kb genomic regions containing the target genes were 
amplified with the appropriate primers (Table 5.1). For transposition reactions 
approximately 200 ng of PCR fragments were mixed with 200-400 ng of donor 
mariner plasmid pR412, which contains a spectinomycin resistance cassette, and 
incubated in the presence of purified Himar1 transposase, as described 
previously (Martin et al., 2000). Gaps in transposition products were repaired with 
T4 DNA polymerase (New England Biolabs, Ipswick, USA) and subsequently by 
E. coli ligase (New England Biolabs). Repaired transposition products were 
transformed into S. pneumoniae D39 using synthetic competence-inducing 
peptide (Alloing et al., 1996). Transformants isolated from selective medium were 
tested for the presence of mariner mini-transposons through PCR and 
sequencing. One of the transposon-specific primers, MP127 and MP128 (Table 
5.1), was used in PCR, together with an appropriate chromosomal primer. In 
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addition, chromosomal primers were also used to confirm the absence of the 
intact copy of the gene that may result due to duplication. Typical PCR conditions 
consisted of 1 cycle of 95ºC denaturation, 35 cycles of amplification (30 s 
denaturation at 94ºC, 60 s annealing at 53-55ºC, and 3 min extension at 72ºC) 
with a final 3 min of final extension at 72ºC. The amplification products were 
analyzed by agarose (1% wt/vol) gel electrophoresis. In addition, the exact 
insertion sites and direction of the antibiotic cassette were also determined by 
sequencing. The amplicons for sequencing were prepared by three rounds of 
PCR using MP128 primer as described previously (Karlyshev et al., 2000), and 
then the purified products were sequenced using the MP127 primer. Sequencing 
indicated that the spectinomycin cassette had been inserted in 608-bp, 833-bp, 
650-bp and 116-bp away from the 5’-end of spd_0229, spd_0235, spd_0420, and 
spd_1774, respectively. SPD0229M, SPD0235M, SPD0420M, and SPD1774M 
(mutated in spd_0229, spd_0235, spd_0420 and spd_1774, respectively) (Fig. 















Table 5.1. Oligonucleotide primers used in this study 
Primer ID Primer Sequence (5’-3’) Target gene in D39 
SPD0229F ACCTCCTGATAAAGTTAAACC spd_0229 
SPD0229R ACGACTAGCGAACCACCG spd_0229 
SPD0235F CAGCCTTACTGAAAGGATG spd_0235 
SPD0232R GGGTTGCCTTAGAAAGAAC spd_0235 
SPD0420F GACAGTTGTTGAAGCACAAG spd_0420 
SPD0420R CTCAATGCATCCAAGGCATC spd_0420 
SPD0420CF GTCCATGGATGGTTGTTAAGACAGTTGTTGAAG spd_0420 
SPD0420CR GTGGATCCTTAGCTCAATGCATCCAAGG spd_0420 
MalF GCTTGAAAAGGAGTATACTT NA* 
PCEPR AGGAGACATTCCTTCCGTATC NA* 
SPD1774F AGACACTTGGGCTATGGA spd_1774 
SPD1774R GTTCCTTAGCCTTGGTGA spd_1774 
MP 127 CCGGGGACTTATCAGCCAACC 
pR412-specific 
(Martin et al., 2000) 
MP 128 TACTAGCGACGCCATCTATGTG 
pR412-specific 
(Martin et al., 2000) 
The underlined sequenced in SPD0420F and SPD0420R complementation primers indicate NcoI 
and BamHI recognition sites, respectively. NA, not applicable. ( *) The recognition sites for MalF and 
PCEPR are in pCEP (Guiral et al., 2006). 
 
 
Complementation of SPD0420M 
To eliminate the possibility of polar effect, SPD0420M was complemented 
by introduction of an intact copy of spd_0420 using pCEP, which is a 
nonreplicative plasmid and allows controlled gene expression following ectopic 
integration into the chromosome (Guiral et al., 2006). The plasmid integrates 
immediately downstream of the well-studied ami operon (Alloing et al., 1996). This 
site is believed to be transcriptionally silent and, as far as it is known, does not 
affect any cellular functions (Guiral et al., 2006). The intact copy of spd_0420 was 
PFL and pneumococcal fermentative metabolism 
 195 
amplified with SPD0420CF and SPD0420CR primers, which incorporate, NcoI 
and BamHI sites to 5’- and 3’- end of the gene, respectively (Table 5.1). The 
amplicons were digested with NcoI and BamHI, and the digested products were 
ligated with NcoI/BamHI digested pCEP. An aliquot of ligation mixture was directly 
transformed into SPD0420M as described previously (Alloing et al., 1996), and 
the transformants were selected in the presence of spectinomycin and 
kanamycin. The successful introduction of the intact copy of the gene was 
confirmed by PCR using malF and pCEPR primers (Table 5.1), whose recognition 
sites are localized in immediately up and downstream of the cloning site, 
respectively. One of the positive transformants, SPD0420Comp, was selected for 
further analysis. 
 
Quantification of fermentation products during growth 
Strains were grown as described above. Culture samples (2 ml) were 
taken at the beginning of the stationary phase of growth, centrifuged (16,000 x g, 
2 min, 4ºC), and the supernatants were stored at -20ºC until analysis by high 
performance liquid chromatography (HPLC) or 1H-NMR (Neves et al., 2002a). 
End-products were quantified using a HPLC apparatus equipped with a HPX-87H 
anion exchange column (Bio-Rad Laboratories Inc., CA, USA) and a refractive 
index detector (Shodex RI-101, Showa Denko K. K., Japan) operating at 60ºC, 
with 5 mM H2SO4 as the eluent at a flow rate of 0.5 ml min
-1 (Neves et al., 2002a). 
Alternatively, quantification of metabolites in the supernatants was performed by 
1H-NMR using a Bruker Avance II 500 MHz spectrometer. 1H-NMR spectra were 
acquired with water presaturation, a 5.5-µs pulse width corresponding to a 70º flip 
angle, and a repetition delay of 50 s. Spectra were referenced to the resonance of 
3-(trimethylsilyl) propanesulfonic acid (sodium salt), designated as 0 ppm. Formic 
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Fig. 5.2. Schematic representation of genomic regions containing putative pfl 
(spd_0235 and spd_0420) (B and C) and pfl-ae (spd_0229 and spd_1774) (A and D). 
The chromosome is represented with a thin solid line and genes are shown with a block 
arrow. The chevrons in spd_0229, spd_0235, spd_0420 and spd_1774, represent 
approximate position of insertion (see text for details), and direction of chevrons represent 
the orientation of the spectinomycin cassette. Diagram is not drawn to scale.  




The putative pfl genes, spd_0235 and spd_0420, are found in all 
sequenced pneumococcal genomes (Tettelin et al., 2001; Hoskins et al., 2001; 
Lanie et al., 2007). The predicted amino acid sequences of spd_0235 and 
spd_0420 exhibit 20% identity over 770 amino acids. While SPD0420 has 
conserved adjacent cysteinyl residues characteristic of a PFL active site 
(EMSCISCCVSPLD) (Sawers and Watson, 1998), as well as the highly conserved 
peptide sequence around the C-terminal glycyl residue (RISGY) (Sawers and 
Watson, 1998), SPD0235 does not have the conserved cysteine residues. This 
implies that spd_0235 is unlikely to be encoding a PFL in spite of the annotation. 
However, it has a sequence motif containing the C-terminal glycyl residue 
(RVAGY), which is converted to a free radical in the PFL of E. coli (Weidner and 
Sawers, 1996; Vey et al., 2008). Thus SPD0235 may be a member of a distinct 
class of glycyl radical enzymes with conserved pentapeptide region containing the 
C-terminal glycyl residue, albeit without PFL activity. This class of proteins is also 
found in E. coli but so far no function has been attributed to them (Sawers and 
Watson, 1998). In the vicinity of spd_0235 there are cellobiose-specific sugar 
phosphotransferase (spd_0234) and fructose 6-phosphate aldolase (spd_0236) 
genes (Fig. 5.2) in all sequenced pneumococcal genomes, suggestive of a 
conserved nature of this locus (Tettelin et al., 2001; Hoskins et al., 2001; Lanie et 
al., 2007). On the other hand, spd_0420 is surrounded by a DNA-polymerase 
gene (dinP, spd_0419), and a hypothetical gene of unknown function (spd_0421) 
(Tettelin et al., 2001; Hoskins et al., 2001; Lanie et al., 2007). The genes adjacent 
to spd_0420 are transcribed in opposite directions (Fig. 5.2), implying that the 
mutation of spd_0420 is unlikely to create a polar effect, and furthermore, a strong 
Chapter 5 
 198
rho-independent transcription terminator with an estimated ΔGf of -12.3 kcal mol
-1 
is located 17-bp downstream of the spd_0420 stop codon. While dinP is 
conserved universally in all sequenced pneumococcal genomes, the hypothetical 
gene (spd_0421) exhibits either sequence variation or is absent in certain 
pneumococcal genomes, such as in TIGR4 or Hungary19A_6, indicating that 
recent evolutionary genetic events have taken place in the region 
(www.ncbi.nlm.nih.gov). In contrast to E. coli, H. influenzae and Clostridium 
pasteurianum (Sauter and Sawers, 1990; Fleischmann et al., 1995; Weidner and 
Sawers, 1996), in S. pneumoniae none of the putative pfl and pfl-ae are 
adjacently located, which is also a feature of the pfl/pfl-ae system in lactococci 
(Arnau et al., 1997). The predicted amino acid sequence of the putative PFL-AE 
proteins, SPD0229 and SPD1774, share 32% identity over 236 amino acids, and 
they are found in all sequenced pneumococcal genomes (www.ncbi.nlm.nih.gov). 
Both of these proteins have a CXXXCXXC consensus sequence motif close to the 
N-terminus of the protein, which is reported to be the catalytic site in the E. coli 
enzyme (Buis and Broderick, 2005). Spd_1774 is the last gene of a predicted 
operon (Ermolaeva et al., 2001) and is surrounded by genes responsible for 
protein export (spd_1773) and pH homeostasis (spd_1775), while the locus 
encompassing spd_0229 contains genes encoding for transcriptional regulators.  
 
End-product analysis 
The PFL enzyme can be measured directly (Yamamoto et al., 2000) or 
indirectly (Arnau et al., 1997). The indirect assay relies on formate detection in 
bacterial culture supernatants to indicate the presence of active enzyme. In this 
study we used the indirect method to assay PFL activity. The fermentation end-
products of pneumococcal strains in aerobiosis and anaerobiosis, in CDM with 
Glc or Gal as sole carbon source, were analyzed using late-exponential culture 
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supernatants. Regardless of aeration, when Glc was used, the main fermentation 
product of D39 was lactate, with a small amount of acetate (Fig. 5.3-A). However, 
replacement of Glc with Gal led to the generation of mixed fermentation products, 
under both aerobic and anaerobic conditions, with formate being the most 
abundant metabolite in both cases (Fig. 5.3-A). Additionally, acetate and ethanol 
were also formed, and the ratio of products was approximately 2:1:1 for formate, 
acetate, and ethanol, both in aerobiosis and anaerobiosis. The end-product 
analysis of SPD0229M and SPD0235M was principally similar to D39 in the 
presence of Glc and Gal regardless of aeration, ruling out their involvement in 
active PFL synthesis (data not shown). On the other hand, in SPD0420M and 
SPD1774M culture supernatants the main end-product was lactate in all growth 
conditions, and no formate was detected under any of the conditions employed, 
indicating that these two genes are responsible for active PFL synthesis (Fig. 5.3-
B and 5.3-D). Introduction of an intact copy of spd_0420 to SPD0420M restored 
formate production (Fig. 5.3-C). In the light of sequence homology and end-
product analysis, it is likely that spd_0420 is responsible for PFL synthesis, and 


















































































































































































































































































































































































































































































































































































































Fig. 5.3. Fermentation end-product analysis for strains D39 (A), SPD0420M (B), 
SPD0420Comp (C) and SPD1774M (D). The pneumococcal strains were grown in CDM 
containing glucose or galactose, aerobically or anaerobically. Glc, glucose; Gal, 
galactose. Each metabolite concentration was measured in duplicate in supernatants of 
three independently grown cultures. 
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Discussion 
The transition from aerobiosis to an oxygen depleted environment signifies 
passage from mucosal surfaces to deep tissue sites for the pneumococcus, 
hence it is integral to pneumococcal virulence (reviewed in Kadioglu et al., 2008). 
This move is expected to trigger a fundamental change in energy metabolism due 
to differences in nutrient availability and oxygen concentration (Philips et al., 
2003). We investigated biochemical aspects of these changes and the implication 
of this metabolic shift on pneumococcal virulence. In many microorganisms, PFL 
is one of the key enzymes for anaerobic energy metabolism, especially in the 
metabolic shift to mixed-acid fermentation (Arnau et al., 1997; Melchiorsen et al., 
2000; Asanuma et al., 2004; Derzelle et al., 2005). We demonstrated that the 
pneumococcal spd_0420 and spd_1774 are responsible for active PFL protein, 
through mutational studies and subsequent metabolite analysis, and by an in 
silico approach. The mutant strains did not produce formate, which is generated 
only in the presence of active PFL, and a homology search indicated conserved 
residues that are found in other PFLs (Sawers and Watson, 1998). The mutation 
of spd_0420 and spd_1774 led to a reduction in virulence, as manifested by 
increased survival time of animals infected with SPD0420M and SPD1774M 
compared to the parental strain, and the bacteremia was developed later in 
cohorts infected with SPD0420M and SPD1774M than in D39 (manuscript by 
Yesilkaya et al., 2009 provided on the CD). Moreover, growth of SPD0420M was 
attenuated in the nasopharynx and lungs, showing that PFL contributes to 
pneumococcal virulence in several tissue sites (Yesilkaya et al., 2009, on the CD). 
Initially, we predicted that the main impact of PFL would be seen in the hypoxic 
environment of blood (Levy, 2005), and no role was envisaged during infection of 
the nasopharynx and lungs, because PFL was expected to be inactivated in these 
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oxygenated sites. Our results indicate that the pneumococcal PFL may not be as 
susceptible to oxygen as other bacterial PFLs (Knappe et al., 1993). Indeed, it 
has been reported previously that PFL in S. mutans and L. lactis is relatively 
resistant to inactivation by oxygen compared to the E. coli enzyme (Yamada et 
al., 1985; Arnau et al., 1997). This could be due to the presence of a deactivation 
system that may protect the PFL (Melchiorsen et al., 2000; Nnyepi et al., 2007). 
PFL deactivation was suggested to occur through removal of the glycyl free 
radical, which is required for the active PFL, by alcohol dehydrogenase during the 
transition from anaerobic to aerobic growth (Sawers and Watson, 1998). Hence, 
future detailed structural and biochemical characterization is required to establish 
the mechanism of the oxygen resistant nature of the pneumococcal PFL. The 
second reason for attenuated virulence of strains lacking active PFL could be 
differences in overall sugar and oxygen composition in different tissue sites. For 
example the mucosal sites of nasopharynx and lungs are rich in Gal whereas 
blood is in Glc (Philips et al., 2003). Hence, as Gal triggers mixed-acid 
fermentation mediated by PFL, it is expected that the lack of PFL will attenuate 
virulence in mucosal sites because of composition of sugars, and in blood 
because of low oxygen concentration. 
The detailed analysis of reduction in SPD0420M and SPD1774M virulence 
was beyond the scope of this study. However, we speculate that the decreased 
virulence was due to reduction in ATP generation, which would have an adverse 
impact on diverse metabolic functions. Alternatively, the defect in PFL synthesis 
may affect purine synthesis, as was reported in S. thermophilus (Derzelle et al., 
2005). In addition, diminished synthesis of acetyl-CoA may influence virulence 
through its impact on choline and fatty-acid biosynthesis (Campbell and Cronan, 
2001; Derzelle et al., 2005). A small but significant change in membrane fatty-acid 
composition was detected in both SPD0420M and SPD1774M, due, most 
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probably, to shortage of acetyl-CoA in the mutant strains (Yesilkaya et al., 2009, 
on the CD). Other studies have also shown that small changes in fatty-acid 
composition are meaningful, and account for membrane fatty-acid adaptation to 
stress conditions, such as temperature, H2O2, and pH (Guerzoni et al., 2001; Di 
Pasqua et al., 2006). Since the growth rate of bacteria depends on membrane 
fluidity (Zaritsky et al., 1985), the lower fatty-acid unsaturation level is likely to 
explain the reduced growth rate in the mutant strains compared to the wild-type, 
thus affecting their virulence in mice (Yesilkaya et al., 2009, on the CD). 
PFL is post-translationally regulated by PFL-AE, which activates PFL by 
generation of a stable and catalytically essential glycyl radical at G734 of PFL 
(based on the E. coli PFL amino acid sequence). In E. coli, induction of pfl in 
anaerobiosis has been shown to involve both FNR and ArcA/ArcB regulators 
(Sawers and Watson, 1998; Melchiorsen et al., 2000; Melchiorsen et al., 2001). 
The global transcription factor FNR was reported to have a role in the expression 
of pfl via two recognition sequences located in the promoter region of this gene 
(Kaiser and Sawers, 1995). However, there is no fnr homolog in S. pneumoniae 
but the pneumococcal genomes contain homologs of ArcA/ArcB transcriptional 
regulators (data not shown). 
In addition to spd_0420 and spd_1774, spd_0235 and spd_0229 closely 
resemble pfl and pfl-ae genes, respectively. However, under the conditions tested 
these genes are not involved in the synthesis of an active PFL. Genomic analysis 
in E. coli indicated the presence of several pfl- and pfl-ae-like genes (Sauter and 
Sawers, 1990; Sawers and Watson, 1998). Many of these PFL-like enzymes are 
unlikely to have a role in the dissimilation of 2-keto acids, and therefore they may 
represent new classes of glycyl radical enzymes with novel enzymatic activities 
(Sauter and Sawers, 1990; Sawers and Watson, 1998). 
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In this study we identified the pneumococcal pfl and pfl-ae and 
demonstrated their involvement in mixed-acid fermentation. It was found that the 
mutation of pfl results in reduced pneumococcal virulence, indicating a strong link 
between the ability to have flexible fermentative metabolism and virulence 
(Yesilkaya et al., 2009, on the CD). The reduced virulence was probably due to a 
defect in ATP and acetyl-CoA biosynthesis, which affects fitness and fatty-acid 
composition, respectively (Yesilkaya et al., 2009, on the CD). At mucosal surfaces 
the concentration of Glc is low, but the pneumococcus is exposed to mucin at 
these sites and mucin is rich in Gal-containing glycosides (Sheehan et al., 1995; 
Yesilkaya et al., 2008). Recently it was demonstrated that the pneumococcus has 
the ability to utilize mucin (Yesilkaya et al., 2008). In light of the available data, we 
conclude that the pneumococcus maintains mixed-acid fermentation in the 
nutrient limited niches of the host, and an active PFL plays a vital role in this 
metabolic event. Thus, future studies investigating pneumococcal virulence 
should not define virulence solely from the host perspective, but the intricacies of 
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In Gram-positive bacteria, the transcriptional regulator CcpA is at the core 
of catabolite control mechanisms. In the human pathogen S. pneumoniae, links 
between CcpA and virulence have been established, but its role as a master 
regulator in different nutritional environments remains to be elucidated. Thus, we 
performed whole-transcriptome and metabolic analyses of S. pneumoniae D39 
and its isogenic ccpA mutant during growth on Glc or Gal, rapidly and slowly 
metabolized carbohydrates presumably encountered by the bacterium in different 
host niches. CcpA affected the expression of up to 19% of the genome covering 
multiple cellular processes, including virulence, regulatory networks and central 
metabolism. Its prevalent function as a repressor was observed on Glc, but 
unexpectedly also on Gal. Carbohydrate-dependent CcpA regulation was also 
observed, as for the tagatose 6-phosphate pathway genes, which were activated 
by Gal and repressed by Glc. Metabolite analyses revealed that two pathways for 
Gal catabolism are functionally active, despite repression of the Leloir genes by 
CcpA. Surprisingly, Gal-induced mixed-acid fermentation apparently required 
CcpA, since genes involved in this type of metabolism were mostly under CcpA-
repression. These findings indicate that the role of CcpA extends beyond 
transcriptional regulation, which seemingly is overlaid by other regulatory 
mechanisms. In agreement, CcpA influenced the level of many intracellular 
metabolites potentially involved in metabolic regulation. Our data strengthen the 
view that a true understanding of cell physiology demands thorough analyses at 
different cellular levels. Moreover, integration of transcriptional and metabolic data 
uncovered a link between CcpA and the association of surface molecules (e.g. 
capsule) to the cell wall. Hence, CcpA may play a key role in mediating the 
interaction of S. pneumoniae with its host. Overall, our results support the 
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hypothesis that S. pneumoniae optimizes basic metabolic processes, likely 
enhancing in vivo fitness, in a CcpA-mediated manner.  
 
 Introduction 
The survival of bacterial pathogens in different host environments depends 
largely on the expression of specific virulence factors (reviewed in Mitchell, 2003; 
Kadioglu et al., 2008), but also on recognition of nutrients and rapid adaptation to 
their availability in fluctuating environments. Human bacterial pathogens are 
heterotrophs that depend on carbon sources to generate energy and catabolic 
intermediates for growth. In many bacteria, adaptation to changing carbon 
sources is accomplished through a regulatory mechanism called carbon catabolite 
control (for reviews see Deutscher et al., 2006; Görke and Stülke, 2008). At the 
molecular level, carbon catabolite control can be achieved through different 
regulatory mechanisms, namely transcription activation and repression of genes 
by global regulators, control of translation by RNA-binding proteins, and allosteric 
regulation, in response to a preferred carbon source. Overall, these phenomena 
ensure that carbon sources yielding a maximum profit for growth are utilized first. 
In low-GC Gram-positive organisms, such as B. subtilis and L. lactis, Glc is 
generally the preferred carbohydrate and the catabolite control protein A (CcpA) is 
the main transcriptional regulator functioning at the core of carbon catabolite 
control (Zomer et al., 2007; Lulko et al., 2007). CcpA binds to DNA at catabolite-
responsive element (cre) sites, the location of which, relative to the promoter 
region, determines whether it acts as a transcriptional inhibitor or activator (Zomer 
et al., 2007; Lulko et al., 2007). The cre-binding activity of CcpA is enhanced by 
interaction with the phosphoprotein HPr, a component of the multi-protein 
phosphoenolpyruvate: carbohydrate phosphotransferase system (PTS-system), 
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when phosphorylated at serine 46 (HPr(Ser46)~P) by a fructose 1,6-bisphosphate 
(FBP) activated kinase (reviewed in Deutscher et al., 2006).  
Although the mechanisms by which catabolite control is exerted are among 
the most studied in model bacteria, a paucity of data hampers our understanding 
on how human pathogens adapt to different host environments. In the pathogenic 
streptococci, increasing evidence supports key roles of CcpA and HPr(Ser46)~P 
(Iyer et al., 2005; Abranches et al., 2008; Shelburne et al., 2008b; Zeng and 
Burne, 2010). Notably, CcpA was shown to influence a high percentage of genes 
in S. mutans (about 9%) and S. pyogenes (up to 20%), including the production of 
a number of virulence factors (Abranches et al., 2008; Shelburne et al., 2008b).  
S. pneumoniae is a major cause of life threatening diseases including 
pneumonia, meningitis and septicaemia, as well as other less severe but highly 
prevalent infections (e.g. otitis media). Pneumococcal disease is preceded by 
colonization of the human nasopharynx, S. pneumoniae’s natural habitat. It is well 
established that progression from carriage to pneumococcal invasion is 
associated with changes in expression of virulence factors, such as capsule and 
surface proteins (reviewed in Mitchell, 2003; Kadioglu et al., 2008), but the basic 
metabolic mechanisms underlying these adaptations remain elusive. Unrelated 
studies have clearly shown that CcpA influences the expression of genes involved 
in pneumococcal carbohydrate metabolism (Giammarinaro and Paton, 2002; Iyer 
et al., 2005; Kaufman and Yother, 2007). Furthermore, CcpA has been implicated 
in the regulation of virulence factors, namely expression of genes in the capsule 
(cps) locus (Giammarinaro and Paton, 2002) and was proven necessary for 
colonization of the nasopharynx and survival in the lungs (Iyer et al., 2005). 
Curiously, CcpA-independent catabolite repression of metabolic enzymes was a 
recurrent observation, leading to a view that minimized the role of CcpA as a 
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master regulator of catabolite control in S. pneumoniae (Giammarinaro and 
Paton, 2002; Iyer et al., 2005). 
In this work, the impact of CcpA on pneumococcal physiology was 
reappraised by combining genome-wide transcriptomics with metabolite analysis 
of S. pneumoniae D39 and its isogenic ccpA mutant. Our approach is in line with 
the current view that true understanding of a microbial metabolism requires 
quantitative analyses of system components at different cellular levels 
(Heinemann and Sauer, 2010). A major question was whether S. pneumoniae 
regulates expression of carbohydrate utilization genes and virulence factors in a 
carbohydrate-dependent, CcpA-mediated manner. Hitherto, the information 
available has largely been limited to the response of a few specific metabolic 
genes involved in carbohydrate utilization (Giammarinaro and Paton, 2002; Iyer et 
al., 2005; Kaufman and Yother, 2007). For our global studies, Glc and Gal were 
used as carbon sources for the growth of S. pneumoniae. This choice was based 
on the following: Glc is the most common preferred carbohydrate, and is also 
found in considerable amounts in the bloodstream and during infection in the 
respiratory tract of the host (Philips et al., 2003). Gal, generally a slowly 
metabolized non-preferred carbohydrate, was selected among other host-derived 
carbohydrates as this monosaccharide is one of the prevailing carbohydrates 
encountered by the pneumococcus in the human nasopharynx (colonization state) 
(Yesilkaya et al., 2008; King, 2010). Our data show that CcpA influences the 
expression profile of central and carbohydrate-specific metabolic genes of S. 
pneumoniae as well as virulence factor-encoding genes in a carbohydrate-
dependent and independent manner. These results enhance our understanding of 
how CcpA-mediated regulation can contribute to the metabolic fitness of 
S. pneumoniae in the host, which further supports the view that virulence and 
basic microbial physiology are closely intertwined.   
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Materials and Methods  
Bacterial strains, media and growth conditions 
Strains and plasmids used in this study are shown in Table 6.1. S. 
pneumoniae strains were grown as standing cultures without aeration in M17 
broth (DifcoTM) containing Glc 0.5% (w/v) or on Glc-M17 (0.5% w/v) agar plates 
with 1% (v/v) defibrinated sheep blood (Johnny Rottier) at 37ºC. When 
appropriate 150 µg ml-1 spectinomycin, 2.5 µg ml-1 chloramphenicol, 0.25 µg ml-1 
erythromycin or 15 µg ml-1 trimethoprim were added to the medium. Capsule 
quantification, transcriptomic and metabolic experiments were performed with 
cells grown in CDM (Chapter 2) in static flasks at 37ºC without pH control (initial 
pH 6.5). Glc (56 ± 1mM) or Gal (57 ± 1mM) was used as the carbon source. For 
complementation studies, nisin was added at time zero. Growth of the cultures 
was monitored by measuring optical density at 600 nm every hour. Maximum 
specific growth rates ( max) were calculated through linear regressions of the plots 
of ln (OD600) versus time during the exponential growth phase. 
 
Molecular techniques  
Chromosomal DNA isolation was performed according to the procedure of 
Johansen and Kibenich (Johansen and Kibenich, 1992). Plasmid isolation was 
carried out using the plasmid isolation kit from Roche. Phusion DNA polymerase 
(Roche), T4 DNA ligase (Roche) and restriction enzymes (Fermentas) were used 
according to the recommendations described by the suppliers. Purification of the 
PCR products was performed using the High pure PCR product purification kit 
from Roche. Purified PCR products or recombinant plasmids were introduced into 
S. pneumoniae by transformation as described in Kloosterman et al. (2006a). 
Positive transformants were selected on Glc-M17 agar with the appropriate 
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antibiotic and confirmed by PCR and sequencing. L. lactis MG1363 was 
transformed with plasmid DNA by electroporation according to Holo and Nes 
(Holo and Nes, 1995). 
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collection) 
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containing em
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Construction of a ccpA mutant of S. pneumoniae D39 
Oligonucleotide primers used in this study are listed in Table 6.2. In S. 
pneumoniae D39, ccpA forms a monocistronic operon, flanked upstream by a well 
defined promoter region and downstream by a strong terminator (predicted ∆Gº = 
-13.8 kcal mol-1). The ccpA deletion was accomplished by allelic replacement 
mutagenesis as follows: the up- (547-bp) and downstream (517-bp) regions of the 
ccpA gene (1010-bp) were PCR-amplified from D39 chromosomal DNA using the 
primer pairs ccpA_D39_KO-1/ ccpA_D39_KO-2 (spec) and ccpA_D39_KO-3 
(spec)/ ccpA_D39_KO-4, respectively. The resulting PCR products were, by 
means of overlap extension PCR (Song et al., 2005), fused to a SpcR gene (1032-
bp, amplified with primers Spec_Fp and Spec_Rp from plasmid pORI38) using 
the primers ccpA_D39_KO-1 and ccpA_D39_KO-4. The ∆ccpA::spc PCR product 
(2096-bp) obtained in this way was  transformed to S. pneumoniae D39, giving 
rise to the ccpA deletion mutant (D39ΔccpA in Table 6.1). Replacement of the 
ccpA gene with the spc gene and correct integration of the insert were confirmed 
by PCR and sequencing (Service XS). To rule out the possibility of suppressor 
mutations arising with the deletion of ccpA, the transformation efficiency of the 
∆ccpA::spc PCR product was compared with that of the spd_0786::spc (spd_0786 
insertion-deletion) PCR product. SPD_0786 is a non-essential transcription factor, 
which disruption does not affect growth of S. pneumoniae in CDM (Kloosterman 
et al., unpublished results). A similar number of transformants per ng of DNA 
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Table 6.2. Oligonucleotide primers used in this study 
Primers Sequence (from 5’ to 3’) REnz 
ccpA_D39_KO-1 CCAATATTCTTTCAAAACTGG - 




ccpA_D39_KO-4 CCCAGTCGCTCTGGTATCAC - 
ccpA_D39-1b GCCGGTCTCTCATGAATGCAGATGATACAGTAACC BsaI 
ccpA_D39-2b GCTCTAGATCGATTCCCTGATTTTTTCTATTTACG XbaI 
PnisAL-fw GTCGATAACGCGAGCATAATAAACG - 
PnisAL-rev CGTGCTGTAATTTGTTTAATTGCC - 
ccpA_D39_KO-1_conf GGAACTATTCGAAACTATGTCACCAATATTCTTTCAAAACTGG - 
ccpA_D39_KO-4_conf CTTCTGCAAAAAGGAATCCCAGTCGCTCTGGTATCAC - 
SpecRev TCTGTCAATGGTTCAGATACGACGACTA - 
SpecFw GCGGGAAATGCAGTGGCTGAATCT - 
Spec_Fp CTAATCAAAATAGTGAGGAGG - 
Spec_Rp ACTAAACGAAATAAACGC - 
Spd_0420-qRT-1 TGGGAAGGCTTCAAAGG - 
Spd_0420-qRT-2 GGACGAGTGTCCATTGG - 
Spd_0667-qRT-1 TCCATATGCATACGACGC - 
Spd_0667-qRT-2 TGGGATAGATTCTACATCAGC - 
metG-D39-2 TTCTGCCAGCTGGCTTTC - 
metG_D39-1 ATCCGTACAACTGATGAC - 
Spd_0790-qRT-1 GGTGAGGACGGATACTGG - 
Spd_0790-qRT-2 TAACAGTTGCCATACGCTC - 
Spd_1053-qRT-1 GTGCAGATGCTGCAGG - 
Spd_1053-qRT-2 GGCCACGAGTCATATAAGC - 
Spd_1078-qRT-1 TTGACCTTAGTCACGCCC - 
Spd_1078-qRT-2 TTACCTACAAGGTCAAGACGAG - 
Spd_1504-qRT-1 ATGAAACTCAACTTTCGGG - 
Spd_1504-qRT-2 GACATTTTCCAAATCTCGTG - 
Spd_1634-qRT-1 CTGAAACTCTTCGCAAAGAC - 
Spd_1634-qRT-2 TGCGCCGTATGTTCC - 
Abbreviations: REnz, restriction enzyme. aOverlap with SpcR gene is indicated in bold. bRestrictions 
enzyme sites are underlined. 
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Transformation frequency assay 
For the transformation frequency assay the 2096-bp fragment comprising 
the ∆ccpA::spc region was PCR-amplified from the chromosomal DNA of the 
ccpA mutant strain using the primer pairs ccpA_D39_KO_1 and 
ccpA_D39_KO_4. Similarly, a fragment (2725-bp) encompassing the 
spd_0786::spc region of a D39 spd_0786::spc strain was amplified using 
appropriate primer pairs. An identical concentration of each product was used to 
transform strain D39 as described above. Spectinomycin resistant colonies were 
selected and counted for each transformation and the number of colonies was 
compared to evaluate the transformation frequency.  
 
Construction of the ccpA complementation strain  
A ccpA complementation strain was constructed using the NICE system 
improved for S. pneumoniae (Kloosterman et al., 2006a). In this arrangement the 
NisRK two-component system, coded by the nisRK genes, activate the 
expression of the nisA promoter in the presence of nisin. The procedure to 
construct the ccpA complementation strain is described as follows. The ccpA 
mutant strain (D39ΔccpA) was transformed with chromosomal DNA from 
D39nisRK, a stable derivative of S. pneumoniae D39 that harbours the nisRK 
genes and a TrimR gene in the bgaA locus. Trimethoprim resistant clones 
(D39ΔccpAnisRK in Table 6.1) were selected and the presence of both the ccpA 
deletion and the nisRK genes was confirmed by PCR. For the construction of the 
plasmid harbouring ccpA under the control of the nisin-indusible promoter nisA 
(pNZ[ccpA] in Table 6.1), the ccpA gene was PCR-amplified from D39 
chromosomal DNA using the primers ccpA_D39-1 and ccpA_D39-2 and cloned 
as a BsaI/XbaI fragment in NcoI/XbaI digested pNG8048e. L. lactis MG1363 was 
used as the cloning host. The ccpA complementation strain 
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(D39ΔccpAnisRKpNZ[ccpA] in Table 6.1) was constructed by transformation of 
the D39ΔccpAnisRK strain with plasmid pNZ[ccpA] selecting for chloramphenicol 
resistant clones. As a control D39ΔccpAnisRK strain was also transformed with 
the empty plasmid pNZ8048 (Table 6.1). Strains were confirmed by PCR. 
 
Transcriptome analysis 
S. pneumoniae D39 and the isogenic ccpA mutant were compared by 
transcriptome analysis using whole-genome S. pneumoniae DNA microarrays, 
representing all TIGR4 ORFs, as well as R6 and D39 ORFs that are not in TIGR4 
(Kloosterman et al., 2006b). See http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? 
acc=GPL11484, for a description of all amplicons and oligo’s present on the DNA 
microarray. The two strains were grown as described above in three biologically 
independent experiments and harvested at mid-exponential (OD600 of 0.35 ± 0.02) 
and transition-to-stationary (OD600 of 1.3 ± 0.1) phases of growth (Fig. 6.1). mRNA 
isolation, synthesis of cDNA, labelling of cDNA, hybridization, scanning of the 
slides and the processing and analysis of the data was carried out as described 
before (Kloosterman et al., 2006b). Genes were considered to have significantly 
altered expression when the bayesian p-value was < 0.001, the false discovery 
rate (FDR) was < 0.01 and the ratio (signal ΔccpA /signal D39) was > 1.5 or < 
0.66, but > 2 or < 0.5 in at least one of the four conditions. For the Gal_TS 
comparison, data were derived from two independent hybridizations and a 
Bayesian p-value < 0.01, FDR < 0.08 was applied. To exploit the data obtained in 
this way, also an in silico comparison was done between Glc and Gal, both for the 
M and TS phases and also in both D39 wild-type as well as ΔccpA. To this end, 
raw signals (i.e. slide images) of the Glc experiments were compared with the 
corresponding signals of the Gal experiments and analyzed as described above. 
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The microarray data have been deposited at GEO under accession number 
GSE31819.  
 
Cre site prediction 
Using the L. lactis consensus sequence (WGWAARCGYTWWMA, a cre 
site prediction was performed in D39, using Genome2D (Baerends et al., 2004; 
Zomer et al., 2007). Subsequently, genes with a cre site in their promoter region 
that were differentially expressed in the DNA microarray analyses of the ccpA 
mutant were used to built a weight matrix, which was subsequently used to 
search the genome again using Genome2D (Baerends et al., 2004), using a cut-
off score of 9.9. In a similar way, the weight matrix of the RegPrecise 
(http://regprecise.lbl.gov/RegPrecise/) prediction was used. The resulting 
predictions (Table S.6.6 on the CD) were compiled together with the original 
prediction of RegPrecise and a prediction done in a recent publication (van 
Opijnen et al., 2009). The resulting list of 340 genes with putative cre sites was 
compared with the genes that were differentially expressed in the arrays. Of these 
340 genes with cre sites, 115 matched with the list of genes differentially 
expressed in the ccpA mutant in at least one condition. After reanalysis of these 
matches with an online cre site prediction tool 
(http://molgen51.biol.rug.nl/websoftware /ppp/ppp_start.php), 90 genes were left 
that contain a putative cre site in their promoter region, or downstream of the 
translational start. 
 
Real-time quantitative RT-PCR 
Cell samples obtained as described above for transcriptome analyses 
using DNA microarrays were treated with RNase-free DNase I (Fermentas, St. 
Leon-Rot, Germany) for 60 min at 37ºC in DNaseI buffer (10 mmol l-1 Tris-HCl, pH 
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7.5, 2.5 mmol l-1 MgCl2, 0.1 mmol l
-1 CaCl2). Samples were purified with the 
Roche RNA isolation kit. Reverse transcription was performed on 5 µg of total 
RNA using the same method as used during the microarray procedure. 
Quantification of specific cDNA of spd_0420 (pfl), spd_0667 (sodA), spd_0790 
(pyk), spd_1053 (lacE), spd_1078 (ldh), spd_1504 (nanA) and spd_1634 (galK) 
was performed on an CFX96 Real-Time PCR System (BioRad, Hercules, CA) 
using Maxima SYBR Green qPCR Master Mix (Fermentas, St. Leon-Rot, 
Germany) on 5 ng cDNA template in a 20 µl reaction volume. Primers used are 
listed in Table 6.2. The qRT-PCR data were normalized to the level of metG 
(spd_0689) cDNA using the 2−ΔΔCT method (Livak and Schmittgen, 2001). The 
data are averages of four repeats. 
  
Quantification of fermentation products during growth 
Strains were grown as described above. Culture samples (2 ml) were 
taken in mid-exponential and transition-to-stationary phases of growth, 
centrifuged (16,000 × g, 2 min, 4ºC), filtered (Millex-GN 0,22 µm filters) and the 
supernatant solutions were stored at -20ºC until analysis by high performance 
liquid chromatography (HPLC). Prior to analysis, samples were allowed to thaw at 
room temperature. Glc or Gal and end-products were quantified in an HPLC 
apparatus equipped with a refractive index detector (Shodex RI-101, Showa 
Denko K. K.) using an HPX-87H anion exchange column (Bio-Rad Laboratories 
Inc.) at 60ºC, with 5 mM H2SO4 as the elution fluid and a flow rate of 0.5 ml min
-1. 
Alternatively, quantification of metabolites in the supernatant solutions was 
performed by 1H-NMR in a Bruker Avance II 500 MHz spectrometer (Bruker 
BioSpin GmbH). Formic acid (sodium salt) was added to the samples and used as 
an internal concentration standard. The ATP yield was calculated as the ratio of 
ATP produced to Glc or Gal consumed. The global yields of ATP were calculated 
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from the fermentation products determined at the time-point of growth arrest 
assuming that all ATP was synthesized by substrate-level phosphorylation. A 
factor of 0.39, determined from a DW (mg ml-1) versus OD600 curve, was used to 
convert OD600 into dry weight (mg biomass ml
-1). Hydrogen peroxide was 
quantified in fresh supernatant solutions using the Amplex® Red Hydrogen 
Peroxide/Peroxidase assay kit from Invitrogen. 
 
Determination of hydrogen peroxide (H2O2) 
Strains were grown in CDM as described above. Culture samples of 1-ml 
were harvested in mid-exponential and transition-to-stationary phases of growth, 
centrifuged (16,000 × g, 2 min, 4ºC) and filtered (Millex-GN 0,2 µm filters). The 
Amplex® Red hydrogen Peroxide/Peroxidase assay kit from Invitrogen was used 
to quantify the hydrogen peroxide contents in the fresh supernatant solutions. 
 
Cold ethanol extractions and determination of intracellular metabolites by 
31P-NMR 
The ethanol extracts were prepared as described previously by Ramos et 
al. (2001). For each extract the volume of cells harvested from mid-exponential 
(OD600 of 0.35 ± 0.02) and transition-to-stationary (OD600 of 1.3 ± 0.1) cultures 
corresponded to approximately 14 mg of protein and the centrifugation was 
performed at 4ºC, 6,000 x g, during 3 min. The dried extract was dissolved in 1-ml 
of deuterated water (pH 6.5 or pH 5.5) containing 5 mM EDTA and stored at -
20ºC for further analysis by 31P-NMR. This methodology was successfully used to 
measure phosphorylated metabolites in L. lactis (Ramos et al., 2001). In S. 
pneumoniae ethanol extracts the following phosphorylated metabolites were 
detected: G6P, FBP, 3-PGA, PEP, α-Gal1P, α-G1P, TBP, UDP-Glc, UDP-N-
acetylmuramoyl-pentapeptide (UDP-MurNAc-pPep), UDP-N-acetylglucosamine 
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(UDP-GlcNAc), UDP-glucosamine (UDP-GlcN), CDP-choline (CDP-cho), NAD+, 
CTP, ATP and ADP. A small peak due to fructose 6-phosphate was also 
detected, but its quantification was hampered by strong overlapping with a 
resonance due to the medium component β-glycerophosphate. A weak 
resonance due to dihydroxyacetone phosphate was present, but reliable 
integration was not possible. The concentration limit for detection/quantification of 
metabolites in ethanol extracts by 31P-NMR was approximately 0.4-0.5 mM. 
Resonances were assigned by addition of pure compounds to the extracts or on 
the basis of comparison with a previous study (Ramos et al., 2001). 
Concentrations were calculated from the areas of the resonances in 31P-spectra 
by comparison with the area of a resonance due to methylphosphonic acid 
(Aldrich), added as an internal standard, and after application of an appropriate 
factor for correcting saturation of resonances. The reported concentration values 
for intracellular phosphorylated compounds are averages of three independent 
growth experiments. 
31P-NMR spectra were recorded using a selective probe head (31P-SEX) at 
37ºC on a Bruker AVANCE II 500 MHz spectrometer (Bruker BioSpin GmbH) by 
using standard Bruker pulse programs. Spectra were referenced to the resonance 
of external 85% H3PO4, designated at 0 ppm. 
 
Quantification of the glucuronic acid content of capsular polysaccharide 
Samples for the determination of the capsular glucuronic acid amounts 
were prepared as follows: cells grown in CDM and harvested in mid-exponential 
(OD600 of 0.35 ± 0.02) and transition-to-stationary (OD600 of 1.3 ± 0.1) phases of 
growth were centrifuged (6,000 x g, 3-7 min, 4ºC), resuspended in PBS and 
pelleted at 3000 x g, 4ºC, for 20min. The pellet was resuspended in 500 µl of 150 
mM Tris-HCl (pH 7.0) and 1 mM MgSO4 and treated as described elsewhere 
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(Morona et al., 2006). The supernatants derived from the two centrifugations 
referred before were pooled and treated with 20% (w/v) trichloroacetic acid for 
protein precipitation. After 2 h of incubation in an ice bath proteins were pelleted 
and the exopolysaccharides were precipitated with cold ethanol as in Ramos et al. 
(2001). The glucuronic acid of capsule attached or loosely attached (lost in 
centrifugations to the supernatants) to the cell wall was quantified by the method 
for quantitative determination of uronic acids as described by Blumenkrantz and 
Asboe-Hansen, 1973. 
 
   
Results  
Growth rates on glucose and galactose are differently affected by CcpA 
Hitherto, a systemic appraisal to the role of CcpA in the physiology of S. 
pneumoniae was missing. We constructed a S. pneumoniae ccpA deletion-
insertion mutant (D39ΔccpA, for details see Material & Methods and Fig. 6.1-A) in 
the D39 serotype 2 background (Table 6.1), and determined the growth profiles of 
the ccpA mutant and the wild-type D39 in chemically defined medium (CDM) 
containing Glc without pH control (Fig. 6.1-B). Under the conditions studied, the 
maximal biomass reached at time-points 8 h and 14 h for strains D39 and 
D39∆ccpA, respectively, was consistently slightly higher in the absence of CcpA. 
Loss of CcpA caused a substantial decrease (about 55%, Table 6.3) of the growth 
rate in Glc-containing CDM. Importantly, this growth rate defect was fully restored 
by complementation of a ccpA strain (D39∆ccpAnisRK, µ = 0.76 ± 0.00 h-1) with 
expression in trans of ccpA under the control of the nisin promoter (Fig. 6.1-B). It 
should be noted that the growth profile of strain D39∆ccpAnisRK closely 
resembles that of D39∆ccpA (data not shown). 
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To extend our knowledge on the role of CcpA in the physiology of S. 
pneumoniae, growth on Gal was also assessed in batch cultivations as described 
for Glc (Fig. 6.1-C). On Gal, the maximal biomass produced was also similar in 
both strains. However, in strong contrast to the effect in Glc-CDM, in Gal-CDM the 
growth rate of strain D39∆ccpA was slightly higher than that of D39, although this 
difference was not statistically significant.  
Our data show that the effect of CcpA on the growth rate of S. 
pneumoniae is carbohydrate-dependent; CcpA noticeably stimulates fast growth 




















Table 6.3. Product yields, total substrate consumption, carbon and redox balances, 
growth and energetic parameters, and pH values determined at the time-point of maximal 
biomass achieved by D39 and D39∆ccpA strains cultured on Glc (56 ± 1 mM) or Gal (57 ± 
1 mM). Substrate consumption rate and the specific growth rate are also shown. Values of 
two or three independent experiments were averaged and errors are reported as ± SD. 
 Glc Gal 
 D39 D39∆ccpA D39 D39∆ccpA 
Product yields
a
     
Lactate 1.86 ± 0.02 1.71 ± 0.01 1.01 ± 0.04 1.78 ± 0.06 
Formate 0.04 ± 0.0 0.20 ± 0.01 0.89 ± 0.00 0.14 ± 0.02 
Acetate BDL 0.12 ± 0.01 0.49 ± 0.01 0.15 ± 0.02 







) 31.4 ± 2.8 9.6 ± 2.0 10.0 ± 2.0 9.8 ± 1.5 
µmax (h
-1
) 0.75 ± 0.03 0.35 ± 0.01 0.27 ± 0.03 0.31 ± 0.01 
Carbon balance
b
 95 ± 1 95 ± 1 95 ± 2 96 ± 4 
Redox balance 93 ± 1 90 ± 2 96 ± 1 92 ± 2 
Biomass yield (g mol
-1
 of substrate) 23.1 ± 0.5 30.3 ± 1.1 38.0 ± 1.7 41.8 ± 1.9 
ATP yield (mol mol
-1
 of substrate) 1.86 ± 0.02 2.00 ± 0.05 2.45 ± 0.00 2.10 ± 0.01 
YATP (g of biomass mol
-1
 of ATP) 12.4 ± 0.3 15.1 ± 0.2 15.5 ± 0.7 19.8 ± 0.8 
Consumed substrate (%) 50 ± 1 42 ± 2 26 ± 2 31 ± 0 
pH (growth arrest) 5.4 ± 0.1 5.5 ± 0.0 5.3 ± 0.0 5.3 ± 0.1 
a
Product yields, [End-product] / [Glc consumed]; 
b
Carbon balance is the percentage of carbon in 
metabolized Glc or Gal that is recovered in the fermentation products (lactate, formate, ethanol and 
acetate); qs
max
 was estimated from a first-order derivative of a polynomial fit of the observed 
substrate consumption time series. Dry weight (DW) was used as a measure of cell mass. BDL, 
below detection limit.  
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Fig. 6.1. Growth profiles of D39 wild-type and the isogenic ccpA mutant on Glc and 
Gal. (A) Schematic overview of the ccpA gene and its flanking genes and the genetic 
replacement of the ccpA gene with a spectinomycin marker in strain D39. Hooked arrow, 
putative promoter; lollipop, putative terminator; black area, ccpA gene replaced with a 
spectinomycin cassette; numbers inside the genes, D39 spd numbers; arrows and 
numbers above the figure indicate primers used to construct the D39ΔccpA mutant; 
zoomed area (inset), putative cre box, -35 and -10 promoter regions; the number of bp 
spacing these regions are subscripted after {n}. (B and C) Growth of strains D39 (), 
D39∆ccpA () and D39ΔccpAnisRKpNZ[ccpA] () in CDM containing 1% Glc (B) or 1% 
Gal (C) at 37ºC in rubber-stoppered static bottles without pH control (initial pH 6.5); 
growth curves as in Fig. 6.4, except that logarithmic scale was used for the y-axis. The 
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growth of the complemented strain was performed without nisin in the medium. Optical 
densities at 600 nm (OD600) were measured hourly. Each point of the growth curves is an 
average of at least three independent experiments and the error was in all cases below 
15%. The growth rates for each strain are also indicated and the values shown are 
averages ± SD. The arrows indicate the mid-exponential and transition-to-stationary time-
points at which D39 and D39∆ccpA samples were withdrawn for transcriptomic and 
metabolic profiling analysis. 
 
 
CcpA is a pleiotropic regulator in S. pneumoniae 
To determine the effect of the ccpA deletion on the transcriptome of S. 
pneumoniae, the transcriptional profile of D39 wild-type was compared to that of 
its isogenic ccpA deletion mutant at mid-exponential (M) and transition-to-
stationary (TS) phases of growth. In the four conditions tested, Glc_M, Gal_M, 
Glc_TS, Gal_TS, between 14 and 19% of the ORFs in the genome were 
significantly, differentially expressed in the ccpA deletion mutant, of which more 
genes upregulated than downregulated (Fig. 6.2; for an overview see also Table 
S.6.1 provided in digital format on the included CD). This is similar to S. pyogenes 
(up to 20% genes affected) (Shelburne et al., 2008b), but higher than in S. 
mutans, L. lactis, and B. subtilis (less than 9% genes affected) (Zomer et al., 
2007; Lulko et al., 2007; Abranches et al., 2008). These findings confirm the role 
of CcpA as a global regulator with a prevalent repressor function. The COG 
category with the highest number of genes affected was carbohydrate transport 
and metabolism [G], which genes are mainly repressed by CcpA (Fig. 6.2-B). 
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Fig. 6.2. Genes differentially expressed due to inactivation of ccpA. (A) Venn 
diagram of the genes significantly differentially transcribed due to loss of ccpA. Transcript 
levels in D39 ccpA were compared to D39 wild-type in Glc_M, Gal_M, Glc_TS, Gal_TS 
as generated by VENNY (http://bioinfogp.cnb.csic.es/tools/venny/index.html). For all 
intersections, which are not drawn to scale, the numbers of genes are indicated. The total 
number of genes influenced in each condition tested was: Glc_M, 334 (15.3%), Glc_TS, 
418 (19.2%), Gal_M, 299 (13.7%), and Gal_TS 299 (13.7%) in a universe of 2177 genes 
in the genome of S. pneumoniae. (B) Numbers of genes significantly differently 
transcribed by the ccpA deletion in strain D39 ordered by COG categories. White bars 
represent M phase of growth, black bars TS phase of growth. [C] Energy production and 
conversion; [D] Cell cycle control, cell division; chromosome partitioning; [E] Amino acid 
transport and metabolism; [F] Nucleotide transport and metabolism; [G] Carbohydrate 
transport and metabolism; [H] Coenzyme transport and metabolism; [I] Lipid transport and 
metabolism; [J] Translation, ribosomal structure and biogenesis; [K] Transcription; [L] 
Replication, recombination and repair; [M] Cell wall/membrane/envelope biogenesis; [O] 
Posttranslational modification, protein turnover, chaperones; [P] Inorganic ion transport 
and metabolism; [Q] Secondary metabolites biosynthesis, transport and catabolism; [R] 
General function prediction only; [S] Function unknown; [T] Signal transduction 
mechanisms; [U] Intracellular trafficking, secretion, and vesicular transport; [V] Defense 
mechanisms; [X] No prediction. The ratio for each gene is > 1.5 or < 0.66, but > 2 or < 0.5 
in at least one of the four conditions. The number 2177 represents the total number of 
amplicons analyzed, covering the entire genome of S. pneumoniae D39. This number is 
slightly higher than the number of genes in the genome of D39 (2069), since some 




Also, 21 genes encoding (putative) transcriptional regulatory proteins were 
affected, among which three two-component systems, indicating intertwinement of 
CcpA with other regulons. In addition, many genes with unknown or unpredicted 
function, as well as a number of genes within the amino acid transport and 
metabolism category [E], were among the differentially expressed genes (see also 
Table S.6.1 on the CD). Strikingly, roughly similar numbers of genes were 
regulated when Gal instead of Glc was used as the carbon source (Fig. 6.2 and 
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Table S.6.1). This means that during growth on the slowly metabolized Gal, 
carbon catabolite repression by CcpA still takes place. Furthermore, a large part 
of the genes (up to 44% per condition) differentially expressed were common to 
all 4 conditions, but carbohydrate and growth phase-specific CcpA-mediated 
regulation was also in effect (Fig. 6.2 and Table S.6.1 on the CD). To firmly 
confirm our microarray data, changes in transcript abundance of selected genes 
linked to metabolic and virulence pathways (lacE, galK, pyk, ldh, pfl, sodA, nanA), 
were assessed by qRT-PCR. For all genes tested, expression data obtained by 
qRT-PCR proved to correlate positively with transcript abundance as measured 
by microarray analysis (Table S.6.2 on the CD). In summary, the role of CcpA as 
a master regulator in S. pneumoniae is undoubtedly substantiated by our 
genome-wide transcriptome analyses. Curiously, not only Glc, but also Gal 
appears in this study as a repressing carbohydrate in S. pneumoniae. 
 
CcpA influences carbohydrate-specific pathways in carbohydrate-
dependent and independent manners 
The first step in the metabolism of any carbohydrate is transport across the 
cell membrane. Genes in 17 out of 29 operons encoding carbohydrate uptake 
systems are affected in the ccpA arrays (Table S.6.3 on the CD). As for many 
other categories, several genes encoding carbohydrate transporters were not only 
strongly repressed by CcpA on Glc, but also on Gal. ManLMN (spd_264-2) 
codifying the mannose/glucose-PTS, a predominant Glc transporter in 
Streptococcaceae (reviewed in Deutscher et al., 2006), was among them. 
Carbohydrate-specific CcpA-mediated regulation was also in effect: spd_0661, a 
Glc-family PTS system, was exclusively repressed in Gal-CDM. This gene is 
predicted to be a direct target of CcpA due to the presence of a cre site in its 
promoter region. Another PTS operon (spd_0559-0562), which also contains a 
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cre site in its promoter region, was strongly negatively regulated on Glc, but only 
mildly on Gal. Curiously, the latter PTS system has been previously postulated to 
transport Gal (Kaufman and Yother, 2007).  
A genome survey of S. pneumoniae indicates that it possesses both the 
Leloir and tagatose 6-phosphate Gal catabolic pathways. Interestingly, the Leloir 
genes were repressed by CcpA independently of the carbohydrate, whereas the 
tagatose 6-phosphate pathway was weakly repressed by CcpA on Glc and 
strongly activated on Gal (Fig. 6.3). Also of note was the observed induction of the 
tagatose 6-phosphate pathway (10- to 12-fold higher) and the Leloir genes galK 
and galT-2 (25 times higher) by Gal, regardless of CcpA (Table S.6.4 on the CD). 
As for the lac genes, other intracellular carbohydrate-specific metabolic steps 
were subjected to CcpA-mediated regulation in a carbohydrate dependent 
manner (Table S.6.1 on the CD). For example, a putative 1-pfk (spd_0772) and 
an upstream lacR were upregulated in the ccpA mutant only on Gal. 
 

























































































Fig. 6.3. Visual representation of the effect of CcpA on the transcription of genes 
involved in key basic metabolic processes. Ratio’s of genes in glycolysis, the Leloir 
and tagatose 6-phosphate pathways, and the pyruvate node, in all four conditions 
analysed in this study (Glc_M, Gal_M, Glc_TS, Gal_TS) are depicted. On top of the figure, 
a colour scale is given for the ratio of the expression in the ccpA mutant over that in the 
wild-type strain. Thus, red means repression by CcpA (upregulation in the microarray 
analysis) and green means activation by CcpA (downregulation in the microarray 
analysis). For each gene the D39 locus tag and the gene name is given on the right. No 
cut-off value was applied for the expression ratios of the genes given in the figure. Genes 
were considered significantly changed when having a Bayesian p-value and FDR meeting 
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the criteria as outlined in the Materials & Methods. Genes that did not meet these criteria 
were given a ratio of 1.0 (black colour), meaning no significant change in expression. See 
Fig. 6.6 for an overview of these pathways in S. pneumoniae D39.  
 
 
Cre site prediction in the genome of S. pneumoniae 
To discern between direct and indirect CcpA dependent effects, an in 
silico cre site prediction was performed in the genome sequence of D39 (for 
details see Materials & Methods), yielding 90 predicted cre sites that match with 
the genes differentially expressed in the ccpA DNA microarray data in at least one 
condition (Tables S.6.1, S.6.5 and S.6.6 on the CD). A consensus cre is shown in 
Fig. 6.1. A rough estimation of operons in S. pneumoniae using Genome2D 
(Baerends et al., 2004), based on sizes of intergenic regions and gene 
orientation, resulted in the division of the differentially expressed genes in 215 
transcriptional units. This means that approximately 42% of the promoters 
regulated in the arrays have a cre site and may therefore be directly regulated by 
CcpA. When considering only the genes with a cre site in their promoter region, 
68 genes (76%) have a cre site in a position that agrees with the observed 
regulation in the DNA microarray analysis (Table S.6.1 on the CD). For the 
remaining genes, either the promoter could not be predicted or regulation was 
weak and opposite when comparing the different conditions. Notably, there were 
many genes with a cre site in their promoter region that were not affected by the 
ccpA deletion (Table S.6.6 on the CD). On the other hand, the expression of 
some genes was highly changed, although a cre site was not found. This 
suggests indirect regulation of these genes, possibly by regulators that are 
influenced by CcpA. 
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CcpA is by large an activator of glycolysis and influences genes involved in 
fermentation 
The role of CcpA in controlling expression of genes involved in central 
carbon metabolism is well established (Zomer et al., 2007; Lulko et al., 2007; 
Shelburne et al., 2008b). Despite its prevalent repressor function, in 
S. pneumoniae CcpA was shown to activate several glycolytic genes (Fig. 6.3). 
The larger positive effects were observed for the key glycolytic gene pfkA 
(6-phosphofructokinase) and in ldh (lactate dehydrogenase), but activation of pyk 
(pyruvate kinase) was also considerable, which strongly suggests a predominant 
role of CcpA in assuring the efficient conversion of carbohydrates to lactate in this 
bacterium. In line, CcpA was in all instances a repressor of pfl (SPD_0420, 
pyruvate formate-lyase), which encodes a key activity that directly competes with 
lactate dehydrogenase for pyruvate, as well as of pfl-ae (SPD_1774, pyruvate 
formate-lyase activating enzyme) (Fig. 6.3 and Table S.6.1 on the CD). 
Carbohydrate-independent CcpA-dependent regulation of genes linked to the 
pyruvate node has been previously reported (Zheng et al., 2011b). Moreover, the 
genes in the pathway leading to acetate, pta (SPD_0985, phosphotransacetylase) 
and ackA, (SPD_1853, acetate kinase) were upregulated in the mutant. Curiously, 
adh (SPD_1834, alcohol dehydrogenase) was also repressed by CcpA, but only 
in Glc-containing medium. Moreover, in the parent strain D39 the expression of 
pfl, pfl-ae and adh was induced by Gal, as denoted by the decimal fold change 
ratio Glc/Gal (Table S.6.4 on the CD). Overall, the expression pattern of genes 
involved in fermentative steps (activation of ldh and repression of mixed-acid 
fermentation genes) (Fig. 6.3) strengthens the view that the pneumococcal CcpA 
promotes homolactic fermentation.  
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Loss of CcpA changes the fermentation profiles of D39 on glucose and 
galactose 
The dissimilar growth of D39 and D39∆ccpA and the resulting expression 
profiles prompted us to perform an in-depth characterization of the fermentation 
patterns on Glc and Gal.  
Substrate consumption and end-products. The pneumococcal strains were 
grown as above. Substrate consumption and concentrations of end-products are 
shown in Fig. 6.4. During growth on Glc strain D39 showed a typical homolactic 
behavior, the major end-product being lactate, which reached a concentration of 
52 ± 1 mM at the time of growth arrest (maximal biomass), accounting for 93% of 
the Glc consumed (Table 6.3); formate was also formed in minor amounts (Fig. 
6.4-A and Table 6.3). Loss of CcpA caused a shift towards a more mixed-acid 
fermentation: a 5-fold increase in the yields of formate, as well as formation of 
acetate and ethanol, were accompanied by a decrease on lactate production, 
which accounted for 85% of the Glc consumed as compared to 93% in D39 (Fig. 
6.4-B and Table 6.3). Hydrogen peroxide (H2O2), a known minor end-product of 
streptococcal aerobic metabolism, was also detected. In the wild-type, the 
maximal concentration reached was about 0.04 ± 0.002 mM, while in the mutant 
this concentration was circa 7-fold enhanced. The low concentrations measured 
most likely reflect a limitation in oxygen availability due to the nearly anaerobic 
conditions used for growth. At the time-point of growth arrest, the ccpA mutant 
had consumed 8% less Glc, and the maximal consumption rate was about 30% of 
the wild-type level (Table 6.3). The observed decrease in Glc consumption was 
paralleled by the reduction in growth rate, which was 53% lower in D39∆ccpA.  
In Gal-containing medium strain D39 displayed a mixed-acid fermentation 
pattern with lactate, formate, acetate and ethanol as end-products (Fig. 6.4-C). At 
the time of growth arrest, lactate and formate accounted each for about 50% of 
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the Gal consumed (Table 6.3). Formate, acetate and ethanol were produced in a 
2:1:1 ratio, denoting pyruvate formate-lyase activity. This pronounced shift to 
mixed-acid fermentation in strain D39 might be partially explained by alleviation of 
the CcpA-mediated repression of adh, pfl and pfl-AE during growth on Gal (Table 
S.6.1 on the CD). The molecular mechanism underlying the partial derepression 
of the mixed-acid fermentation genes by CcpA on Gal is not understood. 
Unexpectedly, in this carbohydrate, inactivation of ccpA resulted in a more 
homolactic profile: the yields of formate, acetate and ethanol decreased, whereas 
the yield of lactate increased (Fig. 6.4-D and Table 6.3). As opposed to Glc-CDM, 
on Gal the H2O2 produced was slightly higher in the wild-type (0.31 ± 0.02 mM) 
than in the ccpA mutant (0.23 ± 0.01 mM). At the time-point of maximal biomass, 
the ccpA mutant had consumed 31% of the initial Gal, 5% more than that 
consumed by D39. Loss of ccpA did not affect the maximal Gal consumption rate 
(Table 6.3).  
Growth and bioenergetic parameters. On Glc, the amount of biomass (g) 
formed per mol of substrate consumed or per mol of ATP (YATP) was higher in the 
CcpA-deficient strain. The same trend was observed for cultures growing on Gal: 
loss of ccpA resulted in higher biomass yields relative to substrate or ATP. The 
lower biomass yields in D39 indicate that, independently of the carbohydrate, 
CcpA directs the carbon source for catabolic processes. Assuming that all ATP is 
formed by substrate-level phosphorylation, the higher ATP yields in conditions 
with higher acetate production were expected (Table 6.3). However, the 
parameters biomass yield and yield on biomass relative to ATP were lower on Glc 
than on Gal for both D39 and the ccpA mutant. These data indicate that Glc is a 
poorer substrate than Gal in bioenergetic terms, as more Glc is necessary to 
produce similar amounts of pneumococcal biomass. 
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 In brief, when Glc was used as carbon source transcriptome and 
metabolic information correlated positively, but on Gal the fermentation end-
products deviated from the predictions based on transcript levels suggesting 
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Fig. 6.4. Fermentation profiles of D39 and D39ΔccpA on glucose and galactose. 
Growth curves, substrate consumption and end-products formed by the D39 (A and C) 
and D39∆ccpA (B and D) strains growing on Glc (A and B) or Gal (C and D). Culture 
supernatant samples for substrate and end-product analysis by HPLC and/or 
1
H-NMR 
were harvested for each of the conditions in the mid-exponential, transition-to-stationary 
and growth arrest (maximal biomass) time-points of the respective growth curves (bars in 
the plots). To calculate end-product concentrations, values of at least two independent 
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experiments were averaged and the error was below 7% for major products (> 2 mM) and 
25% for minor products (< 2 mM). Initial concentrations of Glc and Gal were 56 ± 1 mM 
and 57 ± 1 mM, respectively. Time-points in substrate consumption curves are averages 
of at least two independent experiments and the error is below 5%. Symbols: (), 
substrate consumption; (), growth curve; white bars, lactate; hatched bars, formate; 
black bars, acetate; stripped bars, ethanol. Growth curves as in Fig. 6.1, except that OD600 
scale (y-axis) is decimal. 
 
 
CcpA influences the intracellular levels of phosphorylated metabolites 
Inactivation of ccpA renders a strain with altered growth and fermentation 
profiles both on Glc and on Gal. In particular, the disparate substrate consumption 
rates and the fermentation end-product patterns, led us to surmise that levels of 
intracellular metabolites are also under the influence of CcpA. Intracellular 
metabolites were determined in ethanol extracts obtained as for transcriptome 
analyses (M and TS phases of growth) by targeted metabolomics using 31P-NMR 
(Fig. 6.5). In this way we were able to quantify intracellular concentrations of 
metabolites in central carbon utilization pathways (carbohydrate-specific 
pathways, glycolysis), catabolic precursors in the synthesis of surface structures 
(cell wall, capsule), and co-factors, detailed below (see Fig. 6.6 for an overview of 
the pathways). 
Glycolytic and carbohydrate-specific pathway intermediates. During growth 
on Glc the levels of the upper glycolytic metabolites glucose 6-phosphate (G6P) 
and FBP were higher in the ccpA mutant, independently of the phase of growth. 
Likewise, the lower glycolytic metabolites 3-phosphoglycerate (3-PGA) and 
phosphoenolpyruvate (PEP) accumulated to higher concentrations in strain 
D39∆ccpA. The size of the glycolytic pools showed a growth phase dependency: 
the concentrations of G6P, FBP, 3-PGA and PEP, were smaller in the TS phase. 
The decrease in the level of the lower glycolytic metabolites from M to TS phases 
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of growth was unexpected and is contrary to the accumulation profile of 3-PGA 
and PEP in other Streptococcaceae species (Iwami and Yamada, 1985; Neves et 
al., 2002a), suggesting different regulation at the level of pyruvate kinase in S. 
pneumoniae. The concentrations of the glycolytic intermediates were also lower in 
the TS phase of growth when Gal was used as sole carbon source. In contrast to 
Glc, loss of CcpA on Gal resulted in slightly lower glycolytic pool levels. 
Furthermore, D39 and D39∆ccpA cells growing on Gal accumulated tagatose 
1,6-bisphosphate (TBP), α-galactose 1-phosphate (α-Gal1P) and α-glucose 
1-phosphate (α-G1P), denoting simultaneous dissimilation of Gal via the tagatose 
6-phosphate and Leloir pathways (Figs. 6.5 and 6.6). While deletion of ccpA had 
only a moderate negative effect on the accumulation of the Leloir intermediates 
(α-Gal1P and α-G1P), the concentration of TBP was 10-fold lower in D39∆ccpA. 
This striking difference might be a direct consequence of the higher lac transcript 
levels in D39 (Tables S.6.1 and S.6.4 on the CD), since the overall Gal 
consumption flux was identical in both strains (Table 6.3). It should be noted that 
TBP and α-Gal1P are not detected during growth on Glc, whereas α-G1P, which 
is also the key precursor of structural polysaccharides (e.g. capsule, teichoic 
acids) accumulated exclusively in the ccpA mutant.  
NDP-activated intermediates in the synthesis of surface structures. NDP-
activated intermediates are soluble precursors in the synthesis of several cell 
surface structures of utmost importance for virulence and pathogenesis (reviewed 
in Mitchell, 2003; Kadioglu et al., 2008). During growth on Glc, UDP-glucose, a 
precursor in the biosynthesis of the serotype 2 capsule and other structural 
polysaccharides, showed growth-dependent accumulation in both strains, but the 
reduction from M to TS was more pronounced in the ccpA mutant. Furthermore, 
the accumulation profile of the soluble cell wall precursor UDP-N-
acetylglucosamine was not changed due to inactivation of ccpA, whereas the 
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concentration of UDP-N-acetylmuramoyl-pentapeptide was higher in D39∆ccpA. 
Curiously, on Gal the soluble cell wall components were below detection limits (< 
0.5 mM), except for UDP-N-acetylglucosamine, which accumulated in 
S. pneumoniae D39 in MS growth. Accumulation of CDP-choline, the 
phosphorylcholine donor in the synthesis of teichoic acids, was higher in the ccpA 
mutant, decreasing in both strains from M to TS phases during growth on Glc. 
The growth dependent behavior was also observed on Gal, but in this 
carbohydrate the levels of CDP-choline were approximately the same in D39 and 
D39∆ccpA.  
 



















































































Fig. 6.5. Effect of ccpA deletion on intracellular concentrations of phosphorylated 
metabolites during growth on glucose or galactose.  Phosphorylated metabolites were 
measured by 
31
P-NMR in ethanol extracts of S. pneumoniae D39 and ΔccpA strains 
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grown to mid-exponential (M, white bars, OD600 of 0.35 ± 0.02) or transition-to-stationary 
phases (TS, black bars, OD600 of 1.3 ± 0.1) of growth in CDM supplemented with 56 ± 1 
mM Glc (white background) or 57 ± 1 mM Gal (light grey background). Phosphorylated 
metabolites measured in extracts comprised glycolytic metabolites, phosphorylated 
carbohydrate-specific metabolites, UDP-activated metabolites, and co-factors. The values 
are the mean of three independent experiments ± SD.  
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 Fig. 6.5. continued  
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Fig. 6.5 continued  
 
Concentrations of metabolic cofactors. CcpA-defective cells growing on Glc 
accumulated slightly higher amounts of NAD+, identical levels of CTP and ADP, 
and circa 2-fold higher amounts of ATP in MS growth (Fig. 6.5). In the TS phase 
of growth, NAD+ and ATP were not significantly affected, ADP was slightly lower, 
and CTP was about half the concentration in the ccpA mutant. When Gal was 
used as substrate, the accumulated levels of NAD+, CTP, ATP and ADP were 
lower in the ccpA mutant both in M and TS phases of growth.  
The metabolite profiles herein presented clearly support the operation of 
two routes for Gal catabolism and suggest a unique mechanism underlying the 
regulation of glycolysis in S. pneumoniae. CcpA influences the level of key 
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phosphorylated metabolites (glycolytic metabolites, co-factors, etc.) potentially 
involved in metabolic regulation. These findings extend beyond transcriptional 
regulation the role of CcpA in controlling cellular network properties. Furthermore, 
CcpA-dependent changes in cell wall and capsule UDP-activated precursors 
indicates a role of CcpA in the modulation of cell surface properties, known to be 
critical in virulence and pathogenesis.  
 
CcpA inactivation loosens capsule attachment to the cell wall  
It has previously been reported that CcpA-deficient mutants show 
attenuated virulence, and this behavior was associated with lower expression of 
genes committed to the synthesis of the pneumococcal capsule (Giammarinaro 
and Paton, 2002). Our metabolome data showed significant differences in the 
pools of the capsule cytoplasmic precursors UDP-glucose and α-G1P. Therefore, 
we deemed it important to measure the amounts of capsule produced in D39 and 























































































































Fig. 6.6. Schematic representation of central metabolic pathways in S. pneumoniae 
D39. Glc is oxidized to pyruvate via the Embden-Meyerhof-Parnas pathway (Glycolysis, 
orange box). Homolactic fermentation reduces pyruvate into lactate, whereas mixed-acid 
fermentation leads to other products, such as formate, acetate and ethanol (Pyruvate 
metabolism, yellow box). Gal is converted to G6P by the Leloir pathway (light pink box) 
and to dihydroxyacetone phosphate (DHAP) or glyceraldehyde 3-phosphate (GAP) by the 
tagatose 6-phosphate pathway (light orange box). Pathways for capsule, peptidoglycan 
and phosphorylcholine biosynthesis are shown in light blue, light purple and light green 
boxes, respectively. Putative and functional characterized genes encoding depicted 
metabolic steps are shown in white boxes. Proposed pathways were reconstructed based 
on genome information (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi), literature and 
database surveys (KEGG, MetaCyc). Gene annotation downloaded from NCBI: galM, 
aldose 1-epimerase; galK, galactokinase; galE-1, UDP-glucose 4-epimerase; galT-2, 
galactose 1-phosphate uridylyltransferase; pgm, α-phosphoglucomutase; galU, glucose 1-
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phosphate uridylyltransferase; cps2L, glucose 1-phosphate thymidylyltransferase; cps2K, 
UDP-glucose 6-dehydrogenase, putative; rmlC, dTDP-4-keto-6-deoxy-D-glucose 3,5-
epimerase Cps2M; rmlB, dTDP-glc 4,6-dehydratase Cps2N; rmlD, dTDP-4-keto-L-
rhamnose reductase Cps2O; gki, glucokinase; pgi, glucose 6-phosphate isomerase; pfkA, 
6-phosphofructokinase; fba, fructose bisphosphate aldolase; tpiA, triosephosphate 
isomerase; gap, glyceraldehyde-3-phosphate dehydrogenase; pgk, phosphoglycerate 
kinase; gpmA, phosphoglyceromutase; eno, enolase; pyk, pyruvate kinase; lacA, 
galactose 6-phosphate isomerase subunit LacA; lacB, galactose 6-phosphate isomerase 
subunit LacB; lacC, tagatose 6-phosphate kinase; lacD, tagatose 1,6-diphosphate 
aldolase; ldh, L-lactate dehydrogenase; lctO, lactate oxidase; spxB, pyruvate oxidase; 
ackA, acetate kinase; pta, phosphotransacetylase; pfl, pyruvate formate-lyase; adh 
(spd_1834), bifunctional acetaldehyde-CoA/alcohol dehydrogenase; glmS, D-fructose 6-
phosphate amidotransferase; glmU, UDP-N-acetylglucosamine pyrophosphorylase; murA-
1 and murA-2, UDP-N-acetylglucosamine 1-carboxyvinyltransferase; murB, UDP-N-
acetylenolpyruvoylglucosamine reductase; murC, UDP-N-acetylmuramate-L-alanine 
ligase; murD, UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase; murE, UDP-N-
acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase; murF, UDP-N-
acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate--D-alanyl-D-alanyl ligase; tarJ 
(spd_1126), alcohol dehydrogenase, zinc-containing or TarJ; tarI (spd_1127), 2-C-methyl-
D-erythritol 4-phosphate cytidylyltransferase or TarI; licB, protein LicB; pck, choline kinase 
or LicA; licC, CTP:phosphocholine cytidylyltransferase; licD1, phosphotransferase LicD1; 
licD2, phosphotransferase LicD2. 
 
 
Curiously, inactivation of ccpA did not affect the total amount of capsule either on 
Glc- or Gal-CDM. However, in Gal-containing medium the amount of capsule 
produced was higher for both strains. Furthermore, a major difference in Gal-CDM 
was the amount of loose capsule (not attached to the cell wall), which accounted 
for about 94% of the total polysaccharide in D39∆ccpA (Fig. 6.7). In the parent 
strain, only a small fraction (~13%) of loose capsule was detected, exclusively in 
the TS phase of growth. Although the role of CcpA in the regulation of capsule 
production was not confirmed, our data show a function of CcpA in the 







































Fig. 6.7. Amount of capsule polysaccharide in D39 and its isogenic ccpA mutant. 
Estimation of capsule was performed based on the determination of its glucuronic acid 
content in strains D39 and D39∆ccpA in mid-exponential (white bars, OD600 of 0.35 ± 
0.02) and transition-to-stationary (black bars, OD600 of 1.3 ± 0.1) cultures grown in CDM 
containing 56 ± 1 mM Glc (white background) or 57 ± 1 mM Gal (light grey background). 
Hatched bars indicate loose capsule polysaccharide. All the determinations were done 
twice in two independent cultures and the values are means ± SD. 
 
 
CcpA affects the expression of many virulence genes  
To further identify links between CcpA and virulence we compared all genes 
that have been linked to the virulence of this pathogen with our list of genes 
influenced by deletion of ccpA (Table S.6.7 on the CD). In addition, the ccpA 
microarray data were compared to the list of genes identified in the STM screen 
performed by Hava and Camilli, 2002. Virulence genes affected by CcpA included 
classical virulence factors as well as many genes involved in amino acid and 
carbohydrate metabolism, transcriptional regulators, and genes with unknown 
function (Table S.6.7 on the CD). Of the classical virulence factors, the Mn2+-
dependent superoxide dismutase gene sodA, involved in virulence and protection 
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against oxidative stress (Yesilkaya et al., 2000), was upregulated in the ccpA 
mutant, which fits well with higher H2O2 concentrations observed in this strain. 
Interestingly, two of the three neuraminidase genes, namely nanA and nanB, 
which have been extensively studied regarding their important role in 
pneumococcal virulence (King, 2010), were strongly upregulated in the ccpA 
mutant in all four conditions as well. Recently, NanA had been shown to, in 
conjunction with BgaA and StrH, two other exoglycosidases, protect S. 
pneumoniae from phagocytic killing through prevention of complement deposition 
(Dalia et al., 2010). StrH was affected only slightly in Glc_TS and Gal_TS, but 
bgaA was, like nanA and nanB, upregulated in the ccpA mutant in all four 
conditions, most strongly on Glc; importantly, bgaA was repressed in Glc 
compared to Gal (Table S.6.4 on the CD) only in the wild-type, which further 
supports its role in nasopharyngeal colonization. All these three genes, as well as 
nanB, might be directly affected by CcpA, since there is a predicted cre site in 
their upstream region or in the upstream region of a gene with which they seem to 
be co-regulated in the array analyses. Of a total of 79 virulence genes of which 
transcription is affected in the ccpA mutant, 35 are possibly regulated directly by 
CcpA (Table S.6.7 on the CD). The pcpA gene, implicated in colonization/infection 
of the airways (Johnston et al., 2006), showed Glc-dependent CcpA-mediated 
repression in D39. The pcpA gene is also regulated depending on the 
extracellular concentration of Mn2+ and Zn2+ through the action of PsaR 
(Kloosterman et al., 2008), and activated by the nutritional regulator CodY 
(Hendriksen et al., 2008). It therefore seems to be regulated in a complex way in 
response to various different environmental stimuli. Interestingly, genes involved 
in choline metabolism, namely the tarIJlicABC (lic1) operon, were upregulated in 
the ccpA mutant especially in Glc_TS. In agreement, the levels of CDP-choline 
were higher in the ccpA mutant (Fig. 6.5). Together the data suggest that ccpA 
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could affect the level of choline in the pneumococcal cell wall and as a result the 
decoration of the pneumococcal cell wall with choline-binding proteins, a class of 
virulence factors. An interesting observation, which might be associated with 
virulence, was the strong activation by CcpA of two genes involved in cell wall 
synthesis (glmS and murF) only during growth on Glc. Moreover, the increased 
transcript level of glmS and murF in D39 on Glc might correlate with the high 
demand for synthesis of biomass as denoted by the high growth rate in this 
condition. Of the transcriptional regulators identified as virulence genes, comDE 
was downregulated on Glc, whereas TCS07 was upregulated in all conditions, 
which suggests that their regulons and their respective stimuli are connected to 
that of CcpA. 
With a few exceptions, CcpA acts as a repressor of virulence gene 
expression in S. pneumoniae. Based on our data it is reasonable to assume that 
CcpA is one of the factors controlling the interaction of S. pneumoniae with its 
host during colonization and infection of the airways through regulation of the 




It is well established that bacteria adapt to fluctuating environments by 
altering expression of genes involved in basic metabolic processes. In the 
Firmicutes, the pleiotropic transcriptional regulator CcpA is recognized as a key 
player in carbon catabolite control, i.e. the regulatory phenomena that allow 
bacteria to selectively use substrates for growth (for reviews see Deutscher et al., 
2006; Görke and Stülke, 2008). Importantly, in the last decade an increasing 
number of studies have exposed the role of CcpA in the regulation of virulence in 
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Gram-positive pathogens (Giammarinaro and Paton, 2002; Iyer et al., 2005; Seidl 
et al., 2006; Abranches et al., 2008; Shelburne et al., 2010; Chiang et al., 2011). 
In the human pathogen S. pneumoniae, regulation of carbohydrate-specific 
catabolic pathways as well as modulation of virulence factors by CcpA has been 
reported (Giammarinaro and Paton, 2002; Iyer et al., 2005; Kaufman and Yother, 
2007). However, a comprehensive study of the role of CcpA in the physiology of 
S. pneumoniae was not undertaken so far. In a recent study, ccpA was found to 
interact with 64 other genes by Tn-seq transposon mutagenesis; based on the 
high number of genetic interactions these authors suggested that CcpA appears 
to be a master regulator in S. pneumoniae (van Opijnen et al., 2009). In this work, 
we used genome-wide transcriptome analyses and metabolite profiling to study in 
depth the impact of CcpA on pneumococcal metabolism and virulence. Our data 
show that beyond controlling carbohydrate transport and metabolic genes, CcpA 
is involved in various other cellular processes, including traits connected to 
virulence and pathogenesis (Fig. 6.8). Therefore, the role of CcpA as a master 
regulator in S. pneumoniae is undoubtedly demonstrated by the results in this 
study. 
The CcpA regulon was substantial on Glc, the “preferred” carbohydrate of 
many Firmicutes, which supports high pneumococcal growth rate (Fig. 6.4), but 
remarkably this was also the case in the slowly metabolized Gal, a carbohydrate 
generally recognized as non-repressing. In B. subtilis, besides Glc several other 
PTS-transported carbohydrates are capable of eliciting CcpA-mediated catabolite 
repression (Singh et al., 2008). In S. mutans, the transport of Gal is exclusively 
mediated via PTS systems (Zeng et al., 2010), but curiously the CcpA regulon on 
Gal was markedly smaller than on Glc (Abranches et al., 2008), which is in 
contrast to our observations in S. pneumoniae. Also noticeable is the pronounced 
difference in the amount of genes influenced by CcpA in S. mutans (up to 9%) 
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and S. pneumoniae (up to 19%), which despite their genetic relatedness 
apparently have evolved distinct regulatory networks. In S. mutants, catabolite 
repression can be independent of CcpA and requires specific components of 
carbohydrate-PTS permeases (Zeng and Burne, 2010). A reasonable explanation 
lies in the nutritional diversity encountered by the two streptococci in their 
respective ecological niches. 
 
>300 genes altered in Glc
~300 genes altered in Gal
Altered metabolite 
profiles
Optimization of basic 
metabolic processes




































Fig. 6.8. Model for CcpA regulation of basic metabolic processes and virulence 
factor expression in the presence of glucose or galactose in S. pneumoniae. 
Transport of carbohydrates through the multi-protein phosphoenolpyruvate: carbohydrate 
phosphotransferase system (PTS) ensures a typical PTS-mediated signal transduction 
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pathway for CcpA regulation. CcpA-mediated regulation results in altered expression of 
genes involved in carbohydrate metabolism and classical virulence factors, including cell 
wall associated proteins, transcriptional regulators and phosphorylcholine. Repression 
and activation are represented by red and green arrows, respectively. Dashed lines 
indicate metabolic regulation. G6P, Glucose 6-phosphate; F6P, fructose 6-phosphate; 
CW, cell wall; MA, mixed-acid fermentation; PcpA, choline-binding protein PcpA; BgaA, 
beta-galactosidase A; NanAB, neuraminidases A and B; PCho, phosphorylcholine; SodA, 
superoxide dismutase, manganese-dependent; StrH, β-N-acetylhexosaminidase; TCS07 
and ComDE, two-component systems. 
  
 
In this study, CcpA ensures fast growth on Glc, but not on Gal, as the growth rate 
on the latter carbohydrate is basically independent of this pleiotropic regulator. In 
S. pneumoniae the routes for Gal catabolism have not been biochemically 
characterized, but complete Leloir and tagatose 6-phosphate pathways can be 
deduced from pneumococcal genome sequence data 
(http://www.ncbi.nlm.nih.gov/genome/lproks.cgi). We propose that both pathways 
are operative during growth on Gal. The presence of the intermediates α-Gal1P 
(Leloir) and TBP (tagatose 6-phosphate), as well as the elevated expression 
levels of the genes galM, galKT-2 (Leloir), and lacABCD (tagatose 6-phosphate), 
fully support this claim. Interestingly, lacFE are also induced by Gal, suggesting a 
role of the pneumococcal lactose-PTS in Gal uptake as reported for S. mutans 
and L. lactis (Zeng and Burne, 2010; Neves et al., 2010). The uptake of Gal via a 
PTS system would ensure a typical PTS-mediated signal transduction pathway for 
CcpA regulation and is in agreement with the large CcpA regulon determined 
during growth on Gal. On this carbohydrate, CcpA regulation seems to comply 
with the essence of catabolite control, which is to coordinate metabolic operation 
ensuring a maximum profit for growth. Activation by CcpA of the PTS-dependent 
route (tagatose 6-phosphate pathway) for Gal degradation, while repressing the 
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Leloir genes, is in agreement with that principle. Furthermore, activation of the 
glycolytic genes pfk and pyk, and ldh indicate that CcpA’s role is to enable 
maximal Gal catabolism. In light of our results, an answer to the question as to 
why substrate consumption and growth rates on Gal are not stimulated by CcpA 
is difficult to put forward. Of note in Gal-grown D39 cells, is the elevated 
concentration of TBP (10-fold higher than in D39∆ccpA), which might be toxic for 
the cells. Indeed, unrestricted accumulation of phosphorylated metabolites has 
previously been evoked to explain negative effects on growth rate (Thevelein and 
Hohmann, 1995; Andersen et al., 2001). Also surprising was the pronounced shift 
to mixed-acid fermentation in strain D39, since CcpA represses genes involved in 
that type of metabolism. However, Gal-induced alleviation of the CcpA-mediated 
repression might partially explain the observed behavior (Table S.6.1 on the CD). 
Indeed, higher expression of pfl and pfl-ae allow a more efficient competition with 
lactate dehydrogenase for the common substrate pyruvate, consequently 
increasing the flux to mixed-acid products, including acetate. Production of this 
organic acid is accompanied by ATP formation, which is certainly an advantage 
during the fermentation of Gal, as the glycolytic ATP generation is limited by the 
substrate consumption rate (three times lower than that of Glc). Shifts to mixed-
acid fermentation as a means to counteract for ATP production during growth on 
slowly metabolized carbon sources or limiting carbohydrate concentrations 
carbohydrates are well documented in Streptococacceae (Yamada and Carlsson, 
1975b; Garrigues et al., 1997). In view of the data it is reasonable to assume that 
Gal-dependent regulatory mechanisms at the translational, post-translational 
and/or metabolic levels overlay the transcriptional direct control by CcpA. A good 
example is the Gal-dependent activation of the Leloir pathway, which genes are in 
all instances under CcpA repression. The lack of correlation between phenotypic 
behaviors and changes in transcription levels is not unprecedented (Griffin et al., 
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2002; Daran-Lapujade et al., 2007) and most likely derives from the feedback 
regulation of metabolism on all regulatory layers (Heinemann and Sauer, 2010).  
In this work we show that CcpA is crucial in the control of central 
physiological processes in S. pneumoniae, and thus most likely influences the 
ability to persist and proliferate in the host. Considering our data showing Glc- and 
Gal-dependent regulation it is tempting to hypothesize that in the specific host 
microenvironments basic metabolic processes are tuned by CcpA to maximize 
cellular profit (Fig. 6.8). In this light, the attenuated virulence shown by ccpA 
mutants in mouse models of pneumococcal colonization and infection 
(Giammarinaro and Paton, 2002; Iyer et al., 2005) can plausibly be attributed to 
decreased fitness. However, this hypothesis might not depict the full picture, as 
we discovered that CcpA directly or indirectly influences the transcript level of a 
number of canonical virulence factors (Fig. 6.8). It is interesting to note that 
among the influenced genes several encode moonlighting proteins, with roles in 
host-pathogen interaction and basic metabolic processes. A good example is 
provided by BgaA, an exoglycosidase involved in adherence to epithelial cells 
(King, 2010), and recently found to be important in basal growth (van Opijnen et 
al., 2009), which is repressed by CcpA as determined by us and others (Iyer et 
al., 2005; Kaufman and Yother, 2007). Such findings certainly reinforce the subtle 
link between basic physiology and virulence in S. pneumoniae.   
Involvement of CcpA in the control of classical virulence factors is a 
recurrent observation in Streptococcaceae (Giammarinaro and Paton, 2002; Iyer 
et al., 2005; Abranches et al., 2008; Shelburne et al., 2008b; van Opijnen et al., 
2009). In a previous report, significant repression of the capsular polysaccharide 
biosynthesis locus (cps) was observed in a pneumococcal ccpA mutant 
(Giammarinaro and Paton, 2002). Except for a negligible effect on rfbCBD genes 
in the transition-to-stationary phase of Glc-grown cells, we have not found 
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significantly differentially expressed cps genes in any other tested conditions. 
Furthermore, the amount of capsule produced was not influenced by CcpA (Fig. 
6.7). Accordingly, Camilli and co-workers did not observe a connection between 
CcpA and cps expression (Iyer et al., 2005; van Opijnen et al., 2009). Our data 
unequivocally show that the production of capsule is influenced by the carbon 
source, since the amount of polysaccharide was doubled in Gal-grown cells in a 
CcpA-independent manner. In view that Gal is a prevailing carbohydrate in 
nasopharyngeal secretions (Yesilkaya et al., 2009 on the CD; King, 2010), this 
finding is relevant in terms of host-pathogen interactions, since a relatively thick 
capsule is essential to evade the immune system, and thus, for the 
pneumococcus to persist in the host (Magee and Yother, 2001). Curiously, on this 
carbohydrate the attachment of the capsular polysaccharide to the pneumococcal 
cell wall was substantially altered in the presence of CcpA.  
Our transcriptome analyses revealed that genes involved in the synthesis of 
phosphorylcholine are under the control of CcpA. At the metabolic level, the lower 
concentration of CDP-choline (activated choline precursor) is in full agreement 
with the transcript levels of the biosynthetic genes. The tight control exerted by 
CcpA on the availability of CDP-choline might provide a means to influence the 
association of capsule, proteins and other molecules to the cell wall. Indeed, 
binding of macromolecules to the cell wall is conditioned by the decoration of the 
wall polysaccharides (teichoic acids and lipoteichoic acids) (Neuhaus and 
Baddiley, 2003; Bergmann and Hammerschmidt, 2006), which in S. pneumoniae 
contain residues of phosphorylcholine (Bergmann and Hammerschmidt, 2006). 
Using proteomics others have shown that loss of ccpA caused changes in the 
amounts of several cell wall-associated proteins (Iyer et al., 2005). A good 
correlation between our expression data and the wall fraction protein levels was 
observed for some proteins (Iyer et al., 2005), but for other proteins no significant 
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regulation at the transcriptional level was detected. Although we cannot rule out 
the possibility that this is due to interspecies variation or translational and post-
translation regulation, in light of our results it is reasonable to speculate that, 
rather than altering the protein level, CcpA is somehow affecting the tethering of 
the proteins to the cell wall, as we showed for capsule attachment. CcpA-
dependent effects on the levels of several NDP-activated precursors of wall 
polysaccharides (Fig. 6.5) further strengthen the role of CcpA in shaping the cell 
wall decoration. This unforeseen function of CcpA might be crucial in the host-
pneumococcal interaction, which is heavily dependent on cell wall 
phosphorylcholine and associated proteins (reviewed in Kadioglu et al., 2008). 
Future studies on cell-surface proteome should be performed to address this 
issue in more detail. 
Of the promoters differentially regulated in the ccpA mutant circa 42% are 
presumably subject to direct regulation by CcpA, as denoted by the presence of a 
cre sequence. This value is in good agreement with the 38% previously 
determined using the Tn-seq method to evaluate genetic interactions (van opijnen 
et al., 2009). Still, a large percentage of the regulated promoters lack a canonical 
cre site. CcpA influenced the transcript level of 22 other transcriptional regulators, 
and thereby indirectly affects genes that are under the control of these regulators. 
Interestingly, we found that CcpA-responsive genes are also part of other 
regulatory networks. About 15 genes, mainly involved in amino acid and 
carbohydrate metabolism, but also the virulence gene pcpA, are commonly 
regulated by the nutritional regulator CodY and CcpA (Hendriksen et al., 2008). 
Additionally, CcpA was found to share many gene targets with two-component 
systems regulatory networks, including those of CiaRH (Halfmann et al., 2007), 
TCS04 (McCluskey et al., 2004), TCS06 (Standish et al., 2007), TCS08 
(McKessar and Hakenbeck, 2007), and TCS09 (Hendriksen et al., 2007). Recent 
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studies in S. pyogenes have highlighted the importance of a combination of 
independent transcriptional regulators to coordinate gene expression during 
infection (Shelburne et al., 2010; Kietzman and Caparon, 2010). In this light, our 
data opens new avenues to explore how S. pneumoniae virulence is shaped by 
co-regulation of independent transcriptional regulators.   
Factors controlling the interaction between pathogens and their host are of 
utmost importance for in vivo fitness and persistence in adverse host niches. 
Previously, the role of the transcriptional regulator CcpA in the physiology of the 
pneumococcus has been underappreciated. In this work we resorted to a 
combined transcriptome and metabolite profiling approach to demonstrate that 
CcpA is a master regulator involved in varied cellular processes in S. 
pneumoniae. We have ascertained that S. pneumoniae optimizes basic metabolic 
processes, modulates expression of virulence factors and most likely tunes 
association of macromolecules with the cell wall in a CcpA-mediated manner. The 
observed carbohydrate-dependency of the CcpA regulatory network indicates a 
key role in adjusting to specific nutritional cues within host niches. Exploring the 
unveiled links between CcpA and other regulators will certainly contribute to an 
improved understanding on the ability of S. pneumoniae to colonize and cause 
disease. The insights gained thus far from this comprehensive analysis foresee 
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In 1928 Alexander Fleming discovered the world’s first antibiotic, penicillin. 
Since then, several other natural antibiotics were isolated and broad-spectrum 
semi-synthetic antibiotics were produced. Antibiotics have saved millions of lives 
since the groundbreaking discovery of penicillin. However, their inappropriate use 
combined with the natural capacity of microorganisms to take up foreign DNA has 
dramatically increased the number of antibiotic resistant pathogens. S. 
pneumoniae, a common asymptomatic commensal of the nasopharynx, is among 
those microorganisms. In young children, the elderly and immune-compromised 
people the pneumococcus is a leading cause of bacterial meningitis, pneumonia, 
septicemia, and otitis media. With widespread antibiotic resistance and re-
emergence of non-type vaccine strains, it is urgent to find new targets for the 
development of novel therapeutic and preventive drugs. One such opportunity is 
offered by the recent findings that link pathogenesis to carbohydrate metabolism. 
The work presented in this thesis contributes to the understanding of basic 
metabolic processes, in particular, sugar metabolism and its role in pneumococcal 
virulence.  
 
Glucose and galactose as carbon sources for growth of 
S. pneumoniae 
Glucose is the preferred carbon source of many Gram-positive 
microorganisms. A recent study showed that Glc, among thirty two carbohydrate 
sources, was the one supporting fastest growth of strain DP1004, a rough 
derivative of strain D39 (Bidossi et al., 2012). Even though competition assays 
were not performed, the data point out Glc as the preferred sugar of 
S. pneumoniae. In the human host, Glc is present in the blood and in the inflamed 
lungs of hyperglycemic individuals, but is scarce in the nasopharyngeal milieu 
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(Philips et al., 2003; Shelburne et al., 2008a). In this light, it is tempting to suggest 
that during infection, an increased availability of Glc would enable fast growth of 
S. pneumoniae leading to exacerbated disease. 
Galactose is generally slowly metabolized by bacteria (reviewed in 
Deutscher et al., 2006). In our and other studies the use of Gal as single carbon 
source reduced the growth rate of S. pneumoniae by at least 50% of that 
observed on Glc (Chapter 6) (Bidossi et al., 2012). Despite being a slowly 
metabolized carbohydrate, biomass and energetic yields on Gal are similar (or 
higher) to those registered on Glc (Chapter 6) (Bidossi et al., 2012). In this 
respect, Gal appears as a good carbon source to support avirulent colonization. 
Interestingly, Gal is one of the most abundant carbohydrates released during the 
deglycosylation of human mucins by pneumococcal exoglycosidases (King et al., 
2006). Mucins are heavily glycosylated proteins found in the mucus coating the 
surface of epithelial cells that line the cavities of the body, including the 
nasopharynx, which is the colonization niche of S. pneumoniae (Rose and 
Voynow, 2006; Yesilkaya et al., 2008; Shelburne et al., 2008a). 
S. pneumoniae possesses the genes encoding the specific steps of the 
metabolic routes generally used for Gal catabolism in other Streptococcaceae, i. 
e. the Leloir and the tagatose 6-phosphate pathways (Thomas et al., 1980; 
Abranches et al., 2004; Neves et al., 2010). In this work we have not performed a 
detailed biochemical characterization of the pathways, but our findings provide 
strong evidence for the simultaneous operation of both pathways during growth of 
S. pneumoniae on Gal (Chapter 6). Indeed, the presence of the intermediates 
α-Gal1P of the Leloir pathway and TBP of the tagatose 6-phosphate pathway, as 
well as the elevated expression levels of the genes galM, galK, galT-2 (Leloir 
pathway) and lacABCD (tagatose 6-phosphate pathway) on Gal fully corroborate 
this view (Fig. 7.1) (Chapter 6). Moreover, the accumulation of TBP during Gal 
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metabolism clearly indicates the existence of Gal-PTS transporters in S. 
pneumoniae. This observation is in good agreement with other studies supporting 
the involvement of PTS systems in the uptake of Gal by S. pneumoniae (Kaufman 
and Yother, 2007; Bidossi et al., 2012). Even though the simultaneous operation 
of both pathways for Gal dissimilation represents an additional energetic cost, this 
behavior is not unique for S. pneumoniae. In other Streptococcaceae, the 
occurrence and use of the Leloir and/or the tagatose 6-phosphate pathway for 
galactose utilization is strain-dependent. For instance, in S. mutans UA159 both 
pathways are required for efficient galactose utilization (Abranches et al., 2004). 
Generally laboratorial L. lactis strains harbor the Leloir pathway, whereas dairy 
isolates possess and express both (Neves et al., 2010). Interestingly, the relative 
efficacy of each pathway in the degradation of the sugar has yet to be 
established.    
In S. pneumoniae, the metabolism of Glc is typically homofermentative, 
yielding lactate as major end-product; additionally, minor amounts of formate were 
also detected (Fig. 7.1). On the other hand, the metabolism of Gal was shifted 
towards mixed-acid fermentation with lactate, formate, acetate and ethanol as 
end-products (Fig. 7.1). The production of mixed-acid end-products on Gal is a 
behavior displayed by many Streptococcaceae (Steele et al., 1954; Pierce, 1957; 
Thomas et al., 1980; Abranches et al., 2004; Neves et al., 2010). The metabolic 
shift occurs due to higher flux through pyruvate formate-lyase (PFL) when Gal is 
used as carbon source (Fig. 7.1). PFL is activated post-translationally via a PFL-
activating enzyme (PFL-AE) (Melchiorsen et al., 2000; Buis and Broderick, 2005). 
The genome of S. pneumoniae possesses two copies of pfl (spd_0420 and 
spd_0235) and pfl-ae (spd_1774 and spd_0229) (Tettelin et al., 2001; Hoskins et 
al., 2001; Lanie et al., 2007). In this work, we assigned spd_0420 and spd_1774 
as coding for the functional pyruvate formate-lyase (PFL) and pyruvate formate-
Chapter 7 
 266 
lyase activating enzyme (PFL-AE) in S. pneumoniae, respectively; mutants of 
these genes were not able to produce formate, acetate and ethanol (Chapter 5). 
Gene duplication has long been considered to play a major role in evolution. 
Duplication of pfl and pfl-ae is not exclusive of S. pneumoniae. In the genome of 
S. mutans UA159 and S. pyogenes MGAS5005, two copies of each pfl and pfl-ae 
are also present (Ajdic et al., 2002; Sumby et al., 2005). Interestingly, the 
alignment of the amino acid sequences of the paralogous proteins in each strain 
indicated low number of identical residues (alignments performed with ClustalW, 
data not shown). This might explain why SPD_0235 and SPD_0229, the 
SPD_0420 and SPD_1774 paralogs, respectively, lost the function of PFL and 
PFL-AE. It is worth noting that the functional pneumococcal PFL and PFL-AE 
share high homology with a single copy of these genes in the other streptococci, 
whereas SPD_0235 and SPD_0229 share homology with the other copy. This 
might indicate that the gene duplication event preceded speciation.   
Inactivation of the non-functional PFL and PFL-AE copies in S. 
pneumoniae did not produce a clear phenotype under the conditions studied 
(Chapter 5) (Yesilkaya et al., 2009 on the CD). This genetic flexibility may allow 
for the arousal of new mutations leading to increased fitness of bacteria, or even 
potentiate the appearance of new functions. The regulatory programs involved in 
the evolution of paralogous proteins and their role in the evolutionary innovation at 
the biochemical level currently receive considerable attention (Martínez-Núñez et 
al., 2010).  
 
 




Fig. 7.1. Schematic representation of carbon catabolite control by CcpA during 
growth on glucose and galactose by S. pneumoniae D39. The levels of end-products 
(in µmol mg dw
-1
) can be appreciated from the bar sizes: (), lactate; (), formate; (), 
acetate; (), ethanol. Green solid arrows: overexpression of the genes on Gal as 
compared to Glc; Red solid arrows: underexpression of the genes on Glc as compared to 
Gal. Green dashed arrows: activation by CcpA; Dark green dotted dashed arrows: 
alleviation of activation by CcpA on Gal as compared to Glc; Red dashed arrows, 
repression by CcpA; Dark red dotted arrows: alleviation of repression by CcpA in Gal as 
compared to Glc; The cre site position in promoter region of genes or operons encoding 
for activities downstream of pyruvate is coherent with the type of regulation. The 
intracellular reactions depicted are catalyzed by the following enzymes (the genes that 
code for the enzymes are shown in parenthesis): glucokinase (gki), phosphoglucose 
isomerase (pgi), 6-phosphofructokinase (pfkA), fructose 1,6-bisphosphate aldolase (fba), 
triosephosphate isomerase (tpiA), glyceraldehyde 3-phosphate dehydrogenase (gap), 
phosphoglycerate kinase (pgk), phosphoglyceromutase (gpmA), enolase (eno), pyruvate 





























































































kinase (pyk), galactose 6-phosphate isomerase (lacAB), tagatose 6-phosphate kinase 
(lacC), tagatose 1,6-bisphosphate aldolase (lacD), galactose mutarotase (galM), 
galactokinase (galK), galactose 1-phosphate uridylyltransferase (galT), UDP-galactose 4-
epimerase (galE), α-phosphoglucomutase (pgm); pyruvate oxidase (spxB); pyruvate 
formate-lyase (pfl); bifunctional acetaldehyde-CoA/alcohol dehydrogenase (adh); 
phosphotransacetylase (pta); acetate kinase (ackA); L-lactate dehydrogenase (ldh); 
lactate oxidase (lcto). Abbreviations: Glc, glucose; G6P, glucose 6-phosphate; F6P, 
fructose 6-phosphate; FBP, fructose 1,6-bisphosphate; GAP, glyceraldehyde 3-
phosphate; DHAP, dihydroxyacetone phosphate; 3-PGA, 3-phosphoglycerate; PEP, 
phosphoenolpyruvate; Gal, galactose; Gal6P, galactose 6-phosphate; Gal1P, galactose 1-
phosphate; Tag6P, tagatose 6-phosphate; TBP, tagatose 1,6-bisphosphate; α-G1P, α-
glucose 1-phosphate.  
 
 
Regulation of glucose and galactose metabolism in S. 
pneumoniae 
It is well established that the catabolism of Gal in members of the 
Streptococcaceae originates a mixed-acid end-product profile (Chapters 5 and 6)  
(Steele et al., 1954; Pierce, 1957; Thomas et al., 1980; Abranches et al., 2004; 
Neves et al., 2010). However, the relative amount of products varies between 
species and even strains within the same species, probably due to disparate 
allosteric and transcriptional control exerted over the enzymes in glycolysis and 
downstream of pyruvate (Thomas et al., 1980; Yamada et al., 1985; Yamada and 
Carlsson, 1975a; Garrigues et al., 1997; Asanuma et al., 2004; Abranches et al., 
2008; Lopez de Felipe and Gaudu, 2009). The role of the global regulator of gene 
expression CcpA in the fermentation type displayed by S. pneumoniae on Glc and 
Gal will be discussed in the present section.  
   In S. pneumoniae, during growth on Glc CcpA favors homolactic 
fermentation as evidenced from our transcriptomic, cre site prediction and 
metabolic data. Indeed, on Glc CcpA represses the genes implicated in mixed-
Overview and concluding remarks 
 269 
acid fermentation (pfl, pta, ackA and adh) and activates ldh, thus promoting 
homolactic fermentation (Fig. 7.1, Chapter 6). The position of predicted cre sites 
in the promoter regions upstream of the genes pfl, pta, ackA and adh is consistent 
with repression by CcpA, whereas the position of the predicted cre upstream the 
promoter of the operon containing ldh and the glycolytic gene pfkA, is coherent 
with activation by CcpA (Chapter 6). Furthermore, inactivation of ccpA changed 
the fermentation from homolactic to a mixed-acid profile (Chapter 6). This type of 
regulation by CcpA, promoting homolactic metabolism, is common among the 
Streptococcaceae (Luesink et al., 1998; Gaudu et al., 2003; Asanuma et al., 
2004; Zomer et al., 2007; Abranches et al., 2008; Lopez de Felipe and Gaudu, 
2009). In these fermentative microorganisms lactate dehydrogenase is probably 
the most efficient activity in the anaerobic regeneration of the reducing 
equivalents generated in glycolysis (reviewed in Garvie et al., 1980). Therefore, 
the concerted control exerted by CcpA in the presence of a fast metabolizable 
sugar ensures metabolic efficacy.  
On Gal, CcpA represses the genes coding for the enzymes of the Leloir 
pathway and activates those of the tagatose 6-phosphate pathway (Fig. 7.1) 
(Luesink et al., 1998). Genes encoding the Leloir and tagatose 6-phosphate 
pathways are frequently organized in operon-like structures and are thus prone to 
coordinated regulation. Curiously, in S. pneumoniae the Leloir genes are 
scattered in the chromosome. Nevertheless, galM possesses a cre site 
downstream its promoter region, which position is consistent with repression by 
CcpA; for galKT a clear promoter was not determined but a cre site near the 
starting codon of the galK gene was detected (Chapter 6). In contrast, the 
tagatose 6-phosphate pathway genes are organized in a single transcriptional 
unit, lacABCD. A cre site was not predicted upstream of the promoter region of 
this operon (Chapter 6).  
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 Surprisingly, the Leloir genes, which are under the negative control of 
CcpA irrespectively of the sugar used for growth, appeared strongly upregulated 
on Gal compared to Glc in strain D39 and its ccpA mutant. This finding indicates 
the existence of CcpA-independent Gal-dependent regulatory mechanisms. 
Overexpression of the Leloir and tagatose 6-phosphate genes on Gal as 
compared to Glc was also observed in S. mutans (Abranches et al., 2008).  
The transcriptional regulatory effect of CcpA on the enzymes downstream 
of pyruvate is similar on Gal and Glc, except for a slight derepression of the 
mixed-acid genes and a small alleviation of the ldh activation on the former sugar 
(Fig. 7.1). Unexpectedly, the inactivation of ccpA rendered a more homolactic 
profile on Gal. As for expression of the Leloir genes, CcpA-independent Gal-
dependent control of mixed-acid fermentation genes seems to be in effect in S. 
pneumoniae. Increased expression of mixed-acid genes on Gal as compared to 
Glc is not unprecedented. In S. mutans and L. lactis, pfl expression is strongly 
activated on Gal when compared to Glc (Melchiorsen et al., 2000; Abranches et 
al., 2008). Surprising is the fact that in S. pneumoniae upregulation of the mixed-
acid genes (pfl, pfl-ae, pta) on Gal relative to Glc is lost when ccpA is inactivated 
(Chapter 6). This leads us to propose an indirect contribution of CcpA to the 
mixed-acid profile of D39 on Gal (Fig. 7.1). A likely scenario could involve cross-
talk of CcpA with other regulatory proteins. Of note is the considerable number of 
genes affected by CcpA that are also targets for two-component systems involved 
in sugar metabolism, such as CiaRH, TCS08 and TCS09 (Chapter 6) (McKessar 
and Hakenbeck, 2007; Hendriksen et al., 2007; Halfmann et al., 2007). The 
importance of co-regulation by independent transcriptional regulators to 
coordinate gene expression has been highlighted in recent studies (Kietzman and 
Caparon, 2010; Shelburne et al., 2010). 
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Independently of Glc or Gal, in S. pneumoniae CcpA promotes homolactic 
fermentation as denoted by the strong activation of ldh (Fig. 7.1). An interesting 
feature on Glc is the substantial repression of gki exerted by CcpA. The gene 
encodes glucokinase, which catalyzes the conversion of Glc into G6P, a step 
essential for Glc dissimilation via non-PTS routes. On Gal, CcpA activates the 
PTS-dependent route (tagatose 6-phosphate pathway), while repressing the 
Leloir pathway. In view of the results, sugar uptake via PTSs seems to be highly 
favored by CcpA. PTS uptake systems are more efficient in energetic terms than 
other classes of transporters and provide a typical PTS-mediated signal 
transduction pathway for CcpA regulation (reviewed in Deutscher et al., 2006). 
CcpA regulation in S. pneumoniae thus seems to comply with the essence of 
catabolite control, which is to coordinate metabolic operation ensuring a maximal 
profit for growth. 
Besides its role in determining the type of fermentation exhibited by S. 
pneumoniae, CcpA influences the expression of genes involved in a multitude of 
cellular functions. Up to 19% of the ORFs in the genome of strain D39 were 
affected by CcpA, thus confirming CcpA as a global regulator of gene expression 
in the pneumococcus. The pleiotropic effect of this regulator has also been shown 
for other pathogenic streptococci, namely S. mutans and S. pyogenes (Abranches 
et al., 2008; Shelburne et al., 2008b). In Gram-positive bacteria the repressing 
function of CcpA is mainly mediated by Glc, which is normally the preferred sugar 
(reviewed in Deutscher et al., 2006; Görke and Stülke, 2008). Our work shows 
that in S. pneumoniae Gal, a less preferred sugar, elicits CcpA-dependent 
regulation to an extent similar to that of Glc (Chapter 6). In B. subtilis, the extent 
of CcpA-dependent catabolite repression exerted by different sugars was found to 
correlate with the amount of HPr(Ser46)~P in the cell and thus presumably depends 
on the size of the glycolytic metabolite pools (Singh et al., 2008). The glycolytic 
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intermediates FBP and G6P induce HPrK activity and consequently 
phosphorylation of HPr at Ser46, as well as the formation of the complex CcpA/ 
HPr(Ser46)~P. In agreement with this hypothesis is the identical accumulation of 
FBP and G6P during mid-exponential growth of S. pneumoniae on Gal and Glc 
(Chapter 6). In the closely related S. mutans, the CcpA regulon on Gal was about 
2 times smaller than that on Glc (Abranches et al., 2008; Zeng and Burne, 2010). 
Interestingly, in S. mutans the levels of FBP and G6P on Gal were 2.5 to 4.5-fold 
lower than those on Glc (Abbe et al., 1982). In view of ours and other results, a 
positive correlation between upper glycolytic intermediates and the extent of 
catabolite repression in the Streptococcaceae is also likely.  
 Direct regulation of gene expression via CcpA is performed through 
binding of the protein to cis-cre operator sequences. The position of the cre site in 
the promoter region of the regulated gene dictates the regulation signal. Thus, it is 
expected that the response signal of genes prone to direct regulation by CcpA is 
the same irrespectively of the sugar source, but the magnitude might vary in a 
sugar-dependent manner. In S. pneumoniae, a good example of this notion is 
offered by the CcpA-mediated responses of the mixed-acid genes (pfl, pfl-ae, pta, 
ackA) and ldh during growth on Glc or Gal (Fig. 7.1). 
In summary, CcpA is a master regulator of gene expression in S. 
pneumoniae. Moreover, the global regulator was found to have a prominent role 
in shaping fermentative metabolism in this human pathogen. 
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Metabolic responses of S. pneumoniae to oxygen  
S. pneumoniae is a non-respiring, fermentative organism that tolerates 
oxygen. The bacterium thrives in micro-environments highly exposed to oxygen, 
such as the outer layer of mucosal secretions lining the surface of epithelial 
respiratory tract cells. The deeper the pneumococcus penetrates into the mucus 
layers, the less exposed to oxygen it becomes. In blood, S. pneumoniae 
encounters a “quasi” oxygen depleted environment, since oxygen is mostly bound 
to haemoglobin (LeMessurier et al., 2006). Hence, the human host provides a 
range of environments that vary for oxygen availability. Consequently, 
understanding how oxygen impacts on the physiology of S. pneumoniae is 
essential to comprehend how the pathogen interacts with its host.   
In S. pneumoniae, the sensitivity to oxygen seems to be strain-dependent 
(Auzat et al., 1999; Yu et al., 2001; Chapuy-Regaud et al., 2001; Taniai et al., 
2008). Strain 0100993 (serotype 3) displayed a 2.3-fold decrease in biomass yield 
and a small increment in growth rate under aerobic conditions relatively to 
anaerobiosis  (Yu et al., 2001), whereas the growth parameters of strain CP1015, 
a non-encapsulated derivative of strain D39, remained unaffected by the 
presence of oxygen (Auzat et al., 1999; Chapuy-Regaud et al., 2001). In Chapter 
2, we describe biomass reductions of about 3 and 16 times for strains D39 and 
R6, respectively, when oxygen was provided continuously (40% partial air 
tension) during growth, as compared to semi-aerobic (50-60% initial air tension) 
or anaerobic conditions (argon atmosphere). Moreover, oxygen stimulated the 
growth rate of both strains (Chapter 2). In general, oxygen seems to have a 
detrimental effect on the biomass yield of pneumococcal strains. The ability of 
catalase-negative Streptococcaceae to survive in aerobic environments depends 
on the presence of flavin-type NADH oxidases (e.g. NOX), NADH peroxidases 
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and enzymes capable of detoxifying the cell from molecular oxygen (e.g. 
superoxide dismutases) (Higuchi et al., 1993; Poyart et al., 1995; Gibson et al., 
2000; Neves et al., 2002b). S. pneumoniae is seemingly equipped with 
superoxide dismutase(s) and NADH oxidase(s), but NADH peroxidases have so 
far not been identified (Poyart et al., 1998; Yesilkaya et al., 2000). Multiple copies 
of nox genes are not uncommon in the Streptococcaceae (Higuchi et al., 1999; 
Neves et al., 2002b; Wegmann et al., 2007; Aikawa et al., 2012), but S. 
pneumoniae possesses a single enzyme, which reduces O2 to water at the 
expense of NADH (Auzat et al., 1999).   
Besides the role in detoxification of O2, in dairy Streptococcaceae, NADH 
oxidase has a preponderant role in the re-direction of carbon fluxes during the 
aerobic metabolism of Glc (Neves et al., 2002a). In L. lactis NADH oxidase, the 
expression of which is induced by oxygen, alleviates the need for regeneration of 
NADH at the level of lactate dehydrogenase, allowing a shift from lactate to 
acetate production (Neves et al., 2002a). In S. pneumoniae, lactate is the major 
end-product of Glc metabolism under anoxic or hypoxic conditions (Fig. 7.2) 
(Chapter 2). On the other hand, when oxygen is abundant, a switch from lactate 
to acetate and H2O2 occurs (Fig. 7.2; Chapter 2). The high production of H2O2 
combined with the fact that in S. pneumoniae the nox gene is apparently not 
induced by oxygen (Auzat et al., 1999) minimize the role of the H2O-producing 
NADH oxidase in flux re-rerouting. In this pathogen, pyruvate oxidase (SpxB) 
efficiently competes with NADH oxidase for oxygen, and is the main activity 
responsible for acetate and H2O2 production under aerobic Glc metabolism. 
Besides NADH oxidase and pyruvate oxidase, a third oxidase, lactate oxidase, 
might compete for oxygen in the pneumococcus (Taniai et al., 2008). In the dairy 
Streptococcaceae the activities of lactate oxidase and pyruvate oxidase are only 
detectable under Glc deprivation (Seki et al., 2004; Goffin et al., 2006). In S. 
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pneumoniae, lactate oxidase activity is independent of growth phase and Glc 
availability (Taniai et al., 2008). The latter finding was confirmed in Chapter 2 of 
this work, as evident from the intense lactate utilization without Glc exhaustion 
under aerobic conditions. Lactate oxidase has been proposed to play a role in 
energy generation during aerobic growth on Glc (Taniai et al., 2008). However, 
during efficient Glc consumption the conversion of pyruvate to lactate and back to 
pyruvate seems improbable and is not supported by end-product data in Chapter 
2 and (Taniai et al., 2008). In both datasets the concentration of H2O2 is around 1 
mM at the onset of growth arrest, and in our study lactate increases steadily while 
Glc is being utilized. A considerable increment in H2O2 concentration (1 to ~2-5 
mM), which in our study is concomitant with lactate utilization, is only observed 
after growth stopped (Chapter 2) (Taniai et al., 2008). Interestingly, ~1 mM H2O2 
is reported as the minimal inhibitory concentration (MIC) necessary to prevent 
growth of strain D39 (Pericone et al., 2003). It seems likely that growth arrest 
while Glc is still plentiful is a consequence of H2O2 accumulation in the medium. In 
view of the results we propose that lactate oxidase activity has an important role 
in energy generation and maintenance processes when Glc is limiting or its 
utilization impaired due to a stressful condition, such as that presented by H2O2 
induced cell damage. Indeed, the increase in lactate oxidase activity at the onset 
of growth arrest observed by Taniai et al. (2008) is in agreement with our 
hypothesis. Our view is further supported by the lack of H2O2 accumulation in a 
D39spxB- mutant strain while Glc was available in the growth medium, strongly 
suggesting that lactate oxidase was not active. In accordance, Taniai et al. (2008) 
show that H2O2 production in their spxB mutant is more accentuated after Glc 
consumption. Considering the data, a plausible possibility is Glc-mediated 
repression of the lactate oxidase gene. In L. plantarum, poxB, the lactate oxidase 
encoding gene, is directly repressed by CcpA in a Glc-dependent manner 
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(Lorquet et al., 2004). In Chapter 6 we show that lcto, codifying the pneumococcal 
lactate oxidase, is under the negative control of CcpA in the presence of Glc. This 
regulation is most likely direct, as a cre site was identified downstream the 
promoter region of lcto. Interestingly, in the closely related L. lactis the production 
of lactate as major end-product of aerobic Glc metabolism was ensured by CcpA-
mediated repression of pta and ack genes (mixed-acid) (Lopez de Felipe and 
Gaudu, 2009). In Chapter 6 we demonstrated that the mixed-acid genes are 
under the influence of CcpA, hence a role of CcpA in the regulation of aerobic 
metabolism in S. pneumoniae should not be disregarded. 
Under aerobic conditions, PFL activity is not expected due to oxygen-
induced PFL inactivation (Yamada et al., 1985; Melchiorsen et al., 2000; 
Takahashi-Abbe et al., 2003; Buis and Broderick, 2005). In agreement, in the 
presence of abundant oxygen formate is not produced from the metabolism of Glc 
by S. pneumoniae (Chapter 2). Under low oxygen tensions (semi-aerobic 
conditions) minor amounts of formate were detected in the growth medium, 
suggesting that the pneumococcal PFL is more resistant to oxygen than that of E. 
coli (Knappe et al., 1993). Similar observations have been reported for other 
Streptococcaceae, such as L. lactis (Arnau et al., 1997). 
The behavior of S. pneumoniae in aerobiosis most likely represents a 
competitive advantage in the nasopharynx, where oxygen approximates 
atmospheric levels. Indeed, in this aerobic environment S. pneumoniae co-
inhabits with other microorganisms, and possibly inhibits the growth of 
competitors by producing H2O2 (Pericone et al., 2000). The homolactic behavior in 
semi-aerobic or anaerobic conditions suits the lifestyle of the pneumococcus in 
the deeper layers of the mucus and blood. In such niches, few major competitors 
are present, and the bacterium’s prime goal is to use the nutrients for fast growth.  
 




Fig. 7.2. Schematic representation of end-products resulting from glucose 
metabolism under anaerobic, semi-aerobic and aerobic conditions in S. 
pneumoniae D39 and R6. Pyruvate is the substrate of three competing enzymes: lactate 
dehydrogenase, pyruvate formate-lyase and pyruvate oxidase. Homolactic fermentation 
reduces pyruvate into lactate, through lactate dehydrogenase (LDH), whereas mixed-acid 
fermentation leads to formate, acetate and ethanol. Oxygen might be consumed at the 
level of lactate oxidase (LOX), pyruvate oxidase (SpxB) or H2O-NADH oxidase (NOX). 
The levels of end-products (in µmol mg dw
-1
) can be appreciated from the bar sizes: (), 
lactate; (), formate; (), acetate; (), ethanol. Abbreviations: Ac-P, acetyl-phosphate; 
Ac-CoA, acetyl-coenzyme A; G6P, glucose 6-phosphate. In strain R6 grown under semi-



































































































Pyruvate oxidase is a key enzyme in the sugar metabolism 
of S. pneumoniae  
The pneumococcal pyruvate oxidase (SpxB) catalyses the conversion of 
pyruvate, O2 and inorganic phosphate (Pi) into acetyl-phosphate, CO2 and H2O2 
and requires FAD, thiamin diphosphate and Mg
2+ as cofactors (Spellerberg et al., 
1996). Homologues of this enzyme are present in other Streptococcaceae 
species (e.g. S. sanguinis and S. gordonii) and other Lactobacillales (e.g. L. 
plantarum) (Spellerberg et al., 1996; Goffin et al., 2006; Chen et al., 2011; Zheng 
et al., 2011c). The crystal structure and the mechanism of catalysis of the L. 
plantarum SpxB have been elucidated, (Tittmann et al., 2005), and the data were 
used to propose a structural model of the pneumococcal SpxB (Ramos-Montañez 
et al., 2008). The products of pyruvate oxidase activity, acetyl-phosphate and 
H2O2, play relevant physiological roles. Acetyl-phosphate is a high energy 
compound that serves as phosphoryl donor for the production of acetate and ATP 
via acetate kinase (Pericone et al., 2003). Production of hydrogen peroxide can 
present a competitive advantage within microbial comunities. A number of 
streptococci, including S. pneumoniae, are able to produce H2O2 in 
concentrations that are inhibitory to other co-inhabitants (Pericone, 2000; Regev-
Yochay et al., 2006; Chen et al., 2011). Besides this inhibitory effect, H2O2 
produced by S. pneumoniae also has cytotoxic effects on human cells (Braun et 
al., 2002). H2O2 does not only damage surrounding cells but also the 
pneumococcus itself. It can influence the composition of the cell membrane 
through modulation of fatty-acid biosynthesis protein F (FabF) activity and might 
cause oxidative stress and genetic instability in the pneumococcus (Pericone et 
al., 2000; Pericone et al., 2003; Pesakhov et al., 2007; Benisty et al., 2010). 
Finally, the amount of H2O2 produced presumably correlates with increased 
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mutation frequency in the opaque to transparent phenotypic variation in S. 
pneumoniae (Ramos-Montañez et al., 2008).  
SpxB is assumed to have a relevant role in central metabolism 
(Spellerberg et al., 1996; Ramos-Montañez et al., 2008; Taniai et al., 2008). In 
Chapters 2 and 4 we show that at least for sugar metabolism this is the case. 
First, we describe the pivotal role of pyruvate oxidase in the shift from lactate to 
acetate and H2O2 production during the aerobic metabolism of Glc in S. 
pneumoniae (Chapter 2). Second, we show that spxB inactivation in strain D39 
affects growth rate, end-product profiles (H2O2 and pyruvate accumulation), levels 
of intracellular metabolites (particularly FBP, G6P and acetyl-phosphate) and 
capsule amount during semi-aerobic Glc metabolism (Chapter 4). Third, we 
describe an alteration in the sugar utilization capabilities of strain D39 as a 
consequence of spxB inactivation (Chapter 4).  
SpxB affects negatively the utilization of N-acetylglucosamine and sugars 
potentially present in bacterial capsules or host glycans (rhamnose, glucuronic 
acid and gluconic acid) (Chapter 4). The utilization of host glycans as nutritional 
sources for pneumococcal growth is supported by recent studies (Burnaugh et al., 
2008; Yesilkaya et al., 2008; Marion et al., 2012). Interestingly, pathways 
implicated in the transport and utilization of these sugars were strongly repressed 
in strain D39 relative to the spxB mutant when grown on Glc (Chapter 4). These 
results led us to hypothesize that in specific microenvironments where oxygen 
and Glc are available, e.g. lungs during infection (Philips et al., 2003), SpxB 
produces a signal involved in repression of the catabolic pathways of alternative 
sugars, allowing for rapid proliferation of the pneumococcus through the utilization 
of the preferred substrate. We speculate that regulatory proteins could be 
involved in this mechanism, but such a connection has yet to be found.   
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At this stage our findings prompt further investigations as to the 
mechanisms that link SpxB with repression of sugar catabolic genes and capsule 
synthesis. In particular, the identification of the molecular signals and any specific 
regulators involved are of great interest.  
 
Impact of sugar metabolism on virulence 
The adaptation of S. pneumoniae to certain environmental cues results in 
expression of virulence factors. Accumulating evidence reveals that inactivation of 
proteins involved in central metabolic processes leads to attenuation of virulence. 
Among others, examples include PFL (Chapter 5), SpxB (Ramos-Montañez et al., 
2008) and CcpA (Giammarinaro and Paton, 2002; Iyer et al., 2005). In this thesis 
we show that CcpA affects a large fraction of the genome of S. pneumoniae, 
including genes coding for classical virulence factors and biosynthetic pathways 
of cell surface components (Chapter 6). All together, this could explain the 
avirulent phenotypes of ccpA mutants (Giammarinaro and Paton, 2002; Iyer et al., 
2005). Our data show that capsule synthesis is unaffected by ccpA deletion, 
independently of the sugar (Glc or Gal) used for growth. In agreement, a 
regulation of capsule expression by CcpA was not reported in other studies (Iyer 
et al., 2005; van Opijnen et al., 2009). In contrast, Giammarinaro and Paton 
(2002) proposed that the avirulent behavior of a ccpA mutant most likely was due 
to impaired capsule production. However, in this study capsule amount was not 
quantified (Giammarinaro and Paton, 2002). An explanation for the dissimilar 
results is difficult to put forward, but difference in strain handling and manipulation 
cannot be disregarded. 
Rather than affecting capsule amount per se, CcpA affects the attachment 
of capsule to the cell wall or membrane (Fig. 7.3; Chapter 6). CcpA influences the 
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synthesis of the cell wall component phosphorylcholine via repression of the lic1 
operon involved in synthesis of CDP-Cho and CDP-ribitol, which are the 
precursors of the teichoic acid (Fig. 7.3). In accordance, the levels of CDP-choline 
are lower in D39 than in the ccpA mutant (Fig. 7.3; Chapter 6). Phosphorylcholine 
is the anchor molecule for choline-binding proteins, well known virulence factors 
in S. pneumoniae (reviewed in Bergmann and Hammerschmidt, 2006; Kadioglu et 
al., 2008). Interestingly, genes coding for the choline-binding proteins pspA and 
pcpA were also repressed by CcpA. In this light, CcpA seemingly affects the 
binding of cell wall proteins to the cell wall. The predicted involvement of CcpA in 
modulating the cell surface of S. pneumoniae places the regulator at the core of 
host-pathogen interactions. To substantiate this assumption an in-depth analysis 
of the cell-surface proteome should be performed.   
Phase variation of capsule expression is among the most remarkable 
mechanisms associated with pneumococcal adaptation and virulence of this 
pathogen. In this process, switching between opaque and transparent phenotypes 
is observed in response to environmental cues (Kim et al., 1999; Weiser et al., 
2001). Transparent phenotypes produce less capsule, more cell wall teichoic 
acids, and more choline-binding protein A (CbpA) than opaque variants. 
Moreover, spxB expression is higher in transparent variants (Overweg et al., 
2000; Li-Korotky et al., 2009). Considering their metabolic traits, transparent 
variants are better adapted for colonization, whereas opaque variants perform 
better in infection (Kim and Weiser, 1998; Kim et al., 1999; Nelson et al., 2007). 
Indeed, transparent phenotypes are especially located in close contact with the 
mucosal surfaces of epithelial cells (e.g. in the nasopharynx) or in biofilms, 
whereas opaque phenotypes are predominantly found in blood or watery niches 
(Ogunniyi et al., 2002; Hammerschmidt et al., 2005; McEllistrem et al., 2007, 
Allegrucci and Sauer, 2008).  
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Despite recent studies showing the involvement of the CpsA-D proteins in 
capsule production, the overall molecular mechanism by which this system 
controls capsule synthesis is not completely understood (reviewed in Yother, 
2011; Chapter 1). Moreover, the regulation of capsule transcription remains 
controversial. In S. pneumoniae, polymorphisms in the cps promoter region and 
genetic mobile elements in the region between dexB and cpsA genes (point 
mutations, RUP elements, IS sequences) are proposed to influence the promoter 
strength, the binding of regulatory proteins to the promoter, and to promote 
sequence rearrangements (Moscoso and Garcia, 2009). However, proteins 
involved in the regulation of capsule expression are largely unknown.  
 The higher expression of spxB in transparent as compared to opaque 
variants is well documented (Overweg et al., 2000), however the effect of the 
enzyme on capsule synthesis had not been investigated. Deletion of spxB or a 
reduction in its activity is reported to induce opaque-like or mucoid phenotypes 
(Overweg et al., 2000; Ramos-Montañez et al., 2008; Allegrucci and Sauer, 
2008). In Chapter 4 we show that loss of spxB in strain D39 indeed renders an 
opaque-like phenotype. Importantly, we went on to demonstrate that this 
phenotype is a consequence of increased capsule production (Fig. 7.3; Chapter 
4). Based on the data of Chapter 4, we propose that SpxB is involved in the signal 
transduction cascade adjusting the amount of capsule in S. pneumoniae, and that 
this connection is most likely related to oxygen sensing. In accordance, capsule 
synthesis was shown to respond to changes in oxygen availability (Weiser et al., 
2001). How this signalling mechanism occurs is still to be elucidated. Known is 
the inhibitory effect of H2O2, the product of SpxB activity, on FabF activity, which 
ultimately results in changes in membrane fatty-acid composition (Benisty et al., 
2010). Capsule synthesis is tightly interconnected with peptidoglycan synthesis 
and is partly regulated by membrane proteins (reviewed in Yother, 2011; Chapter 
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1). Hence, it is possible that disturbances in the membrane or cell wall influence 
capsule synthesis. Interestingly, in Chapter 4 the TEM studies indicate subtle 
modifications in the membrane of the spxB mutants.  
Overall, our results highlight a relevant role of a sugar metabolic enzyme 
(SpxB) and a global regulator of gene expression (CcpA) in the expression of 












Fig. 7.3. Schematic representation of the pathways involved in production of 
structural virulence factors (peptidoglycan, PCho cell wall, capsule) and catabolite 
control exerted by CcpA. A comparison between growth on Glc and Gal is depicted. The 
levels of intracellular metabolites can be appreciated from the bar sizes: (), UDP-
GlcNAc; (), UDP-MurNAc-pPep; (), CDP-Cho. The bar size of GlcUA, () is in a 
different scale and should not be compared with the bars of the other metabolites. Green 
arrows indicate activation by CcpA; Red arrows indicate repression by CcpA; Red dashed 
arrows indicate alleviation of repression by CcpA on Gal as compared to Glc; Of all the 
genes affected by CcpA only the lic1 (tarIJlicABC) operon exhibits a possible cre site 
(inside tarj). The intracellular reactions depicted are catalyzed by the following enzymes 
(the genes that code for the enzymes are in parenthesis): phosphoglucose isomerase 
(pgi), α-phosphoglucomutase (pgm), glucose 1-P uridylyltransferase (galU), UDP-Glc 
dehydrogenase (ugd), glucose 1-P thymidylyltransferase CpsL (rmlA), dTDP-glc 4,6-
dehydratase CpsN (rmlB), dTDP-4-keto-6-deoxy-D-glucose 3,5-epimerase CpsM (rmlC), 
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amidotransferase (glmS), UDP-N-acetylglucosamine pyrophosphorylase (glmU), UDP-N-
acetylglucosamine 1-carboxyvinyltransferase (murA), UDP-N-acetylenolpyruvoyl-
glucosamine reductase (murB), UDP-N-acetylmuramate-L-alanine ligase (murC), UDP-N-
acetylmuramoyl-L-alanyl-D-glutamate synthetase (murD), UDP-N-acetylmuramoylalanyl-
D-glutamate-2,6-diaminopimelate ligase (murE), UDP-N-acetylmuramoylalanyl-D-
glutamyl-2, 6-diaminopimelate--D-alanyl-D-alanyl ligase (murF), alcohol dehydrogenase, 
zinc-containing (tarJ), 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (tarI), 
protein LicB (licB), choline kinase or LicA (pck), CTP:phosphocholine cytidylyltransferase 
(licC), phosphotransferase LicD1 (licD1), phosphotransferase LicD2 (licD2). 
Abbreviations: G6P, glucose 6-phosphate; α-G1P, α-glucose 1-phosphate; F6P, fructose 
6-phosphate; UDP-GlcNAc, UDP-N-acetylglucosamine; UDP-MurNAc-pPep, UDP-N-
acetylmuramoyl-pentapeptide; Ru 5-P, ribulose 5-phosphate; R 5-P, ribitol 5-phosphate; 
Cho, choline; CDP-Cho, CDP-choline; Cho-P, choline phosphate; PCho, 
phosphorylcholine; TA, teichoic acid; GlcUA, glucuronic acid.  
 
 
Link between uracil and capsule, the major virulence factor 
of S. pneumoniae 
In Chapter 3 we described the isolation of an irreversible D39 
spontaneous mutant (D39SM), similar to a transparent variant. The 
underproducing capsule phenotype (transparent) resulted from a mutation in the 
promoter region of the cps locus (Chapter 3). The underproducing capsule 
phenotype provided a growth advantage to this strain, i.e. was beneficial, in 
conditions deprived of uracil (Chapter 3). The genomic mutation rate that 
generates beneficial mutations in S. pneumoniae during single-colony serial 
transfer is in the order of 4.8 x 10-4 per genome per generation, a value similar to 
that previously found for E. coli (Perfeito et al., 2007; Stevens and Sebert, 2011). 
These studies support the idea that the number of genes mutating during bacterial 
adaptation is higher than previously imagined, which has negative implications in 
the emergence of antibiotic-resistant strains (Perfeito et al., 2007; Stevens and 
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Sebert, 2011). In the case of S. pneumoniae, the spread of beneficial mutations 
may be exacerbated by the fact that this organism is naturally competent 
(Stevens and Sebert, 2011). We hypothesize that the mutations acquired by our 
D39SM strain most likely resulted from adaptation to deprivation of a nutrient 
required for capsule production, e.g. uracil, and thus is beneficial in conditions in 
which that nutrient is missing (Chapter 3).  
In Chapter 3 we show that the pyrimidine nucleobase uracil plays a 
determinant role in the physiology of the pneumococcus. Uracil is involved in 
central carbon metabolism as the high energy molecule used to activate the sugar 
precursors for the biosynthesis of structural polysaccharides in lactic acid bacteria 
(reviewed in Kilstrup et al., 2005). In S. pneumoniae, UDP-sugars are the building 
blocks for capsule synthesis (Bentley et al., 2006). Altered synthesis of 
polysaccharides in response to variation in pyrimidine concentrations are 
documented in the literature. In E. coli, synthesis of the cellulose 
exopolysaccharide changes in response to variation in pyrimidine availability 
(Garavaglia et al., 2012). Interestingly, inactivation of genes belonging to the de 
novo synthesis of UMP impairs cellulose production, which can be triggered by 
addition of exogenous uracil (Garavaglia et al., 2012). In Vibrio cholerae, 
pyrimidines play an important role in the control of exopolysaccharide production 
and biofilm formation, via the regulator CytR, which represses nucleosides uptake 
and catabolism when these are scarce (Haugo and Watnick, 2002; Garavaglia et 
al., 2012). In Pseudomonas fluorescens, a spontaneous mutation in a gene of the 
de novo synthesis of pyrimidines, carB, affects the proportion of capsulated to 
non-encapsulated subpopulations, by a molecular mechanism yet to be 
discovered (Beaumont et al., 2009; Garavaglia et al., 2012). In a S. thermophilus 
galactose-fermenting mutant strain, displaying increased activities of the Leloir 
genes, exopolysaccharide production was enhanced by overexpressing galU, that 
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codes for the enzyme that converts α-G1P to UDP-Glc at the expense of UTP 
(Levander et al., 2002). Deletions in galU lead to a substantial decrease in 
capsule amounts, growth defects and attenuation of virulence in S. pneumoniae 
(Mollerach et al., 1998; Hardy et al., 2000; Hardy et al., 2001). In view of these 
results, it is conceivable that capsule production in S. pneumoniae is affected by 
uracil availability. Our studies show that capsule expression and production is 
slightly but consistently higher in uracil-containing as compared to uracil-deprived 
medium (Chapter 3). Moreover, uracil shows no effect on strains that have no 
capsule or that exhibit low capsule levels, such as R6 or D39SM (Chapters 2 and 
3). Therefore, the idea that in the human host uracil may be involved in the 
signalling cascade controlling capsule production is not unreasonable.   
A connection between uracil metabolism, the pathways for pyrimidine 
synthesis and the production of capsule was unveiled in this thesis. Deciphering 
the molecular mechanisms associated to these processes is a goal for future 
investigations. In particular, addressing questions such as “is uracil a signal for 
capsule production?”, “how does S. pneumoniae take advantage of uracil sources 
in the host?”, and “what are the mechanisms integrating capsule production and 
pyrimidine metabolism?” is of great interest.   
  
In summary, the work described in this thesis represents a significant 
contribution to the understanding of central metabolism, and in particular sugar 
metabolism and provides clues regarding the relation of these pathways to 
virulence in S. pneumoniae. The scarcity of data on metabolic pathways and their 
regulation in S. pneumoniae has so far hampered a comprehensive 
understanding of the connections between these processes. In the long run, we 
expect that the insights gained form this work will be critical to unveil 
interdependences between carbohydrate metabolism and pneumococcal 
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pathogenesis required to advance our knowledge into new possible ways to 
combat this deadly pathogen. 
The data generated here is already being used to generate descriptive 
and predictive models of S. pneumoniae metabolism. We expect that such 
mathematical representations will contribute to deepen our understanding of how 
a functional state arises from the components, and ultimately will facilitate the 
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